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INTERVENCIONES NUTRICIONALES EN MODELOS DE ENVEJECIMIENTO 
PREMATURO Y CRONOLÓGICO 
 
En el envejecimiento tiene lugar un deterioro funcional progresivo de todos los sistemas 
fisiológicos del organismo, especialmente de los reguladores, el sistema nervioso, el endocrino y el 
inmunitario, lo que conlleva la pérdida de homeostasis y el consecuente aumento de morbilidad y 
mortalidad. Según la teoría de la oxidación-inflamación del envejecimiento, el deterioro al 
envejecer en los sistemas homeostáticos es consecuencia del estrés oxidativo e inflamatorio crónico 
del organismo, y en el que el sistema inmunitario está muy implicado. De esta forma, se propone 
que este sistema que tiene que producir oxidantes e inflamación para llevar a cabo sus funciones, 
puede, si no está bien regulado, condicionar la velocidad de envejecimiento de cada individuo, 
siendo un marcador del estado de salud y predictor de longevidad. 
El envejecimiento es un proceso fisiológico que puede ser acelerado o retardado por factores 
ambientales. Dada la gran longevidad del ser humano se requieren animales de experimentación, 
como los ratones, con una esperanza de vida corta, en los que sea posible estudiar las consecuencias 
de un envejecimiento acelerado y de las intervenciones que puedan conseguir una mayor 
longevidad saludable. Nuestro grupo de investigación ha caracterizado modelos animales de 
envejecimiento prematuro o acelerado. Uno de dichos modelos es la obesidad, en el que se ha 
sugerido la presencia de una inmunosenescencia prematura.   
Por otro lado, la leptina, una hormona pleiotrópica que, aunque relacionada típicamente con 
la obesidad, tiene una gran variedad de funciones fisiológicas en el organismo, experimenta en 
roedores una elevación de sus niveles en los días 4 a 14 postnatales. Estudios previos han apuntado 
que esta elevación neonatal de la leptina tendría una función neurotrópica sobre el hipotálamo en 
desarrollo. Sin embargo, poco se sabe acerca del papel que ese aumento de leptina podría tener en el 
sistema inmunitario, en su capacidad funcional y su estado redox/inflamatorio.  
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Entre los factores de estilo de vida que pueden retrasar el deterioro de los sistemas 
reguladores ocasionado tanto por un envejecimiento prematuro, como puede ser la obesidad, o por 
el propio envejecimiento cronológico, se encuentra la nutrición. Los ácidos grasos 
monoinsaturados, los poliinsaturados derivados de la serie n-3, tales como el ácido 
eicosapentaenoico (EPA) y ácido docosahexaenoico (DHA), y los probióticos son eficaces en 
modular funciones del sistema inmunitario y, además poseen acciones antioxidantes. 
Por todo ello, los objetivos planteados en la presente tesis han sido los siguientes:  
1er objetivo: Estudiar, en ratones, los efectos de la obesidad inducida por dieta en el 
comportamiento, la función inmunitaria y el estado redox/inflamatorio en diferentes edades, así 
como su relación con la longevidad. 
2º objetivo: Estudiar los efectos del bloqueo de la leptina neonatal en la función inmunitaria 
y el estado redox/inflamatorio en ratas machos y hembras en diferentes edades. 
 3er objetivo: Estudiar en ratones adultos, obesos por dieta, los efectos de la suplementación 
nutricional con ácido hidroxioléico (2-OHOA) y con EPA y DHA en la función inmunitaria y el 
estrés oxidativo, así como en la longevidad.  
4º objetivo: Estudiar, en ratones viejos, los efectos de la suplementación nutricional, durante 
diferentes períodos, con una leche fermentada que contiene probióticos, en el comportamiento, la 
función inmunitaria y el estrés oxidativo, así como en la longevidad.    
Los resultados del 1er objetivo permiten concluir que la ingestión de dieta rica en grasa en 
la adolescencia de ratones hembras supone llegar a la edad adulta con una obesidad que se asocia 
con una inmunosenescencia prematura y un estrés oxidativo-inflamatorio. Este deterioro es 
agravado durante el envejecimiento, aunque ya sólo ingieran dieta estándar, llegando a la vejez con 
un estado inmunitario y redox peor que los cronológicamente viejos que nunca fueron obesos. 
Cuando la obesidad es inducida ya en la edad adulta aparece un deterioro del comportamiento, de la 
función inmunitaria y del estado redox en ratones machos y hembras de edad adulta tardía. Se 
observan diferencias por el sexo en algunos de los parámetros comportamentales, inmunitarios y de 
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estado redox, siendo los machos más afectados que las hembras. La inmunosenescencia acelerada 
que presentan estos animales es agravada en la vejez. Estos resultados confirman el envejecimiento 
prematuro y acelerado que aparece como consecuencia de la obesidad inducida por dieta en la 
adolescencia y en la edad adulta, respectivamente, causando un mayor deterioro la primera.  
En cuanto al 2º objetivo, los resultados indican que las ratas machos y hembras tratadas con 
un antagonista de la leptina entre los días 5-9 postnatales, presentan un deterioro de la función 
inmunitaria en el bazo y del estado redox/inflamatorio en el bazo, hipotálamo y tejido adiposo 
durante la adolescencia. El deterioro en la función inmunitaria y en el estado redox del bazo fue 
también observado en la edad adulta por ratas machos y hembras sometidas al mismo tratamiento 
postnatal. Estos resultados corroboran el papel de la leptina neonatal en el establecimiento y 
mantenimiento de la función inmunitaria y del estado redox/inflamatorio en ratas machos y 
hembras.  
En lo referente al 3er objetivo, los resultados muestran que en los ratones hembras adultas 
que son obesas por ingerir una deta rica en grasa durante la adolescencia, y que además del 
deterioro de la función y estado redox en leucocitos, ya observado en el objetivo primero, tienen un 
deterioro redox en el cerebro, hígado, pulmones y riñones, la ingestión de 2-OHOA y la 
combinación de (EPA y DHA), durante el final de la adolescencia, permite revertir tales deterioros. 
Así, esta suplementación puede ser una buena intervención nutricional para restaurar la función 
inmunitaria y el estado redox en ratones obesos, y consecuentemente promover una longevidad 
saludable.  
En el 4º objetivo, los resultados indican que, en ratonas viejas, la suplementación nutricional 
con una leche fermentada con probióticos durante 1, 2 y 4 semanas revierte el deterioro 
comportamental, de función inmunitaria y de estrés oxidativo típicos de su edad. Esa 
suplementación tiene además una acción directa en el funcionamiento de las células inmunitarias.  
Por lo tanto, estos resultados indican que la ingestión de probióticos puede ser una buena 
intervención nutricional para promover una longevidad saludable.  
19
	   	  
	   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
ABSTRACT 
	   	  
	   
NUTRITIONAL INTERVENTIONS IN MODELS OF PREMATURE AND 
CHRONOLOGICAL AGING 
 
Aging is characterized by a progressive deterioration of all physiological systems of the 
organism, especially those of the regulatory systems namely the nervous, endocrine and immune 
systems, leading to loss of homeostasis, and consequently increased morbidity and mortality. 
According to the oxidation-inflammation theory of aging, the age-related deterioration of the 
regulatory systems is the result of the chronic oxidative and inflammatory stresses. This theory also 
proposes that the immune system, due to its capacity of producing oxidant and inflammatory 
compounds in order to carry out its defensive role, if not well regulated, could be involved in the 
rate of aging. Thus, the immune system has been suggested as a marker of health status and 
predictor of longevity.  
Aging is a physiological process that can be accelerated or delayed by environmental 
factors. Experimental animals such as rodents, which have a shorter longevity than humans, have 
been used to study the consequences of an accelerated aging, as well as interventions aimed to 
achieve a healthy aging. Our research group has been characterizing murine models of premature 
and accelerated aging. Along with these models, obesity has been proposed as a possible model of 
premature immunosenescence.  
Leptin, a pleiotropic hormone, which has been classically related to obesity, has shown a 
great variety of physiological functions in the organism. This hormone experiences an elevation of 
its levels in postnatal days (PND) 4 to 14 in rodents. Previous studies suggest that this neonatal 
increase of leptin levels would have a neurotropic function in the developing of hypothalamus. 
However, little is known about the specific physiological role of this increase of neonatal leptin 
regarding the immune system, such as immune function and redox/inflammatory state.  
Among lifestyle factors, nutrition has been proposed as very relevant to delay the 
deterioration of the regulatory systems caused by obesity, a possible model of premature aging, and 
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by chronological aging. Monounsaturated fatty acids, polyunsaturated fatty acids derived from n-3 
series (eicosapentaenoic acid and docosahexaenoic acid) and probiotics are effective in modulating 
immune system functions and also have antioxidant and anti-inflammatory properties.  
Taking all of this into account, the following objectives of the present thesis are:  
1st objective: To study the effects of diet-induced obesity onset on behaviour, immune 
function and redox/inflammatory state at different ages, as well as on the life span of mice.  
2nd objective: To study the effects of the blockage of the neonatal leptin surge (PND5-9) on 
immune function and redox/inflammatory state of male and female rats at different ages.  
 3rd objective: To study the effects of the dietary supplementations with 2-OHOA or with 
the combination of n-3 fatty acids (EPA and DHA) on immune function and redox state of adult 
female diet-induced obese mice, as well as on their life span. 
4th objective: To study the effects of the dietary supplementation with fermented milk 
containing probiotics for different periods of time on behaviour, immune function and redox state of 
old mice, as well as on their life span. 
The results obtained from the 1st objective allow the conclusion that the high-fat intake 
during adolescence produces a state of obesity, which is associated with premature 
immunosenescence and oxidative-inflammatory stresses in adult female mice. Old female diet-
induced (DIO) mice, although ingesting a standard diet during their aging process, show higher 
deterioration of immune function and oxidative stress in comparison with non-DIO mice of the 
same chronological age. In addition, the late adulthood diet-induced obesity onset results in 
impaired behaviour, immune function and redox state of middle-aged male and female mice. Sex 
differences are found in some of the parameters of behaviour, immune function and redox state, 
males being more affected than females. These female animals show accelerated 
immunosenescence, which are partially aggravated with aging. These results confirm the state of 
premature and accelerated aging, as a consequence of the early and late adulthood diet-induced 
obesity onsets, respectively.  
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With regards to the 2nd objective, the results indicate that male and female rats treated with 
the leptin antagonist from PND 5 to PND 9 show impaired immune function and 
redox/inflammatory state in the spleen, hypothalamus and adipose tissue during adolescence. In 
addition, at adulthood, the impairment of immune function and redox state is also observed in male 
and female rats treated with the same leptin antagonist. These results corroborate the important role 
of the neonatal leptin in the establishment and maintenance of a proper immune function and 
redox/inflammatory state in male and female rats.  
Regarding the 3nd objective, the results indicate that adult female DIO mice, as a 
consequence of being fed a high-fat diet during their adolescence, show impaired immune function 
and redox state in leukocytes, as previously observed in the first objective. Additionally, these 
animals exhibit altered redox state in the brain, liver, lungs and kidneys. Nevertheless, the dietary 
supplementations with monounsaturated (2-OHOA) or with the combination of n-3 polyunsaturated 
fatty acids (EPA and DHA) revert these impairments in adult female DIO mice. The results indicate 
that these supplementations could be a good nutritional intervention to restore an appropriate 
immune function and redox state in DIO mice, and consequently promote a healthy aging.  
The results obtained in the 4th objective indicate that the dietary supplementation with 
fermented milk containing probiotics for 1, 2 and 4 weeks reverts the impaired behaviour, immune 
function and redox state in old female mice. The improvement of the immune cell functions seems 
to be due to the direct action of probiotics. Therefore, these results indicate that the ingestion of 
probiotics could be a good nutritional intervention to promote a healthy aging.  
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1. INTRODUCTION 
	   	  
	   
1.1. PROCESS OF AGING 
 
1.1.1. Aging of the population 
The global aging of the population is increasing at an unprecedented rate. The world 
population aged 65 years or older is projected to double from about 506 million in 2008 to 1.3 
billion by 2040, accounting for 14% of the total population in the world. Although developed 
countries have relatively high proportions of older people and the longest life expectancies, the 
most rapidly increase has been experienced by developing countries (Cauley, 2012). The aging of 
the population is being driven mainly by declines in fertility and increases in longevity. In addition, 
the transition of the dominant causes of death and illness from infectious diseases to non-
communicable chronic diseases has positively impacted the life expectancy. Although this transition 
reflects substantial improvements in overall health, new challenges are arising. There is an 
increasing number of elderly people suffering from chronic diseases, including cancer, 
cardiovascular diseases, type 2 diabetes, obesity, and Alzheimer´s disease. These chronic diseases 
are associated with disability, poor health status and loss of autonomy living (Foreman et al., 2018). 
Therefore, according to World Health Organization´s (WHO) report on aging and health, the 
adoption of lifestyle strategies, such as physical activity and good nutrition, is a mandatory 
achievement in order to prevent or delay many of these chronic diseases, and consequently to reach 
advanced ages in healthy conditions (WHO, 2015).  
 
1.1.2. Definition of aging 
Aging is associated with a progressive accumulation of unrepaired molecular and cellular 
damage (Kirkwood, 2005). The accumulation of this damage over time leads to a gradual 
deterioration of physiological functions and to a lower ability to adaptively react to changes and 
maintain homeostasis (or homeodynamics) (De la Fuente, 2018a). The concept of homeodynamics 
refers to the fact that the internal milieu of biological systems is not permanently fixed or static, but 
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rather is dynamically reorganized in response to internal or external challenges (such as stress) in 
order to preserve the functional capacity of the systems (Rattan, 2006). For instance, with aging 
there is a general decreased functional capacity of elderly people to endure extreme temperatures, 
infections or other situations in which stress occurs. If the principal characteristic of a healthy 
organism is to maintain the functional homeostasis (or homeodynamics) at all biological levels of 
organization, with age this fails. Although aging in itself cannot be considered a disease, it strongly 
increases the risk of illness and death (De la Fuente and Miquel, 2009).  
According to Strehler (1977), aging may be defined following four rules (1) it is universal 
(nearly all species of animals including the metazoans with sexual reproduction suffer from aging), 
(2) progressive (the rate of aging is similar after adult age throughout the rest of life) (3) intrinsic 
(the causes of aging are initiated endogenously), and (4) deleterious (aging is harmful to the 
individuals since it results in their death). 
 
1.1.3. Mean and maximum longevity  
The terms life span and longevity, which are used interchangeably, refer to the period of 
time between birth and death of an individual. The mean and maximum longevity values provide 
useful measures to study the process of aging. The mean longevity can be defined as the mean age 
at death of the population who born on the same data (Pletcher et al., 2000). The mean longevity is 
mostly determined by environmental agents, including lifestyle factors (around 75%) and to a lesser 
proportion by genetic factors (around 25%) (Barja, 2013; De la Fuente and Miquel, 2009). In 
contrast, the maximum longevity, which is the age reached by the longest-lived member of a 
species, is stable and cannot be extended (Balcombe, 2001). For instance, in humans, the maximum 
longevity should be limited to around 125 years (the oldest person who ever lived was Jeanne 
Calment from France who reached 122 years old and died in 1997) and, in laboratory mouse strains, 
to around 3 years old (de Beer et al., 2017; De la Fuente, 2008; Marck et al., 2017).  
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1.1.4. Biological age 
The process of aging is very heterogeneous across the human population. The 
interindividual variability of aging arises from variations in the exposure to environmental stressors 
as well as the innate ability of the body to cope with these stressors (Levine, 2013). Although the 
prevalence of functional impairments, illness and mortality rises with age, many people reach old 
age maintaining good health, active lifestyles and autonomy living (Lowsky et al., 2014). 
Therefore, chronological age appears to fail in providing an accurate indicator of the rate of aging 
(Finkel et al., 1995; Karasik et al., 2005). The concept of biological age has emerged as a relevant 
method to quantify the functional capacity and health status of an individual in comparison with 
others of the same chronological age (Kim and Jazwinski, 2015). The assessment of biological age 
may help to recognize individuals at high risk for age-related disorders and mortality independent of 
chronological age (Levine, 2013). However, the exploration and validation of markers that quantify 
biological age remain largely unexplored in gerontology. Some studies have been carried out to 
identify markers for biological aging with the assessment of physiological (based on blood pressure, 
respiration function etc.), biochemical (albumin, cholesterol etc.), genetic (telomere length) or 
epigenetic (DNA methylation) parameters. These studies suggest that individuals showing certain 
parameters with values similar to older individuals live shorter, thus being “biologically older” than 
those found in the majority of the individuals of the same chronological age (Bae et al., 2008; 
Belsky et al., 2015; Jylhävä et al., 2017; Nakamura et al., 2007). Increasing evidence suggests that 
the immune system is a good indicator of health status and longevity (De la Fuente and Miquel, 
2009; Wayne et al., 1990). Moreover, the immune system seems to reflect the degradation of 
biological systems due to age-related changes (De la Fuente and Miquel, 2009). Recently, several 
immune function parameters were validated as markers of biological age and predictors of 
longevity (Martínez de Toda et al., 2016). This study from our research group indicates that there is 
an age-related decline in the immune function parameters analysed in both human blood neutrophils 
and lymphocytes, as well as in peritoneal macrophages and lymphocytes from mice, with the lowest 
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values in elderly humans (65-79 years of age) and old mice (72 weeks of age). In addition, these 
immune function parameters were preserved in long-lived individuals (both human centenarians 
and extremely long-lived mice) (Martínez de Toda et al., 2016). 
 
1.1.5. Theories of aging 
Biological, epidemiologic, and demographic data have generated a large number of theories 
in an attempt to explain the process of aging and its inevitable consequence, death (Weinert and 
Timiras, 2003). Given that aging is extremely complex and multifactorial, more than 300 theories 
have been proposed to explain this process (Medvedev, 1990). Most of these theories describe only 
some features of the aging process. Thus, these theories should be rather considered complementary 
than mutually exclusive (Weinert and Timiras, 2003). To better understanding, these theories were 
classified into three major groups: (1) genetic theories, (2) epigenetic theories, and (3) evolutionary 
theories.  
 
 1.1.5.1. Genetic theories 
The genetic theories support that aging is the result of programmed changes driven by gene 
expression following the reproductive maturation (Weinert and Timiras, 2003). In this group are 
included both the Hayflick´s theory and the shortening telomeres theory. The Hayflick´s theory is 
basically based on the idea that the somatic cells with replicative potential possess a “mitotic clock” 
that fixes their maximum life span (Hayflick, 1965), whereas the shortening telomeres theory is 
based on the progressive loss of telomeres (the caps of noncoding DNA that protect the ends of 
chromosomes) with each cell division, resulting in cellular senescence and aging (Harley et al., 
1990). Both theories can be considered to explain an effect of aging, such as replicative cellular 
senescence, but not its cause. Moreover, these theories can only be applied to cells capable of 
division, thus not considering post-mitotic cells (non-proliferating cells), such as most of neurons 
(Goyns, 2002).  
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In addition, currently, there is no evidence that specific aging genes, which have been 
denominated gerontogenes, could have a role in causing aging. However, some authors suggest that 
gerontogenes when overexpressed or mutated could have an influence on survival, longevity and 
rate of aging (Moskalev et al., 2014; Rattan, 2006). For instance, mutations in certain genes for 
growth and development of yeasts, nematodes, flies, and mice showed to prolong their life span 
(Moskalev et al., 2014). In addition, along with this line, “the gene cluster hypothesis of aging” 
proposes that the maximum longevity would be under the control of gene clusters (Barja, 2008).  
 
1.1.5.2.  Stochastic theories. The free radical and oxidation theory 
Most of gerontology researchers, even those who previously supported the genetic theories, 
currently believe that the aging process, which occurs after reproductive maturation, is driven by 
events that are not guided by a genetic program but are stochastic or random (Hayflick, 2007). 
Among the epigenetic theories, the free radical theory of aging, proposed by Harman (1956), is 
probably one of the most accepted nowadays to explain how the aging process occurs. According to 
this theory, which was further developed by other researchers (Barja 2002; 2004; Miquel, 1998; 
Miquel et al., 1980; Pamplona and Barja, 2003), aging is the result of the accumulation of oxidative 
damage to macromolecules caused by reactive oxygen species (ROS). These compounds are 
produced mostly in the mitochondria respiratory chain as a result of the necessary use of oxygen 
(Barja 2002; 2004; Miquel, 1998; Miquel et al., 1980; Pamplona and Barja, 2003). 
As a variant of the free radical theory of aging, the mitochondrial theory emphasizes the 
important role played by the mitochondria in the process of aging. Thus, mitochondrial components, 
especially mitochondrial DNA (mtDNA), are the principal targets of ROS-induced cellular damage. 
This oxidative damage of mitochondria impairs its function, leading to bioenergetic decline and 
progressive loss of somatic physiological functions (Barja 2002; 2004; 2013; De la Fuente and 
Miquel, 2009; Miquel, 1998; Miquel et al., 1980; Pamplona and Barja, 2003). This is particularly 
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relevant in post-mitotic cells, such as most of neurons, in which regeneration of the damaged 
mitochondria cannot occur (Barja, 2002; Harman, 1972; Miquel, 1998; Miquel et al., 1980).  
In addition, the inflammaging theory, proposed by Franceschi et al. (2000), characterizes 
aging as a consequence of a chronic and sterile (occurring in the absence of infection and primarily 
driven by endogenous signals) low-grade inflammation. A variety of stimuli sustain inflammaging 
during the process of aging, including pathogens (non-self), endogenous cell debris and misplaced 
molecules (self) and nutrients and gut microbiota (quasi-self) (Franceschi et al., 2000; 2018; 
Franceschi and Campisi, 2014). 
More recently, based on these concepts, the oxidation-inflammation theory of aging has 
been suggested as an attempt to explain the cause of aging. This theory supports that with age 
appears a chronic oxidative and inflammatory stress, since both oxidation and inflammation are two 
closely related processes (Vida et al., 2014), affecting all cells and particularly those of the 
regulatory systems, such as the nervous, endocrine and immune systems. Thus, these systems show 
oxidative damage, and consequently functional losses incompatible with an adequate preservation 
of homeostasis (or homeodynamics), resulting in increased morbidity and mortality (De la Fuente 
and Miquel, 2009). In this theory, the immune system has been suggested to play an important role 
in the process of aging, particularly in the rate of aging, since this system can increase or decrease 
the oxidative-inflammatory stress of the organism (De la Fuente and Miquel, 2009). Thus, aging 
and its related diseases are greatly linked to oxidative and inflammatory stress (Bauer and De la 
Fuente, 2016; De la Fuente and Miquel, 2009). 
 
 1.1.5.3. Evolutionary theories 
The evolutionary theories of aging are an attempt to explain why the aging process occurs. 
These theories support that the process of aging is programmed to limit population size or 
accelerate the turnover of generations, therefore sustaining the adaptation of organisms to changing 
environments (Kirkwood and Austad, 2000). According to Weisman (1891), the aging process is 
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necessary for the disposal of the mortal soma in order to prevent organisms competing with their 
progeny for food and space. Moreover, aging would be a consequence of individuals selected by 
evolution as an advantage for the youth subjects of the species allowing them to reach the 
reproductive age in the best condition and thus preserve these species, but are disadvantage for 
older individuals (Trindade et al., 2013). Thus, selection acts before the adult age and the 
maintenance of the species is more relevant biologically than longevity of the individuals. In 
contrast, the antagonistic pleiotropy theory supports the existence of pleiotropic genes that would 
maximize vigour in early life, but at later ages would have harmful effects (Williams, 1957).  
 
1.1.5.4.  An integrated theory of aging: how, where and why of aging 
Most theories of aging support only partial explanations of the causes and effects of aging. 
Moreover, great part of them does not consider all the different levels of biological organization 
(molecular, cellular, and physiological). Given the complexity of the aging process, a theory based 
on only one mechanism could not provide a satisfactory explanation of all its aspects (De la Fuente 
and Miquel, 2009). Therefore, an integrated theory has been proposed in order to answer key 
questions of the aging process, such as: (1) How aging happen? Aging is caused mainly by 
oxidative and inflammatory stresses in which all levels of biological organization are affected, 
including the whole organism. (2) Where does aging start? Aging starts in the mitochondria from 
fixed differentiated cells. (3) Why does aging happen? This answer could be found in the 
evolutionary theories in which aging follows the purpose to limit population size  (Bauer and De la 
Fuente, 2016; De la Fuente and Miquel, 2009; Harman, 1956; Weisman, 1981).  
 
1.2. OXIDATIVE AND INFLAMMATORY STRESSES 
 
Reactive oxygen and nitrogen species (ROS and RNS, respectively) are generated in the 
organism as a result of the normal cellular metabolism. At moderate amounts, they are essential for 
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many physiological processes, including immune response, cellular signalling, mitogenic response, 
and redox regulation (Valko et al., 2007). However, when the amounts of these oxidants are too 
high and cannot be counteracted by antioxidant defences, oxidative stress is established. Oxidative 
stress is deleterious to biological organisms because it damages lipids, carbohydrates, proteins and 
nucleic acids, resulting in the breakdown of the cellular functions. Similarly, inflammatory response 
is necessary to repair tissues and destroy pathogens, but it has to be limited in space and time. Thus, 
the imbalance between the generation of pro-inflammatory and anti-inflammatory compounds in 
favour of the former, which is defined as inflammatory stress, is related to aging and diseases 
(Bauer and De la Fuente, 2016; De la Fuente, 2018a).  
 
1.2.1. Free radicals and oxidant compounds  
Almost all-living organisms require oxygen for efficient production of energy, by the use of 
electron transport chains that ultimately donate electrons to molecular oxygen (O2). Nearly 95% of 
the reduction of oxygen to water follows the mitochondrial enzyme cytochrome oxidase pathway, 
without the generation of any intermediates (Fridovich, 1978; Halliwell and Gutteridge, 1999). 
However, the remaining 5% of oxygen reduction goes through univalent pathway in which reactive 
oxygen and nitrogen species (ROS and RNS) are produced (Hammond et al., 1985). Examples of 
ROS and RNS, which are a collective term that includes both oxygen and nitric oxide radicals and 
certain non-radicals that are oxidizing agents and/or are easily converted into radicals (Halliwell 
and Gutteridge, 1999), are shown in Table 1.  
The mostly known ROS include superoxide anion radical (O2-), hydrogen peroxide (H2O2) 
and hydroxyl radical (OH). O2- is primarily formed with the acceptance of one electron. This 
oxygen free radical may act as a reducing or an oxidizing agent. Dismutation of O2-, which can 
occurs spontaneously or be catalysed by superoxide dismutase (SOD), produces another reactive 
oxygen species, hydrogen peroxide (H2O2). SOD prevents the accumulation of O2-, which can 
damage and inactive proteins containing iron-sulfur clusters (Schieber and Chandel, 2014). 
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Although H2O2 is not considered a free radical, it can be toxic at high concentrations and it can 
produce free radicals. H2O2 is formed by the two-electron reduction of oxygen or by the dismutation 
of O2-. Catalase (CAT) and glutathione peroxidase (GPx) catalyse reactions that reduce 
intracellular levels of H2O2. Thus, these enzymes, SOD, CAT and GPx, act as antioxidant defences 
against ROS. The accumulation of O2- and H2O2 and the presence of a trace metal can potentially 
result in the production of hydroxyl radical (OH). The OH radical can react at high rates with 
almost every cell component, which can lead to extensive cellular damage (Hammond et al., 1985).  
The reactive nitrogen species (RNS) include nitric-derived compounds, such as nitric oxide 
radical (NO), peroxynitrite radical (ONOO), nitrogen dioxide radical (NO3) and nitrous acid 
non-radical (HNO2). NO acts as a relevant signalling molecule in several physiological processes, 
including the regulation of blood pressure, neurotransmission, and immune response, and when 
combined with O2-, produces ONOO, a potent oxidizing agent that cause DNA and lipid 
peroxidation (De la Fuente, 2018a; Vida et al., 2014) 
 Some of these species are much less “reactive” than others, for instance, O2-, NO and 
H2O2, react directly with few molecules in organism, whereas OH can react with anything 
(Halliwell and Gutteridge, 1999). 
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Table 1. Examples of reactive species. 
Free radicals Non-radicals 
Reactive Oxygen Species 
(ROS) 
Reactive Oxygen Species 
(ROS) 
Superoxide, O2− Hydrogen peroxide, H2O2 
Hydroxyl, OH Hypobromous acid, HOBr 
Hydroperoxyl, HO2 Ozone, O3 
Peroxyl, RO2 Singlet oxygen, 1Δg 
Alkaxyl, RO Hypochlorous acid, HOCl 
  Reactive Nitrogen Species 
(RNS) 
Reactive Nitrogen Species 
(RNS) 
Nitric oxide, NO Nitrous acid, HNO2 
Nitrogen radical, NO3 Nitroxyl anion, NO- 
ROS is a collective term that includes both oxygen radicals and certain non-radicals that are 
oxidizing agents and/or are easily converted into radicals. RNS is also a collective term including 
nitric oxide radicals as well as non-radicals. Cited in Halliwell and Gutteridge, 1999. 
 
	  
1.2.1.1. Sources of oxygen and nitrogen species (ROS and RNS)  
ROS and RNS can be produced from either endogenous or exogenous sources. The 
endogenous species are generated from cellular respiration and other metabolic processes. These 
processes include the participation of organelles, such as mitochondria, endoplasmic reticulum, 
peroxisome, as well as a variety of enzymes (De la Fuente, 2018a; Mittal et al., 2014). In contrast, 
exogenous sources result from pollution, alcohol, tobacco smoke, heavy metals, transition metals, 
industrial solvents, pesticides, certain drugs, and radiation. After penetration into the organism by 
different routes, these exogenous compounds are decomposed and metabolized into ROS and RNS 
(Pham-Huy et al., 2008; Phaniendra et al., 2015). 
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Most of the endogenous ROS, about 95-98%, are formed in the mitochondrial respiratory 
chain (mtROS). The superoxide anion radical (O2-) is mainly produced non-enzymatically in the 
mitochondrial complexes I and III (Finkel and Holbrook, 2000). ROS can also be produced in the 
endoplasmic reticulum by the activity of cytochrome P450 enzymes. These are important for 
removing or detoxifying compounds present in the environment that had been ingested (such as 
medicaments) (Valko et al., 2007). Also, peroxisomes are another source for the generation of ROS, 
such as H2O2. For instance, the β- oxidation of fatty acids is the main metabolic process that 
produces H2O2 in the peroxisomes. This organelle also contains high amounts of catalase, which 
prevents the accumulation of H2O2 (Bhattacharyya et al., 2014; Phaniendra et al., 2015; Valko et 
al., 2007).  
In addition, O2- can be generated enzymatically by the activity of xanthine oxidase, nitric 
oxide synthase (NOS), and nicotine adenine dinucleotide phosphate (NADPH) oxidases (NOXs) 
(Mittal et al., 2014). Xanthine oxidase is involved in the metabolism of purines, catalysing the 
oxidation of hypoxanthine to xanthine and the subsequent oxidation of xanthine to uric acid. In both 
steps, molecular oxygen is reduced, forming O2- followed by the generation of H2O2 (Hancock et 
al., 2001). Also, nitric oxide synthase (NOS) and its three isoforms have been shown to be 
susceptible to the formation of O2-.  
Importantly, the NOX family, which compromise 7 members, acts as a major producer of 
ROS in mammalian cells. These enzymes convert cytoplasmic NADPH into NADP+ by liberating 
two electrons and one proton. The proton remains in the cytoplasm whereas the two electrons are 
transported through the plasma/phagosomal membrane and bind two oxygen molecules resulting in 
the formation of two superoxide anions in the extracellular or intraphagosomal space. The NADPH 
oxidase complex has five subunits, namely p47phox (“phox” stands for phagocyte oxidase), 
p67phox, p40phox, p22phox, and gp91phox (also termed NADPH oxidase 2 (NOX2)). This 
complex acts mainly in phagocytic cells (such as neutrophils and macrophages) leading to increased 
cellular oxygen consumption and subsequently generation of ROS. This phenomenon is commonly 
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referred to as the “respiratory burst” because of the burst of consumption of oxygen that happens in 
phagocytosis. In unstimulated cells, p47phox, p67phox, and p40phox exist in the cytosol, whereas 
p22phox and NOX2 are in the membrane, where they occur as a heterodimeric flavoprotein, 
cytochrome b558. On stimulation, p47phox becomes phosphorylated and the cytosolic subunits 
form a complex that translocates to the membrane, where it associates with cytochrome b558 to 
assemble the active oxidase, which transfers electrons from the substrate to O2, forming O2- 
(Paravicini and Touyz, 2008). After conversion of O2- to H2O2 by SOD, an additional step via 
myeloperoxidase (MPO) and inducible nitric oxide synthase (iNOS) is believed to generate 
hypochlorous acid and NO, respectively. These final radicals are considered the mains ROS 
responsible for bactericidal activity in the phagocytes (De la Fuente, 2018a; Dan Dunn et al., 2015). 
In addition, fibroblasts, endothelial cells, vascular smooth muscle cells, and other cells have been 
also described to have superoxide-producing enzymes analogous to the phagocyte NADPH oxidase 
complex, but in these cells, the low amounts of ROS produced may function as second messengers 
to influence redox-sensitive signal transduction pathways (De la Fuente, 2018a; Rada and Leto, 
2008). 
 
1.2.1.2.  Molecular targets of free radicals 
Deoxyribonucleic acid (DNA) 
Both nuclear and mitochondrial DNAs (nucDNA and mtDNA, respectively) are constantly 
exposed to endogenous and exogenous sources of ROS that induce DNA lesions and DNA 
instability, including blockage of DNA replication and transcription as well as chromosomal 
rearrangements. In order to maintain genomic integrity, different DNA repair pathways have 
evolved in cells (Gredilla, 2011). The mtDNA is more susceptible to ROS damage than the 
nucDNA, because it is located closer to where ROS are generated (in the inner mitochondrial 
membrane) and it is organized as histone-free nucleoids (with less extensive packaging than nuclear 
chromatin) (Bogenhagen, 2012). The accumulation of mtDNA mutations, including point mutation 
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and large deletion, is thought to play an important role in the process of aging (Caro et al., 2010). 
For instance, the rate of production of mtROS and the degree of oxidative damage to mtDNA 
correlate negatively with maximum longevity in mammals (Barja and Herrero, 2000; Valko et al., 
2007). In addition, mtDNA fragments may insert into nucDNA contributing to aging and related 
diseases (Caro et al., 2010), this fact could support the previously mentioned idea of where aging 
starts.   
Ribonucleic acid (RNA) 
ROS can extensively damage RNA produced in the organism. Given that RNA is less 
compartmentalized and less compact than nuclear DNA, RNA is more susceptible to oxidative 
damage than DNA. Moreover, the cytoplasmic localization of RNA is near to the mitochondria 
where ROS are produced (Hofer et al., 2005).  
Lipid 
The membrane lipids, particularly the phospholipids containing polyunsaturated fatty acid 
residues are more susceptible to ROS attack. The lipid peroxidation is elicited when ROS react with 
the hydrogen from a methylene group (CH2) in a fatty acid, generating a lipid peroxyl radical 
(LOO). LOO can further propagate the peroxidation process by reacting with hydrogen atoms 
from other lipid molecules. In addition, the membrane lipid peroxidation results in the formation of 
several reactive aldehydes, such as malondialdehyde (MDA), 4-hydroxynonenal (4-HNE) and 
acrolein. These compounds are toxic end products of lipid peroxidation and cause extensive damage 
to the DNA and proteins (Barrera, 2012; Marnett, 1999; Phaniendra et al., 2015).   
Protein 
ROS can damage different amino acids present in the proteins. This damage may result in 
loss of protein functions and/or enzymatic activity. Among the various oxidative modifications of 
amino acids in proteins, carbonyl formation is an early marker of protein oxidation (Phaniendra et 
al., 2015; Reznick and Packer, 1994). Methionine residues of proteins are among the amino acids 
most susceptible to oxidation by ROS. This oxidation leads to methionine sulfoxide in proteins, 
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resulting in the loss of their biological activity. There is evidence that dietary methionine restriction 
by 80% could be responsible for increasing maximum longevity in mammals through the decrease 
of ROS production (Pamplona and Barja, 2006). 
 
1.2.2. Antioxidant defences 
Antioxidant defences are a mechanism developed by organisms against ROS-induced 
oxidative stress. Antioxidants can be defined as molecules that neutralize free radicals by accepting 
or donating electron(s) to a free radical species (R). During this electron transfer, the radical 
character is transferred to the antioxidant, generating an antioxidant-derived radical. This newly 
formed radical is significantly less reactive, longer-lived and less dangerous than those previous 
radicals (Valko et al., 2007). Superoxide dismutase (SOD), catalase (CAT) and glutathione 
peroxidase (GPx) include the main enzymatic antioxidant defences that provide the first line of 
defence against ROS (including superoxide anion and hydrogen peroxide). In contrast, other 
endogenous and exogenous antioxidants such as glutathione (GSH) system, ascorbic acid (vitamin 
C), α-tocopherol (vitamin E), and polyphenols (especially flavonoids), represent the non-enzymatic 
antioxidants and the second line of defence against ROS. The activity of antioxidants helps to 
preserve an adequate redox balance, which is important for health maintenance and disease 
prevention (De la Fuente et al., 2011; De la Fuente and Miquel, 2009; Valko et al., 2007).  
Superoxide dismutase (SOD) is an endogenous antioxidant enzyme. This enzyme catalyses 
the dismutation of superoxide anion (O2-) to hydrogen peroxide (H2O2) and oxygen (O2), 
consequently resulting in the formation of compounds less hazardous than superoxide anion. Given 
that SOD is a metalloenzyme, it requires a metal cofactor for its activity. The metal ions that may be 
bound to SOD include: (1) Iron (Fe), Fe-SOD, which is generally found in prokaryotes and 
chloroplasts of some plants, (2) Manganese (Mn), Mn-SOD, present in prokaryotes and 
mitochondria of eukaryotes and (3) Copper (Cu) and zinc (Zn), Cu/Zn-SOD, which is found mainly 
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in the cytosol of eukaryotes, but also present in peroxisomes (Fridovich, 1995; Ighodaro and 
Akinloye, 2017).  
Catalase (CAT) is an endogenous antioxidant enzyme generally found in all living tissues, 
being abundant in cells. This enzyme uses either Fe or Mn as a cofactor and catalyses the reduction 
of hydrogen peroxide (H2O2) to water and oxygen, thus accomplishing the detoxification process 
initiated by SOD. CAT is mainly found in the cytoplasm and peroxisomes, but is also located in the 
mitochondria (Bai and Cederbaum, 2001; Chelikani et al., 2004; Ighodaro and Akinloye, 2017).  
Glutathione peroxidase (GPx) is an intracellular antioxidant enzyme, which is involved in 
reducing hydrogen peroxide (H2O2) to water as well as lipid peroxides to alcohols. GPxs are a 
family of enzymes composed by at least four forms of GPx (GPx1- GPx4). GPx-1 is a selenoprotein 
with a selenocysteine at the active site of the enzyme. In addition, GPx-1 is the most abundant form 
of GPx and it is present in almost all cells, being mostly located in the cytosol and mitochondria, 
but also found in the peroxisome of some cells (Handy et al., 2009). 
The non-enzymatic antioxidant tripeptide γ-glutamylcysteine (GSH) is described as the 
major thiol intracellular redox buffer. This cysteine-containing tripeptide exists in its reduced 
(GSH) or oxidized (glutathione disulfide or GSSG) forms. GSH is the predominant form and 
account for > 98% of total glutathione. GSH is highly present in the cytosol, nucleus and 
mitochondria, and it is the major soluble antioxidant in these cell compartments. In addition, GSH 
is synthesized in the cytosol and subsequently it is transported to the mitochondria, in which it has a 
relevant role. GSH in the nucleus maintains the redox state of critical protein sulfhydryls that are 
necessary for DNA repair and expression. Moreover, GSH can directly detoxify free radicals or act 
as a substrate for glutathione peroxidase in the reduction of lipid peroxyl radicals as GSH is 
oxidized to GSSG. GSSG in turn is reduced back to GSH by the action of glutathione reductase 
(GR) utilizing NADPH and forming a redox cycle. GR is a flavoenzyme and has an important role 
in recycling GSH. The accumulation of GSSG as well as the ratio GSSG/GSH is a good marker of 
oxidative stress in the organism (Lu, 2009; Masella et al., 2005; Valko et al., 2007). 
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The main pathways of endogenous ROS formation and elimination by antioxidant defences 
are shown in Figure 1. 
 
Figure 1. Main pathways of endogenous ROS generation and elimination. The superoxide 
anion radical (O2-) is generated by reduction of molecular oxygen mediated non-enzymatically by 
redox-reactive compounds of the mitochondrial electron transport chain or enzymatically by 
NADPH oxidases, xanthine oxidase and nitric oxide synthase. O2- is dismutated spontaneously or 
catalysed by superoxide dismutase (SOD) to produce hydrogen peroxide (H2O2). H2O2 is 
neutralized into water (H2O) and molecular oxygen (O2) by the antioxidant enzymes catalase (CAT) 
and glutathione peroxidase (Gpx). GPx requires reduced glutathione (GSH) as the electron donor. 
Oxidized glutathione (GSSG) is reduced back to GSH by the action of glutathione reductase (GR) 
utilizing NADPH. H2O2 and the presence of a trace metal  (Fe2+) result in the production of 
hydroxyl radical (OH). The OH radical can react at high rates with almost every cell component, 
with resulting lipid peroxidation, DNA damage and protein oxidation. 
 
1.2.3. Inflammatory response  
Inflammation is a beneficial response of the host against foreign challenge (such as 
infection) or tissue injury that has the physiological purpose of restoring tissue integrity and 
homeostasis (Medzhitov, 2010).  
According to Medzhitov (2010), the classic inflammatory response includes four 
components: (1) inflammatory inducers (which initiate the inflammatory response), (2) the sensors 
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that detect them, such as Toll-like receptors (TLRs) and NOD (nucleotide-binding oligomerization-
domain protein)-like receptors (NLRs) expressed on innate immune cells, (3) the inflammatory 
mediators induced by the sensors, and (4) the target tissues that are affected by the inflammatory 
mediators. The TLRs and NLRs induce the production of inflammatory cytokines, such as tumour 
necrosis factor (TNF), interleukin-1 (IL-1), interleukin-6 (IL-6) and chemokines, including 
chemokine (C-C motif) ligand 2 (CCL2) and C-X-X motif chemokine ligand 8 (CXCL8), as well as 
eicosanoids (prostaglandins, such as prostaglandin E2 (PGE2)), vasoactive amines and products of 
proteolytic cascades. These inflammatory mediators induce vasodilation, extravasation of 
neutrophils, and leakage of plasma into the target tissue. Reaching the target tissue, neutrophils 
attempt to kill the invading pathogens through the release of ROS. In addition, the inflammatory 
cytokines TNF, IL-1, and IL-6 can have systemic effects. The acute inflammatory response is 
generally ended by the elimination of the inflammatory inducer followed by resolution and repair 
phase, which is mediated by tissue-resident and recruited macrophages. Termination of the 
inflammatory response is a highly regulated process in which there is a switch in lipid mediators 
from pro-inflammatory prostaglandins to anti-inflammatory lipoxins. These latter inhibit 
inflammation and promote tissue repair.  
Infection and tissue injury are considered drastic conditions, which are characterized by a 
high degree of tissue stress, and these induce a classical inflammatory response. Nevertheless, more 
often tissues are exposed to low levels of stressors (such as the presence of high ROS levels, 
hyperglycaemia or hypercholesterolemia) and as a result these tissues may malfunction. Cells of the 
innate immune system can sense stressed cells or tissues and mount an immune response to restore 
tissue homeostasis. However, the magnitude of this immune response is lower than the classic 
inflammatory response (Medzhitov, 2008; 2010; Xu et al., 2009). Medzhitov (2008) has defined 
this type of inflammation as para-inflammation. Para-inflammation can become chronic when 
stressors and tissue malfunction are present for a sustained period. Aging and several diseases, 
including obesity, have been highly associated with para-inflammation (also known as low-grade 
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inflammation) (Medzhitov, 2008). The close relationship between nutrient excess and chronic para-
inflammation (or low-grade inflammation) has emerged the concept of “meta-inflammation” 
(Lumeng and Saltiel, 2011), meaning metabolically-triggered inflammation (Hotamisligil, 2006).  
In the state of meta-inflammation, M1-skewed (classically-activated macrophages) accumulate in 
parallel to adiposity, promoting inflammation and insulin resistance in the obese, whereas, in the 
lean, M2 (alternatively-activated macrophages) dominate insulin-sensitive adipose tissue (Shapiro 
et al., 2011). 
In addition, the concept of “sterile inflammation”, meaning the same as “para-
inflammation”, has also been used to describe the increased chronic levels of pro-inflammatory 
mediators during aging. Thus, even in the absence of infections, innate mechanisms seem to be 
activated, leading to a sterile inflammatory response, which if not appropriately resolved could 
produce chronic inflammation (Bauer and De la Fuente, 2016; Martínez de Toda et al., 2017).  
 
1.3. IMMUNOSENESCENCE 
 
A functional immune system is considered crucial for the continued survival of the organism 
against internal or external threats. In humans, as well as in other species, such as experimental 
rodents, it is well accepted that there are changes in the immune system with the aging process, a 
phenomenon known as immunosenescence, which leads to increased susceptibility to infectious 
diseases, cancer, and neurodegenerative diseases (Aw et al., 2007; De la Fuente, 2008; 2018b). 
Immunosenescence represents a dynamic process with continuous remodelling and adaptation of 
the immune system components. Both innate and adaptive immune system exhibit age-related 
changes, which are associated with increased production of pro-inflammatory cytokines and ROS as 
well as lower ability to respond to new antigens. These changes are not uniform, thus some 
functions are enhanced (such as the pro-inflammatory activity of immune cells), whereas others are 
decreased or unchanged (De la Fuente and Miquel, 2009). These are further commented below. 
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1.3.1. Age-related changes in the haematopoietic system 
Haematopoietic stem cells (HSCs) are defined by their ability to self-renewal as well as to 
differentiate into lymphoid and myeloid lineage cells. HSCs are localized in the bone marrow 
cavity, including the endosteal and vascular niches (Tamma and Ribatti, 2017). Common lymphoid 
progenitors (CLPs) can differentiate into T and B cells, whereas common myeloid progenitors 
(CMPs) can differentiate into megakaryocytes, erythrocytes, monocytes and granulocytes 
(neutrophils, eosinophils and basophils) (Kondo et al., 2003). Approximately two-thirds of the 
haematopoiesis activity is committed to myelopoiesis. Lymphoid and myeloid progenitors, 
generated by haematopoietic stem cells in the bone marrow, migrate to specialized lymphoid 
tissues, such as thymus (another primary lymphoid organ, in which T cells carry out their 
development), and several secondary lymphoid organs (spleen and lymph nodes as the most highly 
organized, and mucosal-associated lymphoid tissue (MALT) as less-organized lymphoid tissue, 
where they further mature, differentiate and acquire self/non-self discrimination (Gruver et al., 
2007). With age, the haematopoietic system loses its self-renewal and regenerative potential (de 
Haan and Lazare, 2018; Konieczny and Arranz, 2018). Moreover, there is a decline in the bone 
marrow cellularity, which seems to be replaced by fat adipose tissue (Compston, 2002). In addition, 
HSCs are skewed towards myeloid differentiation at the expense of lymphopoiesis with aging 
(Shaw et al., 2013; Konieczny and Arranz, 2018). The underlying mechanism is unclear, but 
probably include both aging-associated cell-intrinsic and micro-environmental changes (Shaw et al., 
2013). In addition, dysregulation of cytokine and hormone networks associated with advanced age 
could affect bone marrow haematopoietic system (Compston, 2002).   
 
1.3.2. Age-related changes in the innate immune system 
Innate immunity, defined as the first line of defence against pathogens, parasites and tissue 
damages, has also an important role in the activation and regulation of adaptive immunity. This type 
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of immune defence is non-specific and acts effectively without previous exposure to pathogens. A 
diverse range of cell types and mechanisms mediate innate immunity, including 
monocytes/macrophages, natural killer (NK) and natural killer T (NKT) cells, dendritic cells (DC), 
granulocytes (such as neutrophils, eosinophils and basophils), as well as inflammatory mediators 
(such as cytokines and acute phase proteins) (Shaw et al., 2013). In addition, the complement 
system also supports innate immunity by a robust and rapid response against invading pathogens, 
consisting of a tightly regulated network of proteins. Complement activation results in the 
opsonisation of pathogens and their removal by phagocytes, as well as cell lysis. However, it should 
be noted that complement system also plays an important role in the adaptive immunity involving T 
and B cells, helping them to eliminate pathogens and to maintain immunologic memory, which 
prevents pathogenic reinvasion (Carroll, 2004; Sarma and Ward, 2011). Age-related alterations are 
observed in most of innate immune cell types. These are further commented below. 
Age-related changes in phagocyte cell number 
Polymorphonuclear leukocytes (PMNs), also denominated neutrophils, are the first cells to 
migrate to pathogen-infected tissues, thus providing the primary defence against infection. In 
humans, around 60-70% of blood leukocytes are granulocytes, and of these over 90% are 
neutrophils (Schröder and Rink, 2003). These cells are extensively generated in the bone marrow, 
where their production reaches up to 2 X 1011 neutrophils per day in a normal adult human. During 
infection, however, the production of neutrophils significantly increases mainly by the action of 
GM-CSF (granulocyte-macrophage colony-stimulating factor) (Borregaard, 2010). Also, Th17 
cells-derived cytokines, such as interleukin-17 (IL-17), CXC-chemokine ligand 8 (CXCL8, also 
known as IL-8), interferon-γ  (IFN-γ), and tumour necrosis factor (TNF), favour recruitment, 
activation and prolonged survival of neutrophils at inflammatory sites (Mantovani et al., 2011; 
Pelletier et al., 2010). Neutrophils are considered short-lived cells under in vitro culture conditions 
and thus have an estimated half-life of only 8-12h. However, in vivo and inflammatory-induced 
conditions are known to extend their survival (Mantovani et al., 2011). With age, the total number 
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of neutrophils seems to either remain stable or decrease. Thus, studies using the SENIEUR protocol 
(which includes healthy elderly people without comorbid conditions) showed no alteration or a mild 
decrease in the numbers of neutrophils (Borregaard, 2010; Chatta et al., 1994). 
Monocytes represent about 5-10% of peripheral blood leukocytes in humans and mice. 
These cells, based on the differential surface expression of CD14 and Fc receptor CD16 are 
categorized into distinct subsets, namely classical (CD14++16-) and non-classical (CD14+16++). In 
addition, monocytes are precursors of tissue-resident macrophages and dendritic cells (DCs). 
Migration of monocytes into tissues and differentiation into macrophages or DCs is determined 
mostly by the inflammatory milieu (Wynn et al., 2013). Macrophages are resident in all tissues of 
the body and exhibit great anatomical functional diversity. These cells have roles in development, 
homeostasis, tissue repair and immunity (Wynn et al., 2013). As mentioned above, based on their 
polarization status, macrophages can be broadly categorized into classically activated or M1 
macrophages or alternatively activated or M2 macrophages. Basically, M1 macrophages up-regulate 
pro-inflammatory mediators, whereas M2 macrophages up-regulate anti-inflammatory mediators. 
With age, the frequency or absolute number of monocytes generally remains unchanged, although 
an age-associated increase of non-classical CD14+CD16++ pro-inflammatory monocytes has been 
reported (Herrero et al., 2002; Ratts and Weng, 2012; Shaw et al., 2013). In addition, there are age-
related changes in the balance of visceral adipose tissue macrophages toward the pro-inflammatory 
M1 phenotype in mice (Lumeng et al., 2011). In contrast, other studies showed a significant 
decrease in the number of peritoneal macrophages (CD11b+) with aging (Arranz et al., 2010a; 
Puerto et al., 2005).  
Dendritic cells (DCs) represent an important link between innate and adaptive immune 
responses. The plasmacytoid and the myeloid DC are antigen presenting cells, which recognize 
foreign antigens, take up and process them, and present the antigenic peptides in major 
histocompatibility complex (MHC) molecules of their surface to initiate its recognition by T cells 
(Steinman and Banchereau, 2007). With age, the ability of DC to prime and activate naïve CD8+ T 
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cells is significantly decreased, resulting in a negative impact on immune response of aged people 
(Della Bella et al., 2007; Zacca et al., 2015). In addition, the number of dendritic cells is unaltered 
(Jing et al., 2009) or declined with age (Della Bella et al., 2007).  
Eosinophils, mainly involved in parasitic helminth infections and allergic diseases, can be 
longer lived and more biosynthetically active than usually appreciated. These cells depend on 
granule release for their secretory effector functions (Gordon, 2016; Rothenberg and Hogan, 2006). 
Eosinophil numbers have been reported unaltered with aging (Annema et al., 1995; Lieschke et al., 
1989).  
Age-related changes in phagocytic function 
Neutrophils, monocytes, macrophages, dendritic cells, osteoclasts and eosinophils are 
denominated professional phagocytes (Uribe-Querol and Rosales, 2017). These cells have the 
function of eliminating pathogens through a process known as phagocytosis.  
This process, which is shown in Figure 2, can be divided in several sequential stages: 
rolling, adherence, transmigration, chemotaxis, phagocytosis and killing of the foreign agent. In the 
process of phagocytosis, activated phagocytes enter post-capillary venules - adjacent to sites of 
bacterial infection or tissue trauma - and develop transient adhesive interaction with endothelial 
cells via specific classes of adhesion molecules that include integrins and selectins (Gerhardt and 
Ley, 2015; Zimmerman et al., 1992). The rolling is governed by a weak molecular interaction 
between the phagocytes (which express L-selectin) and endothelial cell (which express E-selectin). 
This interaction allows phagocytes to roll along the surface of the post-capillary venules. In contrast 
to rolling, which is a dynamic low-affinity adhesive interaction, adherence is a stationary high-
affinity (strong) adhesive interaction between phagocytes and endothelial cells. This interaction is 
mediated by integrins and their ligands. Following adherence, phagocytes employ proteases to 
break down the endothelial monolayer and basement membrane to enter the extravascular 
inflammatory (exudate) site. This process is named transmigration, extravasation or diapedesis. 
Phagocytes also require a chemoattractant gradient in order to complete the process of migration 
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(Seely et al., 2003). Chemoattractants are soluble molecules formed by bacterial products, such as 
N-formyl-nethionyl-leucyl-phenylalanine or formylated peptide (fMLP) and chemokines (Cicchetti 
et al., 2002), which confer directionally on cell movement. Thus, phagocytes migrate in the 
direction of increasing concentration of a chemoattractant in a process named chemotaxis (Hammer 
and Apte, 1992; Seely et al., 2003). Finally, phagocytes engulf the foreign agent, resulting in the 
formation of a phagosome containing the antigen, which is ingested in the cytoplasm. Once the 
phagosome has been engulfed, lysosomes fuse with the phagosome, killing any live organism. 
Phagocytes - in particular, neutrophils and macrophages – are able to produce many degradative 
enzymes, antimicrobial peptides, and ROS for antimicrobial activity (Seely et al., 2003). As 
previously commented, the production of ROS in activated phagocyte cells (also known as the 
“respiratory burst”) generates superoxide anion by the phagocytic NADPH oxidase (NOX-2). The 
oxidase is essential for microbial killing, since individuals lacking a functional oxidase suffer from 
enhanced susceptibility to microbial infections (De la Fuente, 2018a; Rada and Leto, 2008).  
Contradictory data have been reported regarding the adherence capacity of peritoneal 
macrophages with aging. Thus, studies indicate both increased (De la Fuente et al., 2000; 2001) and 
unaltered adherence capacity with aging (Ortega et al., 2000a; 2000b). With respect to neutrophil 
adherence, however, most of studies indicate increased adherence capacity in non-stimulated and 
stimulated conditions (such as in response to formylated peptide (fMLP)) of aged individuals 
(Alonso-Fernández et al., 2008; Arranz et al., 2008; De la Fuente et al., 2008).  
Following adherence, phagocyte cells migrate towards the inflammation site through a 
process of chemical attraction known as chemotaxis. In general, it is well accepted that there is 
decreased chemotactic capacity of phagocyte cells with advanced age. Thus, with age macrophages 
from different tissues (spleen, thymus, axillary lymph nodes and peritoneum) of rodents as well as 
of humans (blood neutrophils) showed decreased chemotactic capacity in response to 
chemoattractants, such as formylated peptides (fMLP), GM-CSF or zimosan (Alonso-Fernández et 
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al., 2008; Arranz et al., 2008; 2010a, De la Fuente et al., 2002; 2004a; 2004b; Di Lorenzo et al., 
1999; Fulop et al., 2004; Niwa et al., 1989). 
Once phagocyte cells reach the site of inflammation in the tissue, they phagocyte the foreign 
agent. With age, monocytes/macrophages from diverse tissues (spleen, thymus, axillary lymph 
nodes and peritoneum) of rodents as well as from blood neutrophils of humans showed decreased 
phagocytic capacity (Alonso-Fernández et al., 2008; Arranz et al., 2008; 2010a; Butcher et al., 
2001; De la Fuente, 1985; De la Fuente et al., 2002; 2004a; Martínez de Toda et al., 2016; Sharma 
et al., 2014a; Simell et al., 2011).  
The last stage of the phagocytic process consists in the destruction of the foreign agent. This 
process is carried out mainly by the production of ROS in the phagocyte cell, which has the ability 
of killing pathogens. With age, there is decreased generation of superoxide anion in response to 
stimulated conditions in peritoneal macrophages from old mice (De la Fuente et al., 2000; 2001) 
and in blood neutrophils from elderly humans (Simell et al., 2011; Walrand et al., 2006). These 
findings suggest a lower bactericidal capacity of phagocytic cells in elderly individuals in 
comparison with adult individuals. By contrast, other studies reported an increased generation of 
ROS in peritoneal macrophages (from old mice) and in blood neutrophils (from elderly humans) 
(Butcher et al., 2001; Ortega et al., 2000a; 2000b), whereas others showed this function unaltered 
with aging (Krause et al., 1999; Niwa et al., 1989). 
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Figure 2. The process of phagocytosis by phagocytic cells. This process was divided into the 
sequential stages of rolling, adherence, transmigration, chemotaxis, phagocytosis and destruction of 
the foreign agent. ICAM-1, intercellular adhesion molecule 1. 
 
Age-related changes in NK cell number and function 
Natural killer (NK) cells are defined as effector lymphocytes of the innate immune system 
that participate in the early control of tumour and virus-infected cells. These cells originate from 
common lymphoid progenitors and mature in lymphoid tissues (spleen, bone marrow, tonsil) before 
entering the blood circulation, and their major difference with lymphocytes is the absence of CD3, 
BCR (B-cell receptor), or TCR (T-cell receptor) expression (Camous et al., 2012). NK cells can 
mediate spontaneous cytotoxicity against abnormal cells and quickly secrete a variety of cytokines 
and chemokines to promote activation of adaptive immune response (Campbell and Hasegawa, 
2013). NK cells are distributed throughout lymphoid and non-lymphoid tissues and compromise a 
minor fraction of total lymphocytes (from 2% in mouse spleen to 10% in mouse lung and from 2% 
to 18% in human peripheral blood) (Grégoire et al., 2007). NK cells can be classified based on their 
CD56 surface expression. CD56bright cells are the immature subset, which show a high proliferative 
activity and the ability to release IFN-γ, TNF-α and IL-10. In contrast, CD56dim cells are the mature 
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subset, exhibiting an increased cytotoxicity activity and a decreased production of cytokines 
(Ponnappan and Ponnappan, 2011). 
Age-related alterations are observed in the number and function of NK cells. Thus, several 
studies indicate increased percentage of NK cells in the peripheral blood from elderly people. In 
addition, there is a decrease of CD56bright subset and an increase of CD56dim subset (Solana et al., 
1999; 2012; Solana and Mariani, 2000). However, elderly people with severe medical disorders 
showed decreased circulating NK cells number, as well as decreased cytotoxicity activity 
(Bruunsgaard et al., 2001). In the peritoneum of old mice, the number of NK cells was also 
significantly lower in comparison with adult mice (Puerto et al., 2005). In constrat, the number of 
NKT cells, a subset of T cells, was increased with aging (Solana and Mariani, 2000). 
NK cells from diverse tissues (spleen, thymus, axillary lymph nodes and peritoneum) of 
aged mice (De la Fuente et al., 2002; 2004a; Ferrández et al., 1999; Puerto et al., 2005), as well as 
from peripheral blood of elderly humans (Arranz et al., 2008; 2010a; De la Fuente et al., 2008; Di 
Lorenzo et al., 1999; Mocchegiani and Malavolta, 2004), showed decreased cytotoxic activity. In 
addition, with advanced age, activated NK cells exhibited decreased production of cytokines and 
chemokines (Mocchegiani and Malavolta, 2004; Solana and Mariani, 2000). IL-2-induced NK 
proliferation was also decreased in aged individuals (Takahashi et al., 2003), while induction of 
cytotoxicity by IL-2, IL-12, or IFN-γ was maintained (Gayoso et al., 2011). This impaired function 
of NK cells in aged individuals (both rodents and humans) has been directly linked to morbidity and 
mortality (Aw et al., 2007; Bruunsgaard et al., 2003; Ogata et al., 2001).  
 
1.3.3. Age-related changes in the adaptive immune system 
The adaptive immune system, which is more recent, in evolutionary terms, than the innate 
immune system, is formed with diverse antigen-recognizing lymphocyte populations (naïve 
lymphocytes) and very long-lived antigen-experienced lymphocytes (memory lymphocytes). The 
former represent a specific response to any potential challenges from the universe of foreign 
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antigens, whereas the latter embody a rapid and robust response to subsequent encounters of a 
previously experienced antigen (Weng, 2006). With age, the cells responsible for maintaining 
immune memory overcome the cells capable of taking action (Costantini et al., 2018).  
Age-related changes in T and B lymphocyte numbers  
With age, although a reduction of naïve T cells output has been described, the overall 
number of T cells in the peripheral pool remains relatively stable (Bauer and De la Fuente, 2016; 
Hannet et al., 1992; Hulstaert et al., 1994). This could be explained possibly due to the increase of 
memory T cells, in both CD4+ and CD8+ subsets, as a result of the cumulative effects of past and 
persistent infections (Fagnoni et al., 2000; Pawelec et al., 2005). In addition, age-related changes 
are more marked in CD8+ than CD4+ T cells. CD4+ T cells seem to maintain their number and 
diversity to a much older age than CD8+ T cells. Thus, CD8+ populations dysregulate earlier, with 
an increase in their number, which results in a decreased CD4+/CD8+ ratio (Bauer and De la Fuente, 
2016; Boyd et al., 2013).  
Age-related changes in B lymphocyte numbers are much less clear but appear to have some 
similarities to those changes in T lymphocytes. Thus, there is a decreased output of naïve B cells 
from bone marrow to periphery, which is associated with the concomitant increased number of 
long-lived memory B cells (Ongrádi and Kövesdi, 2010). 
Age-related changes in T and B lymphocyte function  
The most noticeable change of the aging immune system is the involution of thymus, which 
starts after puberty and stabilizes around 65 years old. This fact is believed to contribute 
significantly to immunosenescence. The thymus, called primary lymphoid organ, has an important 
role in the development of T lymphocytes. Thus, the expression of distinct subsets, including CD4+, 
CD8+ and NKT, occurs during T cell maturation in the thymus. These cells migrate from thymus to 
secondary lymphoid organs, such as the spleen and lymph nodes, where they react with foreign 
antigens (Kurd and Robey, 2016). The age-related thymic involution is characterized by reduction 
of tissue mass and thymic cellularity, loss of tissue structure and altered architecture, resulting in 
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the decline output of naïve T cells (Aw and Palmer, 2011). The causes of this decline seem to be 
associated with age-related changes in haematopoietic progenitor cells, growth factors and/or 
hormones, and the surrounding microenvironment of thymus (Weng, 2006). In addition, the age-
related changes of T lymphocytes include the loss of expression of co-stimulatory molecules CD28, 
CD27, CD40L and the gain of the expression of CD28+ cells (Costantini et al., 2018). Recent 
evidence suggests that increased frequency of CD28+CD57+ T cells were also associated with 
prediabetes and obesity (Lee et al., 2019; Yi et al., 2019). 
With regards to the developmental process of B lymphocytes, it starts from naïve cells in the 
bone marrow (Simon et al., 2015). The humoral immune response of elderly individuals is 
characterized by decreased antibody responses (Ongrádi and Kövesdi, 2010). Antibody specificity 
is affected by aging, resulting in increased susceptibility to infectious diseases and decreased 
protective effects of vaccination (Schwab et al., 1989). The degree of impairment seems to be 
greater when T lymphocyte involvement is required to drive the antibody response (Castle, 2000). 
Loss of antibody diversity with age has been associated with decreased percentage and number of 
mature B lymphocytes. Moreover, both aged mice and humans have been associated with an 
increase of autoantibodies, which could predispose to the development of autoimmune diseases 
(Zhao et al., 1995).  
The ability of T and B lymphocytes to adhere and migrate towards the site of inflammation, 
following a chemoattractant gradient, is essential for immune surveillance and recognition of 
antigens. These cells have the ability to recognize antigens and proliferate in response to an antigen 
challenge (Figure 3).    
Regarding the adherence capacity of lymphocytes with age, contradictory data have been 
reported. Thus, studies demonstrated both increased (De la Fuente and Victor, 2000; Hirokawa, 
1999; McArthur, 1998) and decreased adherence capacity of lymphocytes with age (Stohlawetz et 
al., 1996).  
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In addition, there is a decreased chemotactic capacity of lymphocytes in diverse tissues and 
peripheral blood from aged mice and humans, respectively, in response to various stimuli, such as 
formylated peptide (fMLP), sphingosine 1-phosphate (S1P), and chemokine (C-C motif) ligand 21 
(CCL21) (Arranz et al., 2008; De la Fuente et al., 2008; Huang et al., 2011; Martínez de Toda et 
al., 2016).     
Lymphocytes are activated by antigen-specific receptors on their cell surface, which result in 
their proliferation and differentiation into effector cells. Thus, activated T lymphocytes can 
differentiate into cytotoxic T lymphocytes, whereas activated B lymphocytes can become antibody-
producing cells. With age, T and B lymphocyte proliferation tend to decline, both in vitro (in 
mitogen-stimulated cultures) and in vivo conditions (in delayed-type hypersensitivity responses). 
Thus, the proliferation of lymphocytes in aged mice and humans has been described significantly 
decreased when exposed to mitogens specific for T lymphocytes, such as concanavalin A (ConA) 
and phytohaemagglutinin (PHA), and to mitogens specific for B lymphocytes, 
monocytes/macrophages and neutrophils, such as lipopolysaccharide (LPS) (Arranz et al., 2008; 
2010a; De la Fuente et al., 2004a; 2008; Gillis et al., 1981; Inkeles et al., 1977; Martínez de Toda et 
al., 2016; 2017; Medina et al., 2000; Pawelec et al., 2002; Simioni et al., 2007; Song et al., 1993). 
In addition, the lymphoproliferative response to mitogens has been negatively correlated with 
mortality (De la Rosa et al., 2006; Wikby et al., 2005).  
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Figure 3. Lymphocyte functions. Some functions carried out by lymphocytes, including rolling, 
adherence, transmigration (diapedesis) and chemotaxis to the focus of infection as well as 
proliferation of lymphocytes in response to antigens (or mitogens, which are used in assay of 
laboratory). 
 
1.3.4. Age-related changes in the cytokine levels 
Cytokines, defined as small signalling proteins, mediate and regulate many biological 
functions, including innate and adaptive immune responses, haematopoiesis, inflammation and 
tissue repair. Cytokines may act on the cells that secrete them (autocrine action), on nearby cells 
(paracrine action), or in some instances on distant cells (endocrine or systemic action) (Zhang and 
An, 2007). However, with age, there is an impairment of the cytokine network in innate and 
adaptive immune responses (Gon et al., 1996; Krabbe et al., 2001; Lio et al., 1988; McNerlan et al., 
2002). This impairment results in increased production of pro-inflammatory cytokines and of acute 
phase proteins (Fagiolo et al., 1993; Krabbe et al., 2001; Luciani et al., 2001) (a process known as 
inflammaging) (Franceschi et al., 2000). Although the production of pro-inflammatory cytokines is 
essential for effective immune response, such as destruction of pathogens and tumour cells, an over-
production of these compounds by immune cells may lead to deleterious effects on tissues. Indeed, 
inflammaging is a significant risk for increased morbidity and mortality in the elderly people. 
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Moreover, many age-related diseases share an inflammatory pathogenesis (Franceschi and Campisi, 
2014). The age-related changes in the cytokine network are further commented below. 
IL-1 family 
IL-1α and IL-1β are pro-inflammatory cytokines, members of the IL-1 family, and have 
similar biological properties (Garlanda et al., 2013). The IL-1α precursor is constitutively present in 
epithelial layers of the gastrointestinal tract, lungs, liver, kidneys, endothelial cells, and astrocytes. 
Upon cell death by necrosis, the IL-1α precursor is released, and functions as an “alarmin” by 
rapidly initiating a cascade of inflammatory cytokines and chemokines, which accounts for sterile 
inflammation. Thus, IL-1α mediates the early phases of sterile inflammation (Garlanda et al., 2013; 
Rider et al., 2011). In contrast, IL-1β is produced by haematopoietic cells, such as blood 
monocytes, tissue macrophages, skin dendritic cells, and brain microglia in response to toll-like 
receptors (TLRs), activated complement components, other cytokines (such as TNF-α), and IL-1 
itself (Dinarello, 2009). The IL-1β precursor is activated by NLRP3 (nucleotide binding and 
oligomerization domain-like receptor family pyrin domain containing 3)/Capspase-1 inflammasome 
(Garlanda et al., 2013). Both IL-1α and IL-1β bind and activate the IL-1R that is downregulated by 
the receptor antagonist IL-1Rα, which blocks IL-1-mediated signal transduction. Some studies in 
aged people, including centenarians, reported an age-related increase in the IL-1Rα, whereas IL-1β 
showed no detectable age-related trend. However, studies from our laboratory showed, under basal 
conditions, high levels of IL-1β, and, under presence of ConA, low levels of IL-1β, in peritoneal 
leukocytes of old mice (Arranz et al., 2010c; Martínez de Toda et al., 2017). The age-related 
increase of these cytokines has been associated with high co-morbidity, age-related disease, and 
mortality (Cavallone et al., 2003; Rea et al., 2018; Sansoni et al., 2008). 
IL-6 
IL-6 has been recognized as an important cytokine in the process of aging and in age-related 
diseases. IL-6 is promptly and transiently produced in response to infections and tissue injuries, in 
the acute phase response, in the transition from innate to acquired immunity, in the regulation of 
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metabolic, regenerative, and neural processes (Weiss et al., 2013). It has both pro- and anti-
inflammatory activities, and modulates the acute inflammatory response by producing IL-1Rα and 
soluble tumour necrosis factor receptor p55 (sTNF-R55), which supresses IL-1 and TNF-α (Rea et 
al., 2018). IL-6 (under basal conditions) is increased with aging and in subjects with markers of 
frailty and chronic disease (Arranz et al., 2010c; Martínez de Toda et al., 2017; Van Epps et al., 
2016; Varadhan et al., 2014). In the presence of ConA, old mice showed decreased secretion of IL-
6 (Arranz et al., 2010c). High basal levels of IL-6 have been correlated with cardiovascular disease, 
sarcopenia, muscle loss, and mortality in the elderly (Alemán et al., 2011; Ridker et al., 2000). 
However, in long-lived mice both stimulated and basal releases of IL-6 were very increased 
(Martínez de Toda et al., 2017). Nevertheless, in a meta-analysis of longevity in nonagenarians and 
centenarians, carries of the low cytokine producing IL-6 allele showed longevity benefit (Di Bona 
et al., 2009). 
TNF-α 
TNF-α is considered a pro-inflammatory cytokine that can be beneficial when it acts locally 
in the tissues (against a variety of infectious pathogens), but can have host-damaging effects when 
released systemically (Pfeffer, 2003). Elevated TNF-α (under basal conditions) has been reported in 
aged mice and humans, as well as in octogenarians with atherosclerosis, being associated with 
mortality (Arranz et al., 2010c; Bruunsgaard et al., 2000a; 2000b; 2003; Martínez de Toda et al., 
2017). Elevated TNF-α concentrations has also been associated with low muscle mass and strength 
in old individuals (Nilsson et al., 1998).  
IL-10 
IL-10 is an important anti-inflammatory cytokine, which suppresses the actions of IL-6, 
TNF-α, and IL-8 (Ouyang et al., 2011). An age-related decline in cellular stimulation studies has 
been reported in peritoneal leukocytes from mice (Arranz et al., 2010c; Martínez de Toda et al., 
2017). Although in some work the basal levels of IL-10 decrease with age (Arranz et al., 2010c; 
Martínez de Toda et al., 2017), in another high basal levels of this cytokine have been found in the 
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process of aging, probably for the purpose of neutralizing pro-inflammatory cytokines (Alvarez-
Rodríguez et al., 2012). Interestingly, in male Sicilian centenarians, male carriers of the high 
producing GG 1,082 allele of the IL-10 promoter polymorphism showed a survival advantage, 
suggesting that IL-10 anti-inflammatory activites might be a marker for male longevity (Lio et al., 
2003). However, this result could not be replicated in centenarians from other countries (Rea et al., 
2018). In mice, those reaching high longevity showed an increase of IL-10 released by stimulated 
and basal peritoneal leukocytes (Martínez de Toda et al., 2017). 
IL-2 
IL-2 is a pleiotropic cytokine produced after antigen activation that plays an important role 
in the immune response, especially in the lymphocyte proliferation. Thus, IL-2 was first discovered 
as a T-cell growth factor. This cytokine promotes CD8+ T cell and NK cell cytolytic activity, and 
modulates T cell differentiation in response to antigen, promoting naïve CD4+ T cell differentiation 
In addition, IL-2 is essential for the development and maintenance of T regulatory cells, thus 
mediating tolerance and limiting inappropriate immune reactions (Liao et al., 2011; 2013). Many 
studies demonstrated that lymphocytes from aged mice and humans produce significantly lower IL-
2 levels (under mitogen-induced stimulation) than adults (Arranz et al., 2010c; Caruso et al., 1996; 
Martínez de Toda et al., 2017).   
Other sources of cytokines 
It is important to remark that immune cells are not the only source of cytokines. For 
instance, adipocytes produce a variety of cytokines, known as adipokines, which have critical 
functions, such as modulation of metabolic pathways. However, a pro-inflammatory adipokine 
profile has been associated with the development of obesity and its related diseases (Deng and 
Scherer, 2010). Moreover, the process of aging also seems to favour an increased production of pro-
inflammatory adipokines in the adipose tissue (Martyniak and Masternak, 2017).  
With age, the skeletal muscle and endothelial cells have also been described as important 
sources of cytokines, such as IL-6 and TNF-α (Belmin et al., 1995; Beyer et al., 2012; Pedersen et 
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al., 2001). Therefore, other tissues rather than only the immune system seem to contribute to the 
systemic high levels of pro-inflammatory mediators, characteristic of inflammaging.  
 
1.3.5. Oxidation-inflammation: cause and consequence of immunosenescence 
As previously mentioned, the maintenance of health depends on the balance between the 
production of oxidants (ROS) and antioxidants. With aging, this balance is lost, due to an excess of 
the former and/or a lack availability of the latter, establishing an oxidative stress condition. Chronic 
oxidative stress has been suggested as the main contributor of immunosenescence, as well as of 
many age-related diseases (De la Fuente and Miquel, 2009).  
The immune cells, in particular those of innate immunity, generate a great amount of ROS 
due to their defensive role against pathogens. For this reason, the redox maintenance in these cells is 
essential for its correct function. While, an insufficient amount of ROS production by immune cells 
would lead to a poor defensive role, an excessive production of these compounds result in their 
damage. In fact, immune cells are very susceptible to oxidation due to their membrane components 
(Meydani et al., 1995). In addition, with aging an oxidative stress state in the immune cells appears. 
Thus, decreased antioxidant capacity, including low production of reduced glutathione (GSH) 
concentrations, glutathione peroxidase (GPx) activity, glutathione reductase (GR) activity, 
superoxide dismutase (SOD) and catalase (CAT) activities, as well as a high production of 
oxidative compounds, such as oxidized glutathione (GSSG) concentrations, extracellular superoxide 
anion concentrations and xanthine oxidase (XO) activity, have been found in peritoneal immune 
cells from aged individuals (De la Fuente, 2008; De la Fuente et al. 2004b; 2005; 2008; Vida et al., 
2014). In addition, oxidative stress has been also found in immune cells from models of premature 
aging, such as in prematurely aging mice (PAM) (De la Fuente, 2010; 2018a), ovariectomised mice 
and tyrosine hydroxylase haploinsufficient mice (Baeza et al., 2011; Garrido et al., 2018, 
respectively).  
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Oxidative stress and inflammation are closely related, given that ROS can induce an 
inflammatory response. In fact, ROS themselves are considered damage-associated molecular 
pattern (DAMP) molecules and effectors of inflammation. Thus, DAMPs (and concretely ROS) can 
activate the TLR2 (toll-like receptor-2) and TL8 pathways, which initiate an inflammatory response 
with activation and release of pro-inflammatory cytokines. In addition, the activation of 
inflammasomes by DAMPs and ROS also increases the processes of oxidation and inflammation 
through the release of pro-inflammatory cytokines. Among the different inflammasome complexes, 
the pyrin domain containing 3 (NLRP3) is one of the most implicated in the release of pro-
inflammatory cytokines. This NLRP3 inflammasome is directly activated by the presence of 
sustained amounts of ROS  (De la Fuente, 2018a; Kulinsky, 2007; Vida et al., 2014). Although 
inflammation is needed for physiological functions, such as immune response, an excess of 
inflammatory compounds that cannot be counteracted by anti-inflammatory defence results in 
inflammatory stress (Kulinsky, 2007). In fact, oxidative and inflammatory stresses have been 
suggested as the main risk factor underlying aging and its related diseases (Bauer and De la Fuente, 
2016).  
 
1.3.6. Immune system as a marker of biological age and predictor of longevity 
As previously mentioned, the preservation of immune response has been suggested as a 
predictor not only of health, but also of longevity (De la Fuente and Miquel, 2009; Wayne et al., 
1990). In this sense, our research group has recently proposed parameters of immune functions, 
including chemotaxis and phagocytosis of macrophages, anti-tumour activity of NK cells, as well as 
chemotaxis and proliferative response of lymphocytes, as biological age markers. These immune 
function parameters, analysed in both human blood leukocytes and mouse peritoneal leukocytes, 
have been validated as markers of biological age and predictors of longevity (Martínez de Toda et 
al., 2016). Thus, studies performed on individuals reaching an extreme old age (human centenarians 
and long-lived mice), as well as those with premature immunosenesence and lower life expectancy 
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confirmed this concept. Interestingly, centenarians and long-lived mice exhibited a variety of 
immune function and oxidative stress parameters with similar values of adults (Alonso-Fernández et 
al., 2008; Arranz et al., 2010a; Bagnara et al., 2000; Fagiolo et al., 1993; Martínez de Toda et al., 
2016; Paganelli et al., 1992). Therefore, parameters of immune system functions seem to be a valid 
method to measure the biological age of individuals, and consequently their rate of aging. Thus, 
adult individuals who immune function parameters show values similar to subjects of older ages 
would have a greater biological age and a shorter longevity, whereas those who show values similar 
to younger individuals would have a lower biological age and a higher longevity (Martínez de Toda 
et al., 2016; 2017).  
 
1.4. THE NEUROIMMUNOENDOCRINE SYSTEM  
 
The regulatory systems, including the nervous, immune and endocrine systems, are involved 
in the maintenance of homeostasis (or homeodynamics), and therefore of health. The functions of 
these systems are mutually coordinated in order to response to any change originated from the 
internal or external environment (Besedovsky and del Rey, 2007).  
The neuroimmunoendocrine system and their communication are mainly based on the 
following facts: 1) neural, immune and endocrine cells can express receptors for neurotransmitters, 
cytokines and hormones, 2) neural, lymphoid and endocrine tissues are able to synthesize and 
release neurotransmitters, cytokines and hormones, and 3) functions of the nervous, immune and 
endocrine systems are modulated by neurotransmitters, cytokines and hormones (Besedovsky and 
del Rey, 1996). 
Therefore, the nervous, immune and endocrine systems are intimately connected and share a 
bidirectional communication. Moreover, these systems do not function as independent systems. 
Thus, any situation capable of disrupting homeostasis (or homeodynamics) will be recognized by 
one of these systems and communicated to the other, in order to restore homeostasis (Wrona, 2006). 
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The immune system represents a system capable of detecting non-cognitive stimuli (such as viruses, 
bacteria, tumour cells, or other types of foreign cells) and it responds to these stimuli by producing 
cytokines that will be received by the neuroendocrine system. In addition, the neuroendocrine 
system is capable of detecting cognitive stimuli (such as light, sound, stress situations, etc.) to 
which it responds, and its mediators (neurotransmitters and hormones) communicate it to the 
immune system (Blalock, 1984).   
 
1.4.1. Age-related changes in the neuroimmunoendocrine system 
With age, the regulatory systems, including the nervous, immune and endocrine systems, as 
well as the communication between them, show impairments and a lower ability to adaptively react 
to internal and external perturbations and maintain homeostasis (or homeodynamics).  
Studies from our research group support the idea that the impairment of the immune system 
with age can affect the functions of the other regulatory systems through increased oxidative and 
inflammatory stresses, resulting in increased morbidity and mortality (De la Fuente and Miquel, 
2009). In fact, increasing evidence suggests that immunosenescence in mouse and human affects 
the central nervous system and promotes neuronal dysfunction (Deleidi et al., 2015). Thus, 
immunosenescence has shown to induce brain aging, cognitive deficit, and memory loss (Costantini 
et al., 2018). It is difficult to determine precisely whether with aging immune changes induce neural 
changes or an altered nervous system induces immunity changes, or whether both processes occur 
simultaneously, which is the most likely mechanism according to some authors (De la Fuente, 
2018b; De la Fuente and Miquel, 2009). 
The inadequate response to stress is one of the conditions that may lead to an acceleration of 
aging. Thus, studies from our research group have shown that mice with chronic hyperactivity to 
stress and anxiety exhibited premature immunosenescence and, consequently, premature aging (De 
la Fuente and Gimenez-Llort, 2010; De la Fuente 2018a; 2018b; Guayerbas et al., 2002a; 2002b; 
Guayerbas and De la Fuente, 2003).  
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1.5. OBESITY  
 
1.5.1. Prevalence of obesity 
The rising prevalence of overweight and obesity in several countries has been described as a 
global pandemic (Roth et al., 2004). Obesity is the fifth leading cause of death, estimated to be 
associated with 3.4 million deaths in 2010 (Smith and Smith, 2016). Studies forecast that the 
growth in obesity could lead to future falls in life expectancy (Olshansky et al., 2005). Increases in 
the prevalence of overweight and obesity have been described in men and women, in all age groups, 
even among children and elderly people (Samper-Ternet and Al Snih, 2012). The worldwide 
prevalence of overweight and obesity increased from 28.8% in 1980 to 36.9% in 2013 for men and 
29.8% to 38% for women. In addition, there have been substantial increases in the prevalence 
among children and adolescents in developed countries, with 23.8% of boys and 22.6% of girls 
being either overweight or obese (Ng et al., 2014). In European elderly population, aged 65 years or 
older, the prevalence of overweight and obesity is also close to 30% (Mathus-Vliegen, 2012). 
Although current trends in obesity seem stable in most developed countries, morbid obesity in many 
of these countries continuous to rise, particularly among children (Hruby and Hu, 2015).  
 
1.5.2. Definition and diagnosis of obesity 
Obesity may be defined as an energy imbalance between calories consumed and calories 
expended, which results in an abnormal and excessive fat accumulation (Kopelman, 2000).  
Excess of body fat (and obesity) can be assessed using different methods and tools, with 
variable costs, practicality and accuracy (Bacchi et al., 2017). For instance, dual-energy X-ray 
absorptiometry (Bacchi et al., 2017) and magnetic resonance imaging (MRI) (Abate et al., 1994; 
Andres et al., 2011) are considered to have high accuracy in estimating body fat mass. However, 
these methods are expensive and depend on sophisticated equipment, only available in some 
research settings  (Bacchi et al., 2017).  
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Another method to estimate body fat mass is by measuring skinfold thicknesses, which is a 
simple and inexpensive approach. However, this method shows a high variability of fat distribution 
across sex, ethnicity, body type, and age (and is also technique-dependent) (Reilly et al., 1995). For 
practical reasons, the measurement of body mass index (BMI) has been considered the most used 
method to estimate body fat mass. BMI in adults is calculated as weight in kilograms (Kg) divided 
by the square of height in meters (m2), values between 25 and 29.9 Kg/m2 and above 30 Kg/m2 are 
defined as overweight and obese, respectively. In children, BMI percentiles of historical normal 
groups of the same age and sex are used to diagnose obesity. Although BMI has a high correlation 
with body fat mass, it does not quantify total body fat adiposity or provide information about body 
fat distribution (Hubbard, 2000). In addition, BMI does not discriminate between fat mass and fat-
free mass, being consider an inaccurate measure for very muscular individuals, such as athletes, 
leading to their misclassification as overweight or obese. Moreover, elderly individuals may appear 
to have a normal BMI despite having excess fat and reduced muscle mass (Racette et al., 2003). 
 
1.5.3. Aetiology of obesity 
Obesity is the result of complex interactions of multiple factors, including genetic, 
behavioural, environmental and physiological factors (Racette et al., 2003).  
With regards to genetic factors causing obesity, single-gene disorders, which can be grouped 
in Mendelian syndrome and non-syndromic cases, account globally for less than 5% of obesity 
cases. Mendelian syndromes include Prader-Willi syndrome, Bardet-Biedl syndrome, Alstrom 
syndrome and many others. Prader-Willi syndrome (PWS) is the most common and best 
characterized of the human obesity syndromes. PWS is an autosomal dominant disorder 
characterized by obesity, mental retardation, and hyperphagia that usually develops between 12 and 
18 months of age (Ochoa et al., 2004).  
Single-gene non-syndromic disorders are known by mutations in the genes of leptin - 
melanocortin pathway. These may include mutations in the genes of leptin, leptin receptor, pro-
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opiomelanocortin (POMC), melanocortin 4 receptor or pro-hormone convertase 1. However, the 
majority of obese individuals do not have a monogenic cause. Instead, these individuals generally 
have multiple genes that predispose them to develop obesity. Thus, polymorphisms in genes related 
to energy expenditure (uncoupling proteins (UCPs)) and food intake (ghrelin) have also been 
associated with obesity phenotypes (Ochoa et al., 2004).  
Although genetic differences are of undoubted importance, given that individuals in the 
same “obesogenic” environment have different risks of becoming obese (Walley et al., 2009), the 
worldwide epidemic of obesity could be best explained by behavioural and environmental changes 
resulting from modern society (Kopelman, 2000; Walley et al., 2009).  
 
1.5.4. Obesity-related diseases 
Obesity is the major contributor to the global burden of chronic diseases. These chronic 
diseases include type 2 diabetes, cardiovascular diseases, respiratory diseases (such as obstructive 
sleep apnoea), osteoarthritis, neurodegenerative diseases, and some types of cancer. Obesity and 
excessive fat deposition, in particular visceral, is accompanied by profound changes in 
physiological functions of the organism. It is well known that hyperplasia and hypertrophy of 
adipocytes, as a consequence of their excessive store of energy, produce many of the health 
problems associated with obesity, either because of the increased weight and fat mass or because of 
the secretion of free fatty acids and many other pro-inflammatory adipokines from adipocytes 
(Bray, 2004). Stigma of obesity and the behavioural responses it produces, as well as osteoarthritis, 
and sleep apnoea are often associated with an increased mass of fat itself. In contrast, type 2 
diabetes, insulin resistance, metabolic syndrome, hypertension, liver diseases, cardiovascular 
diseases, neurodegenerative diseases and some types of cancer are the result of metabolic changes 
associated with excessive fat (Bray, 2004).  
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1.5.5. Models for the study of obesity in rodents  
Animal models of obesity can be classified basically into two categories: (1) animals 
suffering mutations or manipulations in one or a few individual genes, and (2) genetically intact 
animals exposed to obesogenic environments, such as high-fat diets (Lutz and Woods, 2012).  
Genetic models of obesity 
Studies performed in genetic models of obesity, although they are very reproducible since 
the animals are relatively homogenous, represent a minority percentage of the cases of obesity in 
the human population (De la Fuente and De Castro, 2012). Mutations in specific genes have been 
identified in rodents as causes of obesity. In the following are described some examples of these 
mutations in rodents.  
Agouti gene 
The agouti gene was cloned in 1993 and was the first obesity gene to be characterized at the 
molecular level (Lutz and Woods, 2012). The yellow mouse obesity syndrome results from a 
mutation at the agouti locus and is characterized by obesity, hyperinsulinemia, insulin resistance, 
hyperglycemia, hyperleptinemia, increased linear growth, and yellow coat colour (Moussa and 
Claycombe, 1999). The agouti gene codifies a protein expressed in the follicular melanocyte, where 
it acts as an antagonist of the melanocyte-stimulating hormone receptor (MSH), stimulates 
production of the yellow pigment (pheomelanin) and inhibits the pigment (eumelanin) induced by 
MSH. In addition, the expression of the agouti gene product, especially in the hypothalamus, 
antagonizes the subtype 3 and 4 melanocortine receptors (Mc3r and Mc4r), which are expressed in 
the hypothalamus and play an important role in the regulation of body weight (Lutz and Woods, 
2012; Miltenberger et al., 1997).  
Ob/ob syndrome 
The mouse ob/ob syndrome was discovered in 1949 in an outbred mouse colony at the 
Roscoe B. Jackson Memorial Laboratory, Bar Harbor, Maine, and was transferred to the already 
well-characterized C57B1 mice colony (Zhang et al., 1994). Ob/ob mice are hyperphagic, obese, 
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hyperinsulinemic, and hyperglycemic, and they have been used as a model for the study of diabetes 
and obesity. In addition to obesity, ob/ob mice are infertile and have impaired immune functions. 
Friedman et al. identified in 1994 that ob/ob mice lacked the production of leptin (Zhang et al., 
1994). The ob/ob syndrome can be reversed almost completed by exogenous leptin or transfection 
with the leptin gene (Lindström, 2007).  
Db/db syndrome 
The db/db mouse was identified initially in 1966 and is phenotypically similar to ob/ob 
mouse. The diabetic gene (db) is transmitted as an autosomal recessive trait. The major difference 
from the ob/ob mouse is the marked resistance to leptin because db/db mice have a (spontaneously) 
mutated leptin receptor. These mice also suffer from morbid obesity but their leptin levels are 
markedly elevated. The db/db mice are insulin resistant and develop diabetes (Lutz and Woods, 
2012). These animals show premature immunosenescence and alterations in their behavioural 
responses (De Castro, 2016).  
Analogous to the db/db mice, several rat models of leptin-resistant obesity have mutation in 
the leptin receptor. The obese Zucker (fa/fa or “fatty” rat) and the Koletsky rat carry mutated forms 
of the extracellular domain of the leptin receptor. This is associated with decreased leptin binding 
and signal transduction. They develop a similar phenotype of hyperphagia and reduced energy 
expenditure, leading to morbid obesity (Bray, 1977; Lutz and Woods, 2012). These rats also have 
impaired glucose tolerance, growth deficit, impaired immunity and infertility (De Castro, 2016; 
Lutz and Woods, 2012).  
Diet-induced models of obesity 
High-fat diets are the most common used approach to induce obesity in rodents. In general, 
either carbohydrate-derived calories are replaced with fat-derived calories or saturated fats (such as 
lard, beef tallow, coconut oil) are simply added to normal rodent chow (Bagnol et al., 2012). The fat 
content of high-fat diets, which is derived from vegetal and animal sources, can vary from 20% to 
60% of total energy intake. The application of a well-controlled high-fat in which macronutrient 
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composition is standardized is a clear positive outcome for experimental control, enabling specific 
hypothesis to be generated regarding macronutrient composition and resultant phenotype (Bagnol et 
al., 2012). By contrast, some obesity researches induce obesity in rodents through the so-called 
cafeteria diets. In this type of diet, rodents have free access to a variety of high palatable, energy 
dense foods commonly consumed in western societies, and often associated with obesity. These 
diets are typically high in fat (>40%) and relatively low in protein. Some authors suggest that 
cafeteria diets are more effective to induce obesity in rodents than high-fat diets, given that the 
former are more palatable (Kretschmer et al., 2005; Sampey et al., 2011). However, the 
macronutrient composition of cafeteria diets is difficult to measure and regulate, thus conclusions 
regarding the role of specific nutrients to phenotype cannot be made (Bagnol et al., 2012).  
In addition to diet, rodent species and strain are important variables to consider. In mouse, 
C57B16, AKR, and DBA/2 appear more prone to diet-induced obesity than other inbred strains, 
while SWR/J and A/J are more resistant (Prpic et al., 2002; Surwit et al., 1995). For rat strains, 
outbred Sprague Dawley rats are most often used (Bagnol et al., 2012). 
 
1.5.6. Adipose tissue. Obesity-related changes 
The adipose tissue is composed of two distinct forms, brown and white, with fundamentally 
different functions. The brown adipose tissue (BAT) plays an important role in body temperature 
regulation. In newborns, BAT is well-developed in the neck and interscapular region. Although 
initially thought to disappear soon after birth in humans, evidence now suggests that BAT is present 
in adult humans in the supraclavicular region and neck (McArdle et al., 2013; Yoneshiro et al., 
2011). The brown colour of BAT is derived from a rich vascular network and abundant 
mitochondria and lysosomes. The mitochondria express uncoupling protein 1 (UCP-1) that is 
involved in the production of heat through the oxidation of the stored lipid (Frühbeck, 2008; 
Trayhurn, 2013). In contrast, the white adipose tissue (WAT) is integrally involved in coordinating 
a variety of biological processes including energy metabolism, neuroendocrine function, and 
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immune function (Kershaw and Flier, 2004). Thus, the classical view of the WAT as a passive 
reservoir for energy storage is no longer valid (Kershaw and Flier, 2004). Besides mature 
adipocytes, WAT contains various other cell types and is highly vascularized (Wang et al., 2008), 
and innervated (Fliers et al., 2003; Wang et al., 2008). Blood vessels and nerves connect adipose 
tissue to the whole body for metabolic regulation. Pre-adipocytes (immature adipocyte precursors), 
fibroblasts, blood cells, endothelial cells and immune cells are present in the stroma-vascular 
fraction (SVF) of WAT (Hauner et al., 1988; McArdle et al., 2013). In response to obesity, there is 
an increase in the SVF cell number (McArdle et al., 2013). Thus, obesity is characterized by 
increased number of pre-adipocytes and immune cells and these could be associated with insulin 
resistance (McLaughlin et al., 2007).  
Adipocytes vary in diameter depending on the size of their single, large, lipid droplet 
containing triglycerides. Because around 90% of the cell volume is the lipid droplet surrounded by a 
film cytoplasm (containing mitochondria, endoplasmic reticulum, etc.) and bounded by a plasma 
membrane, the nucleus is pushed to the periphery (Frühbeck et al., 2001). After a meal, 
parasympathetic nerves stimulate adipocytes to take up fatty acids and glycerol from blood and 
synthesize triglycerides for storage. During fasting or when the body requires energy, sympathetic 
nerves acting through β-adrenergic receptors, stimulate lipolysis of adipocytes and triglycerides are 
hydrolysed to glycerol and free fatty acids (FFAs). FFAs, as energy substrates, are released into the 
circulation and are transported to the different tissues (Wang et al., 2008). Adipocytes are long-
lived cells, with a half-life of approximately 9 years, so the excess cells can persist for a long time 
in obese individuals (Tchkonia et al., 2010). Adipocytes respond to the metabolic needs of the body 
and maintain the balance between synthesis (lipogenesis) and breakdown (lipolysis) of triglycerides 
(Wang et al., 2008). The regulation of these processes is responsive to hormones, cytokines, and 
other factors involved in energy metabolism (Frühbeck et al., 2001). The ability to carry out these 
functions is acquired during embryonic development in preparation for the postnatal period, when 
an adipose energy reserve becomes necessary (Cornelius et al., 1994). In human foetuses, the 
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primary fat formation is detectable between the 14th and 16th weeks of prenatal life, while the 
secondary fat formation takes place later in life (after the 23rd week of gestation), as well as in the 
early postnatal period. Adipose tissue is partitioned by connective tissue septa into lobules. The 
number of fat lobules remains constant, while in the subsequent developmental phases the lobules 
continuously increase in size. Adipogenesis, i.e. the development of adipose tissue, varies according 
to sex and age. Furthermore, the existence of critical periods for changes in adipose tissue 
cellularity has been reported. In this sense, two peaks of accelerated adipose mass enlargement have 
been established, namely after birth and between 9 and 13 years of age. The capacity for cell 
differentiation is highest during the first year of life, while it is less pronounced in the years before 
puberty (Bray and Bouchard, 2003). Therefore, the rate of cell proliferation slows down during 
adolescence and, in weight stable individuals, remains fairly constant throughout adulthood (Bray 
and Bouchard, 2003). In case of a maintained positive energy balance, such as obesity, adipose 
mass expansion takes place initially by the enlargement of existing adipocytes and subsequently by 
augmenting their number. Thus, the expansion of white adipose tissue is caused by a combination 
of size increase of preexisting adipocytes (hypertrophy) and de novo adipocyte differentiation 
(hyperplasia) (Wang et al., 2008).  Childhood-onset obesity is characterized by a combination of fat 
cell hyperplasia and hypertrophy, whereas in adult-onset obesity a hypertrophic growth 
predominates. However, it has been shown that adult humans are capable of new adipocyte 
formation of cells with the ability to undergo differentiation (Frühbeck et al., 2001).  
 
1.5.6.1.  Adipose tissue-secreted proteins 
Adipocytes secrete many hormones, growth factors, and cytokines, which have been termed 
adipokines. These adipokines act at both the local (autocrine/paracrine) and systemic (endocrine) 
level and influence several physiological processes concerning energy, glucose metabolism, and 
immunity (Frühbeck et al., 2001; Makki et al., 2013). Dysregulated expression and secretion of 
these adipocyte-derived proteins due to adipose tissue dysfunction can contribute to the 
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pathogenesis of obesity-related problems (Ouchi et al., 2011). Examples of adipocyte-derived 
proteins are described below.  
Leptin is a 16-kDa polypeptide containing 167 amino acids with structural homology to 
cytokines, and is believed to have pro-inflammatory activities. It has been described that leptin 
increases the production of TNF-α and IL-6 by monocytes and stimulates the production of C-C 
chemokine ligands (CCL3, CCL4 and CCL5) by macrophages (Ouchi et al., 2011). Leptin receptors 
are members of the cytokine receptor class I superfamily and are expressed in both central nervous 
system (CNS) and periphery. Leptin is mainly secreted by adipocytes, in a direct proportion to 
adipose tissue mass and nutritional status, and thereby regulates food intake and energy 
expenditure. Caloric restriction and weight loss rapidly decline leptin levels. This decline is 
associated with adaptive physiological responses to starvation including increased appetite and 
decreased energy expenditure. In contrast, obesity is characterized by elevated circulating leptin. In 
addition, obesity is generally accompanied by a state of leptin resistance, which could result from 
defects in leptin signalling or transport across blood-brain barrier (Kershaw and Flier, 2004). 
Tumour necrosis factor-alpha (TNF-α) is implicated in the pathogenesis of obesity and 
insulin resistance (Ruan and Lodish, 2003), given that TNF-α impairs insulin signalling (Ruan et 
al., 2002). In agreement, neutralization of TNF-induced signalling in obese animals leads to an 
improvement in insulin sensitivity (Uysal et al., 1997).  
Interleukin (IL)-6 is another cytokine associated with obesity and insulin resistance 
(Fernández-Real and Ricart, 2003). Adipocytes and stroma-vascular cells secrete IL-6 and express 
its receptor (Fain et al., 2004), which is homologous to the leptin receptor. Thus, in contrast to 
TNF-α, IL-6 circulates at high levels in the bloodstream, and as much as one third of circulating IL-
6 originates from adipose tissue (Fernández-Real and Ricart, 2003). In WAT, only a fraction of IL-6 
is secreted by adipocytes, the other part being produced by other cells, particularly macrophages 
(Weisberg et al., 2003). IL-6 seems to decrease insulin signalling in peripheral tissues by reducing 
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expression of insulin receptor signalling components (Senn et al., 2003). IL-6 also inhibits 
adipogenesis and decreases adiponectin secretion (Fernández-Real and Ricart, 2003).  
Macrophage and monocyte chemoattractant protein (MCP)-1 is a chemokine that recruits 
monocytes to sites of inflammation and it is expressed and secreted by adipose tissue, being 
increased in obesity (Sartipy and Loskutoff, 2003; Wellen and Hotamisligil, 2003). Both adipocytes 
and stroma-vascular cells have been implicated in the secretion of MCP-1. Also, MCP-1 seems to 
contribute to adipose tissue insulin resistance (Sartipy and Loskutoff, 2003). 
Plaminogen activator inhibitor (PAI)-1 is a member of the serine protease inhibitor family 
and is the primary inhibitor of fibrinolysis. PAI-1 has been implicated in the angiogenesis and 
atherogenesis. Adipocytes and stroma- vascular cells secrete PAI-1. Plasma PAI-1 levels are 
elevated in obesity and insulin resistance (Mertens and Van Gaal, 2002). 
Adiponectin is highly and almost exclusively synthetized in adipocytes and circulates at 
high levels in the bloodstream (Chandran et al., 2003). A strong and consistent inverse association 
between adiponectin and both insulin resistance and inflammatory states have been established. 
Adiponectin levels are low with insulin resistance due to either obesity or lipodystrophy, and 
administration of adiponectin improves metabolic parameters in these conditions (Chandran et al., 
2003). In addition, adiponectin levels in the plasma and adipose tissue are decreased in obese 
individuals compared to lean individuals (Ryo et al., 2004). In agreement, the production of 
adiponectin by adipocytes is inhibited by pro-inflammatory cytokines, such as TNF-α and IL-6, as 
well as by hypoxia and oxidative stress state (Hosogai et al., 2007). 
Adipsin is one of several adipose tissue-derived complement components that are required 
for the enzymatic production of acylation stimulating protein (ASP), a complement protein that 
affects both lipid and glucose metabolism (Cianflone et al., 2003). Studies indicate that both adipsin 
and ASP positively correlate with adiposity, insulin resistance, dyslipidemia, and cardiovascular 
disease (Cianflone et al., 2003). 
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Resistin is an approximately 12-kDa polypeptide that belongs to the unique family of 
cysteine-rich C-terminal domain proteins called resistin-like molecules. Resistin has been shown to 
induce resistance insulin in mice (Steppan et al., 2001). Resistin synthesis is restricted to adipocytes 
in mice (Steppan et al., 2001), whereas in humans is mainly produced by macrophages and 
monocytes, and it is not detectable in adipocytes (Savage et al., 2001). In human mononuclear cells, 
transcription of the resistin gene is induced by pro-inflammatory cytokines, including IL-1, IL-6 
and TNF-α (Steppan et al., 2001). In addition, resistin shows pro-inflammatory properties as it 
promotes the expression of TNF-α and IL-6 by human mononuclear cells (Bokarewa et al., 2005).  
Retinol-binding protein 4 (RBP4) is a hepatocyte-secreted factor that is responsible for the 
transport of retinol (vitamin A) throughout the body (Quadro et al., 1999). RBP4 is secreted by both 
adipocytes and macrophages. Increased serum RBP4 levels were found to associate with features of 
the metabolic syndrome, including high blood pressure, low levels of high-density lipoprotein, high 
levels of cholesterol and triglycerides, and increased body mass index. RBP4 is preferentially 
produced by visceral adipose tissues in states of obesity and insulin resistance, and it is a marker of 
intra-abdominal adipose tissue expansion and subclinical inflammation (Ouchi et al., 2011).  
Osteopontin (OPN) acts as an extracellular matrix protein and pro-inflammatory cytokine 
that facilitates the recruitment of monocytes/macrophages and mediates cytokine secretion in 
leukocytes. In WAT from diet-induced and genetically obese mice, OPN secretion is drastically up-
regulated by 40 and 80-fold, respectively (Kiefer et al., 2008). Interestingly, OPN deficiency not 
only leads to decreased adipose tissue inflammation, but also improves whole-body glucose 
tolerance and reduces insulin resistance in mice, independent from body composition or energy 
expenditure. Although OPN secretion can be induced by a variety of growth factors and cytokines, 
the mechanisms by which OPN is up-regulated in inflamed adipose tissue remains incompletely 
understood (Kahles et al., 2014).  
Chemerin is a chemokine highly secreted in liver and WAT. Chemerin has shown to 
regulate adipocyte differentiation, to modulate the expression of adipocyte genes involved in 
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glucose and lipid homeostasis, and to enhance insulin signalling in adipocytes in vitro (Goralski et 
al., 2007; Takahashi et al., 2008). In addition, chemerin was reported to be associated with 
inflammation and components of the metabolic syndrome (Niklowitz et al., 2018).  
Apelin has been described to play a role in the regulation of glucose homeostasis. High 
apelin serum concentrations have been found in patients with obesity, insulin resistance and liver 
cirrhosis. By contrast, low apelin concentrations seem to contribute to improved insulin sensitivity 
independently of significant weight loss (Blüher, 2014).  
Vaspin is a visceral adipose-derived serine protease inhibitor that has been found 
significantly increased in mice with obesity and insulin resistance. It has been proposed that vaspin 
acts as an insulin sensitizer with anti-inflammatory effects. Several studies have assigned an 
important role of vaspin in the development of obesity and metabolic syndrome, but it is not clear 
whether it has causative or protective effect in these conditions (Dimova and Tankova, 2015).    
Visfatin has an important enzymatic function in synthesizing nicotinamide mononucleotide 
(NMN) from nicotinamide and phosphoribosyl pyrophosphate (PRPP). Also, visfatin has been 
described as an adipokine predominantly secreted from visceral fat exerting insulin-mimetic effects. 
However, subsequent studies revealed that other tissues and adipose tissue depots may also secrete 
visfatin and the effects of this molecule, as an insulin mimetic, are controversial. Is has been 
demonstrated that hypercaloric feeding as well as aging compromise visfatin-mediated NAD+ 
biosynthesis and may therefore contribute to the pathogenesis of type 2 diabetes (Blüher, 2014).  
Vascular endothelial growth factor (VEGF) is mostly secreted by stroma cells and by 
adipocytes, acting in adjacent capillaries. During adipose tissue expansion, infiltrating inflammatory 
cells produce a significant part of VEGF. VEGF is the main endothelial cell growth factor, being 
associated with the development of obesity. Animal models of obesity and obese individuals have 
increased VEGF concentrations, which were shown to decrease after weight loss (Letra and Seiça, 
2017). 
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1.5.6.2. Adipose tissue immune cells 
Almost all immune cell types are resident in the adipose tissue. These cells have important 
roles in tissue housekeeping, removal of apoptotic cells and tissue homeostasis maintenance 
(Schipper et al., 2012). However, excessive fat accumulation results in changes in the number of 
immune cells. Thus, it has been described that the total number of T cells, B cells, macrophages, 
neutrophils, and mast cells are increased in the adipose tissue of obese individuals, whereas specific 
subsets of T cells, including Th2, regulatory T (Treg) cell, and invariant natural killer T (iNKT) 
cell, as well as eosinophils are decreased (Schipper et al., 2012). Also, immune cell populations 
shift towards a pro-inflammatory profile with the production of pro-inflammatory cytokines, which 
both affect insulin signalling in peripheral tissues and induce β-cell dysfunction and subsequent 
insulin secretion defect (Klöting and Blüher, 2014). In the following are described immune cell 
types found in the adipose tissue. 
Macrophages 
Macrophages are the most abundant immune cell type found in the adipose tissue. Their 
number, localization, and phenotype are significantly altered during obesity. They comprise 40-60% 
of adipose tissue cell populations in obese mice compared to 10% to 15% of adipose tissue immune 
cells in lean mice (Weisberg et al., 2003; Xu et al., 2003). In addition, macrophages secrete a large 
amount of pro-inflammatory cytokines in response to obesity (McLaughlin et al., 2017). Monocytes 
and macrophages are extensively recruited to adipose tissue through increased expression of 
adipokines, including chemokines (such as MCP-1 and chemokine (C-C motif) receptor type 2 
(CCR2)), and adhesion molecules, such as ICAM-1 and platelet endothelial cell adhesion (PECAM-
1), among others (Osborn and Olefsky, 2012; Schipper et al., 2012).  
In the non-obese state, macrophages predominantly exist as M2, which are induced by anti-
inflammatory cytokines IL-4 and IL-13 and secrete high levels of anti-inflammatory cytokines, such 
as IL-10. By contrast, in the obese, the anti-inflammatory M2 population shifts towards the pro-
inflammatory M1 state, which is induced by pro-inflammatory mediators, such as LPS and IFN-γ, 
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and secretes pro-inflammatory cytokines, including IL-6, IL-1β, iNOS, and TNF-α (McLaughlin et 
al., 2017; Schipper et al., 2012). Adipose tissue macrophages (ATM) cluster around necrotic 
adipocytes in crown-like structures (CLS). M1 macrophages decrease insulin sensitivity as a result 
of high TNF-α, IL-1β, and IL-6 secretion. Free fatty acids (FFAs) can activate macrophages in vitro 
acting through Toll-like receptor (TLR) 2 and TLR4. Also, FFAs induce PAI-1 secretion from 
macrophages in vitro (McArdle et al., 2013). 
Dendritic cells (DCs) 
There are not much data on the presence of DCs in the adipose tissue. The abundance of 
CD11c expressing inflammatory macrophages in adipose tissue probably hampers their 
identification because DCs also express CD11c marker (Geissmann et al., 2010). A study, however, 
showed that DCs are also present in the adipose tissue of both mice and humans and that their 
number are significantly increased during obesity (Bertola et al., 2012).  
Neutrophils 
The role of neutrophils in the adipose tissue inflammation has also been analysed. Plasma 
levels of myeloperoxidase and calprotectin (mainly secreted by neutrophils), as well as neutrophil 
number and activation status are higher in obese compared to non-obese individuals (Nijhuis et al., 
2009). In mice, similar to their immediate recruitment to periphery tissues during infection, 
neutrophils are the earliest cell type recruited to the adipose tissue upon high-fat diet feeding. 
However, they are undetectable in later times points, suggesting that their recruitment is rapid and 
transient and precedes the recruitment of macrophages (Elgazar-Carmon et al., 2008). 
Eosinophils 
Eosinophils are found in different types of adipose tissues, especially in metabolically active 
perigonadal and mesenteric depots (Wu et al., 2011a). Studies in diet-induced (DIO) mice and 
genetically obese (ob/ob) mice showed decreased total number of eosinophils (Wu et al., 2011a). 
As a source of IL-4 in adipose tissue, they maintain the M2 macrophage state that is lost in DIO 
mice. Importantly, eosinophil-deficient mice have worsened glucose tolerance and insulin 
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sensitivity. Therefore, it appears that eosinophils have a protective role in inflammation-associated 
obesity by creating an anti-inflammatory environment in the adipose tissue (Wu et al. 2011a). 
B lymphocytes 
The total number of B cells in the adipose tissue is elevated in DIO mice (Winer et al., 
2011). The finding that antibodies are preferentially located in CLSs (crown-like structures) of the 
adipose tissue suggests their involvement in the clearance of dead adipocytes. In addition, B cell 
abnormal antibody production is involved in the activation of macrophages in the adipose tissue. In 
addition, MHC-1 and MHC-2 molecules on B cells in this tissue show an important role in the 
activation of CD8+ and CD4+ T helper cells, respectively (Winer et al., 2011).     
T lymphocytes 
CD8+T cells, which are important components of adaptive immune response against viral 
infections, are a 3- to 4-fold increased in the adipose tissue of obese mice and humans (Winer et al., 
2009). CD8+ T cells increase the recruitment of macrophages. Thus, depletion of CD8+ cells leads 
to decreased numbers of macrophages in the adipose tissue and lower levels of TNF-α and IL-6. In 
addition, obesity has shown to increase the number of CD4+T cells as well as Th1 cells in the 
adipose tissue due to antigen specific selection and expansion of T cells. In fact, Th1 cells are 
suggested to be one of the responsible cells for adipose tissue inflammation and insulin resistance 
(Nishimura et al., 2009).  
Th17 cells are important in autoimmune diseases along with Th1 cells. Th17 specific 
cytokines (IL-17 and IL-23), which initiate pathogenic inflammation, were observed in the serum 
samples of obese individuals (Chehimi et al., 2017).  
CD4+CD25+Foxp3+ regulatory T cells (Treg) generally play a suppressive role in 
inflammatory diseases and these cells seem to protect obese mice against excessive inflammation, 
by secreting anti-inflammatory cytokines (Feuerer et al., 2009). In the non-obese state, Treg cells 
help to maintain an anti-inflammatory environment secreting IL-10. Obesity is correlated with the 
decrease of Treg population (Feuerer et al., 2009).  
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Natural killer (NK) cells 
NK cells play an important role in the adipose tissue. There is evidence showing increased 
number of NK cells in the visceral adipose tissue of diet-induced obese mice (Lee et al., 2016). 
They produce pro-inflammatory cytokines, such as TNF-α and IFN-γ, and regulate macrophages to 
promote insulin resistance in obesity (Wensveen et al., 2015). When NK cells were depleted either 
with neutralizing antibodies or genetic ablation in E4p4(+/-) mice, obesity-induced insulin 
resistance improved in parallel with decreased adipose tissue macrophage number and inflammation 
(Lee et al., 2016).  
  
1.5.7. Obesity-related oxidative and inflammatory stresses  
Obesity is often accompanied by a moderate and persistent increase of pro-inflammatory 
cytokines, adipokines, and other inflammatory mediators (Bondia-Pons et al., 2012). In addition, 
there is decreased production of “protective factors”, such as adiponectin (Hotta et al., 2000). The 
sustained activation of immune cells as well as dysfunctional adipocytes in the adipose tissue 
greatly contribute to this pro-inflammatory environment of obesity, maintaining and generating a 
state of chronic low-grade inflammation. This pro-inflammatory environment is a potent stimulator 
for oxidative stress, setting a vicious cycle. The complex and close association between both 
increased oxidative stress and increased inflammation, not only in obesity but also in obesity-related 
diseases, such as type-2 diabetes, cardiovascular disease and neurodegenerative diseases, make it 
difficult to establish the temporal sequence of the relationship (Bondia-Pons et al., 2012; 
Cachofeiro et al., 2008).  
When energy intake exceeds energy expenditure, the resulting state of nutrient excess can 
trigger stress responses in many cell types, including endothelial cells, hepatocytes, myocytes, 
adipocytes, and immune cells, that give rise to metabolic dysfunction. Among several adverse 
cellular responses to nutrient excess is the production of ROS. These compounds can be produced 
during oxidation of glucose and fatty acids by mitochondria. Excessive generation of ROS results in 
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oxidative stress, which can damage cellular structures (such as mitochondria) and trigger 
inflammatory response (Hotamisligil, 2006; Wisse et al., 2007). Excess of nutrients may also result 
in endoplasmic reticulum (ER) stress. ER processes newly synthesized proteins into their mature 
forms. ER stress gives rise to the unfold protein response, which is characterized by the 
accumulation of unfold protein in this organelle (de Ferranti and Mozaffarian, 2008; Wisse et al., 
2007). ER stress and increased mitochondrial ROS can induce inflammation and oxidative stress. 
Another cellular response to nutrient excess is the accumulation of fatty acids derivatives that are 
ordinarily oxidized by mitochondria to generate ATP. The accumulation of fatty acids can result in 
mitochondrial dysfunction, which can create a vicious cycle by further increasing the amounts of 
these compounds (Lowell and Shulman, 2005; Wisse et al., 2007). White adipose tissue also seems 
to become hypoxic as adipocyte size and tissue mass expand in obesity and, this condition could 
contribute to the increased oxidative stress and inflammatory state associated with obesity 
(Trayhurn, 2013; Trayhurn and Wood, 2004). These processes share the ability to activate 
signalling pathways, such as jun n-terminal kinase (JNK) and the inhibitor of kappa B kinase beta 
(IκKβ)/nuclear factor kappa B (NFκB), that promote activation of the inflammatory response. Thus, 
inflammation seems to be a common endpoint (Lowell and Shulman, 2005; Wisse et al., 2007). 
In addition, it has been suggested that the NOD-like receptor family pyrin domain 
containing-3 (NLRP3) inflammasome senses obesity-associated non-microbial danger signals and 
contributes to obesity-induced inflammation. The activation of NLRP3 inflammasome initiates 
downstream inflammatory cytokine production, including IL-1β and IL-18 (De Nardo and Latz, 
2011; Vandanmagsar et al., 2011). 
In addition to dysfunctional adipose tissue, increasing evidence suggests that obesity is 
associated with alterations in the gastrointestinal microbiota, known as dysbiosis, which can impact 
body fat, systemic inflammation, and insulin resistance (McLaughlin et al., 2017). Dysbiosis is 
believed to cause low-grade inflammation both systemically, through enhanced leakage of bacterial 
products, such as LPS, and locally in the small bowel and colon. Some of these bacterial products 
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are thought to accumulate and potentiate inflammation in the adipose tissue (Cani et al., 2007; de 
La Serre et al., 2010). 
 
1.5.8. Obesity and the immune system  
It is clear the differences between the environments in which the immune system evolved 
throughout most of human evolution and the current calorie-rich “obesogenic” environment 
(Kanneganti and Dixit, 2012). In an evolutionary context, the ability to store energy excess in the 
adipose tissue was essential for survival in times of food deprivation or fighting against infections. 
Indeed, mounting a potent immune response is energetically costly. Paradoxically, this survival 
characteristic is disadvantageous nowadays when food is abundant and palatable (Racette et al., 
2003). Obesity-related changes in inflammatory status and immunity are known to contribute to the 
development of many chronic diseases, including type 2 diabetes, atherosclerosis, liver disease, 
cancer, and dementia, among others. All these diseases have an inflammatory component as a 
common feature (Kanneganti and Dixit, 2012; Milner and Beck, 2012). 
Obesity and the immune system functions 
It is well known that both malnutrition and obesity severely impair the integrity and proper 
regulation of the immune response (Bray, 2014). In fact, the close relationship between nutrient 
excess and impaired immunity (chronic low-grade inflammation) has emerged the concept of 
“meta-inflammation” (Lumeng and Saltiel, 2011), previously commented. Several components of 
the innate and adaptive immunity are impaired in obesity. These are further detailed below.  
Human studies 
Several studies performed in obese human individuals indicate lower proliferative response 
of lymphocytes T and B in response to mitogens and dysregulated cytokine expression in 
comparison with non-obese individuals (Lamas et al., 2002; Nieman et al., 1999; O´Rourke et al., 
2005; Tanaka et al., 1993; 2001). In addition, NK cell number and cytotoxicity were significantly 
lower in obese subjects compared to lean controls (O´Shea et al., 2010). An impaired immune 
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response has also been observed in studies performed in obese children and adolescents. Thus, they 
exhibited altered lymphoproliferation in response to mitogens and decreased bactericidal capacity 
of polymorphonuclear leukocytes (Chandra and Kutty, 1980; Martí et al., 2001). In addition, 
obesity also impairs the proliferation of peripheral blood lymphocytes and the anti-tumour activity 
of NK cells in elderly individuals (Moriguchi et al., 1995).  
Obesity has also been associated with increased morbidity and mortality from infectious 
diseases (Bandaru et al., 2013) and with poor antibody response (Huttunen and Syrjänen, 2013). 
Moreover, obesity is considered an independent risk factor for infection after trauma (Bochicchio et 
al., 2006; Edmonds et al., 2011; Serrano et al., 2010).  
Animal studies 
Different animal models of obesity have been used in many studies to analyse the effects of 
obesity on immune functions: genetically obese rodents characterized by mutations in the leptin 
gene (ob/ob mice), leptin receptor gene (db/db mice and fa/fa rats) and diet-induced obese rodents 
(Lamas et al., 2002). 
Regarding obese (fa/fa) Zucker rats, many studies described impaired innate and adaptive 
immune responses. Thus, macrophages from these obese rats showed lower migration, phagocytosis 
and capacity to destroy phagocytosed yeasts compared to non-obese rats (De Castro, 2016; Plotkin 
et al., 1996). Also, obese Zucker rats exhibited lower anti-tumour NK activity in comparison with 
non-obese rats (De Castro, 2016; Moriguchi et al., 1998). In addition, these obese rats showed 
decreased proliferative response of splenocytes to mitogens (De Castro, 2016; Moriguchi et al., 
1998; Tanaka et al., 1998). Furthermore, splenic lymphocytes from obese rats showed decreased 
production of IL-2, whereas increased production of pro-inflammatory cytokines (TNF-α, IL-6 and 
IL-1β) (De Castro, 2016; Ruth et al., 2008). All this could explain the greater susceptibility of 
genetically obese rats to infections in comparison with non-obese rats (Plotkin et al., 1996).    
Similarly as observed in genetically obese rats, the induction of obesity by a cafeteria diet in 
rats also resulted in impaired immune functions. Thus, the lymphoproliferative response after LPS 
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or PHA stimulation was significantly impaired in diet-induced obese (DIO) rats (Lamas et al., 
2002). Furthermore, DIO rats showed decreased oxidative burst production, suggesting a lower 
ability to kill bacteria in comparison with lean rats. Also, the NK cytotoxic activity against tumour 
cells was significantly decreased in overweight/obese rats in comparison with control rats (De la 
Fuente and De Castro, 2012; Lamas et al., 2004).   
Regarding models of genetic obesity carried out in mice, particularly in ob/ob mice, an 
atrophy of lymphoid organs has been observed in these animals, affecting mainly the size and the 
number of cells in the thymus (Matarese, 2000). In ob/ob mice a decreased number of lymphocytes 
and NK cells, as well as an impaired NK cytotoxic activity have also been observed (Martí et al., 
2001). In addition, phenotypic abnormalities were found in macrophages of ob/ob mice, such as 
increased production of mitochondrial superoxide and hydrogen peroxide (Lee et al., 1999). 
Another study found decreased number as well as impaired function of dendritic cells in ob/ob mice 
compared to non-obese mice (Macia et al., 2006). In db/db mice a decreased number of T 
lymphocytes (Kimura et al., 1998), an impaired chemotaxis of neutrophils (Kordonowy et al., 
2012), an altered NK activity of splenocytes (Tian et al., 2002) and a decreased proliferative 
response of peritoneal lymphocytes to mitogens (De Castro, 2016) have also been shown. In ob/ob 
and db/db mice a decreased phagocytosis and capacity of killing Candida albicans have also been 
observed (Lindström, 2007; Loffreda et al., 1998; Martí et al., 2001). Thus, both ob/ob and db/db 
mice showed an increased susceptibility to bacterial infections (Milner and Beck, 2012). In 
particular, ob/ob mice displayed an increased susceptibility to Mycobacterium tuberculosis and 
Klebsiella pneumonia infections, whereas db/db mice to infections against Staphylococcus aureus 
and Helicobacter pylori (Bandaru et al., 2013).  
With respect to models of obesity induced by a high-fat diet, it has been found decreased 
phagocytic capacity and ROS production of peritoneal macrophages (Strandberg et al., 2009). The 
number and functionality of hepatic NKT cells were also significantly lower in DIO mice in 
comparison with non-DIO controls (Li et al., 2005). An impaired function of dendritic and T cells 
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regarding the presentation of antigens has also been observed in DIO mice compared to non-DIO 
controls (Verwaerde et al., 2006). Furthermore, DIO mice displayed higher plasma levels of MCP-1 
and number of positive CD11b macrophages/monocytes in comparison with non-DIO mice 
(Takahashi et al., 2003). DIO mice also showed decreased proliferation of spleen lymphocytes in 
response to ConA, PHA or LPS (Sato Mito et al., 2009). In addition, production of IL-2 by splenic 
lymphocytes from DIO mice was suppressed, whereas IFN-gamma and IL-4 production was 
increased (Mito et al., 2000).  
All these studies indicate that both genetically and diet-induced obesity cause a deterioration 
of immune defences in rodents, affecting both the number and functionality of immune cells.  
 
1.5.9. Obesity and the central nervous system 
Increasing evidence suggests that obese individuals show an increased infiltration of 
oxidative and inflammatory compounds into the brain, as well as a higher generation of oxidation-
inflammation in this organ in comparison with non-obese individuals. Thus, recent evidence 
supports the presence of neuroinflammation in the hypothalamus, amygdala, hippocampus, cortex, 
and cerebellum during obesity (Beilharz et al., 2016; Guillemot-Legris et al., 2016). This 
neuroinflammation generated in the central nervous system has been related to the development of 
cognitive, motor and behavioural dysfunctions (Pistell et al., 2010; White et al., 2009).  
One of the earliest studies showing the effects of obesity on brain function described that 
brain myelination was affected in genetically obese mice (Sena et al., 1985). Imaging studies in 
humans confirmed these results and also showed myelin abnormalities associated with obesity 
(Jagust, 2007). Several animal studies demonstrated that diet-induced obesity was associated with 
cognitive alterations, such as decreased spatial learning skills (Jurdak et al., 2008; Molteni et al., 
2002; Stranahan et al., 2008; Wu et al., 2003). Obesity has also been associated with anxiety, 
depressive-like symptoms and poor memory consolidation in rodents (Guillemot-Legris and 
Muccioli, 2017). Different mechanisms have been identified as being able to alter cognitive 
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function, including impaired levels of brain-derived neurotrophic factor, glutamatergic signalling 
and insulin regulation (Guillemot-Legris and Muccioli, 2017). 
 
1.6.  LEPTIN  
 
1.6.1. Main characteristics of leptin 
A search for the biological factor responsible for the homeostatic regulation of body weight 
was initiated by studies on animal models. In 1994, a molecular defect in the obese gene (ob), a 
gene responsible for the obese phenotype of ob/ob mice was identified using a positive cloning 
method. Ob gene was found on chromosome 6 in mice and on chromosome 7q31.3 in humans. The 
protein encoded by the ob gene was isolated and named leptin (from the Greek “leptos” meaning 
thin) (Gorska et al., 2010; Zhang et al., 1994). Leptin, a 16 kDa non-glycosylated polypeptide, is 
mainly produced and secreted by adipocytes in proportion to fat mass. Leptin exhibits structural 
similarities to members of the long-chain helical cytokine family, including leukemia inhibitory 
factor, ciliary neurotrophic factor, oncostatin-M and cardiotrophin-1, as well as IL-6, IL-11 and IL-
12. The three-dimensional structure of the 167-amino acid leptin molecule is based on four 
antiparallel α-helices, connected by two long crossover links and one short loop arranged in a left-
handed helical bundle, which forms a two-layer packing (Frühbeck, 2006). 
Circulating leptin concentrations are correlated with the total amount of body fat, thereby 
reflecting the status of long-term energy stores. In addition, leptin concentrations fluctuate 
according to changes in caloric intake with a marked enhancement during food intake (Frühbeck et 
al., 1998; Park and Ahima, 2015). Although leptin is predominantly produced and secreted to the 
bloodstream by adipocytes, it is also produced at low levels by skeletal muscle, stomach, bone 
marrow, mammary epithelium, pituitary gland, hypothalamus, bone and placenta (Bado et al., 1998; 
Frühbeck, 2006; Hsuchou et al., 2009; Señarís et al., 1997; Wang et al., 1998). Initially, the effects 
of leptin were thought to be only centrally mediated. However, increasing evidence now suggests 
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that leptin has an extreme pleiotropic role. Based on its almost ubiquitous distribution of receptors, 
leptin has been reported to play a role in a diverse range of physiological functions both at the 
central nervous system and at the periphery (Park and Ahima, 2015). These functions include 
regulation of energy balance, brain and bone development, neuroendocrine control, reproductive 
function, metabolism, and immune and inflammatory functions (Allison and Myers, 2014; Otero et 
al., 2005).  
In humans, most circulating leptin is bounded to serum macromolecules, which may 
modulate ligand bioactivity and bioavailability to target tissues (Houseknecht et al., 1998). In lean 
individuals with relatively low adipose tissue mass, the majority of leptin is in the bound form, 
whereas the proportion of free leptin is increased in serum of obese subjects (Frühbeck, 2006; 
Houseknecht et al., 1998). Leptin concentrations exhibit sexual dimorphism. Women tend to have 
higher levels than men even after body fat mass control (Frühbeck, 2006; Park and Ahima, 2015). 
Subcutaneous fat produces more leptin than visceral fat, and this could partly contribute to higher 
leptin levels in women compared to men. Leptin levels can be regulated by a variety of factors, 
including sex steroids, insulin, glucocorticoids, catecholamine, and cytokines (Park and Ahima, 
2015). 
 
1.6.2. Main characteristics of leptin receptor (Ob-R) 
Ob-R receptor, encoded by diabetes (db) gene was first identified in mice using a cloning 
technique (Bazan, 1990). The pleiotropic nature of leptin is supported by the universal distribution 
of Ob-R leptin receptors. Leptin acts via transmembrane receptors and shows structural similarity to 
the class I cytokine receptor family (Gorska et al., 2010; Hegyi et al., 2004). Ob-R can be expressed 
in six alternatively spliced forms, namely Ob-Ra, Ob-Rb, Ob-Rc, Ob-Rd, Ob-Re and Ob-Rf, which 
have in common an extracellular domain of over 800 amino acids, a transmembrane domain of 34 
amino acids and a variable intracellular domain, characteristic for each of the isoforms (Frühbeck, 
2006; Lee et al., 1996). The isoforms of Ob-R can be classified into three categories: short, long 
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and secreted. The Ob-Ra isoform (the short leptin receptor isoform) appears to play an important 
role in transporting leptin across the blood-brain barrier (Kelesidis et al., 2010). The Ob-Rb isoform 
(the long leptin receptor isoform) mediates signal transduction and is highly expressed in the 
hypothalamus, an important site for the regulation of energy homeostasis and neuroendocrine 
function (Kelesidis et al., 2010). The Ob-Rb expression is also present in all types of immune cells 
(Gorska et al., 2010). The lack of the Ob-Rb isoform has been responsible for the obesity 
phenotypes of the db/db mouse and the fa/fa rat (Chua et al., 1996). Relatively weak signal 
transduction through long Ob-Rb isoform observed in obese and hyperleptinemic individuals is 
associated with delayed receptor expression on the cell surface. This fact could explain leptin 
resistance in these individuals (Gorska et al., 2010). 
The binding of leptin to Ob-Rb receptor activates several signal transduction pathways, 
including janus kinase-signal transducer and activator of transcription-3 (JAK-STAT3), which is 
important for regulation of energy homeostasis and phosphatidylinositol 3-kinase (PI3K), which is 
important for regulation of both food intake and glucose homeostasis. Other pathways have also 
been described, including mitogen-activated protein kinase (MAPK), 5´adenosine monophosphate-
activated protein kinase (AMPK), and the mammalian target of rapamycin (mTOR) (Kelesidis et 
al., 2010). 
 
1.6.3. Roles of leptin in the energy homeostasis 
Leptin is widely recognized for its role in regulating food intake and body mass (Anubhuti 
and Arora, 2008).  Leptin exerts immediate effects by acting on the brain to regulate appetite. Via 
Ob-Rb receptor binding in the hypothalamus, leptin interacts with a complex neural circuit to 
control food intake, activating anorexigenic neurons (i.e. appetite-diminishing) that synthesize pro-
opiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript (CART), and 
inhibiting oroxigenic neurons (i.e. appetite-stimulating) that synthesize agouti-related peptide 
(AgRP) and neuropeptide Y (NPY). The fall in leptin stimulates the expression of AgRP and NPY 
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and suppresses POMC and CART, thereby increasing food intake and decreasing energy 
expenditure (Park and Ahima, 2015).  
In addition to regulating food intake, leptin also increases energy expenditure through 
sympathetic nerve activity. In mice, leptin activates brown adipose tissue thermogenesis by 
increasing the expression of uncoupling protein (UCP)-1, but these effects have not been confirmed 
in humans (Kelesidis et al., 2010).  
 
1.6.4. Roles of leptin in the immune system  
The expression of Ob-Rb in the immune system cells (including macrophages, monocytes, 
neutrophils, natural killer (NK) cells, T and B cells) indicates that leptin plays an important role in 
the regulation of immune responses (Naylor and Petri, 2016; Zhao et al., 2003). In addition, leptin, 
which has been shown to function as a pro-inflammatory molecule (Lord et al., 1998), is able to 
modulate a variety of innate and adaptive immune system functions. These are further described 
below. 
Roles of leptin in the innate immune system  
Leptin and macrophages 
Genetic leptin- and leptin receptor-deficient rodent models have been associated with 
impaired macrophage functions, including phagocytosis and the expression of pro-inflammatory 
cytokines both in vivo and in vitro (Fernández-Riejos et al., 2010). However, the administration of 
exogenous leptin was able to revert this impaired macrophage functions (Loffreda et al., 1998). In 
addition, leptin dose-dependently has shown to stimulate the production of pro-inflammatory 
cytokines by monocytes (such as TNF-α and IL-6) (Gabay et al., 2001) and to enhance the 
expression of CC-chemokine ligand in culture murine macrophages, through the activation of a 
janus kinase 2 (JAK2)-signal transducer and activator of transcription 3 (STAT-3) pathway 
(Kiguchi et al., 2009). Also, a previous study showed that, in human monocytes, leptin was able to 
enhance the secretion of IL-18, via activation of caspase-1 inflammasome function, acting 
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synergistically with ATP. This process could contribute to aberrant immune responses, such those 
found in type 2 diabetes and other conditions of hyperleptinemia (Jitprasertwong et al., 2014). 
Another study demonstrated that leptin stimulated the proliferation and activation of human 
circulating monocytes in vitro, promoting the expression of activation markers, such as CD69, 
CD25, CD38, and CD71 (Santos-Alvarez et al., 1999). In addition, leptin was a potent 
chemoattractant for mouse monocytes and macrophages, and this process required the presence of 
full-length leptin receptors on migrating cells (Gruen et al., 2007). Furthermore, leptin stimulation 
resulted in an increased influx of intracellular calcium in macrophages and in activated JAK/STAT, 
mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3K) pathways, 
which suggests that canonical cell motility machinery was activated upon macrophage exposure to 
leptin (Gruen et al., 2007).  
Leptin and dendritic cells (DC)s 
Dendritic cell functions were also impaired in leptin-deficient obese mice. Thus, ob/ob mice 
have been associated with impaired number and functionality of DCs. In fact, DCs from ob/ob mice 
were less potent in stimulating allogenic T cells in vitro compared to those derived from wild type 
mice (Macia et al., 2006). In addition, leptin deficiency impaired the maturation of dendritic cells, 
which resulted in the defective production of IL-12, TNF-α, and IL-6 (Moraes-Vieira et al., 2014). 
Leptin seems to up-regulate the production of IL-1β, IL-6, IL-12, TNF-α, and MIP-1α and to down-
regulate the generation of IL-10 by DCs, driving naïve T cell polarization toward a Th1 phenotype 
(Mattioli et al., 2005).  
Leptin and neutrophils 
Leptin has also an immunomodulatory role in neutrophils (Fernández-Riejos et al., 2010). 
Previous studies found that human neutrophils were able to express the short form of the leptin 
receptor, which transmited the signal inside the cell, enhancing the expression of CD11b and 
preventing neutrophils from apoptosis (Bruno et al., 2005; Procaccini et al., 2017; Zarkesh-
Esfahani et al., 2004). Another study showed that leptin stimulated chemotaxis of neutrophils and 
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exerted by itself a chemoattractive effect comparable to that of formylated peptide (fMLP). Also, 
leptin was able to increase intracellular H2O2 production (Caldefie-Chezet et al., 2003). In addition, 
neutrophils from leptin-deficient mice exhibited impaired phagocytosis of Klebsiella pneumoniae 
and low expression of CD11b (Moore et al., 2003). 
Leptin and Natural killer (NK) cells 
Leptin has been shown to be involved in the processes of NK cell development, 
differentiation, activation, and cytoxicity (Tian et al., 2002; Zhao et al., 2003). Leptin seems to 
enhance these processes in NK cells via the activator of transcription 3 (STAT-3) and by the up-
regulation of the expression of IL-2 and perforin genes (Zhao et al., 2003). In addition, deficient-
leptin mice displayed decreased percentage and total number of NK cells in the liver, spleen, lung, 
and peripheral blood (Tian et al., 2002). Leptin seems to have a specific effect also on invariant 
NKT (iNKT) cells. These cells are essential for several aspects of immunity, as their dysfunction or 
deficiency may result in the development of autoimmune diseases. A previous study showed that 
Ob-R was expressed also on murine iNKT cells and that leptin suppressed iNKT cell proliferation 
and their cytokine production in vitro (Venken et al., 2014). 
Leptin and the adaptive immune system  
Leptin and T lymphocytes 
Leptin has shown to play an important role in T-cell immunity. Lord et al. (1998) was the 
first to demonstrate that leptin exhibited a specific effect on T-cell responses, differentially 
regulating the proliferation of naïve and memory T cells. In this study, leptin specifically promoted 
the proliferation of naïve T cells by increasing the secretion of IL-2, through the activation of the 
mitogen-activated protein kinase (MAPK) and PI3-K pathway. On memory T cells, leptin favoured 
a pro-inflammatory phenotype response by enhancing the production of pro-inflammatory cytokines 
(such as IFN-γ and TNF-α) (Lord et al., 1998). In addition, leptin induced the expression of the 
adhesion molecules ICAM-1 and VLA-2 (very late antigen 2) on CD4+ T cells, possibly by the 
production of pro-inflammatory cytokines, such as IFN-γ (Lord et al., 1998). Another study showed 
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that the administration of human leptin (metreleptin) in women, who were affected by hypothalamic 
amenorrhea with acquired chronic hypoleptinemia, was able to restore both CD4+T cell counts and 
their proliferative response. These changes were accompanied by a transcriptional signature in 
which genes relevant to cell survival and hormonal response were up-regulated, and the apoptosis 
genes were down-regulated in circulating immune cells (Matarese et al., 2013). In addition, another 
study showed that leptin was able to promote lymphocyte survival, by up-regulating lymphocyte 
surface expression of glucose transporters, such as GLUT-1 and GLUT-4 (Sivitz et al., 1997). A 
previous report demonstrated that leptin seemed to be important not only in Th1-dependent immune 
response as described previously by Lord et al. (1998), but also for Th2 cell development (Batra et 
al., 2010). Leptin was also reported as a negative signal for the proliferation of human naturally 
occurring Foxp3+CD4CD25 regulatory T (Treg) cells. Thus, isolated human Treg cells expressed 
high amounts of Ob-R and produced substantial amounts of leptin that were responsible for an 
autocrine inhibitory loop that constrained the expansion of Treg cells (De Rosa et al., 2007). A 
recent study demonstrated decreased frequency of Th17 cells in ob/ob mice. Thus, obese mice with 
leptin or Ob-R deficiency showed decreased capacity for differentiation toward a Th17 phenotype 
and this condition was attributed to low activation of STAT3 and its downstream targets. These 
effects were restored after administration of exogenous leptin (Reis et al., 2015). Several studies 
also demonstrated that leptin was able to regulate the secretion of cytokines from human peripheral 
CD8+ cells. In particular, leptin enhanced the secretion of IL-2 and IFN-γ and inhibited the 
production of IL-4 and IL-10 (Rodríguez et al., 2007).  
Leptin and B lymphocytes 
Similar as found for T lymphocytes, leptin also plays an important role in the modulation of 
B lymphocytes (Procaccini et al., 2017). Thus, leptin deficiency has been associated with a 
significant decrease in lymphopoiesis, as testified by 70% fewer B lymphocytes than normal 
controls. Also, there were decreased counts of pre-B and immature B lymphocytes. However, 
treatment with recombinant leptin was able to promote an increase in B lymphocyte counts, as well 
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as an increase in pre-B and immature B lymphocyte counts of deficient-leptin mice (Claycombe et 
al., 2008). Similar results have also been detected in the bone marrow of fasted mice (Tanaka et al., 
2011). In addition, another study showed that leptin stimulated the secretion of several cytokines, 
such as IL-6, IL-10 and TNF-α, in human B cells via activation of JAK2/STAT3 and p38 mitogen-
activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) 1/2 signalling 
pathways (Agrawal et al., 2011). Nevertheless, leptin seems also to induce the production of pro-
inflammatory cytokines by B cells and these could play a role in the inflammation associated with 
chronic diseases (Gupta et al., 2013).  
 
1.6.5. Roles of leptin in the neonatal development 
 Increasing evidence indicates that leptin has an important role in the prenatal and postnatal 
development. In pregnancy, the production in the placenta rises significantly in rodents and humans 
(Gavrilova et al., 1997; Señarís et al., 1997). In addition, there is a temporary increase of leptin 
levels in rodents during the early postnatal period, constituting a “leptin surge”. Thus, it has been 
described that neonatal mice and rats experience elevated levels of leptin from postnatal day (PND) 
4 to PND 14, with a peak at PND 10 (Ahima et al., 1998; Delahaye et al., 2008). However, unlike 
found in adult rodents, in neonates this rise in leptin is independent of fat mass or food intake 
(Ahima et al., 1998).  
A great body of evidence indicates that the leptin surge is involved in the development of 
the central nervous system (CNS) during early life. In this sense, ob/ob mice showed perturbed 
CNS development, characterized by altered myelination and expression of neuronal and glial cell 
markers (Bereiter and Jeanrenaud, 1979; Sena et al., 1985). The administration of leptin in ob/ob 
animals during postnatal period resulted in an increase of brain size (Ahima et al., 1999; Steppan 
and Swick, 1999). However, restoration of brain weight to wild-type levels required leptin to be 
administered for 6 weeks, from 4 weeks of age. Administration of leptin for 2 weeks from 8 to 10 
weeks of age was ineffective in the rescue of brain weight or protein content (Ahima et al., 1999). 
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Thus, it seems that there is a critical period for leptin administration in the rescue of brain 
development (Cottrell et al., 2011). In addition, the presence of circulating levels of leptin in foetal 
rodents and the expression of leptin receptors (Ob-Rs) throughout the CNS indicate the key role of 
this hormone in brain development (Hoggard et al., 1997; Matsuda et al., 1999; Udagawa et al., 
2007).  
In particular, the leptin surge has shown to contribute to the establishment of hypothalamus 
circuits that regulate energy balance. These seem to occur through modifications in the neuronal 
outgrowth and synaptic connectivity, as well as neurogenesis and neuronal and glial survival 
(Bouret, 2013). In addition, neurotrophic effects of leptin have also been demonstrated in extra-
hypothalamic sites. Leptin administration induced ERK1/2 signalling in the cortex of both neonatal 
and adult mice, and in cultures embryonic cortical neurons affected growth cone size and spreading 
(Valerio et al., 2006). Taken together, these actions of leptin indicate a widespread role for this 
hormone in neuronal development and circuit formation (Cottrell et al., 2011). 
 
1.7. UNSATURATED FATTY ACID SUPPLEMENTATION AS A 
NUTRITIONAL INTERVENTION TO IMPROVE IMMUNITY IN OBESITY 
 
1.7.1. Definition and classification of dietary fatty acids 
Fatty acids, both free and as part of complex lipids, play a number of key roles in 
metabolism, including storage and transport of energy, as essential components of cell membrane 
phospholipids, and as gene regulators (Rustan and Drevon, 2005). Fatty acids consist of elements, 
such as carbon, hydrogen, and oxygen, arranged as a linear carbon chain skeleton of variable length 
with a methyl group at one end (designated as omega, ω) and a carboxyl group at the other end. The 
letter n is also often used instead of the Greek ω to indicate the position of the double bond closest 
to the methyl group. The nomenclature for fatty acids may also indicate the location of double 
bonds with reference to the carboxyl group (Δ) (Table 2) (Rustan and Drevon, 2005). Fatty acids 
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can be separated into three categories: saturated, monounsaturated, and polyunsaturated. In 
saturated fatty acids, the carbon chain has the maximum number of hydrogen atoms attached to 
every carbon atom. If a pair of hydrogen atoms is missing because of a double bond between two 
carbon atoms, it is called an unsaturated fatty acid. A fatty acid with a single double bond is 
monounsaturated, whereas a fatty acid with more than one double bond is polyunsaturated (White, 
2009). 
The most commonly occurring saturated fatty acid (SFA) in animals, plants and 
microorganisms is palmitic acid (C16:0). Shorter-chain saturated fatty acids with 8-10 carbon atoms 
are found in milk and coconut triglycerides. SFAs have a thermodynamically more stable structure, 
which results in a higher melting point than unsaturated fatty acids. Thus, fats containing higher 
levels of saturated bonds tend to be more solid at ambient temperatures than fats containing higher 
levels of unsaturated bonds (White, 2009). 
Most naturally occurring unsaturated fatty acids have the cis configuration of the double 
bonds. This means that the hydrogen atoms on either side of the double bond are oriented in the 
same direction. Trans isomers may be produced during industrial processing (hydrogenation) of 
unsaturated fatty acids and in the gastrointestinal tract of ruminants. The cis configuration gives a 
kink in the molecular shape and cis fatty acids have lower melting points than the trans fatty acids 
or their saturated counterparts (Rustan and Drevon, 2005). The most commonly cis-
monounsaturated fatty acid (MUFA), found in plants and animals, is the oleic acid (C18:1 n-9).  
The most important polyunsaturated fatty acids (PUFA) for human nutrition are those from 
n-3 and n-6 families. Both n-3 and n-6 PUFAs are essential nutrients, and therefore, must be 
obtained from the diet. Linoleic acid (C18:2 n-6) is a major fatty acid found in plant lipids. In 
animals it is derived mainly from dietary plant oils. α-linolenic (C18:3 n-3) is found mainly in 
soybean and rape seed oils and algae (Rustan and Drevon, 2005). Both essential fatty acids can be 
further elongated and desaturated in animal cells forming the n-6 and n-3 families of PUFA. The 
metabolism of the n-6 and n-3 fatty acids is competitive, since both pathways employ the same set 
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of enzymes. The major end product of the n-6 pathway is arachidonic acid (C20:4 n-6), which is a 
component of membrane phospholipids and is also a precursor of some prostaglandins, 
thromboxanes, and leukotrienes. It is present in animal fats and at low levels in many fish oils. This 
pathway is quantitatively the most important pathway of PUFA metabolism in human, given that 
linoleic acid is abundant in vegetable oils and vegetable oil-based products, and is therefore 
consumed in greater amounts than α-linolenic. The major long chain of the n-3 pathway are 
eicosapentaenoic acid (EPA, C20:5 n-3) and docosahexaenoic acid (DHA, C22:6 n-3), which are 
primarily found in fish oils and marine algae (Yaqoob, 2003).  
 
Table 2. Structure of different fatty acids with a methyl end and a carboxyl (acidic) end. 
 
Stearic acid is a saturated fatty acid with 18 carbon atoms and no double bond (C18:0). Oleic acid 
has 18 carbon atoms and one double bond in the n-9 position (C18:1 n-9), whereas eicosapentaenoic 
acid (EPA), with multiple double bonds, is represented as C20:5 n-3. It is also possible to describe 
fatty acids systematically in relation to the carboxyl end of the fatty acids; symbolized Δ (Greek 
delta) and numbered 1. All unsaturated fatty acids are shown with cis configuration of the double 
bonds. DHA, docosahexaenoic acid. Cited in Rustan and Drevon, 2005. 
 
1.7.2. Roles of dietary fatty acids in obesity-related diseases 
Epidemiological data support an association between dietary fat intake and the development 
of obesity. Cross-cultural studies have shown a rising body mass index in countries with high 
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intakes of dietary fat (Bray and Popkin, 1998). In particular, the consumption of saturated fatty 
acids has been linked to an increased risk of obesity and cardiovascular diseases (CVD). This effect 
on CVD appears to be mediated mainly by the rise of low-density lipoprotein (LDL) cholesterol 
concentrations (Artaud-Wild et al., 1993; Hu et al., 1997; Kagan et al., 1974; Keys et al., 1986; 
Mensink and Katan, 1992; Pietinen et al., 1997). Currently, most of dietary recommendations for 
CVD prevention and treatment are focused on the reduction of saturated fat intake. In general, 
clinical trials that have replaced saturated fat with unsaturated fat, especially PUFA, have shown a 
reduction in CVD events as a result of lowering both LDL and HDL (high-density lipoproteins) 
cholesterol concentrations. In contrast, the replacement with a high carbohydrate intake, particularly 
refined carbohydrate, seems to exacerbate the atherogenic dyslipidemia associated with insulin 
resistance and obesity that include increased triglycerides, small LDL particles, and reduced HDL 
cholesterol (Siri-Tarino et al., 2010). 
However, in contrast to the detrimental effects of saturated fatty acids, MUFA and PUFA 
intakes have been associated with positive outcomes on obesity and obesity related-diseases. Thus, 
evidence from human clinical trials demonstrated that compared to carbohydrate rich diets, insulin 
resistant subjects consuming a diet rich in MUFA showed significantly increased fat oxidation rates 
and decreased abdomen-to-leg adipose ratios, thus preventing central body fat distribution 
(Paniagua et al., 2007). Similarly, the substitution of a saturated fatty acid rich diet for MUFA-rich 
diet for four weeks resulted in a decrease in body mass and fat mass in overweight and obese men 
(Piers et al., 2003). In addition, favourable modifications in body weight composition and 
amelioration of weight gain after consumption of MUFA compared to SFA have also been observed 
in healthy subjects (Kien, 2009). Thus, dietary MUFA consumption seems to be associated with 
both decreased body weight and central body fat adiposity, thus ameliorating obesity and obesity-
related diseases risk (Gillingham et al., 2011). In addition, MUFA intake seems to prevent CVD, 
through the reduction of LDL-cholesterol. Thus, a meta-analysis of cohort studies reported a 
significant correlation between MUFA intake and decreased relative risk for CVD (Mente et al., 
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2009). However, some studies found inconclusive data. For instance, Skeaff and Miller (2009) did 
not observe any effect of MUFA-rich diets on relative risk for CVD. In addition, a recent meta-
analysis, which included nine cohort studies, found no significant associations between MUFA 
intake, circulating MUFA and risk of CVD (Chowdhury et al., 2014). One possible justification for 
these inconclusive data could be the different sources of MUFA that were used. In the case of 
adopting a western diet, MUFA is predominantly supplied by foods of animal origin, while in south 
European countries, extra virgin olive oil is the most dominant source used (Schiwingshackl and 
Hoffmann, 2014). Thus, studies that have used olive oil as the main source of MUFA when 
compared to a low-fat diet, such as the PREDIMED trial, have shown CVD benefits (Estruch et al., 
2013). In addition, a recent meta-analysis that considered olive oil intake demonstrated an overall 
risk reduction of all cause mortality and of CVD mortality and events (Schiwingshackl and 
Hoffmann, 2014).  
With regards of the effects of n-3 PUFA on obesity and body weight, studies have shown 
controversial data. Thus, Couet et al. (1997) demonstrated that in healthy adults the replacement of 
6 g of visible fat in diet with 6 g of fish oil did not promote body weight loss. However, the 
interventional group exhibited lower body fat mass and increased lipid oxidation as compared to the 
control group. In addition, Parra et al. (2008) found that satiety is increased after consumption of 
the n-3 PUFAs-enriched meals. However, a recent meta-analysis performed to investigate the 
influence of fish oil on body composition did not find an anti-obesity benefit of n-3 PUFAs in 
overweight/obese adults. However, in this study, the waist hip ratio was improved after 
supplementation with fish oil in obese individuals (Du et al., 2015). Further larger clinical trials are 
needed in order to be able to recommend the most effective dosages and formulas (type of n-3 
PUFA, EPA/DHA ratio) for prevention/treatment of obesity and obesity-related diseases (Lorente-
Cebrián et al., 2013). Regarding the effects of n-3 PUFA intake on CVD, several organizations 
recommend increasing the consumption of EPA and DHA (at least two servings of fish per week) 
for primary prevention of coronary heart disease in general population (Lorente-Cebrián et al., 
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2013). Observational studies in Inuit and Japanese populations were the first suggesting the 
potential cardiovascular protective role of n-3 PUFA, probably due to the high intake of fatty fish in 
their habitual diet (Bang et al., 1976). Later on, several controlled trials provided evidence that the 
consumption of n-3 PUFA was responsible for the protective effects of fish oils against CVD (Bang 
et al., 1980; Dyerberg and Bang, 1979). However, there is still limited evidence about the 
association of n-3 PUFAs intake and prevention in mortality from CVD. For people with specific 
diseases, such as hypertriglyceridemia and hypertension, the effective doses of EPA and DHA 
required are reported to be much higher (Lorente-Cebrián et al., 2013).  
With regards to the consumption of n-6 PUFA, studies consistently have shown that 
replacing SFA or carbohydrate with linoleic acid decreased LDL cholesterol concentrations and 
total cholesterol to HDL ratio (Kris-Etherton and Yu, 1997; Mensink et al., 2003). In addition, a 
meta-analysis based on 13 cohort studies showed that high linoleic acid intake was associated with 
a 15% lower risk of CVD events (Farvid et al., 2014).  
 
1.7.3. Roles of dietary fatty acids in the immune system 
It is largely known that fatty acids can influence the immune system. Thus, extensive 
research over the last years suggests that the quality of dietary fat intake has an important role in 
modulating immune and inflammatory responses. According to Calder (2008), fatty acids have a 
variety of roles in immune cells, which include (1) fuels for generation of energy, (2) components 
of cell membrane phospholipids contributing to their physical and functional properties, (3) 
covalent modifiers of protein structure influencing the cellular location and function of these 
molecules, (4) regulators of gene expression either through effects on receptor activity, on 
intracellular signalling processes, or on transcription factor activation, and (5) precursors for 
synthesis of bioactive lipid mediators like prostaglandins, leukotrienes, lipoxins and resolvins.  
It is well accepted that the influence of fatty acids on immune and inflammatory cell 
responses involves their incorporation into cell membrane phospholipids (Calder, 2008). For 
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instance, the fatty acid composition of immune cells from rodents, maintained on normal laboratory 
chow typically, contained 15-20% of fatty acids as arachidonic acid and very low amounts of EPA 
and DHA (Calder et al., 1990; 1994). However, changes in the dietary fatty acid intake of these 
animals were able to alter the fatty acid composition of immune cells (Kew et al., 2003; Peterson et 
al., 1998; Wallace et al., 2000; 2001; Yaqoob et al., 1995). Thus, inclusion of arachidonic acid or 
EPA and DHA in the diets fed to rodents resulted in high amounts of these fatty acids in the 
immune cells (Kew et al., 2003; Perterson et al., 1998; Wallace et al., 2000; 2001; Yaqoob et al., 
1995). Similarly, studies in human immune cells also confirmed these results. Thus, an increase of 
arachidonic intake resulted in high amounts of this fatty acid in mononuclear cells (MNCs) (Thies 
et al., 2001), while an increase of α-linolenic acid intake resulted in high amounts of this fatty acid 
in MNCs and neutrophils (Caughey et al., 1996; Healy et al., 2000). In both animal and human 
experiments, the incorporation of n-3 fatty acids into membrane phospholipids of immune cells 
occurred in a time and dose-dependent fashion and was largely at the expense of n-6 PUFA, 
especially arachidonic acid (Browning et al., 2012; Healy et al., 2000; Rees et al., 2006; Yaqoob et 
al., 2000). 
Roles of saturated fatty acids in the immune system 
Saturated fatty acids seem to stimulate adipose tissue inflammation, which is highly 
associated with obesity, by a process that involves Toll-like receptor 4 (TLR4), a receptor that binds 
bacterial lipopolysaccharide (LPS). TLR4 activation by saturated fatty acid has shown to increase 
the expression of a number of inflammatory genes in adipocytes by a NFκB-dependent mechanism, 
similar to TLR4 activation by LPS. An excess of saturated fatty acids can also stimulate 
inflammatory molecules in macrophages (Chait and Kim, 2010).  
Regarding the effects of high-saturated-fat diet on animal models, contradictory data have 
been found. Thus, some studies showed that high-saturated-fat diet did not affect lymphocyte 
proliferation, cytokine production or NK cell activity compared to low-fat diets (Alexander and 
Smythe, 1988; Locniskar et al., 1983; Yaqoob and Calder, 1995a; 1995b), whereas others 
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demonstrated a suppressive effect of this type of diet (Friend et al., 1980; Morrow et al., 1985; 
Ossman et al., 1980; Sanderson et al., 1995; Yaqoob et al., 1994a; 1994b).  
Roles of monounsaturated fatty acids in the immune system 
Several studies support that olive oil, rich in oleic acid, is capable of modulating functions of 
the immune system cells. For instance, a study with animals reported a significant inhibitory effect 
of olive oil on the proliferation of mesenteric lymph node lymphocytes in response to the T-cell 
mitogen, ConA, when compared to animals fed low-fat diet or high-fat diet (rich in hydrogenated 
coconut oil or safflower oil) (Yaqoob et al., 1994a). In addition, rats fed a diet rich in olive oil 
displayed a significant suppression of NK cell activity compared to control rats fed a low-fat diet or 
diets containing hydrogenated coconut oil or safflower oil (Yaqoob et al., 1994b). However, it is 
important to notice that these animal studies have administrated diets enriched with large amounts 
of MUFA (200g/kg), contributing for approximately 30% of total energy intake (Yaqoob, 2002). 
Another study that used relatively small amounts of oleic acid in the diet showed an opposite effect. 
Thus, these animals showed increased proliferation of lymphocytes and NK cell activity (Jeffery et 
al., 1997). Thus, there have been contradictory results regarding the effects of MUFA on immune 
functions, which are mostly because of differences in the concentrations of fatty acid supplemented 
(Yaqoob, 2002). 
In contrast to the animal studies, consumption of a MUFA-rich diet by healthy human 
individuals did not produce changes in immune cell functions (Yaqoob et al., 1998). Thus, middle-
aged men who were randomly assigned to consume either a control diet or a diet containing foods 
enriched with highly refined olive oil for 8 weeks showed no change in the proliferative response of 
either whole blood cultures or peripheral blood mononuclear cells in response to ConA (Yaqoob et 
al., 1998). The consumption of MUFA diet also did not affect NK cell activity in humans (Yaqoob 
et al., 1998). The different results obtained in animals and humans may be attributable to the higher 
amount of monounsaturated fat used in the first than in the second (Yaqoob, 2002). 
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Roles of polyunsaturated fatty acids in the immune system 
PUFA are incorporated into cell membrane phospholipids and serve as precursors of 
eicosanoid synthesis. Arachidonic acid (AA, C20:4 n-6) and eicosapentaenoic acid (EPA, 20:5 n-3)  
are converted through phospholipase A2, cyclooxygenase (COX) and lipoxygenase (LOX) to 
prostaglandins, thromboxanes, leukotrienes, as well as various hydroxyl-fatty acids. Resulting 
metabolites from these reactions are widely known as eicosanoids, which are involved in 
modulating the intensity and duration of inflammatory responses. Because of the relatively high 
amount of arachidonic acid in membrane phospholipids of cells involved in inflammation, this fatty 
acid is typically the major precursor for eicosanoid mediators, which are produced in high amounts 
upon cellular stimulation. In general, AA-derived eicosanoids are more physiologically potent and 
of a pro-inflammatory nature than those derived from n-3 PUFA, which are often much less 
biologically active (Calder, 2010; Lorente-Cebrián et al., 2013; Schmitz and Ecker, 2008). 
Although this idea is considered an over-simplification since it is now recognized that eicosanoids 
derived from arachidonic acid, such as PGE2, has both pro- and anti-inflammatory effects (Calder, 
2010). In contrast, EPA and DHA are claimed to act mainly as anti-inflammatory agents (Calder et 
al., 2010). There is a number of ways that n-3 PUFA seems to reduce inflammation, according to 
Calder (2010), these include: (1) decrease the production of eicosanoid mediators from arachidonic 
acid, many of which have pro-inflammatory roles, (2) increase the production of weakly 
inflammatory or anti-inflammatory eicosanoids from EPA, (3) increase the production of anti-
inflammatory resolvins from EPA and DHA, (4) decrease the chemotactic responses of leukocytes, 
(5) decrease the adhesion molecule expression on leukocytes and on endothelial cells and decrease 
the intercellular adhesive interaction, and (5) decrease the production of pro-inflammatory 
cytokines and other pro-inflammatory proteins induced via NFκB system. 
Given that the metabolism of the n-6 and n-3 fatty acids is competitive, an excess of fatty 
acid series may lead to a decrease in the conversion of the other series (Schmitz and Ecker, 2008). 
Thus, an excessive intake of n-6 PUFA (linoleic acid) decreases the formation of n-3 PUFA, such as 
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EPA and DHA, and promotes the synthesis of pro-inflammatory eicosanoids. In fact, when 
competing with larger amounts of n-6 PUFA, the conversion of α-linolenic acid into EPA is very 
low (from 0.2 to 6%) and the conversion into DHA is 0.05% or less (Goyens et al., 2006). The 
balance of n-6/n-3 PUFA is an important determinant in homeostasis maintenance, normal 
development, and mental health throughout life (Simopoulos, 2008; 2009). However, western diets 
contain excessive amounts of n-6 PUFA and very low amounts of n-3 PUFA, resulting in an 
unhealthy n-6/n-3 PUFA ratio of 20:1, instead of 1:1 found during evolution of humans 
(Simopoulos, 2016). This potentially could contribute to a pro-inflammatory milieu and the 
progression of obesity and obesity-related diseases (Lorente-Cebrián et al., 2013).  
Several studies evaluated the effects of polyunsaturated fatty acids on immunity. However, 
most studies in which n-6 PUFA were supplemented in rodent diets showed no effect on 
lymphocyte proliferation (Yaqoob et al., 1994a; 1995a), NK cell activity (Yaqoob et al., 1994b) or 
cytokine production (Yaqoob and Calder 1995a; 1995b). In contrast, a number of dietary 
supplementation studies with n-3 PUFA (delivered as fish oil) demonstrated a time-dependent 
decrease in chemotaxis of human neutrophils and monocytes towards various chemoattractants 
(such as leukotriene B4, bacterial peptides and human serum) (Endres et al., 1989; Lee et al., 1985; 
Luostarinen et al., 1992; Schmidt et al., 1991; Sperling et al., 1993). Both the distance of cell 
migration and the number of cells migrating were decreased. In addition, an inhibition of both 
lymphoproliferation (Arrington et al., 2001; Jeffery et al., 1996; Jolly et al., 1997; Yaqoob et al., 
1994a; 1995) and NK cell activity (Jeffery et al., 1996; Yaqoob et al., 1994b) were found in n-3 
PUFA supplemented rodents. However, as previously commented in MUFA rich diets, it should be 
notice that these animal studies employed large amounts of fatty acids in the diet. For instance, 
these diets can contain as much as 200 g fish oil/kg, reaching approximately 12% of dietary energy 
from n-3 PUFA. Regarding human studies, several studies showed no effect of n-3 PUFA (fish oil) 
intake on the production of inflammatory cytokines (Cooper et al., 1993; Mølvig et al., 1991; 
Schmidt et al., 1996; Yaqoob et al., 2000). However, another work indicates that fish oil 
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supplementation inhibited both lymphocyte proliferation and NK cell activity compared to a 
placebo treatment in healthy subjects aged 55-75 years old (Thies et al., 2001). In addition, previous 
studies report that fish oil supplementation suppressed the production of inflammatory cytokines 
(such as TNF-α, IL-1 and IL-6) in humans (Caughey et al., 1996; Gallai et al., 1995).  
Although some studies demonstrated immunomodulatory effects of n-3 PUFA, it is not yet 
clear whether they are associated with EPA or DHA, or a combined effect of these two n-3 PUFA. 
Animal studies suggest that both EPA and DHA have immunomodulatory effects. For instance, 
both EPA and DHA, fed to rats at 4.4g/100g total fatty acids, inhibited lymphocyte proliferation, 
although only EPA inhibited NK cell activity (Peterson et al., 1998). In addition, both EPA and 
DHA inhibited the proliferation and production of IL-2 by splenic lymphocytes in mice (Jolly et al., 
1997). However, two animal models of inflammation demonstrated differential effects of EPA and 
DHA, one suggesting reduced inflammation by DHA (Tomobe et al., 2000), whereas the other 
suggests that EPA was the most anti-inflammatory (Volker et al., 2000). In humans, a comparison 
of the effects of 3.8 g EPA/day or 3.6g DHA/day, with a control treatment of linoleic acid, reported 
no differential effects of the n-3 PUFA on the phagocytic activity of monocytes (Halvorsen et al., 
1997). Another study compared the effects of supplementation with fish oil (< 1g/day), highly-
purified DHA (< 1g/day) and a placebo on lymphocyte proliferation and NK cell activity in healthy 
subjects and demonstrated that fish oil inhibited lymphocyte proliferation and NK activity, whereas 
DHA had no effect. This finding could suggest that either EPA is responsible for the inhibitory 
effect or that both EPA and DHA are required (Thies et al., 2001).  
In addition, studies conducted in animals, investigating the influence of dietary fatty acids 
on host survival and/or pathogen clearance challenged with a live infectious agent were 
inconclusive, some studies showing that n-3 PUFA improved host defence, whereas others found 
suppressed immune functions (Anderson and Fritsche, 2002).   
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1.8. FERMENTED MILK WITH PROBIOTICS SUPPLEMENTATION AS A 
NUTRITIONAL INTERVENTION TO AMELIORATE THE AGING PROCESS  
 
1.8.1. Main characteristics of the gut microbiota.  
Recent data estimate that around 3.8 x 1013 microbial cells colonize the body of an average 
human male. Thus, this slightly exceeds the number of human cells in the body that constitutes the 
host, which are estimated to number 3.0 x 1013 to 3.7 x 1013 cells, in males (Sender et al., 2016). 
The microbial associates that reside in and on the human body constitute the microbiota, and it is 
mostly constituted by bacteria, but also by other microorganisms such as fungi, archaea, viruses, 
and protozoans (Sekirov et al., 2010). Their combined genomes contain millions of genes 
(microbiome), which are hundred times the number of human genes (Kamo et al., 2017). These 
microorganisms colonize all the surfaces of the human body that are exposed to the environment, 
with the majority residing in the intestinal tract (Clemente et al., 2012). The microbiota interacts 
with the host, greatly impacting human health and disease, being referred as a “forgotten organ” 
(O´Hara and Shanahan, 2006). The gut microbiota is involved in several host functions, including 
the production of micronutrients (such as essential vitamins and cofactors), transformation of 
xenobiotics, breakdown of complex lipids, proteins, and polysaccharides into metabolite 
intermediates (e.g., short-chain fatty acids), and also represents a barrier against pathogens (Picca et 
al., 2018). Importantly, the gut microbiota interacts with the immune system, providing signals to 
promote the maturation of immune cells and the normal development and homeostasis of the host 
immune system (Chow and Mazmanian, 2010). Indeed, 70% of the body immune cells reside in the 
gut-associated lymphoid tissue. The interaction between gastrointestinal cells and gut microbiota 
fosters immunological tolerance or inflammatory responses to pathogens. This crosstalk between 
microbiota and gut mucosal cells (enterocytes, dendritic cells, lymphocytes, macrophages, and M 
cells) modulates the production of various cytokines and chemokines (Picca et al., 2018). 
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In addition, the gut microbiota has an important role in the development and function of the 
central nervous system (CNS) and enteric nervous system (ENS) (Heiss and Olofsson, 2019). 
In contrast with genomic variation between humans, which reaches minimal differences, 
microbiome achieves 80-90% variation between regions of the same person (García-Peña et al., 
2017). Although the high interindividual variability, determined by height, sex, age, or place of 
residence, it has been determined that three specific microbial enterotypes (Bacteroides, Prevotella, 
or Rumunococcus) are constants (Arumugam et al., 2011). In healthy adults approximately 80% of 
the total gut microbiota is integrated by the phyla Firmicutes and Bacteroidetes (García-Peña et al., 
2017).  
The gut microbiota development starts at the birth, showing instability and reduced 
diversity. Environmental factors include the intrauterine microbiota of the mother and birth type. In 
this sense, the microbiota of the infant is more or less diverse according to the birth method. Thus, 
the gut microbiota of babies born by caesarean section showed less diversity of bacteria, 
particularly less Bifidobacteria, than vaginal delivery (Biasucci et al., 2008; Grönlund et al., 1999). 
As soon as the baby starts feeding, the food source (formula or breast milk) also determines the gut 
microbiota. Some authors suggest that microbiota from formula fed babies is characterized by 
having more pro-inflammatory taxa as well as higher bacterial loads than breast milk fed babies 
(O´Sullivan et al., 2015). Gut microbiota remains unstable until the infant is 2-3 years old, and will 
highly depend on environmental factors such as introduction of solid food, place of residence, 
antibiotic exposure and genetic host factors. The microbiota matures at around 3 years old when it 
reaches a more stable composition, as described in adulthood (García-Peña et al., 2017). In 
particular, dietary changes have shown significant effects on the microbiota. For instance, a study 
showed that changing from a low-fat, plant polysaccharide-rich diet to a high-fat, high-sugar 
western diet is able to change the microbiota within a day (Turnbaugh et al., 2009). Similarly, 
another study in human demonstrated that the shift from a high-fat/low-fibre diet to a low-fat/high-
fibre diet caused notable changes in the microbiota within a day (Wu et al., 2011b). Diet also seems 
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to correlate with enterotype, as individuals on a diet high in fat have a Bacteroides-dominated 
enterotype, whereas a carbohydrate-rich diet is associated with the Prevotella-dominated enterotype 
(Wu et al., 2011b). 
Microbiota-gut-brain axis 
Sudo et al. (2004) was the first to find an association between the gut microbiota and CNS, 
showing an increased hypothalamic-pituitary-adrenal (HPA) stress response and decreased brain-
derived neurotrophic factor (BDNF) levels in the hippocampus of germ-free mice. More recently, 
studies found a relationship between gut microbiota and CNS-related disorders in humans, such as 
Parkinson´s disease and autism (Kang et al., 2013; Scheperjans et al., 2015; Tomova et al., 2015). 
A bidirectional gut-brain communication involving the microbiota comprises neural (e.g., enteric 
nervous system (ENS), vagus, and sympathetic and spinal nerves), humoral pathways (e.g., 
cytokines, hormones, and neuropeptides as signalling molecules) and the metabolites of the 
microbiota (Cryan and O´Mahony, 2011). This communication network is referred as the 
“microbiota-gut-brain axis” and signals gastrointestinal perception to the brain, which in turn 
elaborates a gastrointestinal response (Mayer, 2011). The microbiota is able to alter the levels of 
neurotransmitter precursors and to regulate the synthesis and the release of serotonin, dopamine, 
actylcholine, norepinephrine and γ- aminobutyric acid (GABA) (Lyte, 2013; O´Mahony, 2015). 
Events like psychological or physical stress can significantly dysregulate the gut-brain-axis through 
the action of the hypothalamic-pituitary-adrenal axis, which regulates the stress response (Scott et 
al., 2013; Wang and Kasper, 2014). An example of this pathological condition is irritable bowel 
syndrome (O´Mahony et al., 2009). In addition, through this gut-brain axis, the microbiota is able to 
influence numerous aspects of host health, including organ morphogenesis, immune system and 
gastrointestinal tract development and maturation, intestinal vascularization, tissue regeneration, 
carcinogenesis, metabolism, bone homeostasis, memory function, emotional arousal, affective 
behaviour, intuitive decision-making, and a range of neurological diseases (Picca et al., 2018).  
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1.8.2. Age-related changes in the gut microbiota 
The process of aging deeply affects the composition and diversity of the gut microbiota 
(García-Peña et al., 2017; Salazar et al., 2017). In addition, the perturbation of gut microbiota 
(denominated dysbiosis) has been linked to chronic inflammation (Rehman, 2012) and to age-
related diseases, such as neurodegenerative diseases (Friedland, 2015), cognitive decline 
(Magnusson et al., 2015), frailty (Meehan et al., 2015), type 1 and type 2 diabetes (Paun and 
Danska, 2016), non-alcoholic fatty liver disease and cardiovascular disease (Sanduzzi Zamparelli et 
al., 2016). 
Age-related alterations in the gut physiology, such as gastric motility disorders, 
hypochlorhydria, chewing difficulties, and degenerative changes in enteric nervous system, as well 
as changes in diet patterns (such as increased consumption of high sugar-fat foods and reduction in 
plant-based foods) have great effects on the diversity and composition of intestinal microbiota 
(Konturek et al., 2015). In addition, immunosenescence and low-grade chronic inflammation may 
also contribute to alterations in the gut microbiota and vice versa (Vaiserman et al., 2017). 
Although there is a consensus that dominant species that conform microbiota in elderly people 
remains unchanged, it has been reported that there are significant alterations in the proportion and 
composition of the different taxa, leading to a decrease in the microbiota diversity (including low 
Bifidobacteria species), as well as an increase in some enteropathogens that may lead to chronic 
inflammation (Mueller et al., 2006; Rajilić-Stojanović et al., 2009). In addition, the Bacteroidetes 
are increased, while the Firmicutes appear to be lower in elderly individuals compared to younger 
adult controls. The elderly population also shows decreased levels of Clostridium cluster XIV and 
Faecalibacterium Prausnitzii, which are known as major producers of butyrate. Butyrate is a short 
chain fatty acid known as a source of energy for enterocytes and has been implicated in the 
protection against intestinal inflammatory diseases (Mueller et al., 2006; Rajilić-Stojanović et al., 
2009). A previous study indicates that Firmicutes and Bacteroidetes were the dominant phyla in the 
gut microbiota of centenarians (Andersson et al., 2008; Tap et al., 2009). In addition, Eubacterium 
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limosum and relatives are specifically identified as signature bacteria of longevity, as they are more 
than 10-fold increased in centenarians. Authors suggest that at approximately 75-80 years old is the 
group at age at which microbiota changes with aging (Biagi et al., 2010; Vaiserman et al., 2017). In 
a more recent study of super centenarians (105-109 years of age), a higher prevalence of particular 
health-associated groups (such as Akkermania, Bifidobacterium, and Christensenellaceae) has been 
observed in these super centenarians in comparison with adults, elderly and centenarians (Biagi et 
al., 2016). Furthermore, another study demonstrated increased production of compounds with anti-
inflammatory properties in the gut microbiota of centenarians, which could favour the successful 
aging process observed in this population (Collino et al., 2013). 
 
1.8.3. Main characteristics of probiotics 
The word “probiotic” is derived from the Greek meaning “for life” and it has the exact 
opposite meaning of “antibiotic”. The immunologist Élie Metchnikoff was the first to propose the 
beneficial effects of probiotic microorganisms on human health. Metchnikoff hypothesized that 
Bulgarians were healthy and lived longer because of the consumption of fermented milk containing 
Lactobacillus spp (Gordon, 2008). According to Food and Agriculture Organization of the United 
Nations/ World Health Organization (FAO/OMS), probiotics are defined as “live microorganisms 
that, when administered in adequate amounts, confer a health benefit on the host” (FAO/WHO, 
2002; Hill et al., 2014). Probiotics are classified as functional foods. These types of food are 
claimed to have a positive effect on health. The term “functional food” was first used in Japan, in 
the 1980s, for food products fortified with special constituents that have beneficial effects in the 
organism (Kwak and Jukes, 2001; Stanton et al., 2005). Such food products are gaining increasing 
popularity and acceptance in the world. Furthermore, increased commercial interest in exploiting 
the proposed health attributes of probiotics has contributed significantly to the rapid growth and 
expansion of this sector of the market (Saad et al., 2013).   
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The most commonly used probiotics belong to the genera Lactobacillus and Bifidobacterium 
(FAO/WHO, 2001; Holzapfel et al., 2001). However, other bacteria and some yeast (such as 
Saccharomyces boulardii) also have probiotic properties (Table 3). The genus Lactobacillus, which 
belongs to the phylum Firmucutes, is classified as lactic acid bacteria (LAB). These include gram-
positive catalase-negative bacterial species, which produce lactic acid as the main end product of 
the fermentation of carbohydrates. They are ubiquitously found in environments where 
carbohydrates are available, such as food (dairy products, fermented meat, sour dough, vegetable, 
fruits, beverages), respiratory, gastrointestinal and genital tracts of humans and animals. In contrast, 
the genus Bifidobaterium, which belongs to the phylum Actinobacteria, is only poorly 
phylogenetically related to genuine LAB (still they are traditionally listed among LAB) and its 
species use a metabolic pathway for the degradation of hexoses different from those described for 
“genuine” LAB. They are gram-positive, catalase-negative (with some exceptions) and occur in 
animal and human habitats. Also, the two species, Streptococcus thermophiles and Lactococcus 
lactis, which belong to lactic acid bacteria, play an important role in the production of fermented 
milks and dairy products. Streptococcus thermophiles is often used in association with L. 
delbrueckii subsp. bulgaricus as a starter culture for the production of yogurts. These two bacteria 
are associated with alleviation of symptoms of lactose intolerance and other gastrointestinal 
disorders (Felis and Dellaglio, 2007). It is important to mention that probiotic properties are strain 
specific and cannot be extrapolated to other strains, even within the same species (Pineiro and 
Stanton, 2007). In addition, these microorganisms in order to be considered probiotics should be 
normal inhabitants of a healthy intestinal tract, survive the upper digestive tract, be capable of 
surviving and growing in the intestine (acid and bile resistance), and safe for human intestinal cell 
lines and colonization (Guarner and Schaafsma, 1998; Guarner et al., 2005; Morelli, 2000). The 
mechanisms of action of probiotics against gastrointestinal pathogens are not entirely known, but 
some studies suggest that they are involved basically on: (1) the production of inhibitory 
substances, such as some organic acids, hydrogen peroxide and bacteriocins, which are inhibitory to 
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both gram-positive and gram-negative bacteria, (2) blocking of adhesion sites (given that probiotics 
and pathogenic bacteria are in a competition, probiotics seem to inhibit the pathogens by adhering 
to the intestinal epithelial surfaces, (3) competition for nutrients (probiotics seem to inhibit the 
pathogens by consuming the nutrients that pathogens need), (4) improvement of the barrier function 
of the epithelial lining, (5) stimulating of immunity, and (6) influence on other organs of the body 
through the immune system and neurotransmitter production (GABA or serotonin) (Sánchez et al., 
2017). Many studies report effects of probiotic consumption on several health-related outcomes, 
including incidence and duration of gastrointestinal infections, improving vitamin synthesis, 
normalizing intestinal transit, alleviating lactose intolerance, diminishing incidence of allergy, 
prevention of urogenital diseases, and protection against colon and bladder cancers (Sharma and 
Devi, 2014). 
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Table 3. Microorganisms considered probiotics.  
Lactobacillus  
species 
Bifidobacterium 
species 
Other lactic acid  
bacteria 
Non-lactic bacteria 
L. acidophilus B. breve Enterococcus faecium 
Escherichia coli 
strain 
Nissle 
L. casei B. infantis Lactococcus lactis 
Sacchromyces  
cerevisae 
L. delbrueckii B. lactis Leuconstoc mesenteroides 
Saccharomyces  
bourlardii 
subsp. bulgaricus B. longum Pediococcus acidilactici 
 
L. farciminis B. thermophilum 
Streptococcus 
thermophilus 
 
L. fermetum 
 
Streptococcus 
diadetylactis 
 L. gasseri 
 
Streptococcus intermedius 
 L. johnsonii 
   L. paracasei 
   L. plantarum 
   L. reuteri 
   L. rhamnosus    
Cited in Holzapfel et al., 2001 
 
1.8.4. Roles of probiotics in the immune system 
Increasing evidence suggests that probiotics are capable of stimulating both innate and 
adaptive components of the immune system, thereby conferring health benefits to the host. The 
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gastrointestinal tract is the main entry site of bacteria and other pathogens through dietary intake 
and has a potent antigen-presenting region constituted by the gut-associated lymphoid tissue with an 
abundance of immune cells. Probiotics interact with these cells of lymphoid tissue, which finally 
culminates in downstream activation of various immunological pathways. Several studies report 
enhanced phagocytosis and macrophage production, increased secretion of lysosomal enzymes, 
increased ROS production, and modified cytokine release in peritoneal and pulmonary macrophages 
of both animal models and human trials that received oral administration of probiotics (Habil et al., 
2011; Ivec et al., 2007; Kapila et al., 2012; Kekkonen et al., 2008; Perdigón et al., 1998). Studies in 
rats and mice suggest that oral administration of lactic acid bacteria increased the numbers of T 
lymphocytes, CD4+ T cells, and antibody-secreting cells in the intestinal mucosa and enhanced 
lymphocyte proliferation (Aattour et al., 2001; Jain et al., 2009; Schiffrin et al., 1995). However, 
the exact mechanisms underlying these effects of probiotics are incompletely understood. 
Increasing evidence suggests that the immunomodulatory effects of probiotics are based on their 
ability to interact through M cells in the Peyer´s patches of intestinal epithelial lining. These 
mucosal epithelial cells are critical in coordinating the immune defence by releasing cytokines in 
response to external signals and by recruiting cells from both the innate and adaptive immune 
responses. Once inside the lamina propria, probiotics interact with dendritic cells and macrophages, 
stimulating them to produce cytokines, which results in immunomodulatory effects of probiotics. 
These effects include increased proliferation of CD4+ T cells, enhanced IgA production, and 
cytokine synthesis favouring anti-inflammatory responses (Sharma and Devi, 2014). 
Roles of probiotics in immunosenescence  
Probiotics are among the most actively interventions aimed at improving health status in 
aging (Rondanelli et al., 2015; Saraswati and Sitaraman, 2015). The age-related changes of the 
immune system or immunosenesence result in increased incidence, duration and persistence of 
infections in elderly individuals. In particular, the consumption of probiotics has been reported to 
boost immune response against various infections during aging. Thus, a previous study conducted 
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in the elderly population showed that the consumption of fermented milk containing cultures of 
yogurt and the probiotic Lactobacillus casei DN-114001 for 3 weeks reduced the duration of winter 
infections (Turchet et al., 2003). Also, the consumption of the same fermented milk (Lactobacillus 
casei DN-114001) in an elderly free-living population resulted in reduced duration of common 
infectious diseases of the airways and gastrointestinal tract (Guillemard et al., 2010). Moreover, the 
dietary consumption of yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus 
OLL1073R-1 resulted in significantly lower incidence of common cold (2.6 times lower). This was 
corroborated with higher NK cell activity in the probiotic-fed group in comparison with controls 
(Makino et al., 2010). In addition, the enterally fed fermented milk containing Lactobacillus 
johnsonii La1 (NCC533) for 12 weeks decreased the number of days with infections as well as 
enhanced blood phagocytic activity and suppressed the fecal antibiotic-resistant strain methicillin-
resistant Staphylococcus aureus in hospitalized, bed-ridden elderly individuals  (Fukushima et al., 
2007). Another study indicates increased cytotoxicity and phagocytosis of peripheral blood 
mononuclear cells in elderly individuals after dietary supplementation with probiotic cheese 
containing Lactobacillus rhamonosus HN001 and Lactobacillus acidophilus NCFM. These results 
further concluded that daily consumption of the probiotic cheese enhanced parameters of innate 
immunity in elderly volunteers (Ibrahim et al., 2010). Also, the administration of milk 
supplemented with Bifidobacterium lactis HN019 and Lactobacillus rhamnosus HN001 in elderly 
subjects resulted in increased proportions of T lymphocytes and NK cells, as well as improved 
phagocytic activity (Gill et al., 2001). Studies in elderly individuals indicate that dietary 
consumption of probiotic lactobacilli stimulated the production of specific IgA and IgG antibodies 
in response to influenza vaccination (Boge et al., 2009; Bosch et al., 2012). Thus, these data 
indicate that the consumption of probiotics could help to generate an adequate immune response to 
vaccination in the elderly.  
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1.8.5. Roles of probiotics in the central nervous system 
Increasing evidence suggests a role for the gut microbiota in the gut-brain axis, which has 
shown to influence behaviour through the central nervous system (CNS). Thus, the consumption of 
probiotics seems to have an important role in the gut-brain axis communication, beneficiating gut 
and brain functions. For instance, the consumption of probiotics in animal models, which includes 
B. lungum, B. breve, B. infantis, L. helveticus, L. rhamnosus, L. plantarum, or L. casei strains, were 
able to control anxiety and depression, and to improve memory related behaviours (Groeger et al., 
2013; Lomasney et al., 2014; Saulnier et al., 2013). Doses between 109 and 1010 CFU and durations 
of 2 weeks in animals and 4 weeks in humans have shown beneficial effects, such as anxiety, 
depression, autism spectrum disorder, obsessive-complusive disorder, and memory abilities (Wang 
et al., 2016). Although the mechanisms of probiotics effects on CNS functions are largely 
unknown, it seems that probiotics can alter directly CNS biochemistry, through changes in the 
levels of BNDF, γ-aminobutyric acid (GABA), serotonin 5 hydroxytryptamine, and dopamine 
(Bercik et al., 2011; Bravo et al., 2011; Liu et al., 2016). In addition, both the vagus and the enteric 
nerves are involved in the gut-brain axis and can be affected by certain probiotics (Bercik et al., 
2011; Bravo et al., 2011). The HPA stress response, which regulates mood and emotion, has shown 
to be attenuated by probiotics ingestion, decreasing corticosteroid levels (Ait-Belgnaoui et al., 
2012). Furthermore, the immune system can be affected by probiotics, such as limiting pro-
inflammatory status, which, in turn, can influence the endocrine and nervous system (Desbonnet et 
al., 2008; 2010).  
 
1.8.6. Roles of probiotics in longevity 
The consumption of probiotics has been described to have positive effects on the longevity 
of the host. A previous study showed increased longevity in mice supplemented with 
Bifidobacterium lactis for 11 months, possibly due to the suppression of chronic low-grade 
inflammation in the gut (Matsumoto et al., 2011). Lactobacillus rhamnosus CNCM I-3690 also 
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increased the life span in the nematode Caenorhabditis elegans by stimulating the innate immune 
response and reducing oxidative stress (Grompone et al., 2012). In another study, Lactobacillus 
salivarius FDB89 isolated from feces of centenarians in China extended the life span of C. elegans 
by up to 11.9% in a dietary-restriction dependent manner (Zhao et al., 2013). Similarly, the 
supplementation with Lactobacillus gasseri SBT2055 was effective to extend the life span in C. 
elegans by reducing oxidative stress and by stimulating the innate immune response through 
p38MAPK signalling pathway (Nakagawa et al., 2016). Also, a probiotic and synbiotic formulation 
impacted Drosophila melanogaster longevity through reduction of markers of physiological stress, 
oxidative stress and inflammation (Westfall et al., 2018).  
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2. JUSTIFICATION AND 
OBJECTIVES 
	   	  
	   
The aging of the population is a global fact and consequently the number of people who 
reach an advanced age is significantly increasing. This fact justifies the importance of studying the 
inevitable process of aging, conditions that could accelerate it, as well as strategies that could 
ameliorate it, thus preventing age-related diseases and allowing a healthy aging. The maintenance 
of an adequate state of health is achieved by the proper functioning of all physiological systems of 
the organism, especially those of the regulatory systems, namely the nervous, endocrine and 
immune systems, as well as the communication between them. In contrast, the process of aging is 
characterized by a progressive deterioration of the regulatory system functions as well as of their 
communication. According to the oxidation-inflammation theory of aging, the age-related changes 
of the regulatory systems are mainly based on oxidative and inflammatory stresses. This theory also 
proposes that the immune system, due to its property of producing oxidative and inflammatory 
compounds, which in moderate levels are essential to carry out an effective immune response, if not 
well-regulated, could be involved in the rate of aging of each individual through the generation of 
oxidative and inflammatory stresses. In the context of the age-related changes of the immune 
functions, which are termed immunosenescence, our research group has shown that several of these 
immune cell functions as well as redox parameters can predict health status, rate of aging, and 
consequently the life span of mice. Moreover, the age-related changes in these parameters are 
similar to those observed in mice (peritoneal leukocytes) and in humans (blood leukocytes).  
Our research group has been studying possible murine models of premature and accelerated 
aging. Along with these models, obesity has been proposed as a possible model of premature 
immunosenescence. Given that both aging and obesity share common features, such as impaired 
immune function and oxidative and inflammatory stresses, obesity could accelerate the process of 
aging and increases the risk of morbidity and mortality at premature ages. In fact, previous data 
from our research group demonstrated premature deterioration of immune cell functions in 
genetically and diet-induced (cafeteria) obese rats, obesity being proposed as a possible model of 
premature immunosenescence. Therefore, we hypothesized that the early and late adulthood onset 
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of diet-induced obesity would result in impairments of the nervous (behavioural responses) and 
immune system (functions and redox/inflammatory state of leukocytes) associated with oxidative 
and inflammatory stresses, which could finally result in premature and accelerated aging of mice.  
 
The first overall objective of the present thesis is as follows: 
 
1. To study the effects of diet-induced obesity onset on behaviour, immune function 
and redox/inflammatory state at different ages, as well as on the life span of mice. 
 
This objective is subdivided into the following specific objectives: 
 
1.a. To evaluate the effects of the early adulthood diet-induced obesity onset on 
immune function and redox/inflammatory state of adult female mice, as well as on their life 
span.   
 
1.b. To evaluate the effects of the late adulthood diet-induced obesity onset on 
behaviour, immune function and redox state of middle-aged male and female mice, as well as 
on their life span.  
 
Leptin is a pleiotropic hormone synthesized mainly by adipose tissue, which plays not only 
an important role in the central regulation of energy homeostasis and metabolism, but is also 
involved in many other important physiological roles. These include brain and bone development, 
neuroendocrine control, reproductive function, and immune system function. There is a temporary 
increase of leptin levels in rodents during the early postnatal period, which constitutes a “leptin 
surge”. Thus, it has been described that neonatal mice and rats experience elevated levels of leptin 
from postnatal day (PND) 4 to PND 14, with a peak at PND 10. The physiological significance of 
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this “leptin surge” has been mainly studied in relation to its neurotropic role during brain 
development, particularly in the hypothalamus. However, nothing is known about the specific role 
of this neonatal leptin surge in the development and establishment of the immune system functions 
as well as in the redox/inflammatory state of male and female rats.  Therefore, we hypothesized 
that the blockage of the neonatal leptin surge would result in impairments of the immune (functions 
and redox/inflammatory state), nervous and endocrine systems (redox/inflammatory state) of male 
and female rats at adolescent and adult ages. 
 
The second overall objective of the present thesis is as follows: 
 
2. To study the effects of the blockage of the neonatal leptin surge (PND5-9) on the 
immune function and redox/inflammatory state of male and female rats at different ages. 
 
This objective is subdivided into the following specific objectives: 
 
2.a. To evaluate the effects of the blockage of the neonatal leptin surge (PND5-9) on the 
redox/inflammatory state in the spleen, hypothalamus and white adipose tissue of 
peribubertal/adolescent male and female rats. 
 
2.b. To evaluate the effects of the blockage of the neonatal leptin surge (PND5-9) on the 
immune function and inflammatory state in spleen leukocytes of peribubertal/adolescent male 
and female rats. 
 
2.c. To evaluate the effects of the blockage of the neonatal leptin surge (PND5-9) on the 
immune function and redox state in spleen leukocytes of adult male and female rats.  
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During the process of aging, the maintenance of health depends mostly on lifestyle factors 
(approximately 75%), while genetics seem to affect this less (25%). Among these lifestyle factors, 
nutrition, such as an adequate antioxidant intake, has been proposed as very relevant to improve the 
functions and redox state of immune cells, especially in the elderly population. In addition, 
monounsaturated fatty acids (oleic acid derivatives), polyunsaturated fatty acids derived from n-3 
series (eicosapentaenoic acid and docosahexaenoic acid) and probiotics have been proven effective 
in improving immune system functions and in exhibiting antioxidant and anti-inflammatory 
properties. However, little research has been developed to study the repercussion of these nutrients 
on the nervous (behavioural responses) and immune systems (functions and redox state of 
peritoneal leukocytes) particularly in the context of obesity, as a possible state of premature aging, 
and in chronological aging. Therefore, we hypothesized that these nutritional interventions (with 
unsaturated lipids or with fermented milk containing probiotics) would ameliorate the deteriotation 
of the regulatory systems, caused by obesity or by the physiological process of aging.  
 
The third overall objective of the present thesis is as follows: 
 
 3. To study the effects of the dietary supplementations with 2-OHOA or with the 
combination of n-3 fatty acids (EPA and DHA) on the immune function and redox state of 
adult female diet-induced obese mice, as well as on their life span.  
 
This objective is subdivided into the following specific objectives: 
 
3.a. To evaluate the effects of the dietary supplementations with 2-OHOA or with the 
combination of n-3 fatty acids (EPA and DHA) on the function and redox state of leukocytes 
of adult female diet-induced obese mice, as well as on their life span. 
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3.b. To evaluate the effects of the dietary supplementations with 2-OHOA or with the 
combination of n-3 fatty acids (EPA and DHA) on the redox state of several organs from adult 
female diet-induced obese mice. 
 
The fourth overall objective of the present thesis is as follows: 
 
4. To study the effects of the dietary supplementation with fermented milk containing 
probiotics for different periods of time on behaviour, immune function and redox state of old 
mice, as well as on their life span. 
 
This objective is subdivided into the following specific objectives: 
 
4.a. To evaluate the effects of the dietary supplementation with fermented milk 
containing probiotics for one and four weeks on behaviour and immune function of old mice, 
as well as on their life span. 
 
4.b. To evaluate the effects of the dietary supplementation with fermented milk 
containing probiotics for two weeks on behaviour, immune function and redox state of old 
mice, as well as on their life span. 
  
119
	   	  
	   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
3.  EXPERIMENTAL 
DESIGN AND RESULTS 
	   	  
	   
3.1. EFFECTS OF DIET-INDUCED OBESITY ONSET ON BEHAVIOUR, IMMUNE 
FUNCTION AND REDOX/INFLAMMATORY STATE AT DIFFERENT AGES, AS WELL 
AS ON THE LIFE SPAN OF MICE 
 
3.1.1. Effects of the early adulthood diet-induced obesity onset on immune function and 
redox/inflammatory state of adult female mice, as well as on their life span 
 
 
Experimental design 
A group of 20 adolescent mice (14±2 weeks of age) were divided into two groups of similar 
average body weight and were fed either a standard diet (n=10) or a high-fat diet (n=10) for 14 
weeks. A group of middle-aged mice (58±2 weeks old) were fed a standard diet (n=8). The animals 
had free access to water and the diet. When the adolescent mice reached adulthood (i.e., the adult 
control and the adult diet-induced obese (DIO) mice groups, 28±2 weeks of age) and the middle-
aged were considered old (i.e., the old control mice group, 72±2 weeks of age), several parameters 
of function and redox state of leukocytes were evaluated. In addition, adult DIO and adult control 
mice were submitted to the evaluation of biochemical parameters and blood pressure measurements. 
After 14 weeks on the high-fat diet, the adult DIO mice returned to a standard diet, while the adult 
control mice maintained the standard diet. When these animals reached old age (72 weeks old) (i.e., 
the old control and the old DIO mice groups, n=9, in each group), biochemical parameters, blood 
pressure measurements and peritoneal leukocyte functions were measured again.  
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(ADOLESCENT MICE) 
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GROUP 
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13% of fat 
EXPERIMENTAL 
GROUP 
High fat diet 
60% of fat 
During 14 weeks  
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(ADULT DIO MICE AND ADULT 
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The diets used were provided by Harlan Interfauna Iberica and the nutritional compositions 
were: 1) Standard diet (Teklad Global 14% Protein Rodent Maintenance Diet): Energy 2.9 Kcal/g, 
protein 20%, carbohydrate 67% and fat 13%, this being derived from soybean oil (saturated 0.8%, 
monounsaturated 0.7% and polyunsaturated fatty acids 2.1%); and 2) High-fat diet (TD.06414): 
Energy 5.1 Kcal/g, protein 18.4%, carbohydrate 21.3% and fat 60.3%, this fat was derived from 
31% of lard and 3% of soybean oil (saturated 37%, monounsaturated 47% and polyunsaturated fatty 
acids 16%).  
 
Main results  
Body weight, biochemical parameters and arterial blood measurements 
At adulthood (28 weeks), animals fed a high fat diet for 14 weeks displayed a significantly 
higher body weight when compared to animals fed a standard diet. Furthermore, they also presented 
higher levels of triglycerides and systolic pressure, marking them as obese. No significant 
differences were observed in total glucose, cholesterol and diastolic pressure levels between the 
diet-induced obese (DIO) mice and the control group. When these adult DIO animals reached the 
age of 72 weeks, they continued to present a higher body weight than the old control group. The 
glucose, triglycerides and systolic pressure levels were also significantly increased compared to old 
controls. However, with respect to measurements of total cholesterol and diastolic pressure levels, 
no differences were found between old control and old DIO mice groups. 
Peritoneal leukocyte function parameters 
The migration of peritoneal macrophages, measured by the chemotaxis index, declined 
significantly in adult DIO and in old control mice compared to adult controls. In addition, the 
number of latex beads ingested by macrophages and the number of macrophages with phagocytic 
ability were also significantly lower in adult DIO mice and in old controls with respect to adult 
control animals. The levels of intracellular superoxide anion in stimulated macrophages, an 
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important capacity of phagocytic cells in killing pathogens, showed significantly lower values in 
adult DIO mice and in old mice when compared to adult controls. 
Regarding the chemotaxis capacity of peritoneal lymphocytes and the anti-tumour NK 
activity (% lysis), these were significantly lower in adult DIO and in old control mice with respect 
to adult control animals. A lower anti-tumour NK activity was also observed in both adult DIO and 
old control mice in comparison with adult controls. In addition, adult DIO mice and old control 
mice displayed a significantly suppressed mitogen-induced proliferative response compared to adult 
controls. However, the basal lymphoproliferation was not significantly different between the three 
groups of animals, adult DIO (1770±1361 cpm), old mice (1248±100 cpm) and adult controls 
(1459±697 cpm). The levels of a variety of cytokines (IL-1β, TNF-α, IL-6, IL-2 and IL-10) released 
in culture supernatants of peritoneal leukocytes after 48 h of incubation under ConA and LPS- 
displayed a trend towards diminution or were significantly diminished in adult DIO and in old 
animals in comparison with adult controls. In addition, the cytokines IL-1β and IL-10 under LPS-
stimulated conditions and IL-2 under ConA and LPS- stimulated conditions were significantly 
lower in adult DIO mice compared to old mice. Nevertheless, the levels of IL-6 released in response 
to ConA and LPS were significantly higher in adult DIO mice than in old controls. 
With aging, impairments of leukocyte functions became more pronounced in old DIO mice 
in comparison with old controls. Thus, macrophage functions, such as chemotaxis capacity as well 
as phagocytosis index and phagocytosis efficacy, were significantly lower in old DIO mice when 
compared to old controls. However, with respect to stimulated generation of superoxide anion, there 
were no significant differences between both groups. In relation to the anti-tumour NK activity, this 
was significantly lower in old DIO mice than in old controls. The lymphocyte functions 
(chemotaxis index and proliferation in response to ConA and LPS) were highly impaired in old DIO 
mice when compared to old controls. Even though not statistically significant there was a tendency 
of enhanced basal lymphoproliferative response in old DIO with respect to old controls.  
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Peritoneal leukocyte oxidative stress parameters 
In order to investigate the oxidative stress status of peritoneal leukocytes in mice, the 
activity of xanthine oxidase, which is associated with the production of free radicals, and the 
enzymatic and non-enzymatic antioxidants, such as catalase activity and glutathione concentrations 
were evaluated. The levels of total glutathione, which have an important defensive role in 
neutralizing free radicals, presented lower values in peritoneal leukocytes in adult DIO and old 
controls as compared to adult controls. Similarly, catalase activity, which protects against oxidant 
compounds, was diminished in leukocytes from adult DIO and old mice with respect to adult 
control animals. The activity of xanthine oxidase was higher in leukocytes from adult DIO mice and 
in those from old mice when compared to adult controls. When these animals grew older, reaching 
72 weeks of age, DIO mice exhibited significantly lower contents of total glutathione when 
compared to old controls. Nevertheless, the activities of xanthine oxidase and catalase did not 
present statistical differences between old DIO and old control animals.  
Life span 
Although differences were not statistically significant, DIO mice tended to have a shorter 
life span when compared to controls. 
 
Partial conclusions 
The results of this experiment indicate that a high fat intake during adolescence produces an 
obesity state, which is associated with an impaired function and redox/inflammatory state of 
peritoneal leukocytes in adult female mice. Thus, these results demonstrate the state of premature 
immnosenescence in adult DIO female mice. In addition, the early adulthood diet-induced obesity 
aggravates immunosenescence in old female mice. 
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Abstract
Obesity and aging share an impaired immune system and oxidative and inflammatory stress. Therefore, the hypothesis of obesity as a possible model 
of premature immunosenescence has been proposed. In this study, we investigated whether adult obese mice, as a consequence of being fed with 
a fat-rich diet during their adolescence, showed premature immunosenescence and if this was aggravated with aging. Peritoneal cell suspensions 
were obtained when ICR/CD1 obese female mice were adults (28 weeks) and old (72 weeks), and several functions and antioxidant defenses were 
evaluated. The results showed that the chemotaxis of both macrophages and lymphocytes, phagocytosis of macrophages, activity of natural killer 
cells, proliferative response of lymphocytes, interleukin-1β, tumor necrosis factor-alpha, interleukin-6, interleukin-2, and interleukin-10 released in 
leukocyte cultures, as well as antioxidant and oxidant capacity were significantly impaired in adult obese mice with respect to adult nonobese mice, 
with values similar to those in chronologically old mice. When these obese animals grew older, although having been fed with a standard diet, they 
showed a higher deterioration of their immune functions in comparison with the old control group. In conclusion, these results demonstrate that a 
high fat intake during adolescence can produce an obesity state in adult age associated with a premature immunosenescence, which is aggravated 
through aging.
Keywords:  Obesity—Immune function—Oxidative stress—Premature immunosenescence
It is widely accepted that nutrition and diet play an important 
role in maintaining health, as well as in causing certain kinds of 
diseases. Thus, an excessive consumption of energy dense food, 
such as dietary fat, has been associated with the current burden 
of obesity worldwide (1). In particular, adolescence has been 
described as a critical period for the onset of obesity, and once 
this condition is established, it is likely to persist into adulthood 
(2). Furthermore, the early onset of obesity and its related health 
problems may increase the risk of morbidity and premature mor-
tality (3).
Increasing evidence suggests that the central mechanism underly-
ing obesity and its related diseases are a state of persistent low-grade 
systemic inflammation together with a deregulation in the inflamma-
tion–stress feedback mechanisms (4). This inflammatory condition is 
possibly generated by the recruitment of immune cells, mostly bone 
marrow–derived macrophages, into the adipose tissue in response 
to excess nutrients, hypertrophy, and hypoxia of adipocytes (5). 
Consequently, these dysfunctional adipocytes contribute to immune 
activation and to the increased production of several proinflamma-
tory molecules like tumor necrosis factor-alpha (TNF-α), interleu-
kin (IL)-6, and macrophage chemoattractant protein-1 (MCP-1) (6). 
Moreover, dysfunctional adipocytes seem also to be implicated in 
the production of oxidative stress through the generation of reactive 
oxygen species, which could result in further inflammation and tissue 
damage (7). Although an appropriate immune response requires cer-
tain levels of oxidation and inflammation, which are two interlinked 
processes with many feedback loops (8), several studies have shown 
that the enhanced inflammatory milieu observed in obesity is not asso-
ciated with an optimal immune defense. Thus, obese subjects present a 
poorer immune response to pathogen infection and to vaccines (9,10).
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In addition, it is known that the process of aging is accompanied 
by an impairment of the immune system, which is known as inmu-
nosenescence. In this condition, the immune system undergoes a wide 
range of age-associated restructuring that may result in decreased as 
well as increased activities of immune cells. For instance, there is 
a progressive decline in the functional activity of phagocytic cells, 
natural killer (NK) cells, in lymphoproliferative response, and in 
mitogen-stimulated cytokine production (11–14). These age-related 
changes seem to be produced by the oxidative and inflammatory 
stress situation of the immune cells. In fact, although the production 
of low levels of oxidants and inflammatory compounds is essential 
for the normal defensive role of immune cells against infection, when 
these levels are very high, cellular damage appears. Thus, innate 
immune cells, such as macrophages, exhibit an age-related over-
activated production of oxidative and inflammatory compounds, 
which occurs mainly in the absence of antigenic stimulus and can-
not be neutralized by antioxidant and anti-inflammatory defenses. 
This leads to an oxidative and inflammatory stress (8,15–17). It is 
accepted that the process of aging is the result of the accumulation 
of cellular damage, which is caused by oxidative and inflammation 
stress throughout the lifetime of an organism. Moreover, it has been 
recently proposed that the immune system can be involved in these 
stresses and consequently in the rate of aging (16,17).
Because both obesity and aging share common features, such as 
an impaired immune system and oxidative and inflammatory stress, 
the hypothesis of obesity as a possible model of premature immu-
nosenescence, has been proposed (18). Although it is known that 
the physiological conditions at adult age determine the aging pro-
cess and that aging exacerbates obesity-induced oxidative stress and 
inflammation (19), the long-term immune effects of the early onset 
of obesity and its possible consequences in the process of aging have 
been scarcely investigated. Therefore, the aim of this study was to 
confirm whether adult obese mice, as a consequence of being fed 
with a high-fat diet during their adolescence, presented immune 
function and redox values similar to those observed in chronologi-
cally old animals, and if this premature immunosenescence is aggra-
vated with aging.
Methods
Animals
Female ICR/CD1 mice, 8 weeks of age, were purchased from Harlan 
Interfauna Iberica (Barcelona, Spain). The animals were housed in 
polyurethane cages (6–10 animals per cage) and maintained under 
standard laboratory conditions (12:12 hour reversed light/dark 
cycle; lights on at 8:00 pm in order to avoid circadian interferences, 
relative humidity at 50%–60%, temperature of 22 ± 2°C, and ade-
quate ventilation). The experiments were conducted in accordance 
with the guidelines and protocols of the Royal Decree 1201/2005 
regarding the care and use of laboratory animals for experimen-
tal procedures and were approved by the Committee for Animal 
Experimentation of the Complutense University of Madrid.
Experimental Groups
A group of 20 adolescent mice (14 ± 2 weeks of age) were divided 
into two groups of similar average body weight and were fed either 
a standard diet (n = 10) or a high-fat diet (n = 10) for 14 weeks. 
A group of middle-aged mice (58 ± 2 weeks old) were fed a standard 
diet (n = 8). The animals had free access to water and food. When 
the adolescent mice reached adulthood (ie, the adult control and the 
adult obese mice groups, 28 ± 2 weeks of age) and the middle aged 
were considered old (ie, the old control mice group, 72 ± 2 weeks of 
age), several parameters of function and oxidative state of leuko-
cytes were evaluated. In addition, adult obese and adult control mice 
were submitted to the evaluation of biochemical parameters and 
blood pressure measurements. After 14 weeks on the high-fat diet, 
the adult obese mice returned to a standard diet, whereas the adult 
control mice maintained the standard diet. All mice were marked 
for their individual follow-up. When these animals reached old age 
(72 weeks old) (ie, the old control and the old obese mice groups, 
n = 9, in each group), biochemical parameters, blood pressure meas-
urements, and peritoneal leukocyte functions were measured again.
The diets used were provided by Harlan Interfauna Iberica and 
the nutritional compositions were (i) standard diet (Teklad Global 
14% Protein Rodent Maintenance Diet): energy 2.9 Kcal/g, protein 
20%, carbohydrate 67%, and fat 13%, in which fat was derived 
from soybean oil (saturated 0.8%, monounsaturated 0.7%, and 
polyunsaturated fatty acids 2.1%) and (ii) high-fat diet (TD.06414): 
energy 5.1 Kcal/g, protein 18.4%, carbohydrate 21.3%, and fat 
60.3%, in which fat was derived from 31% of lard and 3% of soy-
bean oil (saturated 37%, monounsaturated 47%, and polyunsatu-
rated fatty acids 16%).
Biochemical Parameters and Arterial Blood Pressure 
Measurements
Glucose, cholesterol, and triglyceride levels were measured with 
Accutrend (Roche Diagnostics, Mannheim, Germany) using blood 
samples collected from the tail vein of mice. Arterial blood pres-
sure was measured using a noninvasive pressure gauge (Panlab 
Non-Invasive Blood Pressure System for Rodents, Harvard). 
Measurements were performed three times in a stress-free environ-
ment (without light and background noise), and after subjecting the 
mouse to a temperature of 30°C–35°C for 20 minutes to calm the 
animal and avoid stress inside the holder.
Collection of Peritoneal Leukocytes
The peritoneal suspensions were obtained between 8:00 am and 
10:00 am to minimize circadian variations in the immune system, 
without sacrificing the animals, which allowed monitoring the life 
spans of the mice, by a procedure previously described (20,21). 
Briefly, 3 mL of Hanks’ solution, adjusted to pH 7.4, were injected 
into the peritoneum, the abdomen was massaged and the peritoneal 
exudate cells were collected allowing the recovery of 90%–95% of 
the injected volume. The peritoneal leukocytes, consisting of lympho-
cytes and macrophages, were counted in Neubauer chambers (Blau 
Brand, Germany). The suspensions were adjusted to a final concentra-
tion of 5 × 105 macrophages or lymphocytes/mL in Hanks’ solution or 
106 leukocytes/mL in Hanks’ solution or complete medium (Roswell 
Park Memorial Institute [RPMI] 1640 enriched with l-glutamine 
(PAA, Pasching, Austria) and supplemented with 10% heat-inacti-
vated (56°C, 30 minutes) fetal calf serum (GIBCO) and gentamicin 
(100 mg/mL, GIBCO) with or without phenol red). Macrophages and 
lymphocytes were identified by their morphology. The cellular viabil-
ity was routinely measured using the trepan-blue (Sigma, St. Louis, 
MO) exclusion test, and in all cases, it was higher than 98%.
The peritoneal compartment offers the potential to study unfrac-
tionated leukocytes, which better preserve the physiological environ-
ment surrounding the immune cells in vivo. This is fundamental in 
studies ex vivo that try to reproduce immune cell response in vivo. 
In fact, this response may vary or be lost in populations of purified 
leukocytes (22).
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Chemotaxis Assay
Chemotaxis of peritoneal leukocytes were evaluated according to a 
slight modification of the Boyden’s method (20) consisting basically 
of the use of chambers with two compartments separated by a filter 
with a pore diameter of 3 µm (Millipore, Bedford, MA). Aliquots of 
300 µL of the peritoneal suspensions, with macrophages or lympho-
cytes adjusted to 5 × 105 cells/mL in Hank’s solution, were deposited 
into the upper compartment, and aliquots of 400 µL of the chem-
oattractant, formyl-Met-Leu-Phe (10–8 M) (Sigma) were put into the 
lower compartment. The chambers were incubated for 3 hours, and 
then the filters were fixed and stained. The chemotaxis index was 
determined by counting, using an optical microscope (100×), the 
total number of macrophages and lymphocytes on one third of the 
lower face of the filters.
Phagocytosis Assay
Phagocytosis assay of inert particles was carried out following the 
method described by De la Fuente and colleagues (20). Aliquots 
of 200 µL of the peritoneal suspensions, adjusted to 5 × 105 mac-
rophages/mL in Hanks’ medium, were incubated in migration 
inhibitory factor plates (Kartell, Noviglio, Italy) for 30 minutes. 
The adhered monolayer was washed with prewarmed phosphate 
buffer saline and then 200 µL of Hank’s medium and 20 µL latex 
beads (1.09 µm diluted to 1% phosphate buffer saline) (Sigma) were 
added. After 30 minutes of incubation, the plates were washed, fixed, 
and stained. The number of particles ingested by 100 macrophages 
was counted using an optical microscope (100×) and expressed as 
phagocytic index. The percentage of macrophages, which phago-
cyted at least one latex bead, was also determined and expressed as 
phagocytic efficiency.
Superoxide Anion Production Assay
Superoxide anion production was evaluated assessing its capacity 
to reduce nitroblue tetrazolium (NBT, Sigma), in an equimolecular 
reaction, following the method described by De la Fuente and col-
leagues (20). Briefly, aliquots of 250 µL of peritoneal cell suspensions 
(1 × 106 leukocytes/mL Hank’s medium) were mixed with 250 µL of 
NBT solution (1 mg/mL in Hank’s solution) (Sigma) and with 50 µL 
of latex beads (1%) in stimulated samples. After 60 minutes of incu-
bation at 37°C, the reaction was stopped, the samples were centri-
fuged, and the supernatants were discarded. The reduced NBT was 
extracted with dioxin (Merck, Darmstadt, FRG), and the absorb-
ance of the supernatants was determined at 525 nm using a spectro-
photometer. The data obtained were expressed as nmoles of NBT 
reduced per 106 leukocytes by extrapolating in a standard curve of 
NBT reduced with 1,4-dithoerythritol (Sigma).
Natural Killer Assay
An enzymatic colorimetric assay was carried out for cytolysis meas-
urements of target cells (Cytotox 96 TM Promega, Boehringer, 
Ingelheim) based on the determination of lactate dehydrogenase 
enzyme using tetrazolium salts, as previously used by us in these 
kinds of samples (21). Aliquots of 100 µL of peritoneal leukocytes, 
used as effector cells, were seeded in 96-well U-bottom culture plates 
(Numc, Roskilde, Denmark) adjusted to 106 leukocytes per well in 
RPMI 1640 medium without phenol red. Murine lymphoma YAC-1 
cells, used as target cells, were added adjusted to 105 cells per well. 
Thus, the effector/target ratio was 10:1. The plates were centrifuged 
at 250g for 4 minutes to facilitate cell contacts. After 4 hours of 
incubation, lactate dehydrogenase enzymatic activity was measured 
in 50 µL/well of the supernatants by addition of the enzyme sub-
strate and absorbance recording spectrophotometrically at 490 nm. 
Three kinds of control measurements were performed: a target spon-
taneous release, a target maximum release, and an effector spon-
taneous release. The results were expressed as percentage of lysis 
of target cells. To determine this percentage, the following equation 
was used: %lysis = ((E−ES−TS) / M−ES−TS)) × 100, where E is the 
mean of absorbances in the presence of effector cells; ES is the mean 
of absorbances of effector cells incubated alone; TS is the mean of 
absorbances in target cells incubated with medium alone; and M is 
the mean of maximum absorbances after incubating target cells with 
lysis solution.
Lymphoproliferation Assay
Following the method previously described (21), aliquots 
(200  µL) of peritoneal lymphocytes (106 cells/mL complete 
medium) were seeded in 96-well flat-bottomed microtiter 
plates (Numc, Roskilde, Denmark) and 20  µL of concanalva-
line A (ConA 1 µg/mL; Sigma), a T-cell mitogen (lectin), 20 µL 
of lipopolysaccharide (LPS, Escherichia coli, 055:B5 1  µg/mL; 
Sigma), a B-cell mitogen, or 20 µL of complete medium (spon-
taneous proliferation) were added per well. The plates were 
incubated for 48 hours at 37°C in an atmosphere of 5% CO2. 
After this time, 100 µL of culture supernatants were collected 
for cytokine measurements and the medium was renewed, and 
0.5 µCi3H-thymidine (Du Pont, Boston, MA, USA) were added to 
each well. After 24 hours of incubation, the cells were harvested 
in a semiautomatic microharvester and retained in filter paper. 
Thymidine uptake was measured using a beta counter (LKB, 
Uppsala, Sweden). The results were expressed as 3H-thymidine 
uptake (cpm).
Cytokine Levels
The levels of the cytokines, including growth factors (IL-2), pro-
inflammatory (TNF-α, IL-6, and IL-1β), and anti-inflammatory 
(IL-10) cytokines, released into the supernatants of leukocyte cul-
tures, after 48 hours of incubation with ConA or LPS, were meas-
ured simultaneously using a Luminex xPONENT (Milliplex Mouse 
Cytokine/Chemokine Panel Catalog MPXMCYTO-70K, Millipore 
Corp, Billerica, MA). The results were expressed as pg/mL.
Total Glutathione Levels
The total intracellular glutathione levels were measured using spec-
trophotometry based on a previously described method with some 
modifications (23). Briefly, aliquots of 1 mL of peritoneal suspen-
sion (adjusted to 106 leukocytes per mL in Hank’s medium) were 
centrifuged at 1,200g for 10 minutes at 4°C. The pellet cells were 
resuspended in a medium containing 5% tricloroacetic acid (TCA, 
Panreac, Barcelona, Spain) in 0.01 N HCl (previously degassed with 
helium for a minimum of 10 minutes). This was followed by three 
cycles of sonication for 10 seconds (with 20 seconds rest between each 
cycle), keeping the sample cold. Then, the samples were centrifuged 
at 3,200g for 5 minutes at 4°C. Aliquots of the supernatants of leu-
kocytes samples were measured using the following reaction mixture: 
5,5′-dithiobis (2-nitrobenzoic acid) (6 mM, Sigma), β-nicotinamide 
adenine dinucleotide phosphate, reduced form (β-NADPH, 0.3 mM, 
Sigma), and glutathione reductase (10 U/mL, Sigma). The reaction 
was monitored for 240 seconds and measured using spectropho-
tometry at a wavelength of 412 nm. The results were expressed in 
nmoles/106 cells.
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Catalase Assay
The activity of catalase (CAT) was determined following the method 
described by Beers and Sizer, with slight modifications introduced by 
us (24). The peritoneal suspension was previously adjusted to 106 leu-
kocytes/mL and aliquots of 1 mL were used to perform the enzymatic 
assay. The cells were centrifuged at 1,076g for 10 minutes at 4°C and 
the pellets were resuspended in 50 mM phosphate buffer. Then, the 
samples were sonicated and centrifuged at 3,200g for 20 minutes at 
4°C. The enzymatic assay was followed using spectrophotometry for 
80 seconds at 240 nm through the decomposition of H2O2 (14 mM in 
phosphate buffer) (Merck, Germany) into H2O + O2. The results were 
expressed as international units (U) of enzymatic activity per 106 cells.
Xanthine Oxidase Assay
To study the activity of xanthine oxidase (XO), we employed the 
commercial kit “Amplex Red Xanthine/Xanthine Oxidase Assay 
Kit” (Molecular Probes). The hydrogen peroxide (H2O2) produced 
by XO reacts with horseradish peroxidase present in the reaction 
mixture and generates a fluorescent oxidation compound resoru-
fin whose fluorescence is measured in a plate reader (Fluorestar 
Optima, BMG Labtech Biomedal, Spain). Briefly, 50 µL of perito-
neal suspension adjusted to 106 leukocytes/mL in Hank’s medium 
were incubated with 50 µL working solution of Amplex Red rea-
gent (100  µM) containing horseradish peroxidase (0.4 U/mL) and 
xanthine (200 µM). After 30 minutes of incubation at 37°C, meas-
urements of fluorescence were performed in a microplate reader 
using excitation at 530 nm and emission detection at 595 nm. Data 
analysis was performed with xanthine standard curves at different 
concentrations, the results being expressed in international milliunits 
(mU) of enzymatic activity per 106 cells.
Statistical Analysis
SPSS 10.0 (SPSS, Inc., Chicago, IL) was used for the statistical analysis 
of the results. The data were expressed as mean ± SD. Each value is 
the mean of the data from an assay performed in duplicate or triplicate. 
Normality of the samples was checked by the Kolmogorov–Smirnov test 
and homogeneity of variances by the Levene test. The data were statisti-
cally evaluated by the Student’s t-test for independent samples. p < .05 
was statistically significant and .05 < p < .1 was considered as a trend.
Results
Body Weight, Biochemical Parameters and Arterial 
Blood Measurements
At adulthood (28 weeks), animals fed with a high-fat diet for 14 
weeks displayed a significantly higher body weight when com-
pared with animals fed with a standard diet (p < .01). Furthermore, 
they also presented higher levels of triglycerides (p < .05) and sys-
tolic pressure (p < .001), marking them as obese. No significant 
differences were observed in total glucose, cholesterol, and dias-
tolic pressure levels between the obese and the control group (see 
Supplementary Table 1). When these adult obese animals reached 
the age of 72 weeks, they continued to present a higher body 
weight than the old control group (p < .001). The glucose (p < .01), 
triglycerides (p < .05), and systolic pressure levels (p < .01) were 
also significantly increased compared with that of old controls. 
However, with respect to measurements of total cholesterol and 
diastolic pressure levels, no differences were found between old 
control and old obese mice groups in old age (see Supplementary 
Table 1).
Peritoneal Leukocyte Functions
The migration of peritoneal macrophages, measured by the chemot-
axis index (Figure 1A), declined significantly in adult obese and in old 
control mice compared with that in adult controls (p < .001). In addi-
tion, the number of latex beads ingested by macrophages (Figure 1B) 
and the number of macrophages with phagocytic ability (Figure 1C) 
were also significantly decreased in adult obese mice and in old con-
trols (p < .001) with respect to adult control animals. The levels of 
intracellular superoxide anion in stimulated macrophages, an impor-
tant capacity of phagocytic cells in killing pathogens, showed signifi-
cantly lower values in adult obese mice (p < .001) and in old mice 
(p < .05) when compared with that in adult controls (Figure 1D).
Regarding the lymphocyte functions studied, the chemotaxis 
capacity of peritoneal lymphocytes (Figure  1E) was significantly 
decreased in adult obese and in old control mice (p < .01) with 
respect to adult control animals. A decreased activity of NK cells 
(% lysis) was also observed in both adult obese (p < .05) and old 
control mice (p < .01) in comparison with adult controls (Figure 1F). 
The results of the proliferative capacity of peritoneal lymphocytes 
in response to T-cell mitogen ConA and to B-cell mitogen LPS are 
shown in Figure 1G and H, respectively. Adult obese mice and old 
control mice displayed a significantly suppressed mitogen-induced 
proliferative response compared with that of adult controls (p < 
.001). However, the basal lymphoproliferation was not signifi-
cantly different between the three groups of animals, adult obese 
(1,770 ± 1,361 cpm), old mice (1,248 ± 100 cpm), and adult controls 
(1,459 ± 697 cpm). The levels of several cytokines (IL-1β, TNF-α, 
IL-6, IL-2, and IL-10), released in culture supernatants of perito-
neal leukocytes after 48 hours of incubation under ConA and LPS-
stimulated conditions, are shown in Figure  2. All these cytokines 
displayed a trend towards decrease or were significantly decreased in 
adult obese and in old animals in comparison with adult controls. In 
addition, the cytokines IL-1β and IL-10 under LPS-stimulated condi-
tions (p < .05) and IL-2 under ConA- (p < .01) and LPS-stimulated 
conditions (p < .001) were significantly lower in adult obese mice 
as compared with that in old mice. Nevertheless, the levels of IL-6 
released in response to ConA and LPS were significantly higher in 
adult obese mice than in old controls (p < .05).
With aging, impairments of leukocyte functions became more 
pronounced in old obese mice in comparison with old controls. As 
shown in Table 1, macrophage functions, such as chemotaxis capac-
ity (p < .01) as well as phagocytosis index (p < .01) and phagocytosis 
efficacy (p < .001), were significantly diminished in old obese mice 
when compared with that in old controls. However, with respect to 
stimulated generation of superoxide anion, there were no significant 
differences between both groups. In relation to NK cell activity, there 
was a significant decrease in old obese mice in comparison with old 
controls (p < .05). The lymphocyte functions (chemotaxis index and 
proliferation in response to ConA and LPS), which are shown in 
Table  1, were highly impaired in old obese mice when compared 
with old controls (p < .001). Even though not statistically signifi-
cant, there was a tendency of enhanced basal lymphoproliferative 
response in old obese with respect to old controls (p = .06) (Table 1).
Peritoneal Leukocyte Oxidative Stress Parameters
In order to investigate the oxidative stress status of peritoneal 
leukocytes in mice, the activity of XO, which is associated with 
the production of free radicals, and the enzymatic and nonenzy-
matic antioxidants, such as CAT activity and glutathione levels, 
were evaluated. The levels of total glutathione (Figure 3A), which 
have an important defensive role in neutralizing free radicals, 
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presented decreased values in peritoneal leukocytes in adult obese 
and old controls as compared with that in adult controls (p < .001). 
Similarly, CAT activity (Figure 3B), which protects against oxidant 
compounds, was diminished in leukocytes from adult obese (p < 
.001) and old mice (p < .01) with respect to adult control ani-
mals. The activity of XO (Figure 3C) was increased in leukocytes 
from adult obese mice (p < .001) and in those from old mice (p < 
.01) when compared with adult controls. When these animals grew 
older, reaching 72 weeks old, obese mice exhibited significantly 
lower levels of total glutathione when compared with old controls 
(p < .001). Nevertheless, the activities of XO and CAT did not 
present statistical differences between old obese and old control 
animals (Table 1).
Figure  1. Immune functions. (A) Macrophage chemotaxis index (CI, number 
of macrophages). (B) Macrophage phagocytic index (number latex beads/100 
macrophages). (C) Macrophage phagocytic efficacy (number of phagocyting 
macrophages/100 macrophages). (D) Stimulated intracellular superoxide anion 
levels (nmol/106 cells). (E) Lymphocyte CI (number of lymphocytes). (F) Natural 
killer cell activity (%  lysis). (G) Lymphoproliferative response to ConA (cpm). 
(H) Lymphoproliferative response to lipopolysaccharide (cpm). Each column 
represents the mean ± SD of 8–10 values corresponding to that number of 
animals and each value being the mean of duplicate or triplicate assays. ***p < 
.001; **p < .01; *p < .05 with respect to the values of adult control mice.
Figure  2. Cytokines levels (pg/mL) in supernatants of leukocytes cultured 
under ConA and lipopolysaccharide (LPS)-stimulated conditions. (A) 
Interleukin (IL)-1β (ConA). (B) IL-1β (LPS). (C) TNF-α (ConA). (D) tumor necrosis 
factor-alpha (TNF-α) (LPS). (E) IL-6 (ConA). (F) IL-6 (LPS). (G) IL-2 (ConA). (H) 
IL-2 (LPS). (I) IL-10 (ConA). (J) IL-10 (LPS). Each column represents the mean ± 
SD of 8–10 values corresponding to that number of animals and each value 
being the mean of duplicate or triplicate assays. ***p < .001; **p < .01; *p < 
.05 with respect to the values of adult control mice, ###p < .001; ##p < .01; #p 
< .05 with respect to values of adult obese mice.
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Life Span
Although differences were not statistically significant, obese mice 
tended to have a shorter life span when compared with controls 
(p = 0.08) (Table 1).
Discussion
The present work shows the negative effects on the immune system 
of old mice as adults, were obese due to the ingestion of a high-fat 
diet during adolescence.
Obesity was induced in adolescent mice by the administration 
of a high-fat diet for 14 weeks. These animals progressively and 
significantly increased their body weights and also presented sig-
nificantly elevated levels of triglycerides and systolic arterial pres-
sure when compared with the control group. Moreover, these mice 
showed conditions associated with obesity similar to those obtained 
in mice of a previous study in which an identical experimental design 
was followed to generate adult obesity (25). Thus, the administra-
tion of a high-fat diet during adolescence seems to be a good model 
to induce obesity in adult mice. Additionally, this type of diet and 
the increased adiposity have also been reported to enhance the lev-
els of oxidation and inflammation and to promote a dysfunctional 
immune response (19,26,27). Because obesity has been associated 
with a premature immunosenescence (18), it seems relevant to evalu-
ate whether obesity generated at adolescence, a critical development 
period, could also produce some features of immunosenescence at 
adult age. Moreover, it is also important to know if individuals that 
start their aging process at adult age with premature immunosenes-
cence reach old age with a higher deterioration of immune response 
than those adults showing an appropriate immune response. The 
present study found, on one hand, that the development of obesity 
during adolescence promoted a premature immunosenescence and 
oxidative state of leukocytes in adulthood. Thus, the adult obese 
mice, when compared with the controls of the same age, presented 
several deteriorated immune parameters, such as chemotaxis of both 
macrophages and lymphocytes, phagocytosis of macrophages, NK 
cell activity, mitogen-stimulated lymphoproliferation, and mitogen-
stimulated release of several cytokines (IL-1β, TNF-α, IL-6, IL-2, and 
IL-10) derived from leukocytes culture supernatants. These param-
eters showed values similar to those in chronologically old animals. 
On the other hand, these adult obese mice with a premature immu-
nosenescence reached old age in worsened conditions, although they 
were fed a standard diet during aging. The parameters of immune 
function and redox state of peritoneal leukocytes analyzed in the 
present study have been established as excellent markers of health 
and rate of aging. Moreover, it has been shown that the age-related 
changes in these parameters of peritoneal immune cells are similar to 
those in human blood leukocytes (16).
With respect to the functions studied in the peritoneal mac-
rophages, which represent the first line of immune response, adult 
Table 1. Functions and Oxidative Parameters in Peritoneal Immune Cells From Old Mice. Survival of Mice.
Old Control Mice Old Obese Mice
Macrophage functions
 Chemotaxis index 601 ± 50 473 ± 72**
 Phagocytic index 236 ± 59 144 ± 25**
 Phagocytic efficacy 64 ± 7 41 ± 9***
 Stimulated intracellular superoxide anion (nmol/106 cells) 138 ± 57 86 ± 24
Lymphocyte functions
 Chemotaxis index 660 ± 65 507 ± 66***
 Natural killer cell activity (% lysis) 50 ± 6 36 ± 11*
 Basal lymphoproliferative (cpm) 1,570 ± 269 2,269 ± 873
 Lymphoproliferative response to LPS (cpm) 2,795 ± 1,071 718 ± 241***
 Lymphoproliferative response to ConA (cpm) 2,662 ± 1,062 887 ± 328***
Oxidative stress parameters
 Total glutathione levels (nmol/106 cells) 1.8 ± 0.7 0.6 ± 0.2***
 Catalase activity (UI CAT/106 cells) 9 ± 1.2 14 ± 9
 Xanthine oxidase activity (mU XO/106 cells) 2.7 ± 1.2 2.9 ± 0.9
Survival of mice
 Number of weeks 117 ± 11 106 ± 13
Each data represents the mean ± SD of 8–10 values corresponding to that number of animals and each value being the mean of duplicate or triplicate assays.
*p < .05; **p < .01; ***p < .001 with respect to the values of old control mice.
Figure 3. Oxidative stress parameters. (A) Total glutathione levels (nmol/106 cells). (B) Catalase activity (CAT, U CAT/106 cells). (C) Xanthine oxidase activity 
(mUXO/106 cells). Each column represents the mean ± SD of 8–10 values corresponding to that number of animals and each value being the mean of duplicate 
or triplicate assays. ***p < .001; **p < .01; *p < .05 with respect to the values of adult control mice.
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obese mice showed diminished chemotaxis, phagocytosis and intra-
cellular levels of superoxide in comparison with adult nonobese 
control mice. These parameters showed similar values to those in 
old mice. In fact, in aging individuals, an impaired migration of 
macrophages to the site of inflammation, a diminished phagocytosis 
capacity, and decreased levels of intracellular superoxide needed to 
kill intracellular pathogens, have been observed (12,23,28). Studies 
from genetic models of obesity corroborate these findings, indicating 
a decreased macrophage phagocytic capacity and an impaired oxida-
tive burst in obese individuals (29,30). Morrow and colleagues (31) 
also reported a decreased phagocytosis by peritoneal macrophages 
in mice fed a high-fat diet. In addition, morbidly obese humans had 
a decreased bactericidal capacity by neutrophils (32). Nevertheless, 
another study performed in obese humans found a significantly 
higher phagocytosis and oxidative burst activity by monocytes and 
neutrophils (33). These contradictory results could be due to a dif-
ferent assay technique used in this study.
With respect to NK cells, also critical players of innate immu-
nity, the data obtained in the present study showed a decreased 
cytotoxic capacity in old and in adult obese mice compared with 
that in adult controls. Previous research has indicated that aged 
individuals, despite their increased number of NK cells, present 
depressed NK cytotoxicity (12,14). Obesity also seems to produce 
an impaired NK cell activity. In agreement with our study, earlier 
findings have indicated that obese rats fed a cafeteria diet and obese 
mice fed a high-fat diet, as well as obese human subjects, suffer from 
a diminished NK cell cytotoxicity (18,27,31,34). Moreover, another 
study demonstrated that obese mice fed with a high-fat diet exhib-
ited a poor cytotoxicity against influenza infection and increased 
mortality (35).
In addition, immune functions driven by T and B lymphocytes, 
such as migration and proliferation, also were affected by obesity. 
In fact, the present results showed that both adult obese and old 
mice presented similar deteriorated values in relation to peritoneal 
lymphocyte functions, including chemotaxis and proliferation in 
response to T- and B-cell mitogens such as ConA and LPS, respec-
tively, in comparison with adult controls. There is evidence showing 
that aged individuals exhibit impaired chemotaxis and, especially, 
proliferative response to mitogens of lymphocytes (12,36). In rela-
tion to obese individuals, we did not find studies that evaluated 
chemotaxis of lymphocytes. Therefore, our study seems to be the 
first to describe a decrease in this activity in obese mice. In relation 
to the proliferative response of lymphocytes to mitogen stimulation, 
studies have indicated a reduced capacity of this parameter in obese 
individuals. In obese mice, Sato Mito and colleagues (37) found a 
decreased splenocyte proliferative response with T- and B-cell mito-
gens. Moreover, obese humans also exhibited suppressed stimulated 
proliferation of T and B lymphocytes (33,38). Increasing evidence 
suggests that the conditions of aging and obesity are accompanied 
by overactivation of innate immune cells with increased produc-
tion of proinflammatory cytokines, such as TNF-α, IL-6, and IL-1β, 
especially in basal conditions (13,39–42). However, a previous study 
showed decreased levels of IL-1β, TNF-α, IL-6, IL-2, and IL-10 in per-
itoneal leukocytes from aged mice under mitogen-stimulated states 
(13). The data of the present study agree with those results. Thus, 
following stimulation with mitogens ConA and LPS, the secretion 
of these cytokines presented a decrease (tendency or statistically sig-
nificant differences) in old and adult obese mice in comparison with 
adult controls. These findings are in agreement with those obtained 
in obese mice, in which peritoneal macrophages, in response to a 
bacterial infection, exhibited lower levels of the proinflammatory 
cytokines TNF-α, IL-β, and IL-6 (42–44). A decrease in spleen cells 
of IL-6 under LPS-stimulated conditions (45) and of the IL-2 follow-
ing mitogen stimulation (46) in obese with respect to lean human 
individuals have also been shown. Nevertheless, in young-adult 
overweight human subjects, the generation of IL-2 by mononuclear 
or lymphocyte cells in response to LPS increased, whereas the lev-
els of IL-10 were similar between obese and lean individuals (47). 
One possible explanation for these differences could be that indi-
viduals were considered mildly obese and thus might not produce 
significantly impaired immunity. The data of the present study also 
demonstrate that the release of mitogen-stimulated IL-2 was further 
impaired in adult obese mice with respect to old controls. Among 
several factors that modulate the release of cytokines, prostaglandin 
E2 (PGE2) has been described to inhibit the release of IL-2 (48). 
Although this inflammatory mediator is increased in both processes 
of aging and obesity (49,50), a recent study reported that adipocytes 
from young obese mice displayed higher levels of PGE2 with respect 
to old mice (51). Therefore, it is possible that the release of IL-2 was 
more suppressed in adult obese mice by higher levels of PGE2 than 
in old controls.
Oxidative stress, which is generated by an increase of oxidants 
and a decrease of antioxidants, has been linked to aging and obesity 
(16,52,53). In fact, oxidative stress seems to contribute to the patho-
geneses of several diseases that are common to both aged and obese 
individuals, including diabetes mellitus, cardiovascular diseases, and 
cancer (54). The results demonstrate that old and adult obese mice 
exhibited elevated XO activity (an enzyme that produces oxidants) 
and decreased CAT activity and glutathione levels (two relevant anti-
oxidant defenses). Previous studies have confirmed that peritoneal 
leukocytes from old mice or from prematurely aging mice showed 
enhanced activity of XO (8,55) and a decrease of enzymatic and non-
enzymatic antioxidants, such as CAT activity and glutathione levels 
(12,16,24). In obese individuals, an increased production of oxidants 
and a decreased capacity of antioxidants have also been observed. 
Saiki and colleagues (56) reported increased levels in the blood of 
serum hypoxanthine and uric acid in obese compared with those in 
nonobese individuals, whereas Chiney and colleagues (57) found that 
XO activity was significantly elevated in obese when compared with 
that in nonobese children. Regarding antioxidant defenses, a decrease 
of glutathione levels in erythrocytes of obese individuals during their 
childhood and adulthood was reported (58–60). In addition, CAT 
activity was significantly lower in erythrocytes of obese women (61). 
Therefore, these data indicate that obesity might produce a similar 
oxidative stress to those reported in the elderly, and this condition 
could accelerate the aging process in obese individuals.
Surprisingly, when obese animals grew older, although they 
were fed a standard diet during their aging process, they contin-
ued to exhibit a significant higher body weight than old controls. 
Biochemical parameters, such as glucose and triglycerides, as well 
as systolic blood pressure levels, were also significantly increased in 
old obese mice. In addition, these animals, which maintained obesity 
during their aging process, showed an increased deterioration of the 
immune and oxidative parameters, with respect to old controls. This 
aggravated immunosenescence was reflected in the life span of mice, 
although not statistically significant, obese mice tended to exhibit a 
shorter life span. The consumption of a standard diet across aging 
was not able to restore functions and the redox state of the immune 
cells to the normal levels of the corresponding chronological age.
In conclusion, the results of this study provide evidence that a 
high-fat intake during adolescence can produce an obesity state in 
Journals of Gerontology: BIOLOGICAL SCIENCES, 2016, Vol. 71, No. 8 
 by guest on Septem
ber 29, 2016
http://biom
edgerontology.oxfordjournals.org/
D
ow
nloaded from
 
131
adult age associated with a premature immunosenescence, which is 
aggravated through aging although individuals ingest a normal diet. It 
is possible that intervention with lifestyle strategies, such as a caloric 
restriction diet or the administration of appropriate amounts of anti-
oxidants, as well as physical exercise and environmental enrichment, 
among others, which are effective in improving immune function in 
aging (62,63), could decrease the deterioration of obese mice. Thus, 
further studies are needed to corroborate how inadequate nutrition 
at an early age can influence the immune response in adulthood and 
then accelerate the aging process, as well as if some of the previously 
mentioned lifestyle strategies could prevent or delay these effects.
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3.1.2. Effects of the late-adulthood diet-induced obesity onset on behaviour, immune 
function and redox state of middle-aged male and female mice, as well as on their life span. 
 
 
 
Experimental design  
Late-adult male and female mice, at the age of 28 weeks, were divided into two groups 
(n=8-10) each of similar average body weight and were fed either a standard diet or a high-fat diet 
for 14 weeks. The diets used were the same as those provided in the previous sub-objective. When 
male and female mice were diet-induced obese (DIO) and middle-aged (42 weeks of old), a variety 
of tests and assays were performed in order to evaluate behaviour, biochemical parameters as well 
as functions and redox state of peritoneal leukocytes. After 14 weeks on the high-fat diet, middle-
aged male and female DIO mice returned to a standard diet. During the entire study, all animals had 
free access to water and the diet. Weight and food intake were measured every week throughout the 
study. Given that mice are capable of remembering previously performed behavioural tests, only 
biochemical parameters and the functional and redox states of peritoneal leukocytes were repeated 
in old age (72 weeks old). Moreover, since a significant number of male mice did not reach old age, 
these parameters were assessed only in female mice at the age of 72 weeks.  
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Main results  
Body weight, total fat mass, food intake, and biochemical measurements 
After the period of 14 weeks on a high-fat diet, middle-aged male and female diet-induced 
obese (DIO) mice displayed significantly higher body weights than their control counterparts, with 
males weighing more than females. In addition, male and female DIO mice consumed significantly 
more kilocalories than their controls, with males consuming more kilocalories than females.  
Middle-aged male and female DIO mice showed a higher total fat mass than the 
corresponding controls, with female DIO mice showing a higher total body fat than male DIO mice. 
Female DIO mice showed higher values of glucose than their respective non-DIO counterparts. In 
addition, males displayed significantly higher levels of glucose than females. The levels of 
triglycerides and cholesterol were significantly higher in male and female DIO mice in comparison 
with their respective non-DIO controls. In addition, male DIO mice showed higher cholesterol 
levels than female DIO mice. When females reached 72 weeks of age (old age), they exhibited 
higher levels of glucose than middle-aged females.  
Behavioural parameters 
Motor coordination and equilibrium  
The percentage of falls from the wood rod was significantly higher in male DIO mice than 
in their respective non-DIO controls. In addition, male DIO mice displayed significantly lower 
percentages of test completion and the covering of one segment in the wood rod test than male non-
DIO mice. No differences were observed in these parameters between female DIO mice and their 
respective non-DIO controls. In the wood rod test, male DIO mice showed a worse performance in 
the percentage of falls, on test completion and the covering of one segment than female DIO mice. 
Muscular vigour   
Male and female DIO mice showed significantly higher percentages of falls from the rope 
than their respective female non-DIO controls. In addition, the percentages of the test completed 
and maximum traction capacity were significantly lower in male and female DIO mice in 
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comparison with their respective controls. Male DIO mice showed a worse response in the 
percentage of falls, in the test completed, and traction capacity than female DIO mice. 
 Vertical exploratory activity  
The total number of rearings in the corner and holeboard tests was significantly lower in 
male and female DIO mice than their respective non-DIO controls. Male control and DIO mice 
showed a lower total number of rearings than female control and DIO mice, respectively.  
Horizontal exploratory activity 
Female DIO mice visited a lower number of corners in the corner test than their respective 
controls. Male DIO mice performed a lower number of total line crossings than their respective 
controls. Male DIO mice displayed a significantly lower peripheral ambulation (which was 
measured by the number of line crossings in the peripheral area of the holeboard) than their 
respective controls. Male controls also showed a significantly higher peripheral ambulation than 
female controls. In addition, male and female DIO mice showed a significant lower central 
ambulation (which were measured by the number of line crossings in the central area of the 
holeboard) than their respective non-DIO controls.  
Male and female DIO mice took a longer time to complete the exploration of the three arms 
of the T-maze test than their non-DIO counterparts, with male DIO mice showing a longer time to 
complete the test than female DIO mice. 
Anxiety-like behaviour  
Male and female DIO mice exhibited a lower percentage of time in open arms than their 
respective non-DIO controls, with male DIO mice showing a lower percentage of time than female 
DIO mice. Moreover, the percentage of time in closed arms was higher in male DIO mice in 
comparison with their respective controls and female counterparts. In addition, the time (in seconds) 
spent by mice performing self-grooming in the holeboard test was significantly higher in male and 
female DIO mice than in their respective controls. 
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 Male and female DIO mice also showed a higher percentage and total number of fecal bolei 
present than their respective non-DIO controls, with male DIO mice having a higher percentage of 
the presence of fecal bolei than female DIO mice.  
Peritoneal leukocyte function parameters 
The migration of peritoneal macrophages in response to a chemotactic gradient (formylated 
peptide) was significantly lower in male and female DIO mice compared with their respective non-
DIO controls. Male control and DIO mice displayed a significantly lower chemotactic index (CI) 
than female control and DIO mice, respectively. In addition, the phagocytic index was lower in 
male and female DIO mice with respect to the corresponding controls, with males displaying a 
lower phagocytic index than females. The phagocytic efficacy was also lower in male and female 
DIO mice with respect to the corresponding controls. 
With aging, the chemotactic index (CI) was significantly lower in old female DIO mice than 
in their corresponding non-DIO mice, with old females displaying a lower CI than middle-aged 
females. In addition, the phagocytic index (PI) was significantly lower in old female DIO mice than 
in non-DIO mice, with old females displaying a lower PI than middle-aged females. The phagocytic 
efficacy (PE) was significantly lower in old female DIO mice than in their corresponding controls, 
with old females displaying a lower PE than middle-aged females.  
The CI of peritoneal lymphocytes was significantly lower in male and female DIO mice in 
comparison with their non-DIO counterparts. Male control mice displayed a lower CI than female 
control mice. The NK activity was significantly lower in male and female DIO mice in comparison 
with their non-DIO controls. Male and female DIO mice displayed significantly higher basal 
lymphoproliferation in comparison with non-DIO controls, with male DIO mice showing higher 
basal lymphoproliferation than female DIO mice. However, in response to the mitogen ConA, the 
proliferation of lymphocytes was lower in male and female DIO mice in comparison with their 
controls. Male and female DIO mice also showed lower LPS-stimulated proliferation in comparison 
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with their non-DIO mice, with male DIO mice showing higher LPS-stimulated proliferation than 
female DIO mice. 
With aging, the chemotactic index (CI) of peritoneal lymphocytes in old female DIO mice 
was significantly lower when compared with their corresponding non-DIO mice, with old females 
displaying lower CI than middle-aged females. Old females showed significantly lower anti-tumour 
NK activity than middle-aged females. The basal proliferation of lymphocytes in old female DIO 
mice was higher than in their respective controls, with old females displaying higher basal 
lymphoproliferation than middle-aged females. Nevertheless, old female DIO mice exhibited 
significantly lower proliferation of lymphocytes in response to ConA than old female non-DIO 
mice. In addition, old females displayed significantly lower LPS-stimulated lymphoproliferation 
than middle-aged females.  
Peritoneal leukocyte oxidative stress parameters 
The catalase (CAT) activity was lower in leukocytes of male and female DIO mice in 
comparison with their corresponding non-DIO controls. The glutathione peroxidase (GPx) activity 
in leukocytes of male and female DIO mice was higher in comparison with their respective controls. 
Male control mice showed lower GPx activity than female control mice. The reduced glutathione 
(GSH) concentrations were lower in peritoneal leukocytes of male and female DIO mice in 
comparison with their respective non-DIO controls. 
With aging, old female control mice displayed significantly lower CAT activity than middle-
aged female control mice. Old females also exhibited lower GPx activity than middle-aged females. 
Regarding the GSH concentrations, old female DIO mice displayed lower values than those of old 
female non-DIO mice, with old females showing lower concentrations of GSH than middle-aged 
females. 
The activity of xanthine oxidase (XO) was significantly higher in male and female DIO 
mice in comparison with their corresponding non-DIO controls, with males showing higher XO 
activity than females. The superoxide anion concentrations and the GSSG/GSH ratios (an indicator 
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of oxidative stress) were significantly higher in male and female DIO mice than in their respective 
non-DIO controls. The malondialdehyde (MDA) concentrations, which are an indicator of lipid 
oxidation and oxidative damage in cells, were significantly higher in male and female DIO mice 
with respect to their non-DIO controls, with male DIO mice showing higher MDA concentrations 
than female DIO mice. 
The xanthine oxidase activity in old female controls was significantly higher than in middle-
aged female controls. The MDA concentrations were significantly higher in old female DIO mice 
than in their respective controls, with old female controls showing higher MDA concentrations than 
middle-aged controls. The superoxide anion concentrations were significantly higher in old female 
DIO mice in comparison with old female non-DIO controls, with old female controls showing 
higher superoxide anion amounts than middle-aged controls. 
Life span 
Male DIO mice showed a shorter life span than male non-DIO control mice. Male DIO mice 
also exhibited a shorter life span than female DIO mice. The differences were not statistically 
significant between female DIO mice and female non-DIO mice.  
 
Partial conclusions 
The results of this experiment indicate that the high intake during late adulthood produces an 
obesity state, which is associated with impaired nervous (behavioural responses) and immune 
systems (function and redox state of peritoneal leukocytes) in middle-aged male and female mice. 
Sex differences are found in some of the behavioural, immune cell function and redox state 
parameters, males being significantly more affected than females. In addition, the late adulthood 
diet-induced obesity partially aggravates immunosenescence in old female mice. 
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The aim of the present study was to investigate whether the late onset of diet-induced obesity (DIO) in middle-
aged mice aﬀected behavioral, immunological and oxidative stress parameters as well as life span of male and
female mice. Also, it was analyzed whether the late DIO onset aggravated immunosenescence in old female mice.
Late-adult male and female ICR/CD1 mice (28 weeks old) were fed either a high-fat diet or a standard diet during
14 weeks. After that, in these middle-aged (42 weeks old) diet-induced obese (DIO) and non-DIO controls, be-
havior as well as functions and redox state of peritoneal leukocytes were evaluated. These same parameters
(excepting behavioral tests) were repeated when female mice were old (72 weeks old). The results showed lower
exploratory activity and higher anxiety-like behavior in middle-aged male and female DIO than in controls.
Moreover, these DIO animals from both sexes exhibited statistically signiﬁcant impaired immune cell functions,
such as chemotaxis of macrophages and lymphocytes, phagocytosis of macrophages, natural killer activity and
lymphoproliferation in response to ConA and LPS, as well as an oxidative stress state in comparison with con-
trols. Male DIO mice exhibited higher impairments in a variety of the evaluated parameters and a shorter life
span than their female counterparts. In addition, female DIO mice, at old age, showed aggravated im-
munosenescence. In conclusion, the late DIO onset leads to impairments in behavior as well as in immune system
functions of middle-aged male and female mice, males being signiﬁcantly more aﬀected than females.
1. Introduction
Unhealthy dietary patterns, such as increased consumption of diets
high in fat and energy, have been associated with the worldwide obe-
sity epidemic. The prevalence of obesity has been rising at alarming
rates in all age groups (from young to older ages) and in both sexes
(Johnson et al., 2015; Swinburn et al., 2011).
Obesity has been linked to systemic chronic oxidative stress, low-
grade inﬂammation and dysfunctional immune system (Hunsche et al.,
2016; Huttunen and Sryjänen, 2013; Rath and Haller, 2011; Sheridan
et al., 2012). This condition seems to be generated and maintained in
the adipose tissue by excess of nutrients, reactive oxygen species (ROS)
and inﬂammatory compounds, which in turn promotes increased in-
ﬁltration of immune cells and results in a vicious cycle of oxidation and
inﬂammation. Both chronic oxidative stress and inﬂammation, which
are two closely related processes (Vida et al., 2014), in adipose tissue,
may spread to a systemic level, contributing to the development of
obesity-related complications (de Mello et al., 2018). It is largely known
that a controlled immune response with adequate production of in-
ﬂammatory and oxidative compounds is essential for maintaining
health and protecting against infections, cancer and damages. However,
if the levels of these compounds exceed the capacity of anti-in-
ﬂammatory and antioxidant defenses of the organism, an imbalance
occurs and oxidative and inﬂammatory stresses are established, which
contribute to cellular and tissue damage in all physiological systems,
including the nervous and immune systems (Bauer and De la Fuente,
2016; De la Fuente and Miquel, 2009; Vida et al., 2014). Moreover,
given that the nervous and immune systems share a bidirectional
communication (Vida et al., 2014), it is expected that the dysfunctional
immune system associated with obesity, would have an impact on the
nervous system. In fact, increasing evidence suggests that obese in-
dividuals show increased inﬁltration of oxidative and inﬂammatory
compounds into the brain, and the neuroinﬂammation generated has
been related with the development of cognitive, motor and behavioral
dysfunctions (Pistell et al., 2010; White et al., 2009).
Similar to obesity, the aging process aﬀects functions of all
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physiological systems, including those of the nervous and immune
systems (Vida et al., 2014). Thus, there is a progressive deterioration in
a variety of brain and behavioral functions, including memory as well
as cognitive and motor activity (Rosenzweig and Barnes, 2003;
Vandervoort, 2002). In addition, the immune system also suﬀers age-
related alterations (immunosenescence), which includes marked
changes of the innate and adaptive immune responses. This im-
munosenescence results in impaired migration and phagocytosis of
macrophages, anti-tumor activity of natural killer (NK) cells and pro-
liferative response of lymphocytes (Martínez de Toda et al., 2016).
These impairments seem to be caused mainly by the age-related chronic
oxidative and inﬂammatory stresses of the immune cells, which are also
involved in the oxidative and inﬂammatory state of the organism and,
consequently, in the rate of aging (De la Fuente and Miquel, 2009).
Given that obesity and aging are linked to oxidative and in-
ﬂammatory stresses, and both conditions result in health complications,
there is an increasing concern whether obesity could accelerate the
process of aging and increases the risk of morbidity and mortality at
premature ages (De la Fuente and Castro, 2012; Zamboni et al., 2005).
We have recently shown that the early adulthood diet-induced obesity
onset resulted in premature features of aging (such as im-
munosenescence). Thus, adult diet-induced obese (DIO) mice, as a
consequence of being fed during their adolescence with a high-fat diet,
presented functions and oxidative stress state of peritoneal leukocytes
similar to those observed in chronologically old mice. Furthermore,
when these adult DIO animals reached old age, they continuous to show
higher impairments of immune cell functions, and a shorter life span
than old non-DIO animals (Hunsche et al., 2016).
Previous studies indicate that the age of obesity onset (Boitard et al.,
2012) and sex (Salinero et al., 2018) have an impact on obesity-related
health problems. However, nothing is known about the impacts of the
late adulthood diet-induced obesity onset in the nervous (behavior) and
immune system (immune functions and redox state of peritoneal leu-
kocytes) of middle-aged mice, as well as if there are diﬀerences between
males and females. Therefore, in the present study, we investigated
whether middle-aged male and female DIO mice, as a consequence of
being fed with a high-fat diet during their late adulthood, showed al-
terations in relevant parameters of behavior, immune and redox state as
well as in their life span. Also, it was analyzed whether the late
adulthood obesity onset aggravated immune and redox state para-
meters of old female mice.
2. Materials and methods
2.1. Animals
Male and female ICR/CD1 mice (Mus musculus) were purchased
from Janvier SAS (Chassal, France) at the age 8 weeks. The animals
were housed in polyurethane cages (4–5 animals per cage) and main-
tained under standard laboratory conditions (12:12 h reversed light/
dark cycle; lights on at 8:00 pm, relative humidity of 50–60%, tem-
perature of 22 ± 2 °C and adequate ventilation). The experiments were
conducted in accordance with the guidelines and protocols of the Royal
Decree 53/2013 regarding the care and use of laboratory animals for
experimental procedures, and were approved by the Committee for
Animal Experimentation of the Complutense University of Madrid.
2.2. Experimental groups
Late-adult male and female mice, at the age of 28 weeks, were di-
vided into groups (8–10 animals for each group) of similar average
body weight and were fed either a standard diet or a high-fat diet for
14 weeks. A table with detailed nutritional content of diets is provided
in a previously published paper (Hunsche et al., 2018). Brieﬂy, the diets
used were provided by Harlan Interfauna Iberica (Barcelona, Spain) and
the nutritional compositions were (i) standard diet (Teklad Global 14%
Protein Rodent Maintenance Diet, reference 2014): energy 2.9 Kcal/g,
protein 20%, carbohydrate 67%, and fat 13% and (ii) high-fat diet
(Teklad Custom Diet, reference TD. 06414): energy 5.1 Kcal/g, protein
18.4%, carbohydrate 21.3%, and fat 60.3%. When male and female
mice were diet-induced obese (DIO) and middle-aged (42 weeks of old),
a variety of tests and assays were performed in order to evaluate be-
havior, biochemical parameters as well as functions and redox state of
peritoneal leukocytes. After 14 weeks on the high-fat diet, middle-aged
male and female DIO mice returned to a standard diet. During the entire
study, all animals had free access to water and food. Body weight and
food intake were measured every week throughout the study.
Given that mice are capable of remembering previously performed
behavioral tests, only biochemical parameters and functional and redox
states of peritoneal leukocytes were repeated in old age (72 weeks old).
Moreover, since a signiﬁcant number of male mice did not reach old age
(3–6 animals for each group), these parameters were assessed only in
female mice at the age of 72 weeks (5–8 animals for each group).
2.3. Total body fat mass
Nuclear magnetic resonance (NMR) was used to evaluate the total
fat mass in mice. NMR was performed using magnetic resonance ima-
ging (MRI) technology Biospec BMT 47/40 with a ﬁeld of 4.7 Tesla.
MRI was obtained in vivo and analyzed (acquisition, reconstruction, and
data processing) using advanced digital technology with imaging soft-
ware. During the measurements, mice were anaesthetized with iso-
ﬂurane (Judex et al., 2010).
2.4. Biochemical parameters
Glucose, triglyceride, and total cholesterol levels were measured
with Accutrend (Roche Diagnostics, Mannheim, Germany) using blood
samples collected from the tail vein of mice.
2.5. Behavioral tests
Behavioral tests were carried out between 8 am and 10 am during
three consecutive days, under illumination of ﬂuorescent lamps (20W).
On the ﬁrst day, a battery of tests (reﬂexes, corner, T-maze, wood rod
and tightrope tests) was performed in mice. On the second day, mice
were subjected to the holeboard test, and on the third day mice were
assessed in the elevated plus maze. The experimental apparatus was
cleaned before the performance of each mouse in order to avoid ol-
factory trails.
2.5.1. Reﬂexes
When the mouse was suspended by the tail and lowered toward a
solid black surface, the visual placing reﬂex was evaluated by observing
the complete extension of the forelimbs, and the hindlimb reﬂex was
measured by the complete extension of these limbs. The mean response
was rated in three trials.
2.5.2. Motor coordination and equilibrium abilities
In order to assess motor coordination and equilibrium, animals were
placed in the center of a wood elevated rod for one trial of 60 s (Baeza
et al., 2010). Motor coordination and equilibrium were measured by the
time (in seconds) to leave the ﬁrst segment and by the percentage of
mice falling oﬀ the rod. In addition, the percentages of mice that cover
at least 1 segment and that complete the test were also considered as
motor coordination and equilibrium abilities.
2.5.3. Muscular vigor and traction
Muscular vigor and traction were evaluated in an elevated hor-
izontal tightrope, using a test trial of 60 s (Baeza et al., 2010). Muscular
vigor was assessed as the percentage of mice falling oﬀ the rope and
that complete the test. Traction was evaluated by analyzing the
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diﬀerent parts of the body that mice used to remain hanged (forelimbs,
hindlimbs and tail) and, subsequently, the percentage of mice dis-
playing the maximum traction capacity (using forelimbs, hindlimbs and
tail).
2.5.4. Vertical exploratory activity
The vertical exploratory activity (studied as the performance of
“rearing”, that is, when the mouse stands up on his hindlimbs so that his
body becomes more perpendicular to the ground) was evaluated in the
corner test and in the holeboard test. The corner test consists in placing
the mouse in a new cage with bedding during 30 s (Baeza et al., 2010).
In contrast, the holeboard test consists in placing the animal in a box
made of wood with matte-painted metallic walls, divided into 36
squares, bearing four equally spaced holes in the central area (all but 20
peripheral squares were considered central) (Baeza et al., 2010). The
test was performed during 5min.
2.5.5. Horizontal exploratory activity
Horizontal exploratory activity was assessed as the number of cor-
ners of the cage visited (corner test) and as the peripheral ambulation
(number of line crossings in the peripheral area, by the walls) and
central ambulation (number of line crossings in the central area) in the
holeboard test. Peripheral ambulation was considered lower ex-
ploratory activity than central ambulation due to the tendency of mice
to remain close to walls (thigmotaxis) (Simon et al., 1994). In addition,
horizontal exploratory behavior was also recorded using the T-maze
test, which is a wooden apparatus with three enclosed arms (Baeza
et al., 2010). The mouse was placed inside the “short” arm of the maze
with its head facing the wall. The time (in seconds) to complete the test
(exploration of all three maze arms) was assessed as horizontal ex-
ploratory activity.
2.5.6. Goal-directed exploratory behavior
The goal-directed exploratory behavior of mice was assessed in the
holeboard test. A small plastic object was placed into each of the four
holes of the holeboard to attract mice attention. The frequency (per-
centage and number) of mice that perform head-dips (when the animal
places its head into the hole) was considered as a goal-directed ex-
ploratory behavior.
2.5.7. Anxiety-like behavior
The anxiety-like behavior was measured in the elevated plus maze,
as previously described (Garrido et al., 2018). The test was performed
during 5min. The total numbers of entries (four paws criteria) in open
arms and in closed arms were recorded. The percentage of time spent in
open and closed arms, and platform was calculated. In addition, the
frequency of self-grooming (when mouse cleans, licks or scratches its
body) as well as the presence of defecation in the holeboard and in the
T-maze tests were also considered as anxiety-like behaviors (Archer,
1973; Sake and Graybiel, 2003).
2.6. Collection of peritoneal leukocytes
The peritoneal suspensions were obtained between 8 am and 10 am
to minimize circadian variations in the immune system, by a procedure
previously described, without animal sacriﬁce (Guayerbas et al.,
2002a,b), which allowed monitoring the life span of the mice. Brieﬂy,
3ml of Hank’s solution, adjusted to pH 7.4, were injected into the
peritoneum, the abdomen was massaged and the peritoneal exudate
cells were collected allowing the recovery of 90–95% of the injected
volume. The peritoneal leukocytes, consisting of lymphocytes and
macrophages, were counted in Neubauer chambers (Blau Brand, Wer-
theim, Germany). The suspensions were adjusted to a ﬁnal concentra-
tion of 5× 105 macrophages or lymphocytes per ml in Hank’s solution
or 106 leukocytes per ml in Hank’s solution or complete medium (RPMI
1640 enriched with L-glutamine (PAA, Pasching, Austria) and
supplemented with 10% heat-inactivated (56 °C, 30min) fetal calf
serum (PAA, Pasching, Austria) and gentamicin (100mg/ml, PAA,
Pasching, Austria) with or without phenol red, depending on the type of
assay used. Macrophages and lymphocytes were identiﬁed by their
morphology. The cellular viability was measured using the trypan-blue
(Sigma-Aldrich, Madrid, Spain) exclusion test and in all cases was
higher than 98%.
The immune functions and redox state parameters studied were
performed using unfractionated peritoneal leukocytes, which better
preserved the physiological environment surrounding the immune cells
in vivo (Alonso-Fernández and De la Fuente, 2011).
2.7. Chemotaxis assay
Chemotaxis of peritoneal leukocytes was evaluated according to a
slight modiﬁcation of Boyden’s method (Guayerbas et al., 2002a),
consisting basically of the use of chambers with two compartments
separated by a ﬁlter with a pore diameter of 3 µm (Millipore, Bedford,
MA, USA). The chemotaxis index (CI) was determined by counting, in
an optical microscope (100×), the total number of macrophages and
lymphocytes on one third of the lower face of the ﬁlters.
2.8. Phagocytosis assay
Phagocytosis assay of inert particles (latex beads) was carried out
following a method previously described (Guayerbas et al., 2002a). The
number of particles ingested by 100 macrophages was counted using an
optical microscope (100×) and expressed as phagocytic index (PI). The
percentage of macrophages, which phagocyted at least one latex bead,
was also determined and expressed as phagocytic eﬃciency (PE).
2.9. Natural killer assay
An enzymatic colorimetric assay was carried out to measure the
cytolysis of tumor cells (murine lymphoma YAC-1 cells) (Cytotox 96 TM
Promega, Boehringer Ingelheim, Germany) based on the determination
of lactate dehydrogenase enzyme (LDH), as previously described
(Guayerbas et al., 2002a). The results were expressed as percentage of
lysis of tumor cells.
2.10. Lymphoproliferation assay
Following the method previously described (Guayerbas et al.,
2002b), aliquots (200 µl) of peritoneal leukocytes (106 cells/ml com-
plete medium) were seeded in 96 well ﬂat-bottomed microtitre plates
(Numc, Roskilde, Denmark) and 20 µl of concanavaline A (ConA 1 µg/
ml, Sigma-Aldrich), 20 µl of lipopolysaccharide (LPS, E. coli, 055:B5
1 µg/ml, Sigma-Aldrich) or 20 µl of complete medium (spontaneous
proliferation) were added per well. After 48 h of incubation at 37 °C in
an atmosphere of 5% CO2, 0.5 µCi 3H-thymidine (Du Pont, Boston, MA,
USA) were added to each well. The cells were harvested in a semi-
automatic microharvester 24 h later. Thymidine uptake was measured
using a beta counter (LKB, Uppsala, Sweden). The results were ex-
pressed as 3H-thymidine uptake (cpm).
2.11. Catalase activity assay
The activity of catalase (CAT) was determined following a pre-
viously described method (Alvarado et al., 2006). The enzymatic assay
was followed using spectrophotometry for 80 s at 240 nm. The results
were expressed as international units (U) of enzymatic activity per 106
cells.
2.12. Glutathione peroxidase activity assay
The glutathione peroxidase activity was determined according to
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the method described by Lawrence and Burk (1976) with some mod-
iﬁcations (Alvarado et al., 2006). The reaction was followed spectro-
photometrically by the decrease of the absorbance at 340 nm. The re-
sults were expressed as milliunits (mU) of enzymatic activity per 106
cells.
2.13. GSH and GSSG concentrations assay
Both reduced (GSH) and oxidized (GSSG) concentrations of glu-
tathione were measured using a ﬂuorometric method, with some
modiﬁcations (Garrido et al., 2018). Measurement of ﬂuorescence was
performed in a microplate reader using excitation at 350 nm and
emission detection at 420 nm. The results were expressed as nmol/106
Fig. 1. (A) Body weight (g) of male and female control and diet-induced obese (DIO) mice during high-fat diet feeding (28–42weeks of age) and aging (43–72weeks
old). (B) Food intake (kcal) of male and female control and DIO mice during high-fat diet feeding (28–42weeks of age) and aging (43–72 weeks old). Signiﬁcant
diﬀerences: a: male control vs male DIO; b: female control vs female DIO; c: male control vs female control; d: male DIO vs female DIO. Data represent mean ± SEM
(n=3–10 animals for each group). (C) Total body fat mass (mm3). Each column represents mean ± SEM (n=4 animals for each group). ***P < 0.001; **P < 0.01
with respect to the corresponding values of control mice. ##P < 0.01 with respect to the corresponding values of middle-aged male DIO mice. (D) Glucose levels
(mg/dL). ***P < 0.001 with respect to the corresponding values of control mice. ###P < 0.001; #P < 0.05 with respect to the corresponding values of middle-aged
male control mice and middle-aged male DIO mice. •••P < 0.001; ••P < 0.01 with respect to the corresponding values of middle-aged female control mice and
middle-aged female DIO mice. Data represent median ± SEM (n=5–10 animals for each group). (E) Triglyceride levels (mg/dL). **P < 0.01 with respect to the
corresponding values of control mice. Data represent median (IQR) (n=5–10 animals for each group). (F) Total cholesterol levels (mg/dL). **P < 0.01 with respect
to the corresponding values of control mice. #P < 0.05 with respect to the corresponding values of middle-aged male DIO mice. Data represent median (IQR)
(n=5–10 animals for each group).
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cells. The GSSH/GSH ratio was calculated for each sample.
2.14. Xanthine oxidase activity assay
Xanthine oxidase (XO) activity was measured by ﬂuorescence using
a commercial kit “Amplex Red Xanthine/Xanthine Oxidase Assay Kit”
(Molecular Probes, Paisley, UK), as previously described (Vida et al.,
2011). Measurement of ﬂuorescence was performed in a microplate
reader using excitation at 530 nm and emission detection at 595 nm.
Data analysis was performed with xanthine standard curves at diﬀerent
concentrations, the results being expressed in international milliunits
(mU) of enzymatic activity per 106 cells.
2.15. Lipid peroxidation (malondialdehyde) assay
The estimation of malondialdehyde (MDA) concentration in cells
was evaluated using the commercial kit “MDA Assay Kit” (Biovision,
Mountain View, CA, USA), which measures the reaction of MDA with
thiobarbituric acid (TBA) and the MDA-TBA adduct formation, as pre-
viously described (Hunsche et al., 2018). The MDA-TBA adduct was
measured using a spectrophotometer at 532 nm of absorbance. The
results were expressed as nmol/106 cells.
2.16. Superoxide anion concentration assay
The superoxide anion concentration was evaluated assessing its
capacity to reduce nitroblue tetrazolium (NBT, Sigma-Aldrich, Madrid,
Spain), in an equimolecular reaction, following the method previously
described (Guayerbas et al., 2002a). The reduced NBT was extracted
with dioxin (Merck, Germany) and the absorbance of the supernatants
was determined at 525 nm using a spectrophotometer. The data ob-
tained were expressed as nmoles of NBT reduced per 106 leukocytes by
extrapolating in a standard curve of NBT reduced with 1,4-dithoery-
thritol (Sigma-Aldrich, Madrid, Spain).
2.17. Statistical analysis
SPSS 25.0 (SPSS, Inc., Chicago, USA) was used for the statistical
analysis of the results. The data were tested for normality of distribu-
tion (Kolmogorov-Smirnov test) and homogeneity of variance (Levene
test). For non-normal distributions and non-homogeneous variances,
the non-parametric Kruskal-Wallis and Friedman tests were used, and
Mann-Whitney and Wilcoxon Signed Ranks to run pairwise compar-
isons, respectively. Two-way analysis of variance (ANOVA) with the
factors being diet (standard and high-fat) and sex (male and female)
was used to analyze results from middle-aged male and female mice.
Two-way repeated ANOVA with the factors being diet (standard and
high-fat diet) and age (middle-aged and old) was used to analyze results
from old and middle-aged female mice. If signiﬁcant eﬀects were ob-
served, post-hoc comparisons were performed as appropriate, with
Bonferroni corrections for multiple comparisons. For comparison of
qualitative data in behavioral tests, the chi-square was employed.
Finally, a Kaplan-Meir survival analysis was conducted to verify the
eﬀects of obesity on the survival of male and female mice. The data
were expressed as mean ± standard error of the mean (SEM), or
median and interquartile range (IQR), depending upon the normality of
data. P value < 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Body weight, total fat mass, food intake and biochemical parameters
After the period of 14 weeks on a high-fat diet, male and female
diet-induced obese (DIO) mice displayed signiﬁcantly higher body
weight than their control counterparts, with males weighing more than
females (Fig. 1A; Kruskal-Wallis test X2(3)= 31.059, P < 0.001;
signiﬁcant diﬀerences: male control vs male DIO, P < 0.001; female
control vs female DIO, P < 0.001; male control vs female control,
P < 0.001; male DIO vs female DIO, P < 0.001, pairwise comparisons
with Mann-Whitney). In addition, male and female DIO mice consumed
signiﬁcantly more kilocalories than their controls, with males con-
suming more kilocalories than females (Fig. 1B; Kruskal-Wallis test
X2(3)= 29.631, P < 0.001; signiﬁcant diﬀerences: male control vs
male DIO, P < 0.001; female control vs female DIO, P < 0.001; male
control vs female control, P=0.010; male DIO vs female DIO,
P=0.008, pairwise comparisons with Mann-Whitney). At old age
(72 weeks old), male DIO mice continue to exhibit a higher body weight
than their respective controls, with males weighing more than females
(Fig. 1A; Kruskal-Wallis test X2(3)= 13.540, P=0.004; signiﬁcant
diﬀerences: male control vs male DIO, P=0.02; male control vs female
control, P=0.005; male DIO vs female DIO, P=0.024, pairwise
comparisons with Mann-Whitney).
Male and female DIO mice showed higher total fat mass than the
corresponding controls, with female DIO mice showing higher total
body fat than male DIO mice (Fig. 1C; two-way ANOVA, signiﬁcant
interaction diet× sex F(1,12)= 5.889, P=0.032, main eﬀect of diet F
(1,12)= 71.798, P < 0.001, main eﬀect of sex F(1,12)= 10.797,
P=0.007; signiﬁcant diﬀerences: male control vs male DIO,
P=0.001; female control vs female DIO, P < 0.001; male DIO vs fe-
male DIO, P=0.002, post-hoc comparisons with Bonferroni correc-
tions).
Female DIO mice showed higher values of glucose than their re-
spective non-DIO counterparts. In addition, males displayed sig-
niﬁcantly higher levels of glucose than females (Fig. 1D; two-way
ANOVA, signiﬁcant interaction diet× sex F(1,32)= 6.187, P=0.018,
main eﬀect of diet F(1,32)= 9.716, P=0.004, main eﬀect of sex F
(1,32)= 31.178, P < 0.001; signiﬁcant diﬀerences: female control vs
female DIO, P < 0.001; male control vs female control, P < 0.001;
male DIO vs female DIO, P=0.046, post-hoc comparisons with Bon-
ferroni corrections). The levels of triglycerides were signiﬁcantly higher
in male and female DIO mice in comparison with their respective non-
DIO controls (Fig. 1E; Kruskal-Wallis test X2(3)= 25.135, P < 0.001;
signiﬁcant diﬀerences: male control vs male DIO, P=0.001; female
control vs female DIO, P=0.003, pairwise comparisons with Mann-
Whitney). In addition, the levels of total cholesterol were higher in male
and female DIO mice than in their respective non-DIO mice, with male
DIO mice showing higher cholesterol levels than female DIO mice
(Fig. 1F; Kruskal-Wallis test X2(3)= 20.255, P < 0.001; signiﬁcant
diﬀerences: male control vs male DIO, P=0.001; female control vs
female DIO, P=0.001; male DIO vs female DIO, P=0.013, pairwise
comparisons with Mann-Whitney).
At old age, when females reached 72weeks of age, they exhibited
higher levels of glucose than middle-aged females (Fig. 1D; two-way
repeated ANOVA measures, signiﬁcant main eﬀect of diet F
(1,11)= 43.099, P < 0.001, main eﬀect of age F(1,11)= 31.385,
P < 0.001; signiﬁcant diﬀerences: old female control vs old female
DIO, P < 0.001; middle-aged female control vs old female control,
P < 0.001; middle-aged female DIO vs old female DIO, P=0.007,
post-hoc comparisons with Bonferroni corrections). In addition, old
female DIO mice showed lower levels of triglycerides than middle-aged
female DIO mice (Fig. 1E; Friedman test, X2(3)= 9.000, P=0.029;
signiﬁcant diﬀerences: middle-aged female DIO vs old female DIO,
P=0.043, pairwise comparisons with Wilcoxon Signed Ranks).
3.2. Behavioral tests
3.2.1. Reﬂexes
No signiﬁcant diﬀerences were found between middle-aged male
and female DIO mice and their respective non-DIO counterparts in re-
ﬂexes (male control: 100%; male DIO: 100%; female control: 100%;
female DIO: 100%).
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3.2.2. Motor coordination and equilibrium
The abilities of motor coordination and equilibrium that were
evaluated, using the wood rod test, are shown in Table 1. The percen-
tage of falls from the wood rod was signiﬁcantly higher in male DIO
mice than in their respective non-DIO controls (Table 1; Chi square test,
X2(1)= 8.526, P=0.004). In addition, male DIO mice displayed sig-
niﬁcantly lower percentages of test completion and the covering of one
segment in the wood rod test than male non-DIO mice (Table 1; Chi
square test, X2(1)= 20.056, P < 0.001). No diﬀerences were observed
in these parameters between female DIO mice and their respective non-
DIO controls (Table 1). In the wood rod test, male DIO mice showed a
worse performance in the percentage of falls (Table 1; Chi square test,
X2(1)= 8.526, P=0.004), on test completion (Table 1; Chi square test,
X2(1)= 20.056, P < 0.001) and the covering of one segment (Table 1;
Chi square test, X2(1)= 20.056, P < 0.001) than female DIO mice.
3.2.3. Muscular vigor
The muscular vigor characteristics of mice, which were evaluated
by the tightrope test, are shown in Table 1. Male and female DIO mice
showed signiﬁcantly higher percentage of falls from the rope than their
respective non-DIO controls (Table 1; Chi square test, X2(1)= 33.837,
P < 0.001) for male and (Table 1; Chi square test, X2(1)= 4.467,
P=0.035) for female. In addition, the percentage of the test completed
was signiﬁcantly lower in male and female DIO mice in comparison
with their respective controls (Table 1; Chi square test, X2(1)= 33.837,
P < 0.001) for male and (Table 1; Chi square test, X2(1)= 4.467,
P=0.035) for female. The percentage of mice that used their forelimbs,
hindlimbs and tail to remain hanging and consequently showed max-
imum traction capacity, was signiﬁcantly lower in male and female DIO
mice in comparison with their respective controls (Table 1; Chi square
test, X2(1)= 18.483, P < 0.001) for male and (Table 1; Chi square
test, X2(1)= 20.056, P < 0.001) for female. Male DIO mice showed a
worse response in the percentage of falls (Table 1; Chi square test,
X2(1)= 23.652, P < 0.001), test completed (Table 1; Chi square test,
X2(1)= 23.652, P < 0.001), and traction capacity (Table 1; Chi square
test, X2(1)= 18.484, P < 0.001) than female DIO mice.
3.2.4. Vertical exploratory activity
The vertical exploratory activity of mice, which was evaluated by
the performance of rearing in the corner and holeboard tests, is shown
in Table 1. The total number of rearings in the corner test was sig-
niﬁcantly lower in male and female DIO mice than their respective non-
DIO controls (Table 1; two-way ANOVA, signiﬁcant main eﬀect of diet F
(1,32)= 11.083, P=0.002; signiﬁcant diﬀerences: male control vs
male DIO, P=0.027; female control vs female DIO, P=0.023, post-
hoc comparisons with Bonferroni corrections). In addition, male and
female DIO mice performed signiﬁcantly lower number of rearings in
the holeboard test than their respective controls, with males showing a
lower total of rearings than females (Table 1; two-way ANOVA, sig-
niﬁcant main eﬀect of diet F(1,32)= 25.176, P < 0.001, main eﬀect of
sex F(1,32)= 45.773, P < 0.001; signiﬁcant diﬀerences: male control
vs male DIO, P < 0.001; female control vs female DIO, P=0.005;
male control vs female control, P < 0.001; male DIO vs female DIO,
P < 0.001, post-hoc comparisons with Bonferroni corrections).
3.2.5. Horizontal exploratory activity
The horizontal exploratory activity was evaluated by the ambula-
tion of mice in the corner, holeboard and T-maze tests (Table 1). Female
DIO mice visited lower number of corners in the corner test than their
respective controls (Table 1; two-way ANOVA, signiﬁcant main eﬀect of
diet F(1,32)= 4.861, P=0.035; signiﬁcant diﬀerences: female control
vs female DIO, P=0.049, post-hoc comparisons with Bonferroni cor-
rections). Male DIO mice performed lower number of total line cross-
ings than their respective controls (Table 1; two-way ANOVA,
Table 1
Behavioral tests in middle-aged male and female control and middle-aged male and female DIO (diet-induced obese) mice.
Middle-aged male Middle-aged female
Control DIO Control DIO
Motor coordination and equilibrium (Wood rod test)
% of mice falling oﬀ 0 10** 0 0##
% of mice that cover at least 1 segment 100 80*** 100 100###
% of mice that complete the test 100 80*** 100 100###
Time to leave ﬁrst segment (s) 4 ± 1 5 ± 1 2 ± 0 4 ± 1
Muscular vigor (Tightrope test)
% of mice falling oﬀ 33 75*** 25 40*###
% of mice that complete test 67 25*** 75 60*###
% of mice that show maximum traction capacity 80 50*** 100### 80***###
Vertical exploratory activity
Total number of rearings (Corner test) 8 ± 1 6 ± 1* 8 ± 1 5 ± 1*
Total number of rearings (Holeboard test) 24 ± 2 15 ± 2*** 34 ± 2### 27 ± 2**###
Horizontal exploratory activity
Total number of corners visited (Corner test) 11 ± 1 9 ± 1 11 ± 1 8 ± 1*
Total number of line crossings (Holeboard test) 354 ± 15 275 ± 16** 296 ± 16 301 ± 15
Number of line crossings in the peripheral area (Holeboard test) 231 ± 11 188 ± 13* 172 ± 13## 198 ± 11
Number of line crossings in the central area (Holeboard test) 123 ± 6 87 ± 7*** 125 ± 7 104 ± 6*
Time to complete the test (s) (T-maze test) 17(3) 56(52)*** 21(6) 23(6)*##
Anxiety-like behavior
Total number of entries in open arms (Elevated plus maze test) 8 ± 1 6 ± 2 13 ± 2 9 ± 1
% of time in open arms (Elevated plus maze test) 36 ± 2 16 ± 2*** 39 ± 2 31 ± 2*###
Total number of entries in closed arms (Elevated plus maze test) 8 ± 2 14 ± 2 11 ± 2 11 ± 2
% of time in closed arms (Elevated plus maze test) 37 ± 2 55 ± 2*** 37 ± 2 43 ± 2###
% of time in central platform (Elevated plus maze test) 25 ± 3 30 ± 3 26 ± 3 27 ± 3
Total number of self-grooming (T-maze test) 0 ± 0 0 ± 0 0 ± 0 1 ± 0
Time of self-grooming (s) (Holeboard test) 2(4) 15(9)*** 2(8) 7(6)*#
Total number of fecal bolei (Holeboard test) 1 ± 0 4 ± 0*** 2 ± 0 4 ± 0***
% fecal bolei presence (T-maze test) 0 40*** 0 20***##
Each value represents the mean ± SEM or median (IQR) (n=8–10 animals for each group). ***P < 0.001; **P < 0.01; *P < 0.05 with respect to the values of the
corresponding control mice. ###P < 0.001; ##P < 0.01; #P < 0.05 with respect to the values of middle-aged male control mice and middle-aged male DIO mice.
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signiﬁcant main eﬀect of diet F(1,32)= 5.563, P=0.025; signiﬁcant
diﬀerences: male control vs male DIO, P=0.001, post-hoc comparisons
with Bonferroni corrections). Male DIO mice displayed signiﬁcantly
lower peripheral ambulation (which was measured by the number of
line crossings in the peripheral area of the holeboard) than their re-
spective controls. Also, male controls showed signiﬁcantly higher per-
ipheral ambulation than female controls (Table 1; two-way ANOVA,
signiﬁcant interaction diet× sex F(1,32)= 8.341, P=0.007, main
eﬀect of sex F(1,32)= 4.460, P=0.043; signiﬁcant diﬀerences: male
control vs male DIO, P=0.016; male control vs female control,
P=0.001, post-hoc comparisons with Bonferroni corrections). In ad-
dition, male and female DIO mice showed a signiﬁcant lower central
ambulation (which were measured by the number of line crossings in
the central area of the holeboard) than their respective non-DIO con-
trols (Table 1; two-way ANOVA, signiﬁcant main eﬀect of diet F
(1,32)= 20.303, P < 0.001; signiﬁcant diﬀerences: male control vs
male DIO, P < 0.001; female control vs female DIO, P=0.023, post-
hoc comparisons with Bonferroni corrections).
Male and female DIO mice took a longer time to complete the ex-
ploration of the three arms of the T-maze test than their non-DIO
counterparts, with male DIO mice showing a longer time to complete
the test than female DIO mice (Table 1; Kruskal-Wallis test
X2(3)= 23.553, P < 0.001; signiﬁcant diﬀerences: male control vs
male DIO, P < 0.001; female control vs female DIO, P=0.044; male
DIO vs female DIO, P=0.001, pairwise comparisons with Mann-
Whitney).
3.2.6. Goal-directed exploratory behavior
The goal-directed exploratory behavior, which was evaluated by the
percentage and total number of mice that performed head-dips in the
holeboard test, was not signiﬁcantly diﬀerent between the studied
groups for percentage of head-dips (male control: 100%; male DIO:
100%; female control: 100%; female DIO: 100%), and for total number
of head-dips (male control: 12 ± 4; male DIO: 10 ± 5; female control:
13 ± 5; female DIO: 10 ± 2).
3.2.7. Anxiety-like behavior
The anxiety-like behavior, which was assessed by the elevated plus
maze test, is shown in Table 1. Male and female DIO mice exhibited a
lower percentage of time in open arms than their respective non-DIO
controls, with male DIO mice showing a lower percentage of time than
female DIO mice (Table 1; two-way ANOVA, signiﬁcant interaction
diet× sex F(1,32)= 6.820, P=0.014, main eﬀect of diet F
(1,32)= 36.992, P < 0.001, main eﬀect of sex F(1,32)= 17.599,
P < 0.001; signiﬁcant diﬀerences: male control vs male DIO,
P < 0.001; female control vs female DIO, P=0.02; male DIO vs
Fig. 2. Immune cell functions. (A) Macrophage chemotaxis index (CI, number of macrophages). (B) Macrophage phagocytic index (PI, number latex beads/100
macrophages). (C) Macrophage phagocytic eﬃcacy (PE, number of phagocyting macrophages/100 macrophages). (D) Lymphocyte chemotaxis index (CI, number of
lymphocytes). (E) Natural killer cell activity (% lysis). (F) Basal lymphoproliferation (cpm). (G) Lymphoproliferative response to concanalvaline A (ConA) (cpm). (H)
Lymphoproliferative response to lipopolysaccharide (LPS) (cpm). Data represent mean ± SEM or median (IQR) (n=5–10 animals for each group). ***P < 0.001;
**P < 0.01; *P < 0.05 with respect to the corresponding values of control mice. ##P < 0.01; #P < 0.05 with respect to the corresponding values of middle-aged
male control mice and middle-aged male DIO mice. •••P < 0.001; ••P < 0.01; •P < 0.05 with respect to the values of middle-aged female control and DIO mice and
middle-aged female DIO mice.
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female DIO, P < 0.001, post-hoc comparisons with Bonferroni cor-
rections). Moreover, the percentage of time in closed arms was higher
in male DIO mice in comparison with their respective controls and fe-
male counterparts (Table 1; two-way ANOVA, signiﬁcant interaction
diet× sex F(1,32)= 8.932, P=0.005, main eﬀect of diet F
(1,32)= 30.330, P < 0.001, main eﬀect of sex F(1,32)= 7.884,
P=0.008; signiﬁcant diﬀerences: male control vs male DIO,
P < 0.001; male DIO vs female DIO, P < 0.001, post-hoc comparisons
with Bonferroni corrections). In addition, the time (in seconds) spent by
mice performing self-grooming in the holeboard test was signiﬁcantly
higher in male and female DIO mice than in their respective controls
(Table 1; Kruskal-Wallis test X2(3)= 21.087, P < 0.001; signiﬁcant
diﬀerences: male control vs male DIO, P < 0.001; female control vs
female DIO, P=0.027; male DIO vs female DIO, P=0.027, pairwise
comparisons with Mann-Whitney).
Male and female DIO mice also showed a higher percentage of fecal
bolei presence (Table 1; Chi square test, X2(1)= 47.531, P < 0.001)
for male and (X2(1)= 20.056, P < 0.001) for female, with male DIO
mice having a higher percentage of fecal bolei presence than female
DIO mice (Table 1; Chi square test, X2(1)= 8.595, P=0.003). In ad-
dition, the total number of fecal bolei was higher in male and female
DIO mice than their respective non-DIO controls (Table 1; Kruskal-
Wallis test X2(3)= 23.908, P < 0.001; signiﬁcant diﬀerences: male
control vs male DIO, P < 0.001; female control vs female DIO,
P < 0.001, pairwise comparisons with Mann-Whitney).
3.3. Peritoneal leukocyte functions
The peritoneal macrophage functions are shown in Fig. 2. The mi-
gration of peritoneal macrophages in response to a chemotactic gra-
dient (formylated peptide), which mimics the migration of immune
cells towards the infection site, was signiﬁcantly lower in male and
female DIO mice compared with their respective non-DIO controls.
Males displayed signiﬁcantly lower chemotactic index (CI) than females
(Fig. 2A; two-way ANOVA, signiﬁcant main eﬀect of diet F
(1,28)= 51.573, P < 0.001, signiﬁcant main eﬀect of sex F
(1,28)= 19.477, P < 0.001; signiﬁcant diﬀerences: male control vs
male DIO, P < 0.001; female control vs female DIO, P < 0.001; male
control vs female control, P=0.019; male DIO vs female DIO,
P=0.001, post-hoc comparisons with Bonferroni corrections). In ad-
dition, the number of latex beads ingested by macrophages (the pha-
gocytic index) was lower in male and female DIO mice with respect to
the corresponding controls, with males displaying a lower phagocytic
index than females (Fig. 2B; Kruskal-Wallis test X2(3)= 26.087,
P < 0.001; signiﬁcant diﬀerences: male control vs male DIO,
P=0.002; female control vs female DIO, P=0.016, male control vs
female control, P=0.001; male DIO mice vs female DIO mice,
P=0.001, pairwise comparisons with Mann-Whitney). The number of
macrophages with phagocytic ability (measured by phagocytic eﬃcacy)
were also lower in male and female DIO mice with respect to the cor-
responding controls (Fig. 2C; two-way ANOVA, signiﬁcant main eﬀect
of diet F(1,28)= 19.211, P < 0.001; signiﬁcant diﬀerences: male
control vs male DIO, P=0.008; female control vs female DIO,
P=0.002, post-hoc comparisons with Bonferroni corrections).
With aging, the chemotactic index (CI) was signiﬁcantly lower in
old female DIO mice than in their corresponding non-DIO mice, with
old females displaying a lower CI than middle-aged females (Fig. 2A;
two-way repeated measures ANOVA, signiﬁcant main eﬀect of diet F
(1,11)= 30.551, P < 0.001, main eﬀect of age F(1,11)= 41.213,
P < 0.001; signiﬁcant diﬀerences: old female control vs old female
DIO, P=0.002; middle-aged female control vs old female control,
P < 0.001; middle-aged female DIO vs old female DIO, P=0.010,
post-hoc comparisons with Bonferroni corrections). In addition, the
phagocytic index (PI) was signiﬁcantly lower in old female DIO mice
than in non-DIO mice, with old females displaying a lower PI than
middle-aged females (Fig. 1B; Friedman test, X2(3)= 13.653,
P=0.003; signiﬁcant diﬀerences: old female control mice vs old female
DIO mice, P=0.012, middle-aged female control vs old female control,
P=0.012, middle-aged female DIO vs old female DIO, P=0.043,
pairwise comparisons with Wilcoxon Signed Ranks). The phagocytic
eﬃcacy (PE) was signiﬁcantly lower in old female DIO mice than in
their corresponding controls, with old females displaying a lower PE
than middle-aged females (Fig. 2C; two-way repeated measures
ANOVA, signiﬁcant main eﬀect of diet F(1,11)= 12.892, P=0.004,
main eﬀect of age F(1,11)= 30.985, P < 0.001; signiﬁcant diﬀer-
ences: old female control vs old female DIO, P=0.032; middle-aged
female mice vs old female control, P < 0.001; middle-aged female DIO
vs old female DIO, P=0.015, post-hoc comparisons with Bonferroni
corrections).
The chemotactic index (CI) of peritoneal lymphocytes was sig-
niﬁcantly lower in male and female DIO mice in comparison with their
non-DIO counterparts. Male control mice displayed lower CI than fe-
male control mice (Fig. 2D; two-way ANOVA, signiﬁcant interaction
diet× sex F(1,28)= 17.467, P < 0.001, main eﬀect of diet F
(1,28)= 86.028, P < 0.001; signiﬁcant diﬀerences: male control vs
male DIO, P=0.001; female control vs female DIO, P < 0.001; male
control vs female control, P=0.003, post-hoc comparisons with Bon-
ferroni corrections).
The NK activity was signiﬁcantly lower in male and female DIO
mice in comparison with their non-DIO controls (Fig. 2E; two-way
ANOVA, signiﬁcant interaction diet× sex F(1,28)= 17.467,
P < 0.001, main eﬀect of diet F(1,28)= 16.420, P < 0.001; sig-
niﬁcant diﬀerences: male control vs male DIO, P=0.003; female
control vs female DIO, P=0.019, post-hoc comparisons with Bonfer-
roni corrections).
The basal proliferative capacity of peritoneal lymphocytes as well as
in response to T-cell mitogen (ConA) and to B-cell mitogen (LPS) are
shown in Fig. 2F, G and H, respectively. Male and female DIO mice
displayed signiﬁcantly higher basal lymphoproliferation in comparison
with non-DIO controls, with male DIO mice showing higher basal
lymphoproliferation than female DIO mice (Fig. 2F; two-way ANOVA,
signiﬁcant main eﬀect of diet F(1,28)= 24.967, P < 0.001; main ef-
fect of sex F(1,28)= 8.982, P=0.006; signiﬁcant diﬀerences: male
control vs male DIO, P < 0.001; female control vs female DIO,
P=0.028; male DIO vs female DIO, P=0.002, post-hoc comparisons
with Bonferroni corrections). However, in response to the mitogen
ConA, the proliferation of lymphocytes was lower in male and female
DIO mice in comparison with their controls (Fig. 2G; two-way ANOVA,
signiﬁcant main eﬀect of diet F(1,28)= 25.513, P < 0.001; signiﬁcant
diﬀerences: male control vs male DIO, P=0.019; female control vs
female DIO, P < 0.001, post-hoc comparisons with Bonferroni cor-
rections). Male and female DIO mice also showed lower LPS-stimulated
proliferation in comparison with their non-DIO mice, with male DIO
mice showing higher LPS-stimulated proliferation than female DIO
mice (Fig. 2H; Kruskal-Wallis test X2(3)= 23.172, P < 0.001; sig-
niﬁcant diﬀerences: male control vs male DIO, P=0.021; female
control vs female DIO, P=0.001; male DIO vs female DIO, P=0.001,
pairwise comparisons with Mann-Whitney).
With aging, the chemotactic index (CI) of peritoneal lymphocytes in
old female DIO mice was signiﬁcantly lower when compared with their
corresponding non-DIO mice, with old females displaying lower CI than
middle-aged females (Fig. 2D; two-way repeated measures ANOVA,
signiﬁcant interaction diet× age F(1,11)= 13.264, P=0.004, main
eﬀect of diet F(1,11)= 72.556, P < 0.001, main eﬀect of age F
(1,11)= 92.563, P < 0.001; signiﬁcant diﬀerences: old female control
vs old female DIO, P=0.005; middle-aged female control vs old female
control, P < 0.001; middle-aged female DIO vs old female DIO,
P=0.003, post-hoc comparisons with Bonferroni corrections). Old fe-
males showed signiﬁcantly lower anti-tumor NK activity than middle-
aged females (Fig. 2E; two-way repeated measures ANOVA, signiﬁcant
main eﬀect of age F(1,11)= 27.653, P < 0.001; signiﬁcant diﬀer-
ences: middle-aged female control vs old female control, P=0.001;
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middle-aged female DIO vs old female DIO, P=0.011, post-hoc com-
parisons with Bonferroni corrections).
The basal proliferation of lymphocytes in old female DIO mice was
higher than in their respective controls, with old females displaying
higher basal lymphoproliferation than middle-aged females (Fig. 2F;
two-way repeated measures ANOVA, signiﬁcant main eﬀect of diet F
(1,11)= 24.379, P < 0.001, main eﬀect of age F(1,11)= 150.177,
P < 0.001; signiﬁcant diﬀerences: old female control vs old female
DIO, P=0.006; middle-aged female control vs old female control,
P < 0.001; middle-aged female DIO vs old female DIO, P < 0.001,
post-hoc comparisons with Bonferroni corrections). Nevertheless, old
female DIO mice exhibited signiﬁcantly lower proliferation of lym-
phocytes in response to ConA mitogen-stimulated condition (Fig. 2G;
two-way repeated measures ANOVA, signiﬁcant main eﬀect of diet F
(1,11)= 46.743, P < 0.001, main eﬀect of age F(1,11)= 22.975,
P=0.001; signiﬁcant diﬀerences: old female control vs old female DIO,
P=0.001; middle-aged female control vs old female control,
P < 0.001, post-hoc comparisons with Bonferroni corrections). In ad-
dition, old females displayed signiﬁcantly lower LSP-stimulated lym-
phoproliferation than middle-aged females (Fig. 2H; Friedman test,
X2(3)= 13.776, P=0.003; signiﬁcant diﬀerences: middle-aged female
control vs old female control, P=0.012; middle-aged female DIO vs
old female DIO, P=0.043, pairwise comparisons with Wilcoxon Signed
Ranks).
3.4. Peritoneal leukocyte oxidative stress parameters
Fig. 3 shows the results of enzymatic and non-enzymatic anti-
oxidants, such as catalase (CAT) and glutathione peroxidase (GPx) ac-
tivities as well as reduced glutathione (GSH) concentrations, respec-
tively. The CAT activity was lower in leukocytes of male and female
DIO mice in comparison with their corresponding non-DIO controls
(Fig. 3A; two-way ANOVA, signiﬁcant main eﬀect of diet F
(1,28)= 37.361, P < 0.001; signiﬁcant diﬀerences: male control vs
male DIO, P < 0.001; female control vs female DIO, P < 0.001, post-
hoc comparisons with Bonferroni corrections). The GPx activity in
leukocytes of male and female DIO mice was higher in comparison with
their respective controls, with male control mice showing lower GPx
activity than female control mice (Fig. 3B; two-way ANOVA, signiﬁcant
main eﬀect of diet F(1,28)= 33.633, P < 0.001, main eﬀect of sex F
(1,28)= 17.618, P < 0.001; signiﬁcant diﬀerences: male control vs
male DIO, P < 0.001; female control vs female DIO, P=0.003, male
control vs female control, P=0.001, male DIO vs female DIO,
P=0.043, post-hoc comparisons with Bonferroni corrections). The
GSH concentrations were lower in peritoneal leukocytes of male and
female DIO mice in comparison with their respective non-DIO controls
(Fig. 3C; two-way ANOVA, signiﬁcant main eﬀect of diet F
(1,28)= 27.421, P < 0.001; signiﬁcant diﬀerences: male control vs
male DIO, P=0.004; female control vs female DIO, P < 0.001, post-
hoc comparisons with Bonferroni corrections).
With aging, old female control mice displayed signiﬁcantly lower
CAT activity than middle-aged female control mice (Fig. 3A; two-way
repeated measures ANOVA, signiﬁcant main eﬀect of age F
(1,11)= 22.686, P=0.001; signiﬁcant diﬀerences: middle-aged fe-
male control vs old female control, P < 0.001, post-hoc comparisons
with Bonferroni corrections). Old females also exhibited lower GPx
activity than middle-aged females (Fig. 3B; two-way repeated measures
ANOVA, signiﬁcant main eﬀect of age F(1,11)= 80.339, P < 0.001;
signiﬁcant diﬀerences: middle-aged female control vs old female con-
trol, P < 0.001; middle-aged female DIO vs old female DIO,
P < 0.001, post-hoc comparisons with Bonferroni corrections). Re-
garding the GSH concentrations, old female DIO mice displayed lower
values than those of old female non-DIO mice, with old females
showing lower concentrations of GSH than middle-aged females
(Fig. 3C; two-way repeated measures ANOVA, signiﬁcant main eﬀect of
diet F(1,11)= 9.116, P=0.012, main eﬀect of age F(1,11)= 21.591,
P=0.001; signiﬁcant diﬀerences: old female control vs old female DIO,
P=0.005, middle-aged female control vs old female control,
P=0.001, middle-aged female DIO vs old female DIO, P=0.033, post-
hoc comparisons with Bonferroni corrections).
Fig. 4 shows the values of enzymatic and non-enzymatic oxidants,
including the activity of xanthine oxidase, the concentrations of MDA
and superoxide anion as well as the GSSG/GSH ratios. The activity of
xanthine oxidase, which is associated with the production of free ra-
dicals, was signiﬁcantly higher in male and female DIO mice in com-
parison with their corresponding non-DIO controls, with males showing
higher XO activity than females (Fig. 4A; two-way ANOVA, signiﬁcant
main eﬀect of diet F(1,28)= 58.360, P < 0.001, main eﬀect of sex F
(1,28)= 34.629, P < 0.001; signiﬁcant diﬀerences: male control vs
male DIO, P < 0.001; female control vs female DIO, P < 0.001; male
control vs female control, P < 0.001; male DIO vs female DIO,
P < 0.001, post-hoc comparisons with Bonferroni corrections). The
MDA concentrations, which are an indicator of lipid oxidation and
oxidative damage in cells, were signiﬁcantly higher in male and female
DIO mice with respect to their non-DIO controls, with male DIO mice
showing higher MDA concentrations than female DIO mice (Fig. 4B;
two-way ANOVA, signiﬁcant interaction diet× sex F(1,28)= 8.633,
P=0.007, main eﬀect of diet F(1,28)= 61.532, P < 0.001, main ef-
fect of sex F(1,28)= 8.475, P < 0.001; signiﬁcant diﬀerences: male
control vs male DIO, P < 0.001; female control vs female DIO,
P=0.002; male DIO vs female DIO, P < 0.001, post-hoc comparisons
with Bonferroni corrections). The concentrations of superoxide anion
were signiﬁcantly higher in male and female DIO mice with respect to
their non-DIO controls (Fig. 4C; two-way ANOVA, signiﬁcant main ef-
fect of diet F(1,28)= 20.017, P < 0.001; signiﬁcant diﬀerences: male
control vs male DIO, P=0.001; female control vs female DIO,
P=0.017, post-hoc comparisons with Bonferroni corrections). The
GSSG/GSH ratios, an indicator of oxidative stress, were signiﬁcantly
higher in male and female DIO mice than in their respective non-DIO
controls (Fig. 4D; two-way ANOVA, signiﬁcant main eﬀect of diet F
Fig. 3. Antioxidant parameters. (A) Catalase activity (U/106 cells). (B) Glutathione peroxidase activity (mU/106 cells). (C) Reduced glutathione concentration (GSH)
(nmol/106 cells). Data represent mean ± SEM (n=5–10 animals for each group). ***P < 0.001; **P < 0.01 with respect to the corresponding values of control
mice. ##P < 0.01 with respect to the corresponding values of middle-aged male control mice and middle-aged male DIO mice. •••P < 0.001; ••P < 0.01; •P < 0.05
with respect to the values of middle-aged female control mice and middle-aged female DIO mice.
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Fig. 4. Oxidative parameters. (A) Xanthine oxidase activity (mU/106 cells). (B) MDA concentration (nmol/106 cells). (C) Superoxide anion concentration (nmol/106
cells). (D) Oxidized glutathione (GSSG)/Reduced glutathione (GSH) ratio. Data represent mean ± SEM (n=5–10 animals for each group). ***P < 0.001;
**P < 0.01; *P < 0.05 with respect to the corresponding values of control mice. ###P < 0.001 with respect to the corresponding values of middle-aged male
control mice and middle-aged male DIO mice. •••P < 0.001; ••P < 0.01 with respect to the values of middle-aged female control mice and middle-aged female DIO
mice.
Fig. 5. Mortality records from male and female control mice and from male and female DIO (diet-induced obese) mice. *P < 0.05 with respect to the corresponding
values of middle-aged control mice. #P < 0.05 with respect to the corresponding values of middle-aged male DIO mice.
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(1,28)= 75.625, P < 0.001; signiﬁcant diﬀerences: male control vs
male DIO, P < 0.001; female control vs female DIO, P < 0.001, post-
hoc comparisons with Bonferroni corrections).
With aging, the xanthine oxidase activity in old female controls was
signiﬁcantly higher than in middle-aged female controls (Fig. 4A; two-
way repeated measures ANOVA, signiﬁcant main eﬀect of age F
(1,11)= 8.372, P=0.015; signiﬁcant diﬀerences: middle-aged female
control vs old female control, P=0.003, post-hoc comparisons with
Bonferroni corrections). The MDA concentrations were signiﬁcantly
higher in old female DIO mice than in their respective controls, with old
female controls showing higher MDA concentrations than middle-aged
controls (Fig. 4B; two-way repeated measures ANOVA, signiﬁcant in-
teraction diet× age F(1,11)= 5.573, P=0.038, main eﬀect of diet F
(1,11)= 13.696, P=0.004, main eﬀect of age F(1,11)= 27.484,
P < 0.001; signiﬁcant diﬀerences: old female control vs old female
DIO, P=0.034; middle-aged female control vs old female control,
P < 0.001, post-hoc comparisons with Bonferroni corrections). The
superoxide anion concentrations were signiﬁcantly higher in old female
DIO mice in comparison with old female non-DIO controls, with old
female controls showing higher superoxide anion amounts than middle-
aged controls (Fig. 4C; two-way repeated measures ANOVA, signiﬁcant
main eﬀect of diet F(1,11)= 38.509, P < 0.001, main eﬀect of age F
(1,11)= 14.439, P=0.003; signiﬁcant diﬀerences: old female control
vs old female DIO, P=0.003; middle-aged female control vs old female
control, P=0.002, post-hoc comparisons with Bonferroni corrections).
3.5. Life span
Male DIO mice showed a shorter life span than male non-DIO con-
trol mice (Fig. 5; Kaplan-Meier survival curve, P=0.043). Male DIO
mice also exhibited a shorter life span than female DIO mice (Fig. 5;
Kaplan-Meier survival curve, P=0.033). The diﬀerences were not
statistically signiﬁcant between female DIO mice and female non-DIO
mice (Fig. 5).
4. Discussion
This is the ﬁrst study, to the best of our knowledge, showing that the
late adulthood diet-induced obesity onset led to signiﬁcant impairments
in behavior as well as in functions and redox state of peritoneal leu-
kocytes of middle-aged male and female mice, with males being sig-
niﬁcantly more aﬀected than females. Thus, middle-aged male DIO
mice exhibited greater impairments in a variety of behavioral, immune
and redox state parameters, and consequently showed a shorter life
span than their female counterparts. In the middle-aged female DIO
mice some parameters presented values similar to those in old female
animals. These results conﬁrm the state of accelerated im-
munosenescence as the consequence of the diet-induced obesity of the
present study. In addition to obesity-related impairments of the im-
mune system, other factors, such as insulin resistance (Frasca et al.,
2017), dysbiosis and increased intestinal permeability (Boulangé et al.,
2016), could also contribute to oxidative and inﬂammatory systemic
stresses, and consequently to the process of accelerated aging in obese
individuals.
We have previously shown that the high-fat diet intake is a good
model to develop obesity in mice (Hunsche et al., 2016, 2018). This
experimental animal model of obesity has been demonstrated to be
capable of mimicking human obesity, regarding its etiologic aspects
(Kanasaki and Koya, 2011). Thus, this is applied to both sexes, since in
the present study, middle-aged male and female mice fed on a high-fat
diet during 14weeks of their late-adulthood displayed signiﬁcantly
higher body weight and fat mass than their respective non-DIO coun-
terparts. Moreover, middle-aged male and female DIO mice showed
higher levels of triglycerides and total cholesterol, which are well-
known common features of obesity (Hunsche et al., 2016, 2018; Klop
et al., 2013). Furthermore, the late adulthood diet-induced obesity
onset diﬀerentially aﬀected the total body fat of middle-aged male and
female mice. Thus, female DIO mice showed signiﬁcantly higher body
fat mass in comparison with their male counterparts. In agreement,
previous studies reported that females have a higher propensity to gain
body weight and consequently to store more fat in the adipose tissue
than males (Mauvais-Jarvis, 2015). In general, females, prior to me-
nopause, tend to accumulate more fat in the subcutaneous adipose
tissue, while males in the visceral adipose tissue. This visceral accu-
mulation of fat has been associated with worsen metabolic outcomes in
this sex (Palmer and Clegg, 2015). In agreement, in the present study,
middle-aged male DIO mice showed higher plasma levels of glucose and
total cholesterol than their female counterparts.
With respect to the results of behavioral tests, we observed lower
muscular vigor, horizontal and vertical exploratory activities as well as
higher anxiety in middle-aged male and female DIO mice than in their
respective non-DIO controls. Middle-aged male and female DIO mice
displayed a signiﬁcantly lower central ambulation in the holeboard,
which indicates a lower exploratory activity and higher anxiety beha-
vior, since mice with anxiety tend to ambulate more in the peripheral
area (close the walls) than in the central area (Simon et al., 1994).
Moreover, middle-aged male and female DIO mice exhibited a longer
time to complete the exploration of the three arms of the T-maze test
than their respective non-DIO counterparts, which also indicates a
lower exploratory activity. Regarding the elevated plus maze test,
middle-aged male and female DIO mice displayed a lower percentage of
time in the open arms. It is known that a lower activity in the open arms
of the elevated plus maze apparatus indicate higher anxiety behavior
(Walf and Frye, 2007). Moreover, the behavior of self-grooming and the
presence of defecation, which could be considered as anxiety-related
measures (Archer, 1973; Sake and Graybiel, 2003), were also sig-
niﬁcantly higher in middle-aged male and female DIO mice in com-
parison with their respective non-DIO controls. Previous studies in-
dicate lower cognitive and exploratory activity as well as higher anxiety
in DIO mice. However, in these studies, the high-fat diet was ad-
ministered soon after weaning (André et al., 2014; Arnold et al., 2014;
da Costa et al., 2015; Sharma and Fulton, 2013; Vallodolid-Acebes
et al., 2011; Yamada et al., 2011). Studies in humans, including data
from younger to older individuals, also observed an association be-
tween increased body weight and worse performance on gross and ﬁne
motor skills, equilibrium and muscular vigor (Deforche et al., 2009;
Gentier et al., 2013; Kumar et al., 2008; Maﬃuletti et al., 2007). Ac-
cordingly, it can be suggested that obese individuals perform worse
gross motor tasks because a greater proportion of excess mass has to be
supported or moved against gravity during these tasks. However, the
worse performance on ﬁne motor tasks cannot be solely explained by
excess fat mass, given that ﬁne motor skills are not directly inﬂuenced
by the amount of mass (Gentier et al., 2013). In this sense, previous
studies suggest that obese individuals show lower neural eﬃciency and
slowed integration and processing of information (Gunning-Dixon and
Raz, 2000; Mehta and Shortz, 2014). In addition, an association has
been found between increased muscular fat inﬁltration in obese and
aged individuals and lower muscle quality and strength (Marcus et al.,
2010; Moore et al., 2014). The results of the present study also showed
sex diﬀerences in the evaluation of behavioral tests, with males being
more aﬀected than females. Thus, middle-aged male DIO mice showed
a worse performance than their female counterparts in the tests that
evaluated motor coordination, equilibrium, muscular vigor, vertical
and horizontal exploratory activities and anxiety-like behavior. How-
ever, most of the previous studies on obesity performed in rodents have
used a single sex (André et al., 2014; da Costa et al., 2015; Sharma and
Fulton, 2013; Vallodolid-Acebes et al., 2011; Yamada et al., 2011), thus
there is little information comparing the behavioral eﬀects of obesity in
both sexes. Nevertheless, in agreement with our data, a previous study
considering sex diﬀerences in the performance of behavioral tests,
showed males more vulnerable than females to high-fat diet (HFD)-
induced impairments, such as learning functions and synaptic plasticity
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(Hwang et al., 2010). The mechanisms underlying this higher impact of
HFD and obesity in males than in females remain unknown, but some
evidence indicates that estrogen could have a positive eﬀect in pro-
tecting female mice. In this sense, male mice treated with estradiol
showed less adiposity than controls (Salinero et al., 2018).
With respect to the functions studied in the peritoneal macrophages,
middle-aged male and female DIO mice showed diminish chemotactic
and phagocytic capacities of these cells in comparison with their re-
spective non-DIO counterparts. These results are in agreement with
those obtained in our previous study in which obesity in early adult-
hood was induced during the adolescent period (Hunsche et al., 2016).
Thus, both the diﬀerent ages of obesity onset (early and late adult-
hoods), resulted in impaired innate immune response. In addition,
diﬀerently from our previous study, the present study also evaluated
the immune eﬀects of obesity in males. The results showed that middle-
aged male DIO mice had lower chemotactic and phagocytic indexes
than their respective female counterparts. Moreover, sex diﬀerences
were also observed in non-DIO controls, with males showing lower
values than females in some functions. Previous evidence conﬁrms that
males display a lower innate immune response against infection in
comparison with females (Jaillon et al., 2017). Thus, it is possible that
obesity could further exacerbate these impairments found in the innate
immunity of males.
Regarding the anti-tumor activity natural killer (NK) of peritoneal
leukocytes, middle-aged male and female DIO mice showed a lower
response than their non-DIO counterparts, although no sex diﬀerences
were observed in this function. The migration capacity of lymphocytes
to a chemoattractant was signiﬁcantly lower in middle-aged male and
female DIO mice in comparison with their respective non-DIO controls.
Similarly, the proliferation of lymphocytes in ConA and LPS-stimulated
conditions, two mitogens for T and B lymphocytes, respectively, were
also lower in middle-aged male and female DIO mice than in their non-
DIO counterparts. These results are in agreement with those obtained in
adult DIO female mice that ingested the diet rich in fat during adoles-
cence (Hunsche et al., 2016). Thus, both early and late adulthood
obesity onsets resulted in impaired functions of lymphocytes. Although
middle-aged male control mice had lower values than middle-aged fe-
male control mice in chemotaxis of lymphocytes, male DIO mice pre-
sented higher chemotactic index and LPS-stimulated proliferation of
lymphocytes than female DIO mice. The higher response of these im-
mune functions in males could be possibly interpreted as a compensa-
tory mechanism to counteract the lower response found in innate im-
mune cell functions (Franceschi et al., 1995), especially in the context
of an obesity state.
Oxidative stress, which is generated by an imbalance between oxi-
dants and antioxidant in favor of oxidants, is associated with the de-
velopment of obesity, aging and health complications (Bauer and De la
Fuente, 2016; Marseglia et al., 2014). The current results demonstrated
that middle-aged male and female DIO mice showed higher values of
oxidants, such as xanthine oxidase activity, lipid peroxidation (MDA)
concentrations, and GSSH/GSH ratios as well as lower values of anti-
oxidant defenses (such as catalase activity and GSH concentrations).
These results are partly in concordance with our previous experiment in
which it was found increased oxidative stress in adult DIO female mice
(Hunsche et al., 2016). However, diﬀerently from these previous data,
the activity of glutathione peroxidase (an antioxidant enzyme) was
signiﬁcantly higher in middle-aged DIO animals in comparison with
their respective non-DIO counterparts. In this sense, it is possible that
the higher activity of this antioxidant enzyme could be explained by a
compensatory mechanism in an attempt to restore the appropriate
redox state of DIO animals. In fact, the activity of this enzyme can in-
crease or decrease in oxidative stress situations depending on the mo-
ment of their evolution and the amount of peroxides generated (Liu
et al., 2004; Yan and Harding, 1997). Sex diﬀerences were observed in
the redox parameters studied of middle-aged non-DIO animals, with
males being more aﬀected than females. Thus, in response to the late
age of obesity onset, middle-aged male DIO mice showed higher values
of xanthine oxidase and lipid peroxidation (MDA) and lower values of
glutathione peroxidase activities in comparison with their female
counterparts. Previous studies indicate that males are more susceptible
to present higher oxidative stress than females (Baeza et al., 2011);
however this condition is still controversial and contradictory data have
been reported (Kander et al., 2017). Moreover, there is a lack of evi-
dence about sex diﬀerences in the redox state of obese individuals.
At old age, female DIO mice continuous to exhibit some impaired
immune functions and redox state parameters than old female non-DIO
controls. However, diﬀerently from our previous data (in the early
adulthood obesity onset) (Hunsche et al., 2016), the late adulthood
diet-induced obesity onset resulted in no signiﬁcant diﬀerences in some
immune functions (such as anti-tumor NK cell activity and LPS-stimu-
lated proliferation of lymphocytes), redox state (xanthine oxidase ac-
tivity, GSSG/GSH ratio, catalase and glutathione peroxidase activities)
and in the life span between female DIO mice and female non-DIO mice.
Thus, the early adulthood obesity onset, in which adolescent mice were
exposed to a high-fat diet, had more long-lasting deleterious eﬀects in
the immune system and consequently in the life span than a later
obesity onset. Increasing evidence suggest that adolescence is a critical
period in which the nervous and immune systems are still experiencing
developmental changes and thus are more susceptible to stresses, such
as an increased consumption of high-fat diet (Boitard et al., 2012;
Holder and Blaustein, 2014; Simon et al., 2015; Spear, 2000).
Although several innate and adaptive immune functions were ana-
lyzed here, other relevant aspects of immunosenescence should be
considered in future studies. Thus, acquisition of the senescence-asso-
ciated phenotype (SASP), immunophenotyping aging subsets, and in-
tracellular signaling pathways, could conﬁrm the accelerated im-
munosenescence state of obese individuals.
In conclusion, the results of the current study provide evidence that
the late adulthood diet-induced obesity onset leads to impairments in
the functions of the nervous (behavior) and immune system (function
and redox state of peritoneal leukocytes) of middle-aged male and fe-
male mice. Sex diﬀerences were found in some of the behavioral, im-
mune function and redox state parameters, being males signiﬁcantly
more aﬀected than females. Since many of these functions have been
proposed as markers of health, rate of aging and predictor of longevity
(De la Fuente and Miquel, 2009, Martínez de Toda et al., 2016), the
results show a worst health status in middle-aged female and especially
male DIO mice and, consequently, a lower life span. In addition, the late
adulthood obesity partially exacerbated the age-related impairments in
immune cell functions and redox state of old female mice.
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 3.2. EFFECTS OF THE BLOCKAGE OF THE NEONATAL LEPTIN SURGE 
(PND5-9) ON THE IMMUNE FUNCTION AND REDOX/INFLAMMATORY STATE OF 
MALE AND FEMALE RATS AT DIFFERENT AGES 
 
3.2.1. Effects of the blockage of the neonatal leptin surge (PND5-9) on the 
redox/inflammatory state in the spleen, hypothalamus and white adipose tissue of 
peripubertal/adolescent male and female rats. 
 
 
Experimental design 
From PND5 until PND9 rats were injected subcutaneously with 5 mg/kg bodyweight (bw) 
of rat pegylated super leptin antagonist (mutant D23L/L39A/D40A/F41A). In order to avoid the 
stress effect caused by marking the animals at this early age, each litter was treated with either 
vehicle (controls) or antagonist. The animals received one injection per day at 9:00 am. Control rats 
were injected with the same volume of distilled water as the vehicle (2.5 ml/kg). After each 
injection the animals were immediately returned to their mothers. Each experimental group 
consisted of 12 animals. To avoid/minimize a possible litter effect, all experimental groups 
contained animals from at least three different litters. All rats were left undisturbed until weaning at 
PND22 at which time they were separated into 4 rats of the same sex per cage. Body weight was 
153
	   	  
	   
monitored weekly until 5 days before sacrifice. Each experimental group consisted of 12 rats. 
Female (PND33) and male (PND43) rats were sacrificed after a 12h fast by decapitation. The 
hypothalamus, white adipose tissue (WAT) and spleen were rapidly and aseptically removed. The 
hypothalamus and WAT were frozen and stored at -80ºC until the assays were performed. The 
spleen was freed of fat, weighed, and divided into two parts. One of them was stored at -80ºC until 
the assays were performed. The other was minced with scissors, and gently pressed through a mesh 
screen to obtain the cell suspension. The levels of pro-inflammatory (TNF-α) and anti-inflammatory 
(IL-10, IL-13) cytokines released into the supernatants of spleen leukocyte cultures, after 48 hours 
of incubation with ConA or LPS, were collected and stored at -80°C until used for cytokine 
analysis.  
 
Main results  
Body and spleen weight measurements 
There were no significant differences in body weight between control and treated animals 
during the treatment period and/or at the end of the experiment. Regarding spleen weights, a 
significant effect of the neonatal leptin antagonist treatment was found in both sexes, with treated 
males exhibiting lower spleen weights and treated females showing higher spleen weights when 
comparing with their respective control counterparts.  
Oxidative stress parameters 
Both males and females treated neonatally with the leptin antagonist showed significantly 
lower values of three enzymes analysed: superoxide dismutase, catalase, and glutathione peroxidase 
activities. In addition, male and female treated animals showed higher glutathione reductase 
activity. No significant differences were found in the GSSG/GSH ratios.  
Cytokine levels 
The concentrations of the anti-inflammatory cytokine IL-10 released by spleen leukocytes 
from treated animals were significantly lower in the presence of LPS and also in the presence of 
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ConA. The treatment with the leptin antagonist resulted in lower values of the anti-inflammatory 
cytokine IL-13 in male leukocytes stimulated with LPS and in female leukocytes stimulated with 
ConA. The concentrations of the pro-inflammatory cytokine TNF-α were also modified by the 
neonatal treatment with the leptin antagonist. In the presence of LPS, leukocytes of treated males 
released lower concentrations, and those of females higher concentrations of this cytokine than their 
corresponding control counterparts. In the presence of ConA, treated males showed higher TNF-α 
values, whereas no differences were found in females.  
Hypothalamic mRNA levels 
The leptin antagonist had no significant effect on catalase, superoxide dismutase and 
glutathione reductase mRNA levels, although there was a tendency to increase mRNA levels of 
glutathione peroxidase in males. Regarding cytokine mRNA levels, there was a trend to increase 
TNF-α values in males and a significant decrease in females due to the treatment. No effect was 
found in IL-10 mRNA levels. 
Adipose tissue mRNA levels 
The levels of catalase and glutathione reductase mRNA were decreased by the leptin 
antagonist in males, with no significant effect in females. A similar effect was found in superoxide 
dismutase mRNA values where the treatment trended towards a decrease in males. No effects were 
found in glutathione peroxidase mRNA levels. In addition, increases in IL-1β and IL-6 were found 
in treated males with no significant effect in female groups. 
 
Partial conclusions 
The results of this experiment indicate that the blockage of the neonatal leptin surge results 
in an altered redox/inflammatory state of the spleen, hypothalamus and white adipose tissue in 
peripubertal/adolescent male and female rats. 
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a b s t r a c t
The importance of the neonatal leptin surge in rodents in neurodevelopmental processes has aroused
curiosity in its implication in other physiological systems. Given the role of leptin in neuro-immune
interactions, we hypothesized that the neonatal leptin surge could have an effect on the oxidative and
inﬂammatory stress situations of both systems. We blocked the neonatal leptin surge by a leptin
antagonist and measured several parameters of oxidative and inﬂammatory stress in the spleen, hypo-
thalamus and adipose tissue of peripubertal/adolescent rats. The treated rats showed lower activity of
several antioxidant enzymes in the spleen and their leukocytes released lower levels of mitogen-
stimulated IL-10 and IL-13 and higher levels of TNF-alpha. In conclusion, the neonatal leptin surge
may have a key role in the establishment of adequate redox and inﬂammatory states in the immune
system, which is important for the generation of adequate immune responses and to obtain and maintain
good health.
© 2017 Elsevier B.V. All rights reserved.
1. Introduction
Leptin, an adipokine produced mainly by adipocytes, is a pleio-
tropic hormone involved in many physiological processes such as
food intake and energy balance, immune system functions, repro-
duction, reward, stress and neurodevelopment (Bellefontaine et al.,
2014; Folch et al., 2012; Meyer et al., 2014). In rodents, there is a
postnatal leptin surge, that in male mice begins around postnatal
day (PND) 5 and peaks between PND9 and 10 (Ahima and Hileman,
2000). In rats, leptin increases between PND4 and 7, is elevated
between PND7 and 10 and then declines by PND14 (Delahaye et al.,
2008). This leptin surge has been implicated in hypothalamic
development by modifying neuronal outgrowth and synaptic con-
nectivity, as well as neurogenesis and neuronal and glial survival
(Bouret, 2013). The timing and magnitude of this surge appears to
be important for normal metabolic control and weight gain in the
adult animal (Ahima et al., 1998; Attig et al., 2008; Cottrell et al.,
2009; Delahaye et al., 2008; Yura et al., 2005). Most studies on
the neurotrophic role of leptin during its neonatal peak have
focused on the hypothalamus (Bouret, 2013; Bouret et al., 2004;
Garza et al., 2008; V Mela et al., 2012a,b; Pinto et al., 2004;
Udagawa et al., 2006a, 2006b; Viveros et al., 2010). In fact, this
brain structure has traditionally been the focus of studies related to
central leptin actions. For instance, we recently found that admin-
istration of a pegylated super leptin antagonist from PND 5 to 9,
coincident with the neonatal leptin surge, affects the gene expres-
sion of growth factors, glial proteins, and neuropeptides involved in
the control of metabolism and reproduction in the hypothalamus of
peri-pubertal male and female rats (Mela et al., 2015).
Currently, there are abundant studies that conﬁrm the bidirec-
tional communication between the homeostatic systems, namely
the nervous, endocrine and immune systems, which is mediated by
neurotransmitters, hormones and cytokines through the presence
of their receptors on the cells of all three systems. Thus, any in-
ﬂuence exerted on one of these systems will have an effect on the
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others and vice versa (Vida et al., 2014; Wrona, 2006). Leptin re-
ceptors are highly expressed in immune cells such as monocytes,
macrophages, neutrophils and lymphocytes (Goldenberg, 2014)
and, thus, leptin affects almost all cells of the immune system
(Zabeau et al., 2014), modulating immune cell functions and cyto-
kine networks, which may contribute to the protection from in-
fections (Conde et al., 2014; Procaccini et al., 2013). Consequently, a
decrease in leptin release or a disruption of its actions could be
deleterious for the immune response. Indeed, Farooqi et al (Sadaf
Farooqi et al., 2002)., showed that individuals with leptin deﬁ-
ciency were more likely to suffer infections due to the impairment
in T cell proliferation and cytokine release. In leptin deﬁcient ob/ob
mice, dendritic cells are less effective in the stimulation of allogenic
T cells (Macia et al., 2006) and the balance of Th1/Th2 cytokines is
deregulated, changing the sensitivity to autoimmune diseases
(Zabeau et al., 2014).
Leptin can also promote the release of reactive oxygen species
(ROS) and ROS have an important role as signaling molecules in the
central nervous system, andmore particularly in the hypothalamus.
In POMC neurons, ROS levels that may be regulated among other
factors by leptin, appear to play a crucial role in modulating cellular
responses involved in the regulation of energy metabolism. In fact,
the short-term hypothalamic ROS peak generated by metabolic
signals (nutrients and hormones) appears to be fundamental to
elicit a proper behavioral, endocrine and autonomic response to
nutrient intake (Diano, 2013; Drougard et al., 2015). In an experi-
mental model of L. donovani infection, leptin induced macrophage
phagocytic activity by enhancing intracellular ROS generation,
which helps in phagolysosome formation and oxidative killing of
the parasite (Dayakar et al., 2016). ROS production is important for
appropriate body function, including the immune response. How-
ever, when there is an excessive increase in ROS levels, due to an
enhancement in their production or a decrease in the antioxidant
defenses that neutralize the excess of ROS, a situation of oxidative
stress appears, and these ROS can be deleterious for the organism
causing oxidation of macromolecules (Gyengesi et al., 2012; Vida
et al., 2014). It is known that oxidation and inﬂammation are
related processes and that an excess of oxidant and inﬂammatory
compounds maintained through time produces a situation of
oxidative and inﬂammatory stress, which deregulates immune
function and is the cause of aging, illness and death (Vida et al.,
2014). Alterations in immune and inﬂammatory responses are
present in leptin- and leptin-receptor deﬁcient animals, as well as
during starvation and malnutrition, two conditions characterized
by low levels of circulating leptin (Fantuzzi and Faggioni, 2000).
In spite of the ﬁndings described above, the speciﬁc role of the
neonatal leptin surge on the development and establishment of a
correct redox state and a regulated inﬂammatory response has not
been investigated. To address this question, diverse parameters
related to oxidative and inﬂammatory stress were analyzed in the
spleen, as well as in the hypothalamus and white adipose tissue of
peripubertal/adolescent male and female rats that received daily
injections of a rat pegylated super leptin antagonist from PND5
until PND9, the time period of the neonatal leptin surge. This allows
a ﬁrst approach to determine if this leptin surge has a role in the
redox and inﬂammatory states of peripubertal/adolescent animals,
at least at the level of the immune and nervous systems as well as in
white adipose tissue.
2. Materials and methods
2.1. Animals
Adult Wistar rats were purchased from Harlan Interfauna Iber-
ica S.A. (Barcelona, Spain) and allowed to acclimatize for 2 weeks
before mating. One male was placed in a cage with two females for
10 days. On the day of birth (PND0), litters were culled to eight pups
per dam (four males and four females). No cross-fostering was
employed. Thus, only litters with at least 4 pups of each sex at birth
were used. Rats were maintained at a constant temperature
(22 ± 1 C) and humidity (50± 2%) in a reversed 12-h light-dark
cycle (red light on at 08:00 and white light on at 20:00). Preg-
nant rats were given free access to rat chow (commercial diet for
rodents; A03, Safe, Augy, France) and water. The animals used in
this study were the same as those used in a recently published
paper that focused on the effects of the same leptin antagonist
treatment on hypothalamic systems related to reproduction (Mela
et al., 2015). As our aim in that studywas to investigate the pubertal
transition, right before the appearance of external phenotypic signs
of puberty, and because the timing of puberty differs between the
sexes, females were euthanized on PND33 and males on PND43.
These studies were approved by the local ethics committee and
complied with the Royal Decree 1201/2005 (BOEn 252) pertaining
to the protection of experimental animals and with the European
Communities Council Directive (86/609/EEC). The experiments
were conducted in accordance with the guidelines and protocols of
the Royal Decree 53/2013 regarding the care and use of laboratory
animals for experimental procedures, and were approved by the
Committee for Animal Experimentation of the Complutense Uni-
versity of Madrid.
2.2. Leptin antagonist treatment
From PND5 until PND9 rats were injected sc with 5 mg/kg
bodyweight (bw) of rat pegylated super leptin antagonist (mutant
D23L/L39A/D40A/F41A), a gift of Protein Laboratories (Rehovot,
Israel), which was prepared as described in Jamroz-Wisniewska
et al. (2014). In order to avoid the stress effect caused by marking
the animals at this early age, we treated each litter with either
vehicle (controls) or antagonist. The animals received one injection
per day at 9:00. Control rats were injected with the same volume of
distilled water as vehicle (2.5 ml/kg). After each injection the ani-
mals were immediately returned to their mothers. Each experi-
mental group consisted of 12 animals. To avoid/minimize a possible
litter effect all experimental groups contained animals from at least
three different litters.
2.3. Body weight increase
All rats were left undisturbed until weaning at PND22 at which
time they were separated into 4 rats of the same sex/cage. Body
weight was monitored weekly until 5 days before sacriﬁce. Each
experimental group consisted of 12 rats.
2.4. Tissue collection
Female (PND33) and male (PND43) rats were sacriﬁced after a
12 h fast by decapitation. The hypothalamus, white adipose tissue
(WAT) and spleen were rapidly and aseptically removed. The hy-
pothalamus and WAT were frozen and stored at 80 C until the
assays were performed. The spleenwas freed of fat and divided into
two parts. One of them was stored at 80 C until the assays were
performed. The other was minced with scissors, and gently pressed
through a mesh screen (Sigma, St. Louis, and USA) to obtain the cell
suspension.
2.5. Antioxidant enzymes
2.5.1. Superoxide dismutase (SOD) activity
Total SOD activity was measured (n ¼ 8e11) by a modiﬁed
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method described by Marklund and Marklund (1974), with slight
modiﬁcations (Alvarado et al., 2006). The tissue samples (50 mg/
ml) in TriseHCl buffer (50 mM, pH 8.2) were homogenized and
centrifuged at 3200 g for 20 min at 4 C. Supernatant (750 ml) was
mixed with an ice-cold ethanol-chloroform mixture (5:3 v/v;
600 ml) and immediately shaken for 60 s and centrifuged at 2500 g
for 10 min at 4 C. Supernatant (SOD extract; 25 ml) was mixed with
TriseHCl buffer (50 mM, pH 8.2) containing DTPA (1 mM) and
pyrogallol (24 mM prepared in HCl 10 mM; 25 ml). The enzymatic
activity was measured spectrophotometrically at 420 nm through
the oxidation of pyrogallol. One unit of activity is deﬁned as the
amount of enzyme causing a 50% inhibition of the autoxidation of
pyrogallol at 25 C. The protein contents of the same samples were
evaluated following bicinchoninic acid protein assay kit protocol
(Sigma-Aldrich, Spain). The results were expressed as arbitrary
units (U) of enzymatic activity permilligram of protein (AU SOD/mg
protein).
2.5.2. Catalase (CAT) activity
Catalase activity was determined (n ¼ 6e11) following the
method described by Aebi (1984) with modiﬁcations previously
introduced by Alvarado et al. (2006), and based on the decrease of
the absorbance at 240 nm because of the decomposition of H2O2 by
the enzyme. The assays were performed using aliquots of the ho-
mogenized tissue samples (50 mg/ml in tampon phosphate 66 mM,
pH 7.5) and centrifuged at 3200 g for 20 min at 4 C. The super-
natant extract (30 ml) was mixed with 670 ml of H2O2 (14 mM in
phosphate buffer 66 mM). The enzymatic activity was measured
spectrophotometrically for 80 s at 240 nm through the decompo-
sition of H2O2 into H2O þ O2. One unit of CAT was deﬁned as the
amount of enzyme that liberates half of the peroxide oxygen from
H2O2 solution in 80 s at 25 C. Protein content was evaluated
following the same bicinchoninic acid protein assay kit protocol.
The results were expressed as units (U) of enzymatic activity per
milligram of proteins (U CAT/mg protein).
2.5.3. Glutathione peroxidase (GPx) activity
The glutathione peroxidase (GPx) activity was determined
(n ¼ 7e11) according to the technique described by Lawrence and
Burk (1976). The assays were performed with aliquots of the ho-
mogenate tissue samples (50 mg/ml in tampon phosphate 50 mM,
pH 7.5) and centrifuged at 3200 g for 20 min at 4 C. The total ac-
tivity was determined using cumene hydroperoxide (Sigma-
Aldrich), which carried out the oxidation of the glutathione re-
generated by the addition of B-nicotinamide adenine di-nucleotide
phosphate, in its reduced form (b-NADPH, Sigma-Aldrich, Spain), in
the presence of glutathione reductase (Sigma-Aldrich). The reac-
tion was followed spectrophotometrically by the decrease of the
absorbance at 340 nm. The protein contents were evaluated
following the previously mentioned protocol. The results are
expressed as milliunits of enzymatic activity per milligram of
proteins (mUGPx/mg protein).
2.5.4. Glutathione reductase (GR) activity
The glutathione reductase (GR) activity was measured
(n ¼ 8e10) by the method described by Massey and Williams
(1965). The assays were performed with aliquots of the homoge-
nate tissue samples (50 mg/ml in tampon phosphate 50mM, pH 7.5
with 6.3 mM EDTA) and centrifuged at 3200 g for 20 min at 4 C.
The total activity was measured through the oxidation of NADPH
spectrophotometrically at 340 nm. The protein contents of the
same samples were again evaluated following the previously
described protocol. The results are expressed as milliunits of
enzymatic activity per milligram of proteins (mUGR/mg protein).
2.5.5. Total glutathione, GSH and GSSG concentrations
The total glutathione (GSH plus GSSG) was measured
(n ¼ 10e12) by ﬂuorometry, according to the Hissin and Hilf
method (Hissin and Hilf, 1976), with some modiﬁcations (Schultz
et al., 2010), in which GSH was sequentially oxidized by o-phthal-
dialdehyde and reduced by NADPH in the presence of GR. The
oxidized glutathione level (GSSG) was determined by masking GSH
with N-ethylmaleimide. The protein contents of the same samples
were evaluated following the previously mentioned protocol. The
amounts of GSH and GSSG were calculated using standard curves,
which were prepared using a glutathione solution (glutathione
reductase and oxidized form 1 mg/ml) (Sigma-Aldrich, Spain), and
expressed in nmol per milligram of protein (nmol/mg protein). The
redox index was calculated by dividing the concentration of GSSG
by that of GSH.
2.6. Cytokine levels released by spleen leukocytes
Spleen cell suspensions were centrifuged in a gradient of Ficoll-
Hypaque (Sigma-Aldrich, Spain) with a density of 1.070 g/ml. The
cells were recollected from the interface and resuspended in RPMI
1640 medium enriched with L-glutamine (PAA, Pasching Austria)
and supplemented with 10% heat-inactivated fetal calf serum
(Gibco, Canada) and gentamicin (10 mg/ml, Gibco) (complete me-
dium). Aliquots of 200 ml of mononuclear cell suspension adjusted
to 1  105 cells/ml complete medium were cultured in 96-well
plates in the presence of lipopolysaccharide (LPS) (Escherichia coli
055:B5, 1 mg/ml per well; Sigma-Aldrich, Spain) or concanavaline A
(ConA, 1 mg/mL per well; Sigma Sigma-Aldrich, Spain). After 48 h of
incubation at 37 C in a sterile and humidiﬁed atmosphere of 5%
CO2,100 ml of culture supernatant from eachwell was collected and
stored at 80 C until used for cytokine analysis. Levels of proin-
ﬂammatory (TNF-a) and anti-inﬂammatory (IL-10, IL-13) cytokines
were measured (n ¼ 6e8) simultaneously by Luminex xPONENT
(Rat Bio Plex Pro Cytokine assays using magnetic beads, U.S, BIO-
RAD). The results were expressed as pg/mL.
2.7. Quantitative real-time PCR
To determine whether leptin antagonist treatment affected the
redox state in other tissues, apart from spleen, we measured the
mRNA expression proﬁle of redox enzymes on hypothalamus and
subcutaneous adipose tissue by quantitative real-time PCR.
Total mRNA from hypothalamus and subcutaneous adipose tis-
sue was isolated with Trizol® Reagent (Invitrogen Carlsbad, CA,
USA) following the manufacturer's recommendation. A high-
capacity cDNA RT kit (Applied Biosystems, Foster City, CA) was
used to transcribe 1 mg of total mRNA on a thermal cycler Tetrad 2
(Peltier Thermal Cycler, Bio-Rad). cDNA template ampliﬁcation was
performed by using a TaqMan Universal PCR Master Mix (Applied
biosystems) on a thermal cycler ABI PRISM 7900HT Sequence
Detection System (Applied Biosystems) andmRNA levels of catalase
(CAT, Rn00560930_m1), superoxide dismutase 2 (SOD,
Rn00690588_g1), glutation peroxidase (GPx, Rn00577994_g1) and
glutation reductase (Grs, Rn01482159_m1) were assessed by Taq-
Man Gene Expression Assay-on-demand kits (Applied Biosystems)
for each gene in both tissues. Each sample was run in duplicate
(n ¼ 5e6). Various housekeeping genes were analyzed and the
gene that showed no variation between groups was chosen to
normalize the data in that tissue. The results were normalized to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH,
Rn99999916_s1) in the hypothalamus, and Rps18 (Rn01428915_g1)
and PPIA (Rn00690933) for adipose tissue. The DDCT was used to
determine relative mRNA levels. Statistics were performed using
DDCT values.
V. Mela et al. / Molecular and Cellular Endocrinology 454 (2017) 125e134
158
2.8. Statistical analysis
Data were analyzed by SPSS for Windows, release 15.0.
Normality was checked by Shapiro-Wilks0s test (p > 0.05). Data
were analyzed by one-way analysis of variance (ANOVA) and for the
change in body weight during the leptin antagonist treatment an
ANOVA with repeated measures was performed. As males and fe-
males were of a different chronological age due to the differential
timing of puberty onset, data were not directly compared between
sexes (see Fig. 1).
3. Results
3.1. Body and spleen weights
There were no signiﬁcant differences between control and
treated animals during the treatment period and/or at the end of
the experiment (Fig. 2). Regarding spleen weights, a signiﬁcant
effect of the neonatal leptin antagonist treatmentwas found in both
sexes [Males: F(1,22) ¼ 22.012; p < 0.001. Females: F(1,17) ¼
22.380; p < 0.001] with treated males exhibiting lower spleen
weights and treated females showing higher spleen weights when
comparing with their respective control counterparts (Fig. 2).
3.2. Parameters of oxidative stress
Both, males and females treated neonatally with the leptin
antagonist showed signiﬁcantly lower activity of the three enzymes
analyzed, CAT [Males: F(1,20) ¼ 3.027; p < 0.001. Females:
F(1,15) ¼ 19.732; p < 0.001] (Fig. 3A), SOD [Males: F(1,19) ¼ 8.625;
p < 0.01. Females: F(1,17) ¼ 4.752; p < 0.05] (Fig. 3B) and GPx
(Fig. 4A), [Males: F(1,19) ¼ 42.964; p < 0.001. Females: F(1,16) ¼
11.034; p < 0.01]. In addition, male and female treated animals
showed higher GR activity (Fig. 4B) [Males: F(1,18) ¼ 73.738;
p < 0.001. Females: F(1,16) ¼ 29.017; p < 0.001]. No signiﬁcant
differences were found in the GSSG/GSH ratios (Fig. 5).
3.3. Cytokine levels
The levels of the anti-inﬂammatory cytokine IL-10 released by
spleen leukocytes from treated animals were signiﬁcantly lower in
the presence of LPS [Males: F(1,10) ¼ 682.412; p < 0.001. Females:
F(1,14) ¼ 17.044; p < 0.01] and also in the presence of ConA [Males:
F(1,14) ¼ 44.522; p < 0.001. Females: F(1,14) ¼ 8.256; p < 0.05]
(Fig. 6). The treatment with the leptin antagonist resulted in lower
levels of the anti-inﬂammatory cytokine IL-13 in male leukocytes
stimulated with LPS (Fig. 7A) [F(1,14) ¼ 28.767; p < 0.001] and in
female leukocytes stimulated with ConA (Fig. 7B) [F(1,13) ¼ 13.506;
p < 0.01].
As shown in Fig. 8, the levels of the proinﬂammatory cytokine
TNF-awere alsomodiﬁed by the neonatal treatmentwith the leptin
antagonist. In the presence of LPS, leukocytes of treated males
released lower levels, and those of females higher levels of this
cytokine than their corresponding control counterparts [Males:
F(1,12) ¼ 14.960; p < 0.01. Females: F(1,14) ¼ 22.464; p < 0.001]. In
the presence of ConA, treated males showed higher TNF-a levels
[Males: F(1,25) ¼ 6.639; p < 0.05], whereas no differences were
found in females (Fig. 8).
3.4. Hypothalamic mRNA levels
The leptin antagonist had no signiﬁcant effect on catalase, SOD
and GR mRNA levels although, as Table 1 shows, there was a ten-
dency to increase mRNA levels of GPx in males [F(1,10) ¼ 4.57;
p ¼ 0.058].
Regarding cytokine mRNA levels, there was a trend to increase
TNFa levels inmales and a signiﬁcant decrease in females due to the
treatment [Males: F(1,8) ¼ 3.70; p ¼ 0.09, Females: F(1,8) ¼ 6.73;
p < 0.05]. No effect was found on IL10 mRNA levels.
3.5. WAT mRNA levels
The levels of catalase and GR mRNA were decreased by the
leptin antagonist in males [catalase: F(1,8) ¼ 7.46; p < 0.05, GR:
F(1,9) ¼ 7.12; p < 0.05] with no signiﬁcant effect in females. A
similar effect was found in SOD mRNA levels where the treatment
trended towards a decrease in the levels of this enzyme in males
[F(1,9) ¼ 3.63; p ¼ 0.06]. No effects were found in GPx mRNA levels
(Table 2).
As Table 2 shows, an increase in IL1b [F(1,10) ¼ 12.19; p < 0.01]
and IL6 [F(1,7) ¼ 24.66; p < 0.005] was found in treated males with
no signiﬁcant effect in female groups.
4. Discussion
The observation that the activity of diverse antioxidant enzymes
Fig. 1. Experimental design diagram.
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and the levels of pro-inﬂammatory and anti-inﬂammatory cyto-
kines are modiﬁed during the peripubertal/adolescent phase in the
neonatally treated rats provides the ﬁrst evidence for a program-
ming role of the physiological leptin surge in the redox and in-
ﬂammatory state of the animal later in life.
Similar to that described in mice (Ahima et al., 1998), rats also
experience a plasma surge of leptin during the neonatal period
(Delahaye et al., 2008). In these animals, leptin increases between
PND4 and 7, is elevated between PND7 and 10, declining by PND14.
Therefore, the present leptin antagonist treatment was adminis-
tered precisely during the time of the leptin surge. Leptin appears
to play a key role in immune and inﬂammatory responses (Conde
Fig. 2. Changes in body weight gain during the treatment (A) and at the end of the experiment (B) and spleen weight(C) at the time of sacriﬁce in peripubertal male and female rats
treated neonatally with a leptin antagonist (Antag) or vehicle (Co). Data expressed as mean ± S.E.M. (n ¼ 8e12 per experimental group). One way ANOVA: ***p < 0.001.
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et al., 2014; Valleau and Sullivan, 2014). However, the implication of
the neonatal leptin surge in the development and establishment of
these responses later in life has not been previously analyzed. In
fact, to the best of our knowledge, we provide here the ﬁrst evi-
dence that disruption of leptin signaling during the time period of
the physiological neonatal leptin surge has delayed consequences
affecting the oxidative and inﬂammatory state in peripubertal/
adolescent male and female rats.
The spleen is the largest secondary immune organ in the body
and is responsible for initiating immune reactions to blood-borne
antigens and for ﬁltering the blood of foreign material and old or
damaged red blood cells. In rats, this organ reaches peak devel-
opment at puberty, followed by gradual involution. It appears to be
a key player in cytokine production when there is an infection or
after trauma resulting in systemic inﬂammation regulated by the
autonomic nervous system (Gigliotti and Okusa, 2014). In this
study, we show changes in the spleen weights of peripubertal an-
imals treated neonatally with the leptin antagonist. The spleen of
treated males weighed less and those of treated females weighed
more than their controls. Since leptin acts as an immunomodulator
(Conde et al., 2014; Valleau and Sullivan, 2014), it seems plausible
that the treatment affected the correct development of the spleen.
Neonatal leptin antagonist treatment clearly impairs the matura-
tion of peripheral tissue such as pancreas, kidney, thymus and
ovary in rats (Attig et al., 2011), so it is not surprising to ﬁnd changes
in spleen weight. In addition, we found changes in the weights of
adipose tissue and gonads (Mela et al., 2015). Regarding body
weight, we found no effect of the leptin antagonist treatment on
body weight of either sex during neonatal and prepubertal life, as
previously reported (Attig et al., 2008; Granado et al., 2011; Mela
et al., 2012a,b). As previously suggested (Mela et al., 2015), one
possible explanation for no change in body weight, but a decrease
in adipose tissue in males could be that there is an increase in lean
body mass.
Fig. 3. Changes in CAT (A) and SOD (B) activity in spleen homogenate (data expressed
as mean ± S.E.M.) at the time of sacriﬁce in peripubertal male and female rats treated
neonatally with a leptin antagonist (Antag) or vehicle (Co). n ¼ 6e11 per experimental
group. One way ANOVA: *p < 0.05, **p < 0.01,***p < 0.001.
Fig. 4. Changes in GPx (A) and GR (B) activity in spleen homogenate (data expressed as
mean ± S.E.M.) at the time of sacriﬁce in peripubertal male and female rats treated
neonatally with a leptin antagonist (Antag) or vehicle (Co). n ¼ 7e12 per experimental
group. One way ANOVA: **p < 0.01,***p < 0.001.
Fig. 5. Changes in GSSG/GSH ratio in spleen homogenate (data expressed as
mean ± S.E.M.) at the time of sacriﬁce in peripubertal male and female rats treated
neonatally with a leptin antagonist (Antag) or vehicle (Co). n ¼ 10e12 per experi-
mental group. One way ANOVA: *p < 0.05.
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SOD acts as an enzymatic antioxidant defense that transforms
the superoxide anion to H2O2 andworks in parallel with CAT, which
is responsible for the elimination of the excess of H2O2 (Vida et al.,
2014). In the present study, we show lower activities of both en-
zymes in the animals treated in the neonatal period with the leptin
antagonist. These results are indicative of decreased antioxidant
defenses in the spleen. The glutathione system includes GPx and
GR, two enzymes that play an important role in maintaining the
correct balance between GSH and GSSG levels. In normal condi-
tions, glutathione is usually found in its reduced form since GR is
constitutively active (Vida et al., 2014). In the present study, the
treated animals showed higher GR activity and lower GPx activity
than the corresponding controls. It is plausible that an increase in
GR activity acts as a compensatory mechanism to mitigate the
oxidative stress. In fact, when the ratio GSSG/GSHwas analyzed as a
marker of oxidative stress, no signiﬁcant effect of the neonatal
treatment was found.
Appropriate levels of leptin are needed for a correct immune
response (Stofkova, 2009). Leptin appears to stimulate both innate
immunity, through the up-regulation of TLR expression in mono-
cytes, and adaptive immune response carried out by lymphocytes.
This stimulation is related with the protection against infections
and associated with the production of pro-inﬂammatory cytokines
and autoimmune diseases (Conde et al., 2014; Zabeau et al., 2014;
Zarkesh-Esfahani et al., 2001). Indeed, both obese ob/ob (leptin
deﬁcient) and db/db (deﬁcient in leptin receptors) mice have
deteriorated immune responses and increased infection suscepti-
bility (Milner and Beck, 2012) and leptin administration
counteracts this impaired immune response in animal models of
leptin deﬁciency (Busso et al., 2002; Lord et al., 1998). In addition,
leptin deﬁciency is associated with decreased production of several
cytokines. However, leptin regulation of cytokines is very different
depending on several factors, notably the type of stimulus involved
(R Faggioni et al., 2000a,b). Therefore, in order to measure the ef-
fects of the leptin antagonist on pro-inﬂammatory and anti-
inﬂammatory cytokine secretion by spleen leukocytes, these cells
were stimulated with either LPS or ConA. With both types of
stimulation, we found lower IL10 levels in spleen leukocytes from
males and females that had been treated with the antagonist. Since
IL10 is clearly an anti-inﬂammatory cytokine, this observation
suggests decreased protection against a potential inﬂammatory
state. Moreover, lower levels of anti-inﬂammatory cytokines such
as IL-10 have been detected in ob/ob mice after LPS treatment
(Faggioni et al., 2000a,b). The levels of IL13, a typical Th2 cytokine
with anti-inﬂammatory and immunoregulatory actions (Huang
et al., 2015; Wynn, 2015), were lower in LPS-stimulated leuko-
cytes from males and in ConA-stimulated leukocytes from females.
The pro-inﬂammatory cytokine TNFa was lower in the LPS-
stimulated leukocytes from males treated with the leptin antago-
nist, whereas the opposite was found in LPS-stimulated leukocytes
from treated females, i.e. TNFa levels increased. In regards to this
latter result, leptin has been shown to inhibit TNFa induction by LPS
in femalemice (Faggioni et al., 2000a,b). Some results suggest that a
Fig. 6. Changes in IL10 levels released (data expressed as mean ± S.E.M.) by spleen
leucocytes treated with either LPS (A) or ConA (B) at the time of sacriﬁce in peri-
pubertal male and female rats treated neonatally with a leptin antagonist (Antag) or
vehicle (Co). n ¼ 6e8 per experimental group. ANOVA one way:*p < 0.05, **p < 0.01,
***p < 0.001. Fig. 7. Changes in IL-13 levels released (data expressed as mean ± S.E.M.) by spleen
leucocytes treated with either LPS (A) or ConA (B) at the time of sacriﬁce in peri-
pubertal male and female rats treated neonatally with a leptin antagonist (Antag) or
vehicle (Co). n ¼ 7e8 per experimental group. One way ANOVA: **p < 0.01,
***p < 0.001.
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defect in leptin production is associated with a shift of the immune
response toward a pro-inﬂammatory phenotype as consequence of
the up-regulation of pro-inﬂammatory and down-regulation of
anti-inﬂammatory cytokines. However, no conclusive data are
available on TNF levels with LPS, with unchanged, decreased or
increased production of this cytokine having been reported
(Faggioni et al., 2001). As a whole, the present data support the
view that the pattern of cytokines regulated by leptin is very
different depending on the type of stimulus used to induce their
release (R Faggioni et al., 2000a,b). Moreover, we show clear dif-
ferences between males and females. It is worth re-emphasizing
that, due to the reason indicated in the method section, the
males and females used in this study were of different chronolog-
ical ages and, therefore, the differences observed between males
and females may not be exclusively attributed to their sex. This
does not negate the fact that blockage of neonatal leptin signaling
affects the future oxidative status of the animals and their ability to
respond to inﬂammatory insults during the critical period close to
pubertal onset in both males and females.
Whenwe analyzed if there were changes in the immune system
in other tissues, we found signiﬁcant effects in WAT. Males
appeared to be more affected by the treatment with leptin antag-
onist than females, as they presented an increase in IL1b and IL6
and a decrease in CAT and GR mRNA levels. However, we found a
decrease in TNFa mRNA levels in females treated with the antag-
onist, corroborating the idea that the effect of this leptin antagonist
is sex dependent. How these effects compromise the health status
of individuals in the presence of an injury or immune challenge is
unknown. Further investigation is needed to clarify the inﬂam-
matory state of these animals throughout their life.
We have previously found that maternal deprivation (MD)
during 24 h on postnatal day 9 (i.e., during the neonatal leptin surge
period) produces a marked decrease in leptin levels (Viveros et al.,
2010), as well as short- and long-term detrimental effects on the
immune system (De La Fuente et al., 2009; Viveros et al., 2009).
Thus, it is likely that both a social intervention such as MD and the
present pharmacological treatment affect the development of the
organism's defense system by interfering with the neonatal leptin
surge.
5. Conclusion
These ﬁndings point to a possible programming effect of the
neonatal leptin surge on the establishment of an appropriate redox
and inﬂammatory state. Since this is relevant to maintain a healthy
state in adulthood and throughout the aging process (De la Fuente
and Miquel, 2009; Hunsche et al., 2015), it follows that any situa-
tion that avoids/interferes with the neonatal leptin surge could
represent a risk factor for the future health of the individual.
Fig. 8. Changes in TNFa levels released (data expressed as mean ± S.E.M.) by spleen
leucocytes treated with either LPS (A) or ConA (B) at the time of sacriﬁce in peri-
pubertal male and female rats treated neonatally with a leptin antagonist (Antag) or
vehicle (Co). n ¼ 6e8 per experimental group. One way ANOVA: *p < 0.05, **p < 0.01,
***p < 0.001.
Table 1
Hypothalamic mRNA levels.
IL-10 TNFa CAT SOD GPx GR
Males Co 100 ± 19.3 100 ± 7.6 100 ± 5.3 100 ± 3 100 ± 3 100 ± 5
Antag 76.5 ± 23.2 152.8 ± 26.8 106.9 ± 4 105.6 ± 1.7 112.6 ± 5.7 107.4 ± 3.7
Females Co 100 ± 17.5 100 ± 6.2 100 ± 12 100 ± 7.8 100 ± 9.8 100 ± 4.3
Antag 76.4 ± 16.6 75.2 ± 7.3* 88.3 ± 6.2 87.3 ± 3 108.8 ± 4.7 101.8 ± 4.1
Data are expressed as mean ± SEM from rats treated with vehicle (Vh) or with leptin antagonist treatment (Antag) from postnatal day (PND) 5 to PND9. Data are normalized to
Co treated rats for each sex. N ¼ 4e6 per experimental group. One-Way ANOVA: *p < 0.05.
Table 2
WAT mRNA levels.
IL-1b IL-6 CAT SOD GPx GR
Males Co 100 ± 4.4 100 ± 13 100 ± 18.4 100 ± 11.6 100 ± 13.6 100 ± 18.1
Antag 262.9 ± 63.7** 237.4 ± 25.6*** 47.3 ± 15.3* 67.7 ± 14.9 68.3 ± 14.6 50.4 ± 28.3*
Females Co 100 ± 12.42 100 ± 44 100 ± 18.7 100 ± 22.8 100 ± 26.4 100 ± 24
Antag 149.7 ± 45.5 62.1 ± 19.3 62.6 ± 14.3 58.23 ± 9.3 78.1 ± 15 78 ± 15.4
Data are expressed as mean ± SEM from rats treated with vehicle (Vh) or with leptin antagonist treatment (Antag) from postnatal day (PND) 5 to PND9. Data are normalized to
Co treated rats for each sex. N ¼ 4e6 per experimental group. One-Way ANOVA: *p < 0.05, **p < 0.01, ***p < 0.005.
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3.2.2. Effects of the blockage of the neonatal leptin surge (PND5-9) on immune function 
and inflammatory state in spleen leukocytes of peripubertal/adolescent male and female rats. 
 
 
Experimental design 
The animals used in this study were the same as those used in the previous sub-objective 
that focused on the effects of the leptin antagonist treatment on the redox/inflammatory state of the 
spleen, hypothalamus and white adipose tissue in peripubertal/adolescent rats.   
From PND5 until PND9 rats were injected with 5 mg/kg bodyweight (bw) of rat pegylated 
super leptin antagonist (mutant D23L/L39A/D40A/F41A). The animals received one subcutaneous 
injection on their back per day at 9:00 am. In order to avoid the stress effect caused by marking the 
animals at this early age, each litter was treated with either vehicle (controls) or antagonist. Control 
rats were injected with the same volume of distilled water as the vehicle (2.5 ml/kg). After each 
injection the animals were immediately returned to their mothers. Each experimental group 
consisted of 12 animals. To avoid/minimize possible litter effects, all experimental groups 
contained animals from at least three different litters. Female (PND33) and male (PND43) rats were 
sacrificed after a 12 h fast by rapid decapitation. The spleen was rapidly and aseptically removed. 
The spleen was then freed of fat and divided into two parts. One fragment of the spleen was stored 
at -80 °C for the study of the redox parameters (data from the previous sub-objective). The other 
fragment of the spleen was minced with scissors, and gently pressed through a mesh screen to 
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obtain the cell suspension. These cell suspensions were centrifuged in a gradient of Ficoll-Hypaque 
and used in the present sub-objective to evaluate immune function and inflammatory state of spleen 
leukocytes in peripubertal/adolesecent rats.  
 
Main results  
Spleen leukocyte function parameters  
Peripubertal male and female rats exposed to the leptin antagonist in the neonatal period 
showed in spleen leukocytes significantly lower values of anti-tumour NK activity than those in 
cells of controls. The chemotaxis capacity of spleen leukocytes also showed lower values in treated 
male and female rats than in controls. The lymphoproliferation in response to T-cell mitogen 
(ConA) and B-cell mitogen (LPS) was significantly lower in female treated rats than in controls. 
However, no differences were found in the lymphoproliferation of male rats with respect to 
controls. 
Cytokine levels 
With respect to the cytokine IL-2 released in response to ConA and LPS-stimulated 
leukocytes, the concentrations were lower in treated females than in controls. In males, the 
concentrations of IL-2 in ConA-stimulated leukocytes were higher than in controls, but no 
differences were observed in cultures with LPS. 
The values of IL-1α and IL-1β were lower, in general, in peripubertal male and female rats 
treated neonatally with the leptin antagonist than in controls. The differences were statistically 
significant in the case of females for IL-1α with ConA and LPS as well as for IL-1β with ConA. In 
males statistical significances were observed for IL-1α and IL-1β in presence of LPS. 
The values of IL-6 were lower in treated animals than in the corresponding controls, in LPS-
stimulated leukocytes from males, as well as in ConA and LPS-stimulated leukocytes from females. 
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The IL-12p70 concentrations were lower in leukocytes from treated females in the presence 
of ConA and in those from treated males in the presence of LPS, than in controls. However, IFN-γ 
values were higher in male treated rats under ConA-stimulated conditions than in controls. 
The GM-CSF showed lower levels in male treated rats under LPS-stimulated conditions 
than in controls. Peripubertal female rats showed a tendency for lower levels in ConA-stimulated 
spleen leukocytes with respect to controls. 
The Th2 cytokines, IL-4 and IL-5, which are commonly known for their anti-inflammatory 
actions, showed lower values in leukocytes from treated animals than in controls. The differences 
were statistically significant only in the case of males, in cultures in the presence of LPS. 
 
Partial conclusions 
The results of this experiment indicate that the blockage of the neonatal leptin surge results 
in an impairment of immune function and in an altered cytokine release of spleen leukocytes in 
peripubertal male and female rats.  
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33 Abstract
34
35 Leptin is a pleiotropic hormone with not only an important role in the central regulation of energy homeostasis, but also 
36 involved in other peripheral processes, such as the modulation of immune system functions. There is a physiological 
37 surge of leptin in rodents during the neonatal period, which has been mainly studied in relation to its neurotropic role 
38 during brain development. However, little is known about the effects of this neonatal leptin surge in relation to 
39 immunity. Therefore, we investigated if the blockage of this leptin surge could affect several immune functions. A 
40 leptin antagonist administered during the neonatal period (PND5-10) in male and female rats were used, and in the 
41 peripubertal period of these animals relevant functions as well as cytokine release by spleen leukocytes were studied. 
42 The results showed that these animals displayed significantly impaired anti-tumor NK activity, chemotaxis capacity and 
43 proliferation of lymphocytes in response to mitogens. In addition, several cytokine concentrations, released under 
44 mitogen-stimulated conditions, were also altered. In conclusion, the neonatal leptin surge seems to be involved in the 
45 establishment of an adequate immune response and cytokine profile, which are crucial for the maintenance of a healthy 
46 life.
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65 1. Introduction
66
67 Leptin is a 16-kDa pleiotropic hormone with not only an important role in the central regulation of energy 
68 homeostasis, but also involved in other peripheral processes, such as the modulation of immune system functions (Feng 
69 et al., 2013; Lago et al., 2008). Leptin is predominantly secreted by adipocytes in adipose tissue but at lower levels also 
70 by skeletal muscle, stomach and placenta (Bado et al., 1998; Sagawa et al., 2002; Señarís et al., 1997; Wang et al., 
71 1998). Increasing evidence suggests that leptin has an important role in fetal development. For instance, in pregnancy, 
72 the production in the placenta rises significantly in rodents and humans (Gavrilova et al., 1997; Sagawa et al., 2002; 
73 Señarís et al., 1997). In addition, there is a temporary increase of leptin levels in rodents during the early postnatal 
74 period, constituting a “leptin surge”. Thus, it has been described that neonatal mice and rats experience elevated levels 
75 of leptin from postnatal day (PND) 4 to PND 14, with a peak at PND 10 (Ahima et al., 1998; Delahaye et al., 2008). 
76 This leptin surge, which is not influenced by nutritional intake and body fat (Ahima et al., 1998), seems to be important 
77 for brain development, particularly in the establishment of hypothalamic circuits that regulate food intake (Bouret et al., 
78 2004). Currently, it is well known that early life is a critical developmental period and stresses generated in this period 
79 could result in long-lasting detrimental effects in later life (De la Fuente et al., 2009; Lucassen et al., 2013; Viveros et 
80 al., 2009). Indeed, perturbations in the early neonatal circulation levels of leptin in rodents have been associated with 
81 long-terms alterations in energy homeostasis and reproduction (Attig et al., 2008; Mela et al., 2015). 
82 Although leptin receptors are highly expressed in the central nervous system, they can also be detected in other 
83 systems, such as the immune system (Lord et al., 1998; Mercer et al., 1996). The expression of leptin receptors in 
84 immune system cells (including macrophages, monocytes, neutrophils, natural killer (NK) cells, T and B cells), which 
85 showed to be increased by leptin stimulation, indicates that leptin may play an important role in the regulation of 
86 immune and inflammatory responses (Naylor and Petri, 2016; Zhao et al., 2003). In fact, nutritional dysfunctional 
87 states, such as malnutrition and obesity, in which there are diminished or enhanced levels of leptin, respectively, have 
88 been shown to lead to a poorer immune response against infection (Zhang et al., 2005). Thus, increasing evidence 
89 suggests that adequate levels of leptin are essential for the maintenance of an optimal immune response. Leptin, which 
90 shares similarities with members of the cytokine family (Zhang et al., 2005), has been shown to also function as an 
91 inflammatory molecule. It has been reported that leptin is able to modulate a variety of immune system functions, such 
92 as chemotaxis, NK cell activity, proliferation of lymphocytes and the production of inflammatory cytokines (Gainsford 
93 et al., 1996; Gruen et al., 2007; Lago et al., 2008; Lam and Lu, 2007; Lord, 2006; Lord et al., 1998; Martín-Romero et 
94 al., 2000; Naylor and Petri, 2016; Santos-Alvarez et al., 1999; Tian et al., 2002; Zhang et al., 2005; Zhao et al., 2003).
95 Preliminary research suggests an association between the neonatal leptin surge and the immune system. For 
96 instance, leptin blockage during the early neonatal phase affected the maturation of key immune organs, such as thymus 
175
97 and spleen (Attig et al., 2011). Also, we have recently reported that the exposure to a leptin antagonist during the 
98 postnatal period resulted in alterations of redox and inflammatory state in spleen, hypothalamus and adipose tissue of 
99 peripubertal male and female rats (Mela et al., 2017). Nevertheless, nothing is known about the physiological role of the 
100 postnatal leptin surge in functions of the immune system. Therefore, the aim of the present study was to determine if the 
101 use of a leptin antagonist during the period corresponding to the physiological surge of leptin (PND5-10) could affect 
102 relevant functions of the immune cells as well as cytokine release by spleen leukocytes in peripubertal male and female 
103 rats. 
104
105 2. Materials and methods 
106
107 2.1. Animals
108
109 Experimental subjects were the offspring of Wistar rats purchased from Harlan Interfauna Ibérica S.A. (Barcelona, 
110 Spain). The parental generation was mated (one male x two females) in our animal facilities approximately two weeks 
111 after their arrival. After 10 days, female animals were isolated and the day of delivery strictly controlled. On the day of 
112 birth (postnatal day 0, PND0), litters were sex-balanced and culled to eight pups per dam (four males and four females). 
113 No cross-fostering was employed. Thus, only litters with at least four pups of each sex at birth were used. The animals 
114 were housed in plastic Makrolon® III cages and maintained at a constant temperature (22 ± 1°C) and humidity (50 ± 
115 2%) in a reversed 12-h light-dark cycle (red light on at 8:00 am and white light on at 8:00 pm). Pregnant rats were given 
116 free access to food (commercial diet for rodents; A03, Safe, Augy, France) and water. The animals used in this study 
117 were the same as those used in a recently published paper that focused on the effects of the same leptin antagonist 
118 treatment on hypothalamic systems related to reproduction (Mela et al., 2015). As the aim in that study was to 
119 investigate the pubertal transition, immediately before the appearance of external phenotypic signs of puberty, and 
120 because the timing of puberty differs between the sexes, females were euthanized on PND33 and males on PND43. 
121 These studies were approved by the local ethics committee and complied with Royal Decree 1201/2005 (BOE n° 252) 
122 pertaining to the protection of experimental animals and with the European Communities Council Directive 
123 (86/609/EEC). The experiments were conducted in accordance with the guidelines and protocols of Royal Decree 
124 53/2013 regarding the care and use of laboratory animals for experimental procedures, and were approved by the 
125 Committee for Animal Experimentation of the Complutense University of Madrid. 
126
127 2.2. Leptin antagonist treatment 
128
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129 From PND5 until PND9 rats were injected with 5 mg/kg bodyweight (bw) of rat pegylated super leptin antagonist 
130 (mutant D23L/L39A/D40A/F41A), a gift of Protein Laboratories (Rehovot, Israel), as previously described (Jamroz-
131 Wiśniewska et al., 2014). The animals received one subcutaneous injection on their back per day at 9:00 am. In order to 
132 avoid the stress effect caused by marking the animals at this early age, we treated each litter with either vehicle 
133 (controls) or antagonist. Control rats were injected with the same volume of distilled water as the vehicle (2.5 ml/kg). 
134 After each injection the animals were immediately returned to their mothers. Each experimental group consisted of 12 
135 animals. To avoid/minimize possible litter effects all experimental groups contained animals from at least three 
136 different litters.
137
138 2.3. Collection of spleen and leukocyte suspensions
139
140 Female (PND33) and male (PND43) rats were sacrificed after a 12 h fast by rapid decapitation. The spleen was 
141 rapidly and aseptically removed. The spleen was then freed of fat and divided into two parts. One fragment of spleen 
142 was stored at -80 °C for the study of the oxidative stress parameters (data previously published) (Mela et al., 2017). 
143 Another fragment of spleen was minced with scissors, and gently pressed through a mesh screen (Sigma-Aldrich, 
144 Madrid, Spain) to obtain the cell suspension. The cell suspensions were centrifuged in a gradient of Ficoll-Hypaque 
145 (Sigma-Aldrich) with a density of 1.070 g/ml. Cells from the interface were collected and suspended in Roswell Park 
146 Memorial Institute (RPMI) 1640 medium enriched with L-glutamine (PAA, Pasching, Austria) and supplemented with 
147 10% heat-inactivated (56 °C, 30 min) fetal calf serum (PAA) and gentamicin (100 µg/ml, PAA). After a wash step, 
148 leukocytes were counted in a Neubauer chamber (Blau Brand, Wertheim, Germany) and their number adjusted to 106 
149 cells/ml. Cell viability was routinely measured before each experiment by the trypan-blue exclusion test, and was higher 
150 than 98% in all experiments. All incubations were performed at 37 °C in a humidified atmosphere of 5% CO2.  
151
152 2.4. Immune functions
153
154 2.4.1. NK activity assay
155
156 An enzymatic colorimetric assay was carried out to measure the cytolysis of tumor cells (Cytotox 96 TM Promega, 
157 Boeringher Ingelheim, Germany) based on the determination of lactate dehydrogenase enzyme (LDH), as previously 
158 described (De la Fuente et al., 2004). Aliquots of 100 µl of leukocytes, used as effector cells, were seeded in 96-well U-
159 bottom culture plates (Numc, Roskilde, Denmark) adjusted to 106 leukocytes/ml in RPMI 1640 medium without phenol 
160 red. Murine lymphoma YAC-1 cells, used as target cells, were added adjusted to 105 cells/ml. Thus, the effector/target 
177
161 ratio was 10:1. The plates were centrifuged at 250 g for 4 min to facilitate cell contacts. After 4 hours of incubation, 
162 lactate dehydrogenase enzymatic activity was measured in 50 µl/well of the supernatants by addition of the enzyme 
163 substrate and absorbance recording spectrophotometrically at 490 nm. Three kinds of control measurements were 
164 performed: a target spontaneous release, a target maximum release, and an effector spontaneous release. The results 
165 were expressed as percentages of lysis of target cells. To determine this percentage the following equation was used: 
166 %lysis = ((E-ES-TS)/M-ES-TS)) x 100, where E is the mean of absorbance in the presence of effector cells; ES, the 
167 mean of absorbance of effector cells incubated alone; TS, the mean of absorbance in target cells incubated with medium 
168 alone; and M is the mean of maximum absorbance after incubating target cells with lysis solution. 
169
170 2.4.2. Chemotaxis assay
171
172 Chemotaxis of leukocytes was evaluated according to a slight modification of Boyden´s method (De la Fuente et 
173 al., 2004) consisting basically of the use of chambers with two compartments separated by a filter with a pore diameter 
174 of 3 µm (Millipore, Bedford, MA, USA). Aliquots of 300 μl of the leukocyte suspensions, adjusted to 5X105 cells/ml in 
175 Hank´s solution, were deposited in the upper compartment, and aliquots of 400 µl of the chemoattractant, formyl-Met-
176 Leu-Phe (10-8 M) (Sigma-Aldrich), were put into the lower compartment. The chambers were incubated for 3h and then 
177 the filters were fixed and stained. The chemotaxis index (CI) was determined by counting, in an optical microscope 
178 (100X), the total number of lymphocytes on one third of the lower face of the filters. 
179
180 2.4.3. Lymphoproliferation assay
181
182 The proliferation of lymphocytes in response to the mitogens concanavalin A (ConA) and lipopolysaccharide 
183 (LPS) was measured following a method previously described (De la Fuente et al., 2004). Aliquots (200 µl) of spleen 
184 leukocytes (106 cells/ml complete medium) were seeded in 96 well flat-bottomed microtiter plates (Numc, Roskilde, 
185 Denmark), and 20 µl of ConA (1μg/ml; Sigma-Aldrich), a T-cell mitogen (lectin) or 20 µl of lipopolysaccharide 
186 (Escherichia coli, 055:B5 1µg/ml; Sigma-Aldrich), a B-cell mitogen, were added per well. After 48h of incubation at 
187 37°C in an atmosphere of 5% CO2, 0.5 µCi 3H-thymidine (Du Pont, Boston, MA, USA) were added to each well. The 
188 cells were harvested in a semiautomatic microharvester 24h later. Thymidine uptake was measured using a beta counter 
189 (LKB, Uppsala, Sweden) and the results were expressed as 3H-thymidine uptake (cpm). 
190
191 2.5. Cytokine concentrations 
192
178
193 The concentrations of the cytokines, including interleukin-2 (IL-2), interleukin-1α (IL-1α), interleukin-1β (IL-1β), 
194 interleukin-6 (IL-6), interleukin-12p70 (IL-12p70), interferon-γ (IFN-γ), granulocyte-macrophage colony-stimulating 
195 factor (GM-CSF), interleukin IL-4 (IL-4) and interleukin-5 (IL-5), released into the supernatant of spleen leukocytes 
196 cultures, after 48 hours of incubation with ConA or LPS, were measured simultaneously using a Luminex xPONENT 
197 (Rat Bio Plex Pro Cytokine assays using magnetic beads, Bio-Rad, USA). The results were expressed as pg/mL.
198
199 2.6. Statistical analysis 
200
201 SPSS 21.0 (SPSS, Inc., Chicago, USA) was used for the statistical analysis of the results. The data were expressed 
202 as mean ± standard deviation (SD). Each value is the mean of the data from an assay performed in duplicate or 
203 triplicate. Normality of the samples was checked by the Kolmogorov-Smirnov test and homogeneity of variances with 
204 the Levene test. The data were statistically evaluated by the Student´s t-test for independent samples. P<0.05 was 
205 considered as statistically significant and 0.05<P<0.1 as a trend. As males and females were of a different chronological 
206 age due to the differential timing of the onset of puberty, data were not directly compared between sexes.
207
208 3. Results
209
210 3.1. Lymphocyte immune functions
211
212 The immune functions of spleen leukocytes are shown in Figure 1. Peripubertal male and female rats exposed to 
213 the leptin antagonist in the neonatal period showed significantly lower values of activity of NK cells than those in 
214 controls (P<0.001 and P<0.05, respectively. Figures 1C and 1A).  The chemotaxis capacity of spleen leukocytes 
215 (Figures 1D and 1B) also showed lower values in treated male and female rats than in controls (P<0.001). 
216 The lymphoproliferation in response to T-cell mitogen (ConA) and B-cell mitogen (LPS) (Figure 1) was 
217 significantly lower in female treated rats than in controls (P<0.05. Figures 1A and 1B). However, no differences were 
218 found in the lymphoproliferation in male rats with respect to controls (Figures 1C and 1D). 
219
220 3.2. Cytokine concentrations
221
222 The concentrations of several cytokines released in spleen leukocytes cultured in presence of the mitogens ConA 
223 or LPS, are shown in Figures 2 to Figure 7. They have important roles regulating innate and adaptive immune functions 
224 and belong to the T helper type1 (Th1) or T helper type 2 (Th2) group. 
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225 With respect to the cytokine IL-2 released in response to ConA and LPS-stimulated leukocytes (Figure 2), the 
226 concentrations were lower in treated females than in controls (P<0.01 and P<0.001, respectively. Figures 2A and 2B). 
227 In males, the concentrations of IL-2 in ConA-stimulated leukocytes were higher than in controls (P<0.05), but no 
228 differences were observed in cultures with LPS (Figures 2C and 2D). 
229 The values of IL-1α and IL-1β concentrations (Figure 3) were lower, in general, in peripubertal male and female 
230 rats treated neonatally with the leptin antagonist than in controls. The differences were statistically significant in the 
231 case of females for IL-1α with ConA and LPS as well as for IL-1β with ConA (P<0.05. Figures 3A, 3B and 3E).  In 
232 males statistical significances were observed for IL-1α and IL-1β in presence of LPS (P<0.05 and P<0.01, respectively. 
233 Figures 3D and 3H). 
234 The values of IL-6 were lower in treated animals than in the corresponding controls, in LPS-stimulated leukocytes 
235 from males (P<0.001. Figure 4D) as well as in ConA and LPS-stimulated leukocytes from females (P<0.05. Figures 4A 
236 and 4B). 
237 The IL-12p70 concentrations were lower in leukocytes from treated females in the presence of ConA and in those 
238 from treated males in the presence of LPS, than in controls (P<0.05. Figures 5A and 5D, respectively). However, IFN-γ 
239 values were higher in male treated rats under ConA-stimulated conditions than in controls (P<0.01. Figure 5G). 
240 The GM-CSF showed lower concentrations in male treated rats under LPS-stimulated conditions than in controls 
241 (P<0.05. Figure 6D). Peripubertal female rats showed a tendency for lower concentrations in ConA-stimulated spleen 
242 leukocytes with respect to controls (0.05<P<0.1. Figure 6A).
243 The Th2 cytokines, IL-4 and IL-5, which are commonly known for their anti-inflammatory actions, showed lower 
244 values in leukocytes from treated animals than in controls (Figure 7). The differences were statistically significant only 
245 in the case of males, in cultures in the presence of LPS (P<0.05. Figures 7D and 7H). 
246
247 4. Discussion 
248
249 In the present work, we demonstrated for the first time that the exposure to a leptin antagonist during a critical 
250 developmental period of early postnatal life resulted in impaired immune function and cytokine release in spleen 
251 leukocytes of peripubertal male and female rats. We carried out the study in spleen since this secondary lymphoid 
252 organ, which is the largest in both humans and rodents, is responsible for mounting effective innate and adaptive 
253 immune responses and for regulating cytokine production (Nolte et al., 2002; Cesta, 2006; Huston et al., 2006). The 
254 animals treated with a specific leptin antagonist during the leptin surge (PND5-10) displayed significantly impaired 
255 chemotactic capacity, anti-tumor NK activity and proliferation of lymphocytes in response to mitogens (LPS and 
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256 ConA). Moreover, in cultures of those leukocytes under ConA and LPS-stimulated conditions, an impaired of the 
257 release of several cytokines was shown in general in these rats treated with the leptin antagonist. 
258 The immune system in early life goes through rapid and critical changes. Thus, perturbations in this period could 
259 result in long-lasting detrimental effects in later life (Goenka and Kollmann, 2015). In this sense, the neonatal 
260 programming of adult immune function has been previously reported. Thus, the neonatal exposure to an immune 
261 challenge, such as bacterial endotoxin LPS, showed to alter neuroendocrine and immune responses in adult animals 
262 (Spencer et al., 2001; Skanks et al., 1995; Shanks et al., 2000). Several mechanisms underlying these effects seem to be 
263 related to hypothalamic-pituitary-adrenal axis modifications (Spencer et al., 2001). In fact, a previous study in which 
264 rats were neonatally treated with the same leptin antagonist found long-term alterations on hypothalamic expression of 
265 reproductive and metabolic neuropeptides (Mela et al., 2016). Given the bidirectional communication between nervous 
266 and immune system, this alteration exerted on the hypothalamus could also have an impact on the immune system (Vida 
267 et al., 2014). In addition, although there is increasing evidence showing the effects of leptin on several immune system 
268 functions, no information is available specifically correlating the neonatal leptin surge with these functions at 
269 peripubertal age. For this, in the present study, the pegylated super leptin antagonist was administrated in male and 
270 female rats from PND5 to 9. This period of time is coincident, according with previous reports, to the plasma surge of 
271 leptin in neonatal mice and rats (Ahima et al., 1998; Delahaye et al., 2008). With respect to the innate immunity, the 
272 functions studied were significantly impaired in spleen leukocytes of peripubertal male and female rats neonatally 
273 treated with leptin antagonist. Thus, the NK cells showed a lower lytic activity against tumor cells in treated animals 
274 than in controls. Therefore, it seems that the leptin surge has an important role in establishing and maintaining the 
275 proper function of NK cells. In fact, it was previously reported that leptin is involved in the processes of NK cell 
276 development, differentiation, activation, and cytoxicity (Tian et al., 2002; Zhao et al., 2003). It was found that leptin 
277 enhanced these processes in NK cells via the activator of transcription 3 (STAT-3) and by the up-regulation of the 
278 expression of IL-2 and perforin genes (Zhao et al., 2003). In relation to the chemotaxis activity, this function was 
279 suppressed in cells from male and female treated animals. The role of leptin in the migration of immune cells has been 
280 observed given that it shows a chemoattractant capacity at low concentrations. This effect seems to be mediated via full-
281 length leptin receptors and canonical migratory signaling pathways (Gruen et al., 2007). Moreover, leptin has been 
282 shown to stimulate the expression of chemokines in murine macrophages through the activation of the janus kinase 2 
283 (JAK-2)-signal transducer and STAT3 pathway (Kiguchi et al., 2009). 
284 The neonatal administration of the leptin antagonist also resulted in impaired adaptive immunity in peripubertal 
285 rats. Thus, the proliferation of spleen lymphocytes in response to T- and B-cell mitogens, such as ConA and LPS, 
286 respectively, was lower in peripubertal female treated rats than in controls. An increased proliferation of lymphocytes 
287 has been observed in the presence of leptin (Lord et al., 1998). An enhanced proliferation and activation of human T 
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288 lymphocytes with leptin was also observed when cells were co-stimulated with phytohemagglutinin (PHA) or 
289 concanavalin A (ConA) (Martín-Romero, 2000). Moreover, leptin also plays an important role in the development of 
290 lymphocytes. In this sense, leptin receptor-deficient db/db mice showed impaired lymphopoiesis and reduced numbers 
291 of lymphocytes in peripheral blood (Bennett et al., 1996).
292 Increasing evidence suggests that leptin has a regulatory role within the cytokine network (Gainsford et al., 1996; 
293 Santos-Alvarez et al., 1999; Martín-Romero et al., 2000; Lord, 2006; Lam and Lu, 2007). Thus, in the present study, in 
294 agreement with the impairments found in innate and adaptive immune functions, the neonatal leptin antagonist 
295 treatment also resulted, in general, in a lower release of several cytokines in ConA and LPS-stimulated spleen 
296 leukocytes of peripubertal rats. The IL-2, which is an essential regulatory cytokine that acts mainly on lymphoid 
297 populations, including T, B, and NK cells (Liao et al., 2011), was found to be diminished in female neonatally treated 
298 animals. In this sense, leptin has been shown to influence the proliferation and secretion of IL-2 by immune cells, 
299 through the activation of the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-kinase (PI3-K) 
300 pathways (Liao et al., 2011; Lord et al., 1998). Since IL-2 is related to the proliferation of lymphocytes, the lower 
301 concentrations of this cytokine in treated females could explain the reduced lymphoproliferative response in the cells of 
302 this sex.
303 In addition, several studies have shown that leptin signaling increases inflammatory mediators through direct 
304 activation of immune cells (Matarese et al., 2005; Procaccini et al., 2012; Spencer et al., 2001; Tian et al., 2002). Thus, 
305 IL-1α and IL-1β, which are classic pro-inflammatory cytokines and are also involved in the proliferative response of 
306 lymphocytes (Zarkesk-Esfahani et al., 2001), exhibited lower concentrations in peribupertal male and female rats 
307 neonatally treated with leptin antagonist under LPS or ConA-stimulated conditions. Lower concentrations of IL-6 were 
308 also found in treated peripubertal male and female animals under mitogen (LPS or ConA) stimulation. Together with 
309 IL-2, IL-1α and IL-1β, IL-6 is crucial in the orchestration of the differentiation and function of innate and adaptive 
310 immune cells (Dinarello, 2009). These cytokines regulate T lymphocyte activation and differentiation (GArlanda et al., 
311 2013; Sims and Smith, 2010). In addition, IL-1β and IL-6 promote B cell functions and antibody production (Dinarello, 
312 2009; Fisher et al., 2014). Previous studies have clearly demonstrated an association between the regulation of these 
313 cytokines and leptin. Thus, leptin has been shown to directly induce the release of IL-1β and IL-6 in microglia cells 
314 (Ataie-Kachoie et al., 2014; Tang et al., 2007) and to mediate the LPS-induced symptoms of sickness behavior through 
315 a process that involves IL-1β induction in the brain (Lafrance et al., 2010; Sachot et al., 2004).
316 The concentrations of IL-12p70, a pro-inflammatory cytokine known to promote Th1 immune differentiation 
317 against intracellular pathogens, including bacteria and some viruses (Raphael et al., 2015), were lower in ConA or LPS-
318 stimulated leukocytes from male and female treated rats. In addition, GM-CSF concentrations were diminished in LPS-
319 stimulated leukocytes from treated males and it should be borne in mind that this cytokine, which has been typically 
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320 recognized as a hematopoietic growth factor, plays an important role in Th1 and Th17 responses (Shiomi and Usui, 
321 2015). However, the concentrations of IFN-γ, also known as a Th1 cytokine with pro-inflammatory properties, were 
322 increased in ConA-stimulated leukocytes from treated males, whereas no differences were found in female treated rats. 
323 A study recently published, in which the same experimental design was used (Mela et al., 2017), also found increased 
324 concentrations of TNF-α (which is also a Th1 cytokine with pro-inflammatory properties) in ConA-stimulated 
325 leukocytes from treated males. In addition, previous data indicate that, in several cases, a defect in leptin production 
326 could lead to an increase in the secretion of several pro-inflammatory cytokines, favoring the up-regulation of pro-
327 inflammatory mediators (Faggioni et al., 2001). However, other studies using rodents with genetic abnormalities in 
328 leptin or leptin receptors have shown suppressed expression of pro-inflammatory cytokines, such as IL-12 and IL-6, in 
329 response to LPS stimulation (Loffreda et al., 1998).
330 The release of T-helper type 2 (Th-2) cytokines, including the anti-inflammatory cytokines IL-4 and IL-5, which 
331 are commonly involved in enhancing clearance of parasites and allergic reactions (Li et al., 2011), were reduced in 
332 LPS-stimulated leukocytes from male treated rats. However, no significant differences were found in female animals. 
333 Our results suggest that the blockage of neonatal leptin surge have led to impairments both on Th1 and Th2 
334 responses, although with a greater impact on Th1, since statistically significant differences were greater in Th1 
335 cytokines, such as IL-2, IL-12p70 and IFN-γ, than in Th2 cytokines (IL-4 and IL-5). In this sense, previous data have 
336 pointed that the reduction of leptin concentrations (commonly seen in conditions of malnutrition, anorexia nervosa or 
337 genetic leptin deficiency) results in impaired Th1 response and reduced immunocompetence as well as increased 
338 susceptibility to infection (Procaccini et al., 2012). 
339 Given that previous studies have shown the activation of JAK-2/STAT, MAPK and PI3K signaling pathways by 
340 leptin (Sánchez-Margalet et al., 2003), we could suggest a possible involvement of these intracellular pathways in the 
341 alterations of immune and inflammatory responses of peripubertal rats neonatally treated with a leptin antagonist.
342 In conclusion, these data indicate that the blockage of the neonatal leptin surge results in an impairment of 
343 immune function and in an altered cytokine release of spleen leukocytes peripubertal male and female rats. Therefore, 
344 the neonatal leptin surge seems to have an important physiological role in the establishment and maintenance of 
345 adequate immune response. Given the critical role of the immune system in maintaining health during adulthood and 
346 the aging process (De la Fuente and Miquel, 2009; Hunsche et al., 2016), it is reasonable to assume that any 
347 disruption/blockage of the neonatal leptin surge could represent a risk factor for the proper maintenance of the immune 
348 system function as well as overall health in later life. 
349
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573 FIGURE LEGENDS
574
575 Figure 1. Lymphocyte immune functions. Natural killer cell activity (% lysis) in peripubertal female (A) and male 
576 rats (C) treated neonatally with a leptin antagonist or vehicle (control). Chemotaxis index in peripubertal female (B) and 
577 male rats (D) treated neonatally with a leptin antagonist or vehicle (control). ConA-stimulated proliferation in 
578 peripubertal female (E) and male rats (F). LPS-stimulated proliferation in peripubertal female (G) and male rats (H) 
579 treated neonatally with a leptin antagonist or vehicle (control). * P<0.05, *** P<0.001 with respect to the values of 
580 control rats.
581
582 Figure 2. IL-2 concentrations (pg/ml) in supernatants of spleen leukocytes cultures under concalavalin A (ConA) 
583 and lipopolysaccharide (LPS)-stimulated conditions. IL-2 concentrations (ConA) in peripubertal female (A) and 
584 male rats (C) treated neonatally with a leptin antagonist or vehicle (control). IL-2 concentrations (LPS) in peripubertal 
585 female (B) and male rats (D) treated neonatally with a leptin antagonist or vehicle (control). * P<0.05, ** P<0.01, *** 
586 P<0.001 with respect to the values of control rats.
587
588 Figure 3. IL-1 family concentrations (pg/ml) in supernatants of spleen leukocytes cultured under concalavalin A 
589 (ConA) and lipopolysaccharide (LPS)-stimulated conditions. IL-1α concentrations (ConA) in peripubertal female 
590 (A) and male rats (C) treated neonatally with a leptin antagonist or vehicle (control). IL-1α concentrations (LPS) in 
591 peripubertal female (B) and male rats (D) treated neonatally with a leptin antagonist or vehicle (control). IL-1β 
592 concentrations (ConA) in peripubertal female (E) and male rats (G) treated neonatally with a leptin antagonist or vehicle 
593 (control). IL-1β concentrations (LPS) in peripubertal female (F) and male rats (H) treated neonatally with a leptin 
594 antagonist or vehicle (control). * P<0.05, ** P<0.01 with respect to the values of control rats.
595
596 Figure 4. IL-6 concentrations (pg/ml) in supernatants of spleen leukocytes cultures under concalavalin A (ConA) 
597 and lipopolysaccharide (LPS)-stimulated conditions. IL-6 concentrations (ConA) in peripubertal female (A) and 
598 male rats (C) treated neonatally with a leptin antagonist or vehicle (control). IL-6 concentrations (LPS) in peripubertal 
599 female (B) and male rats (D) treated neonatally with a leptin antagonist or vehicle (control). * P<0.05, *** P<0.001 
600 with respect to the values of control rats.
601
602 Figure 5. IL-12p70 and IFN-γ concentrations (pg/ml) in supernatants of spleen leukocytes cultures under 
603 concalavalin A (ConA) and lipopolysaccharide (LPS)-stimulated conditions. IL-12p70 concentrations (ConA) in 
604 peripubertal female (A) and male rats (C) treated neonatally with a leptin antagonist or vehicle (control). IL-12p70 
191
605 concentrations (LPS) in peripubertal female (B) and male rats (D) treated neonatally with a leptin antagonist or vehicle 
606 (control). IFN-γ concentrations (ConA) in peripubertal female (E) and male rats (G) treated neonatally with a leptin 
607 antagonist or vehicle (control). IFN-γ concentrations (LPS) in peripubertal female (F) and male rats (H) treated 
608 neonatally with a leptin antagonist or vehicle (control). * P<0.05, **P<0.01 with respect to the values of control rats.
609
610 Figure 6. GM-CSF concentrations (pg/ml) in supernatants of spleen leukocytes cultures under concalavalin A 
611 (ConA) and lipopolysaccharide (LPS)-stimulated conditions. GM-CSF concentrations (ConA) in peripubertal 
612 female (A) and male rats (C) treated neonatally with a leptin antagonist or vehicle (control). GM-CSF concentrations 
613 (LPS) in peripubertal female (B) and male rats (D) treated neonatally with a leptin antagonist or vehicle (control). t 
614 0.05<P<0.1, * P<0.05 with respect to the values of control rats.
615
616 Figure 7. IL-4 and IL-5 concentrations (pg/ml) in supernatants of spleen leukocytes cultures under concalavalin 
617 A (ConA) and lipopolysaccharide (LPS)-stimulated conditions. IL-4 concentrations (ConA) in peripubertal female 
618 (A) and male rats (C) treated neonatally with a leptin antagonist or vehicle (control). IL-4 concentrations (LPS) in 
619 peripubertal female (B) and male rats (D) treated neonatally with a leptin antagonist or vehicle (control). IL-5 
620 concentrations (ConA) in peripubertal female (E) and male rats (G) treated neonatally with a leptin antagonist or vehicle 
621 (control). IL-5 (LPS) in peripubertal female (F) and male rats (H) treated neonatally with a leptin antagonist or vehicle 
622 (control). * P<0.05 with respect to the values of control rats. 
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3.2.3. Effects of the blockage of the neonatal leptin surge (PND5-9) on the immune 
function and redox state in spleen leukocytes of adult male and female rats.   
 
 
 
Experimental design 
From PND5 until PND9 rats were injected subcutaneously with pegylated super leptin 
antagonist (mutant D23L/L39A/D40A/F41A) (5 mg/kg bodyweight (bw) of rat). In order to 
consider the stress effect caused by marking the animals at this early age, each litter was treated 
with either vehicle (controls) or antagonist. The animals received one injection per day at 9:00 am. 
Control rats were injected with the same volume of distilled water as the vehicle (2.5 ml/kg). After 
each injection the animals were immediately returned to their mothers. Each experimental group 
consisted of 12 animals. To avoid/minimize possible litter effect, all experimental groups contained 
animals from at least three different litters. Male and female rats were sacrificed by rapid 
decapitation on PND102-103 after a 12 h fast. The spleen was rapidly and aseptically removed, 
freed of fat, minced with scissors, and gently pressed through a mesh screen to obtain the cell 
suspensions. The cell suspensions were centrifuged in a gradient of Ficcoll-Hypaque and used in the 
present sub-objective to evaluate immune function and redox state of spleen leukocytes in adult 
rats. 
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Main results  
Spleen leukocyte function parameters 
Adult male and female rats exposed to the leptin antagonist in the neonatal period showed 
significantly higher values of chemotaxis capacity of spleen leukocyte cells than those in controls. 
However, the anti-tumour NK activity showed lower values in treated male and female rats than in 
controls. 
The lymphoproliferation in response to ConA was significantly lower in female and male 
treated rats than in controls. In addition, both treated adult males and females displayed lower 
values in lymphoproliferation in response to LPS with respect to controls. 
Spleen leukocyte oxidative stress parameters 
Reduced glutathione (GSH) and its related enzymes, including glutathione peroxidase (GPx) 
and glutathione reductase (GR) constitute the major intracellular redox buffer for cells against 
oxidant damage. The neonatal treatment with leptin antagonist resulted in a lower glutathione 
system antioxidant defence in adult rats. Thus, treated adult male and female rats showed lower 
GSH concentrations and GPx and GR activities. 
With regards to the production of oxidants, adult male and female rats exhibited 
significantly higher concentrations of oxidized glutathione (GSSG) than their respective controls. In 
addition, the GSSG/GSH ratios, which are an indicator of oxidative stress, were significantly higher 
in adult male and female rats treated neonatally with the leptin antagonist than in controls. The 
activity of xanthine oxidase was significantly higher in treated adult male and female rats as 
compared with controls. In addition, the MDA concentration, which is an indicator of lipid 
oxidation and oxidative damage in cells, showed significantly higher values in treated adult female 
rats with respect to control female rats. Nevertheless, there were no significant differences in MDA 
concentrations between male treated rats and non-treated controls. 
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Partial conclusions 
The results of this experiment indicate that the blockage of the neonatal leptin surge results 
in an impaired immune function and an altered redox state of spleen leukocytes in adult male and 
female rats.  
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Abstract 33 
 34 
Most of studies have focused on the association between neonatal leptin surge and the development of nervous 35 
central circuits that regulate energy homeostasis. However, new evidence has emerged suggesting that the surge of 36 
leptin could also have an important role in the establishment and development of the immune system. We previously 37 
reported that leptin surge disruption affected several immune functions and oxidative-inflammatory parameters in 38 
peripubertal rats. In the present study, we further investigated, in adult male and female rats, whether the use of a leptin 39 
antagonist during the postnatal surge of leptin could affect relevant parameters of immune and redox state of spleen 40 
leukocytes. Male and female rats were neonatally treated with a specific leptin antagonist from postnatal day (PND) 5 to 41 
9 and several parameters of immunity and oxidative stress state were measured at adult age. The results showed that 42 
adult male and female rats exposed to this leptin antagonist displayed significantly impaired chemotaxis capacity, anti-43 
tumor NK activity and proliferation of lymphocytes in response to the mitogens concanavalin A and lipopolysaccharide. 44 
In addition, these animals showed higher oxidant parameters (xanthine oxidase activity and oxidized glutathione 45 
concentrations) and lower antioxidant defense (reduced glutathione concentrations and its related enzymes glutathione 46 
peroxidase and glutathione reductase activities) with higher lipid peroxidation (malondialdehyde) amounts than the 47 
corresponding controls. In conclusion, the disruption of the neonatal leptin surge leads to long-term impaired immune 48 
functions and increased oxidative stress state of spleen leukocytes of adult male and female rats.  49 
 50 
Keywords: Neonatal leptin surge; Leptin antagonist; Immune functions; Oxidative stress; Adult male and female rats 51 
 52 
 Neonatal blockage of leptin surge impairs immune response of adult rats. 53 
 Neonatal blockage of leptin surge increases oxidative stress of adult rats. 54 
 55 
 56 
 57 
 58 
 59 
 60 
 61 
 62 
 63 
207
  
1. Introduction 64 
 65 
Leptin is a pleiotropic hormone with not only an important role in the central regulation of energy homeostasis, 66 
but also involved in other peripheral processes, such as the modulation of immune system functions [19]. Leptin is 67 
predominantly secreted by adipocytes in adipose tissue but at low amounts also by skeletal muscle, stomach and 68 
placenta [4,28,29,33]. During the gestational period, the expression of leptin and its receptor significantly increases in 69 
placenta and fetal tissues of humans and rodents [28,29]. Thus, these findings suggest that leptin has an important role 70 
in the development of fetus. In addition, there is a transient 5-to 10-fold increase of plasma leptin concentrations in mice 71 
and rats during the early postnatal period, which has been termed as leptin surge. Both male and female rodents 72 
experience elevated levels of leptin during the first two weeks after birth, followed by a decline in its levels at weaning 73 
[6,12]. Particularly, this leptin surge has shown to be important for the establishment of hypothalamic circuits that 74 
regulate energy homeostasis and reproduction [4,23]. Increasing evidence suggests that early life is a critical 75 
developmental period and any stress generated in this period could result in long-term negative effects in later life [21]. 76 
Indeed, the disruption of neonatal levels of leptin has been associated with long-term impairments in energy 77 
homeostasis and reproduction [4,23]. 78 
Increasing evidence suggests that leptin is able to modulate a variety of innate and adaptive immune responses, 79 
including the migration and proliferation of immune cells and the antitumor activity of natural killer (NK) cells 80 
[20,22,26]. The expression of leptin receptors by several immune cells, such as macrophages, monocytes, neutrophils, 81 
NK cells, T and B cells confirms the important role that leptin plays in the regulation of immune responses [20,31]. In 82 
addition, leptin is able to promote the production of reactive oxygen species (ROS) [9,34]. ROS generation are involved 83 
in various important physiological processes of the body, including the immune response. However, under certain 84 
conditions of metabolic stress, an imbalance between ROS and antioxidant defenses in favor of ROS production may 85 
lead to oxidative stress [18]. The enhancement of oxidative stress has potentially deleterious effects, such as immune 86 
system dysfunction. In addition, increased oxidative stress state throughout life is believed to contribute to the aging 87 
process [18]. In fact, increased oxidative stress state, dysfunctional immune response as well as abnormal leptin levels 88 
were found to be common features of aging and many pathological conditions (such as obesity, insulin resistance and 89 
cardiovascular diseases) [6,16,32]. 90 
Most of studies have focused on the association between neonatal leptin surge and development of central 91 
nervous system [23]. However, emerging evidence suggests that the surge of leptin could also have an important role in 92 
the establishment and development of the immune system. In this regard, a previous study demonstrated that the 93 
blockage of leptin levels during the early neonatal period resulted in dysfunctional maturation of key immune organs, 94 
such as thymus and spleen [3]. In addition, we also showed that the exposure to a leptin antagonist during the postnatal 95 
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period resulted in impaired immune function in spleen [unpublished data] as well as in increased inflammatory and 96 
oxidative state in spleen, hypothalamus and adipose tissue during the peripubertal/adolescence period of rats [24]. 97 
However, it remains unclear whether the blockage of the leptin surge has long-term effects on immune functions and 98 
oxidative stress state during adulthood. Therefore, in the present study, we further investigated if the use of a leptin 99 
antagonist during the period corresponding to the physiological surge of leptin (PND5-9) could affect relevant 100 
parameters of immune and redox state of spleen leukocytes in adult male and female rats.  101 
 102 
2. Materials and methods  103 
 104 
2.1. Animals 105 
 106 
Experimental subjects were the offspring of Wistar rats purchased from Harlan Interfauna Ibérica SA 107 
(Barcelona, Spain). The parental generation was mated (one male x two females) in our animal facilities approximately 108 
two weeks after their arrival. After 10 days, female animals were isolated and the day of delivery strictly controlled. On 109 
the day of birth (postnatal day 0, PND0), litters were sex-balanced and culled to eight pups per dam (four males and 110 
four females). No cross-fostering was employed. Thus, only litters with at least four pups of each sex at birth were used. 111 
The animals were housed in plastic Makrolon® III cages and maintained at a constant temperature (22 ± 1°C) and 112 
humidity (50 ± 2%) in a reversed 12-h light-dark cycle (red light on at 8:00 am and white light on at 8:00 pm). All rats 113 
were given free access to rat chow (commercial diet for rodents, A03, Safe, Augy, France) and water.  114 
These studies were approved by the local ethics committee and complied with Royal Decree 53/2005 (BOE n° 115 
252) pertaining to the protection of experimental animals and with the European Communities Council Directive 116 
(86/609/EEC).  117 
 118 
2.2. Leptin antagonist treatment  119 
 120 
From PND5 until PND9 rats were injected subcutaneously with pegylated super leptin antagonist (mutant 121 
D23L/L39A/D40A/F41A) (5 mg/kg bodyweight (bw) of rat) a gift of Protein Laboratories (Rehovot, Israel), which was 122 
prepared as previously described [17]. In order to consider the stress effect caused by marking the animals at this early 123 
age, we treated each litter with either vehicle (controls) or antagonist. The animals received one injection per day at 124 
9:00 am. Control rats were injected with the same volume of distilled water as the vehicle (2.5 ml/kg). After each 125 
injection the animals were immediately returned to their mothers. Each experimental group consisted of 12 animals. To 126 
avoid/minimize possible litter effect all experimental groups contained animals from at least three different litters. 127 
209
  
 128 
2.3 Collection of spleen and leukocyte suspensions 129 
 130 
Male and female rats were sacrificed by rapid decapitation on PND102-103 after a 12 h fast. The spleen was 131 
rapidly and aseptically removed. The spleen was then freed of fat and minced with scissors, and gently pressed through 132 
a mesh screen (Sigma-Aldrich, Madrid, Spain) to obtain the cell suspensions. The cell suspensions were centrifuged in a 133 
gradient of Ficoll-Hypaque (Sigma-Aldrich) with a density of 1.070 g/ml. Cells from the interface were collected and 134 
suspended in Roswell Park Memorial Institute (RPMI) 1640 medium enriched with L-glutamine (PAA, Pasching, 135 
Austria) and supplemented with 10% heat-inactivated (56 °C, 30 min) fetal calf serum (PAA) and gentamicin (100 136 
µg/ml, PAA). After a wash step, leukocytes were counted in a Neubauer chamber (Blau Brand, Wertheim, Germany) 137 
and their number adjusted to 106 cells/ml. Cell viability was routinely measured before each experiment by the trypan-138 
blue exclusion test, and was higher than 98% in all experiments. All incubations were performed at 37 °C in a 139 
humidified atmosphere of 5% CO2.   140 
 141 
2.4. Immune functions 142 
 143 
2.4.1. NK cell activity assay 144 
 145 
An enzymatic colorimetric assay was carried out to measure the cytolysis of tumor cells (Cytotox 96 TM 146 
Promega, Boehringer Ingelheim, Germany) based on the determination of lactate dehydrogenase enzyme (LDH), as 147 
previously described [10]. Aliquots of 100 µl of spleen leukocytes, used as effector cells, were seeded in 96-well U-148 
bottom culture plates (Numc, Roskilde, Denmark) adjusted to 106 leukocytes/ml in RPMI 1640 medium without phenol 149 
red. Murine lymphoma YAC-1 cells, used as target cells, were added adjusted to 105 cells/ml. Thus, the effector/target 150 
ratio was 10:1. The plates were centrifuged at 250 g for 4 min to facilitate cell contacts. After 4 hours of incubation, 151 
lactate dehydrogenase enzymatic activity was measured in 50 µl/well of the supernatants by addition of the enzyme 152 
substrate and absorbance recording spectrophotometrically at 490 nm. Three kinds of control measurements were 153 
performed: a target spontaneous release, a target maximum release, and an effector spontaneous release. The results 154 
were expressed as percentages of lysis of target cells. To determine this percentage the following equation was used: 155 
%lysis = ((E-ES-TS)/M-ES-TS)) x 100, where E is the mean of absorbance in the presence of effector cells; ES, the 156 
mean of absorbance of effector cells incubated alone; TS, the mean of absorbance in target cells incubated with medium 157 
alone; and M is the mean of maximum absorbance after incubating target cells with lysis solution.  158 
 159 
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2.4.2. Chemotaxis assay 160 
 161 
Chemotaxis of spleen leukocytes was evaluated according to a slight modification of Boyden´s method [10] 162 
consisting basically of the use of chambers with two compartments separated by a filter with a pore diameter of 3 µm 163 
(Millipore, Bedford, MA, USA). Aliquots of 300 μl of the spleen leukocyte suspensions, adjusted to 5X105 cells/ml in 164 
Hank´s solution, were deposited in the upper compartment, and aliquots of 400 µl of the chemoattractant, formyl-Met-165 
Leu-Phe (10-8 M) (Sigma-Aldrich), were put into the lower compartment. The chambers were incubated for 3h and then 166 
the filters were fixed and stained. The chemotaxis index (CI) was determined by counting, in an optical microscope 167 
(100X), the total number of lymphocytes on one third of the lower face of the filters.  168 
 169 
2.4.3. Lymphoproliferation assay 170 
 171 
The proliferation of lymphocytes in response to the mitogens concanavalin A (ConA) and lipopolysaccharide 172 
(LPS) was measured following a method previously described [10]. Aliquots (200 µl) of spleen leukocytes (106 cells/ml 173 
complete medium) were seeded in 96 well flat-bottomed plates (Numc, Roskilde, Denmark), and 20 µl of ConA 174 
(1μg/ml; Sigma-Aldrich), a T-cell mitogen or 20 µl of lipopolysaccharide (Escherichia coli, 055:B5 1µg/ml; Sigma-175 
Aldrich), a B-cell mitogen, were added per well. After 48h of incubation at 37°C in an atmosphere of 5% CO2, 0.5 µCi 176 
3H-thymidine (Du Pont, Boston, MA, USA) were added to each well. The cells were harvested in a semiautomatic 177 
microharvester 24h later. Thymidine uptake was measured using a beta counter (LKB, Uppsala, Sweden) and the results 178 
were expressed as 3H-thymidine uptake (cpm).  179 
 180 
2.5. Oxidative stress parameters 181 
 182 
2.5.1. Glutathione peroxidase activity 183 
 184 
 The glutathione peroxidase (GPx) activity was determined according to method previously described [1]. 185 
Aliquots of 1 ml of spleen leukocytes adjusted to 106 cells/ml of Hank´s solution were centrifuged at 1200 g for 10 min 186 
at 4°C. The pellets of cells were resuspended in phosphate buffer (50mM, pH 7.4, Sigma-Aldrich). Then, the samples 187 
were sonicated and centrifuged at 3200 g for 20 minutes at 4°C. The total activity was determined using cumene 188 
hydroperoxide (cumene-OOH, Sigma-Aldrich), which carried out the oxidation of the glutathione regenerated by the 189 
addition of β-nicotinamide adenine di-nucleotide phosphate, in its reduced form (β-NADPH, Sigma-Aldrich), in the 190 
presence of glutathione reductase (Sigma-Aldrich). The reaction was followed spectrophotometrically by the decrease 191 
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of the absorbance at 340 nm. The results were expressed as international milliunits (mU) of enzymatic activity per 106 192 
cells.  193 
 194 
2.5.2. Glutathione reductase activity 195 
 196 
 The glutathione reductase (GR) activity was measured by a method previously described [1]. Aliquots of 1 ml 197 
of spleen leukocytes adjusted to 106 cells/ml of Hank´s solution were centrifuged at 1200 g for 10 min at 4°C. The 198 
pellets of cells were resuspended in phosphate buffer (50mM, pH 7.5, Sigma-Aldrich) containing 199 
ethylenediaminetetraacetic acid (EDTA) (6.3 mM, Sigma-Aldrich). Then, the samples were sonicated and centrifuged at 200 
3200 g for 20 minutes at 4°C. The total activity was measured through the oxidation of NADPH spectrophotometrically 201 
at 340 nm. The results were expressed as international milliunits (mU) of enzymatic activity per 106 cells. 202 
 203 
2.5.3. Glutathione concentrations  204 
 205 
 Both reduced (GSH) and oxidized (GSSG) concentrations of glutathione were measured using a fluorometric 206 
method. This method is based on the reaction of a fluorescence probe, o-phthaldialdehyde (OPT; Sigma-Aldrich), with 207 
GSH at pH 8 and with GSSG at pH 12, which generates a fluorescence derivative. Aliquots of 1 ml of spleen leukocytes 208 
adjusted to 106 cells/ml of Hank´s solution were centrifuged at 1200 g for 10 min at 4°C. The pellets of cells were 209 
resuspended in phosphate buffer containing EDTA (0.1 M, pH 8, Sigma-Aldrich). Then, samples were sonicated and 210 
proteins were precipitated by adding 5 μl of perchloric acid (HClO4) (60%; Sigma-Aldrich). Spleen leukocytes samples 211 
were centrifuged at 9500 g for 10 min at 4°C and supernatants were maintained in ice for measurement of GSH and 212 
GSSG concentrations. For GSH contents determination, 10 μl of the supernatant, 190 μl of phosphate-EDTA buffer and 213 
20 μl of OPT solution (1 mg/ml in methanol) were added to a 96-well black plate (Nunc, Roskilde, Denmark) and 214 
incubated at room temperature for 15 minutes. Fluorescence was determined in a plate reader (Fluostar Optima, BMG 215 
Labtech, Spain) using excitation at 350 nm and emission detection at 420 nm. For the determination of GSSG contents, 216 
8 μl of N-ethylmaleimide (NEM, 0,04M, Sigma-Aldrich) was added to each well and incubated at room temperature for 217 
30 minutes. Then, 182 μl of sodium hydroxide (NaOH) (0.1 N; Panreac Quimica SA, Barcelona, Spain) with 20 μl of 218 
OPT solution were added to a 96-well black plate. After incubation (room temperature, 15 min), fluorescence was 219 
measured as previously described for GSH determination. The results were expressed as nmol/106 cells. The 220 
GSSG/GSH ratio was then calculated for each sample.  221 
 222 
2.5.4. Lipid peroxidation (MDA) levels 223 
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 224 
 The estimation of malondialdehyde (MDA) in cells was evaluated using the commercial kit “MDA Assay Kit” 225 
(Biovision, Mountain View, CA, USA), which measures the reaction of MDA with thiobarbituric acid (TBA) and the 226 
MDA-TBA adduct formation. Aliquots of 1 ml of spleen leukocytes adjusted to 106 cells/ml of Hank´s solution were 227 
centrifuged at 1200 g for 10 min at 4°C. The pellets of cells were re-suspended in 300 μl of MDA lysis buffer with 3 μl 228 
BHT. Then, the cell suspensions were sonicated and centrifuged at 13000 g for 10 minutes at 4°C to remove insoluble 229 
material. The supernatant (200 μl) from each sample was added to 600 μl of TBA reagent. After the incubation at 95°C 230 
for 60 minutes, samples were cooled to room temperature in an ice bath for 10 minutes and then 200 μl of supernatant 231 
was dispensed into a 96-well plate. The MDA-TBA adduct was measured using a spectrophotometer at 532 nm of 232 
absorbance. The results were expressed as nmol/106 cells. 233 
 234 
2.5.5. Xanthine oxidase activity  235 
 236 
 Xanthine oxidase (XO) activity was measured by fluorescence using a commercial kit “Amplex Red 237 
Xanthine/Xanthine Oxidase Assay Kit” (Molecular Probes, Paisley, UK). The hydrogen peroxide (H2O2) produced by 238 
XO reacts with the horseradish peroxidase (HRP) present in the reaction mixture and generates a fluorescent oxidation 239 
compound resorufin whose fluorescence is measured in a plate reader (Fluostar Optima, BMG Labtech, Spain). Spleen 240 
leukocyte suspension (50 μl) adjusted to 106 cells/ml in Hank´s medium was incubated with 50 μl working solution of 241 
Amplex Red reagent (100 μM) containing HRP (0.4 U/ml) and xanthine (200 μM). After 30 minutes of incubation at 242 
37°C, measurements of fluorescence was performed in a plate reader using excitation at 530 nm and emission detection 243 
at 595 nm. XO supplied in the kit was used as the standard, and XO activity was measured by comparing the 244 
fluorescence of samples with that of standards. The results were expressed in international milliunits (mU) of enzymatic 245 
activity per 106 cells. 246 
 247 
2.6. Statistical analysis  248 
 249 
SPSS 21.0 (SPSS, Inc., Chicago, USA) was used for the statistical analysis of the results. The data were 250 
expressed as mean ± standard deviation (SD). Each value is the mean of the data from an assay performed in duplicate 251 
or triplicate. Normality of the samples was checked by the Kolmogorov-Smirnov test and homogeneity of variances 252 
with the Levene test. The data were statistically evaluated by the Student´s t-test for independent samples. P<0.05 was 253 
considered as statistically significant.  254 
 255 
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3. Results  256 
 257 
3.1. Immune functions 258 
 259 
3.1.1. Lymphocyte innate immune functions 260 
 261 
The innate immune functions of spleen leukocytes are shown in Figure 1. Adult male and female rats exposed 262 
to the leptin antagonist in the neonatal period showed significantly higher values of chemotaxis capacity of spleen 263 
leukocyte cells than those in controls (P<0.05. Figure 1A). The activity of NK cells showed lower values in treated 264 
male and female rats than in controls (P<0.05. Figure 1B).  265 
 266 
3.1.2. Lymphocyte adaptive immune functions 267 
 268 
The lymphoproliferation in response to T-cell mitogen (ConA) and B-cell mitogen (LPS) are shown in Figure 269 
2. The lymphoproliferation in response to ConA was significantly lower in female and male treated rats than in controls 270 
(P<0.01 and P<0.0001, respectively. Figure 2A). In addition, both adult male and female showed lower levels in the 271 
lymphoproliferation in response to LPS in comparison with controls (P<0.01 and P<0.001, respectively. Figure 2B).   272 
 273 
3.2. Oxidative stress parameters 274 
 275 
3.2.1. Antioxidative parameters 276 
 277 
Reduced glutathione (GSH) and its related enzymes, including glutathione peroxidase (GPx) and glutathione 278 
reductase (GR), which are shown in Figure 3, constitute the major intracellular redox buffer for cells against oxidant 279 
damage. The neonatal treatment with leptin antagonist resulted in lower glutathione system antioxidant defense in adult 280 
rats. Thus, adult male and female rats showed lower values of reduced glutathione concentration (P<0.05. Figure 3A) 281 
and of GPx (P<0.05. Figure 3B) and GR activities (P<0.01 and P<0.05, respectively. Figure 3C).  282 
 283 
3.2.2. Oxidative parameters 284 
 285 
Figure 4 shows oxidative parameters of spleen leukocytes. Adult male and female rats exhibited significantly 286 
higher concentration of oxidized glutathione (GSSG) than their respective controls (P<0.05 and P<0.001, respectively. 287 
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Figure 4A). In addition, the ratio between GSSG and GSH, which is an indicator of oxidative stress, was significantly 288 
higher in adult male and female rats treated neonatally with the leptin antagonist than in controls (P<0.05. Figure 4B).    289 
The activity of xanthine oxidase (Figure 4C), which is associated with the production of free radicals, was 290 
significantly higher in adult male and female rats as compared with controls (P<0.05 and P<0.01, respectively).  291 
The estimation of MDA levels (Figure 4D), which is an indicator of lipid oxidation and oxidative damage in 292 
cells, showed significantly higher values in adult female rats with respect to control female rats (P<0.05). Nevertheless, 293 
there were no significant differences in MDA levels between male treated rats and non-treated controls (Figure 4D).  294 
 295 
4. Discussion  296 
 297 
Although we previously demonstrated that the neonatal disruption of the leptin surge resulted in impairments 298 
of immune functions [unpublished data] and oxidative stress [24] during the peripubertal/adolescence period of rats. It 299 
seemed relevant to investigate whether this disruption could produce these effects at adult age (i.e., when the immune 300 
system has reached its complete development) [30]. The results of the present study found that the exposure to a leptin 301 
antagonist from PND 5 to 9, which is coincident with the neonatal leptin surge, resulted in long-term impaired immune 302 
response and redox state of spleen leukocytes of adult male and female rats. The immune functions and redox state were 303 
evaluated in the spleen, since this secondary lymphoid organ is essential for effective innate and adaptive immune 304 
responses in both humans and rodents [27].  305 
With respect to the functions of the innate immunity studied, both the chemotaxis and anti-tumor NK activities, 306 
were significantly impaired in spleen leukocytes of adult male and female rats treated with a leptin antagonist. 307 
However, the neonatal leptin antagonist treatment resulted in chemotactic response differences between 308 
peripubertal/adolescent and adult rats. Thus, adult treated rats showed higher chemotactic response after peptide 309 
stimulation, whereas, in peripubertal/adolescent treated rats, this response was lower in comparison with their respective 310 
controls [unpublished data]. The higher chemotactic response in adults treated rats could be interpreted as a possible 311 
compensatory mechanism to compensate the lower response found in other immune cell functions, such as the NK cell 312 
activity [14]. In fact, the blockage of leptin in the neonatal period affected the NK activity so highly that not only did 313 
this function appear diminished at peripubertal age [unpublished data], but also at adult age. Previous studies 314 
demonstrated that leptin was able to modulate immune innate response, such as chemotaxis and NK cell activities. 315 
Therefore, leptin at low concentrations exhibited a chemoattractant capacity [14] as well as to stimulating the 316 
expression of chemokines in immune cells [18]. In addition, leptin seems to modulate the NK cell activity via the 317 
activator of transcription 3 (STAT-3) and by the up-regulation of IL-2 and perforin genes [13]. The lack of leptin 318 
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receptor expression in mice also results in impaired NK cell activity, which highlights the important role of leptin in 319 
regulating immune responses [12,13]. 320 
The neonatal administration of the leptin antagonist also resulted in long-term impaired adaptive immune 321 
response in adult rats. In agreement with our previous data found in peripubertal rats [unpublished data], the 322 
proliferation of spleen lymphocytes in response to T- and B-cell mitogens, such as ConA and LPS, respectively, 323 
continued to be lower in adult male and female treated rats. Increasing evidence indicates that leptin is able to modulate 324 
immune functions of lymphocytes. For instance, leptin receptor deficient mice displayed impaired lymphopoiesis and a 325 
low number of lymphocytes in peripheral blood, which indicates that leptin is important for the development of 326 
lymphocytes [7]. In addition, an in vitro study demonstrated that leptin increased the proliferation of lymphocytes in the 327 
presence of mitogens [22].  328 
In the present study, we found long-term increased oxidative stress state in spleen leukocytes of adult treated 329 
rats. Thus, adult male and female rats neonatally treated with a leptin antagonist exhibited higher values of oxidant 330 
production, such as xanthine oxidase (XO) activity and GSSG contents, as well as lower concentrations of the 331 
antioxidant GSH and activities of its related antioxidant enzymes (GPx and GR) than those in the corresponding 332 
controls. Moreover, the GSSG/GSH ratios were higher, which show an oxidative stress [2] and consequently the 333 
amount of MDA, a lipid peroxidation marker, was also higher than in controls. These findings are partially in 334 
concordance with those found in a recently published study, which also evaluated a variety of oxidative stress 335 
parameters in the spleen leukocytes of peripubertal rats. Thus, in contrast to the results in adult rats, in which a lower 336 
activity of GR (an antioxidant enzyme) was observed, this activity was higher in treated peripubertal rats. The higher 337 
values of GR activity in treated peripubertal rats could be potentially explained as a compensatory mechanism in an 338 
attempt to restore redox homeostasis in animals treated with leptin antagonist. Similarly, the aging process, which has 339 
been linked to increased oxidative stress state, also described higher production of antioxidant enzymes as a 340 
compensatory mechanism [28]. Some studies have pointed to the possible involvement of leptin in modulating the 341 
oxidative stress response. Thus, in malnourished children with low amounts of leptin, enhanced lipid peroxidation as 342 
well as decreased antioxidant defense such as superoxide dismutase and catalase activities and GSH concentrations 343 
were observed [8]. Moreover, another study found that enhanced levels of leptin (in obesity and cardiovascular 344 
diseases) were also associated with increased production of ROS. It was demonstrated that leptin seems to increase 345 
ROS generation mainly by the activation of NADPH oxidase [13,25]. Therefore, it appears that abnormal circulating 346 
levels of leptin, either diminished or enhanced, could contribute to the imbalance of redox homeostasis. It is curious that 347 
the decrease of leptin levels in neonatal period allowed the maintenance of an oxidative stress in spleen at adult age.  348 
In conclusion, the disruption of the neonatal leptin surge resulted not only in impaired immune functions and 349 
increased oxidative stress state in spleen leukocytes at peripubertal/adolescent age, as previously demonstrated 350 
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[unpublished data, 29], but also at adult age. Thus, these results indicate that the disruption of the neonatal leptin surge 351 
has long-term effects in immune function and oxidative stress parameters. Moreover, given that impaired immune 352 
system functions and increased oxidative stress generated at adult age have been associated with premature aging and a 353 
shorter life span [11], it is possible that the disruption of neonatal leptin levels could also have detrimental effects in the 354 
process of aging. 355 
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FIGURE LEGENDS 509 
 510 
Figure 1. Lymphocyte innate functions. Chemotaxis index in adult male and female rats (A) treated neonatal with a 511 
leptin antagonist or vehicle (control). Natural killer cell activity (% lysis) in adult male and female rats (B) treated 512 
neonatal with a leptin antagonist or vehicle (control). * P<0.05, ** P<0.01 with respect to the values of control rats. 513 
 514 
Figure 2. Lymphocyte adaptive immune functions. ConA-stimulated proliferation in adult male and female rats (A) 515 
treated neonatal with a leptin antagonist or vehicle (control). LPS-stimulated proliferation in adult male and female rats 516 
(B) treated neonatal with a leptin antagonist or vehicle (control). * P<0.01, ***P<0.001 with respect to the values of 517 
control rats. 518 
 519 
Figure 3. Antioxidants parameters. Reduced glutathione concentrations in adult male and female rats (A) treated 520 
neonatal with a leptin antagonist or vehicle (control). Glutathione peroxidase activity in adult male and female rats (B) 521 
treated neonatal with a leptin antagonist or vehicle (control). Glutathione reductase activity in adult male and female 522 
rats (C) treated neonatal with a leptin antagonist or vehicle (control). * P<0.05, ** P<0.01 with respect to the values of 523 
control rats. 524 
 525 
Figure 4. Oxidative parameters. Oxidized glutathione concentrations in adult male and female rats (A) treated 526 
neonatal with a leptin antagonist or vehicle (control). GSSG/GSH ratios in adult male and female rats (B) treated 527 
neonatal with a leptin antagonist or vehicle (control). Xanthine oxidase activity in adult male and female rats (C) treated 528 
neonatal with a leptin antagonist or vehicle (control). MDA levels in adult male and female rats (D) treated neonatal 529 
with a leptin antagonist or vehicle (control). * P<0.05, ** P<0.01, ** P<0.001 with respect to the values of control rats. 530 
 531 
 532 
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3.3. EFFECTS OF THE DIETARY SUPPLEMENTATIONS WITH 2-OHOA OR 
WITH THE COMBINATION OF N-3 FATTY ACIDS (EPA AND DHA) ON THE IMMUNE 
FUNCTION AND REDOX STATE OF ADULT DIET-INDUCED OBESE MICE, AS WELL 
AS ON THEIR LIFE SPAN  
 
3.3.1. Effects of the dietary supplementations with 2-OHOA or with the combination of 
n-3 fatty acids (EPA and DHA) on the function and redox state of leukocytes of adult female 
diet-induced obese mice, as well as on their life span  
 
Experimental design  
During the first 5 days of acclimatization to the new environment, all mice were fed a 
standard maintenance diet (Teklad Global 14% Protein Rodent Maintenance Diet, reference 2014, 
Harlan Interfauna Iberica, with 13% Kcal from fat). At 9 weeks of age, the animals were separated 
into the following four groups (n=10, per group). 1) The control mice group (C) which was fed with 
a standard maintenance diet until the end of the study. 2) The diet-induced obese mice group (DIO) 
which was fed with a high-fat diet (HFD, 60% of calories from fat, reference TD. 06414, Harlan 
Interfauna Iberica) for 14 weeks. 3) The MUFA-supplemented DIO mice group (MUFA-DIO) 
which was fed with a high-fat diet for 14 weeks, but during the last 6 weeks of HFD, this diet was 
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supplemented with 2-hydroxyoleic acid (2-OHOA) (1500 mg of 2-OHOA per Kg of HFD, BTSA-
Biotecnologías Aplicadas S.L.). 4) The n-3 PUFA-supplemented DIO mice group (PUFA-DIO) 
which was fed with a HFD for 14 weeks, this being supplemented during the last 6 weeks with the 
combination of EPA and DHA (3000 mg of EPA and DHA per Kg of HFD, BTSA-Biotecnologías 
Aplicadas S.L.).  The 2-OHOA is a synthetic derivative of oleic acid, and it is also known as 2-
hydroxy-D9-cis-octadecenoic acid. The n-3 PUFA were extracted from fish (anchovy). The fatty 
acid supplements (2-OHOA in powdered form and n-3 PUFA in oil form) were mixed with the 
chow, which was of malleable consistency, and then pelleted. In order to progressively increase the 
amount of fat in the diet of groups 2, 3 and 4, they were fed with an intermediate-fat diet (IFD, 22% 
of calories from fat, Teklad Global 2019, Harlan Interfauna Iberica) for 4 weeks previous to the 
ingestion of HFD. After receiving the HFD for 14 weeks, animals in groups 2, 3 and 4 returned to 
the standard maintenance diet until the end of the study, that is the say the natural death of the 
animals, which was monitored. During the entire study mice had free access to water and the diet. 
Weight and food intake were measured every week throughout the study.  
 
Main results 
Body weight and food intake measurements 
All mice fed on a high-fat diet increased their body weight significantly in comparison with 
controls. After nutritional supplementation, when all mice received the standard maintenance diet, 
only DIO mice that were supplemented with MUFA significantly decreased their body weight when 
compared with DIO mice and with n-3 PUFA-DIO mice, having similar weights to those of 
controls. In addition, the three groups of DIO mice (DIO, MUFA-DIO and PUFA-DIO) fed a HFD, 
although ingesting a lower food intake, showed significantly higher quantities of calories consumed 
than animals fed a standard diet. However, when DIO mice supplemented with MUFA and n-3 
PUFA or not, returned to the standard maintenance diet, no significant differences in food intake 
and total calories consumed were observed among all groups of mice.  
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Peritoneal leukocyte function parameters 
The chemotaxis index of macrophages in response to a chemotactic gradient (formylated 
peptide) was significantly suppressed in DIO mice compared with controls. In addition, the number 
of latex beads ingested by macrophages, which is expressed as the phagocytic index, and the 
phagocytic efficiency were significantly lower in DIO mice with respect to controls. Nevertheless, 
the supplementations, with MUFA or with n-3 PUFA, in DIO mice were able to increase the 
chemotaxis index, the phagocytic index, and the phagocytic efficiency in comparison with non-
supplemented DIO mice. 
The values of intracellular superoxide anion in stimulated leukocytes (in the presence of 
latex beads), an indicator of the capacity of immune cells in killing pathogens in their phagosomes, 
were lower in DIO mice than in controls. The supplementation with the two types of dietary 
unsaturated fatty acids, MUFA or n-3 PUFA, resulted in higher concentrations of the superoxide 
anion than those of DIO mice.  
The chemotaxis index of lymphocytes showed a significant decrease in DIO mice in 
comparison with control mice. The MUFA-DIO and PUFA-DIO groups of mice showed a 
significant increase when compared with non-supplemented DIO mice. 
The NK activity against tumour cells was significantly suppressed in DIO mice as compared 
with that in non-obese control mice. However, the supplementation with n-3 FUFA tended to 
enhance this activity compared with that in non-supplemented DIO mice. 
The lymphoproliferation in response to T-cell mitogen (ConA) and to B-cell mitogen (LPS) 
was highly suppressed in DIO mice with respect to non-obese control mice. The supplementations 
with MUFA and n-3 PUFA in DIO mice significantly increased the proliferation of lymphocytes in 
response to ConA and LPS when compared with non-supplemented DIO mice.  
Peritoneal leukocyte oxidative stress parameters 
The amount of total glutathione, which has an important antioxidant role, was decreased in 
leukocytes of DIO mice in comparison with those in non-obese controls. Mice that were 
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supplemented either with MUFA or with n-3 PUFA displayed significantly higher values of total 
glutathione than DIO animals.  
The catalase activity was significantly diminished in DIO mice as compared with that in 
non-obese controls. The DIO mice that were supplemented with MUFA or with n-3 PUFA showed 
a significant increase in this antioxidant activity.  
The activity of xanthine oxidase, which was significantly increased in DIO mice as 
compared with non-obese control mice, showed lower levels in DIO mice supplemented with n-3 
PUFA when compared with those in non-supplemented DIO mice. Thus this supplementation 
decreases an activity associated with the production of free radicals.  
The MDA concentrations, which are indicators of lipid oxidation and oxidative damage in 
cells, were significantly increased in DIO mice with respect to those in non-obese control mice. In 
turn, the supplementation with MUFA was able to diminish MDA concentrations in comparison 
with DIO mice.  
Life span 
The differences were not statistically significant among the groups of mice, however DIO 
mice exhibited a lower average survival (105 ± 13 weeks old) than controls (115 ± 15 weeks old). 
In addition, DIO mice supplemented with 2-OHOA displayed values similar to controls (110 ± 20 
weeks old), whereas DIO mice supplemented with n-3 PUFA remained similar to DIO mice (105 ± 
35 weeks old). 
 
Partial conclusions 
The supplementations with 2-OHOA or with the combination of n-3 PUFA (EPA and DHA) 
improve immune function and redox state of peritoneal leukocytes, which were impaired in DIO 
mice, bringing them to similar values to those in non-DIO controls.  
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treatments also improved oxidative stress parameters such 
as xanthine oxidase activity, which decreased, catalase 
activity and glutathione levels, which increased.
Conclusion These data suggest that dietary supplemen-
tation with monounsaturated and n-3 polyunsaturated 
fatty acids could be an effective nutritional intervention 
to restore the immune response and oxidative stress state, 
which are impaired in obese mice.
Keywords Obese mice · Monounsaturated fatty acids · 
n-3 Polyunsaturated fatty acids · Immune function · 
Oxidative stress
Introduction
Nutrition and dietary patterns have been shown to have a 
great impact on the functions of the immune system [1, 
2]. Thus, as previously demonstrated in animal and human 
studies, the excessive consumption of energy-dense food, 
such as dietary fat, is associated with the development 
of obesity and dysfunctional immune response [3–7]. 
Although the precise mechanisms that underlie impaired 
immunity in obese individuals remain unclear, increasing 
evidence suggests that obesity and its related complica-
tions, including insulin resistance, type-2 diabetes mellitus 
and cardiovascular diseases, are linked to a state of chronic 
inflammation and oxidative stress [8, 9]. This condition 
seems to be generated and maintained by immune cell 
infiltration in the adipose tissue and its increased produc-
tion of pro-inflammatory compounds and reactive oxygen 
species (ROS) [10, 11]. It is well known that inflammatory 
mediators and ROS have important physiological func-
tions, such as those in immune response [12]. However, an 
excessive production of these compounds by immune cells 
Abstract 
Purpose Obesity is associated with impaired immune 
defences and chronic low levels of inflammation and oxi-
dation. In addition, this condition may lead to premature 
aging. The aim of the study was to evaluate the effects of a 
nutritional supplementation with monounsaturated and n-3 
polyunsaturated fatty acids on several functions and oxida-
tive stress parameters in peritoneal immune cells of obese 
mice, as well as on the life span of these animals.
Methods Obesity was induced in adult female ICR/
CD1 by the administration of a high-fat diet (HFD) for 14 
weeks. During the last 6 weeks of HFD feeding, one group 
of obese mice received the same HFD, supplemented with 
1500  mg of 2-hydroxyoleic acid (2-OHOA) and another 
with 3000  mg of eicosapentaenoic acid (EPA) and doco-
sahexaenoic acid (DHA). Several functions and oxidative 
stress parameters of peritoneal leukocytes were evaluated.
Results The groups of obese mice treated with 2-OHOA 
or with EPA and DHA showed a significant improvement 
in several functions such as chemotaxis, phagocytosis, 
digestion capacity, Natural killer activity and lymphopro-
liferation in response to mitogens. All of these functions, 
which were decreased in obese mice, increased reaching 
similar levels to those found in non-obese controls. Both 
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results in a vicious cycle of more inflammation, oxidation 
and detrimental effects, such as tissue damage and immune 
system dysfunction [11, 12]. Therefore, obese individuals 
have shown a worse immune response to bacterial and viral 
infections, and an increased prevalence of immune-related 
diseases [5, 6, 13]. Similar to obesity, the process of aging 
has been also associated with a less competent immune 
system. This immunosenescence results in a higher risk 
of age-related complaints [14]. In fact, it has recently been 
found that the development of obesity in experimental adult 
mice results in similar features of impaired immune sys-
tem to those found in aged individuals, which suggests a 
premature aging of obese subjects [7, 15]. Therefore, the 
search for nutritional strategies that could ameliorate dys-
functional immunity in obese individuals and consequently 
promote a healthier aging seems important.
In this context, adequate amounts of certain kinds of 
nutrients have been proven to positively modulate immune 
cell functions. For instance, adequate antioxidant intake has 
been shown to maintain the antioxidant/oxidant balance of 
immune cells during aging, protecting these cells from age-
related oxidative stress and immune dysfunction [16, 17]. 
Also, dietary unsaturated fatty acids have been suggested to 
promote a variety of health benefits, particularly in obesity 
[18, 19] and in the modulation of immune system functions 
[20–33]. Moreover, it is necessary to consider the quality of 
fats consumed. Thus, in contrast to the negative effects of 
the excessive intake of calories and dietary fat on immune 
functions, adequate amounts of unsaturated fatty acids that 
include monounsaturated (MUFA) of the n-9 series and 
polyunsaturated fatty acids of the n-3 series, seem to have 
beneficial effects on immune functions [20–34]. Thus, the 
n-9 MUFAs and n-3 PUFAs, i.e., eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA), which show anti-
inflammatory actions, have been demonstrated as capable 
of modulating several functions of innate and adaptive 
immunity, including chemotaxis, phagocytosis of mac-
rophages and generation of ROS in response to pathogens, 
anti-tumour NK cell activity and proliferation of B and T 
cells [20–33]. One of the possible mechanisms involved in 
these effects could be the incorporation of fatty acids into 
the immune cell membranes. This occurs after dietary lipid 
administration since it modulates cell functions, by modify-
ing membrane fluidity, lipid peroxide formation, eicosanoid 
production and gene regulation [35]. In addition, a syn-
thetic MUFA derivative of oleic acid, 2-hydroxyoleic acid 
(2-OHOA), has been found to induce body weight loss in 
rats [36] and in obese mice fed a high-fat diet [37]. Fur-
thermore, this compound, at low doses and without appar-
ent toxicity in animals [38], has shown to rapidly reduce 
arterial blood pressure when compared with natural oleic 
acid [39]. Thus, it is possible that this compound could also 
have immune benefits in obese individuals. Nevertheless, 
little is known about how supplementation with this oleic 
acid derivative or with n-3 fatty acids could affect immune 
cell functions and their oxidative stress state in obese sub-
jects. Thus, the aim of this study was to evaluate several 
functions and parameters of oxidative stress in peritoneal 
leukocytes from high-fat diet-induced obese (DIO) mice 
supplemented with 2-OHOA, an oleic acid-derived com-
pound, or with the combination of n-3 fatty acids (EPA and 
DHA). Since the parameters studied have been established 
as markers of health and longevity [14], the effects of these 
dietary supplementations on life span were also analysed.
Materials and methods
Animals
Female ICR/CD1 mice, 8  weeks of age, were purchased 
from Harlan Interfauna Iberica (Barcelona, Spain). The 
animals were housed in polyurethane cages (5 animals per 
cage) and maintained under standard laboratory conditions 
(12:12 h reversed light/dark cycle; lights on at 8:00 p.m., 
relative humidity of 50–60%, temperature of 22 ± 2 °C and 
adequate ventilation). The experiments were conducted in 
accordance with the guidelines and protocols of the Royal 
Decree 53/2013 regarding the care and use of laboratory 
animals for experimental procedures, and were approved 
by the Committee for Animal Experimentation of the Com-
plutense University of Madrid.
Experimental groups
During the first 5 days of acclimatization to the new envi-
ronment, all mice were fed a standard maintenance diet 
(Teklad Global 14% Protein Rodent Maintenance Diet, 
reference 2014, Harlan Interfauna Iberica, with 13% Kcal 
from fat). At 9  weeks of age, the animals were separated 
into four groups (n = 10, per group), namely (1) the control 
mice group (C) were fed with a standard maintenance diet 
until the end of the study; (2) the diet-induced obese mice 
group (DIO) were fed with a high-fat diet (HFD, 60% of 
calories from fat, reference TD. 06414, Harlan Interfauna 
Iberica) for 14 weeks; (3) The MUFA-supplemented DIO 
mice group (MUFA-DIO) were fed with a high-fat diet for 
14 weeks, but during the last 6 weeks of HFD, this diet was 
supplemented with 2-OHOA (1500 mg of 2-OHOA per Kg 
of HFD, BTSA-Biotecnologías Aplicadas S.L.); (4) the n-3 
PUFA-supplemented DIO mice group (PUFA-DIO) were 
fed with a HFD for 14  weeks, this being supplemented 
during the last 6 weeks with the combination of EPA and 
DHA (3000 mg of EPA and DHA per Kg of HFD, BTSA-
Biotecnologías Aplicadas S.L.). To progressively increase 
the amount of fat in the diet of groups 2, 3 and 4, animals 
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of those groups were fed with an intermediate-fat diet 
(IFD, 22% of calories from fat, Teklad Global 2019, Har-
lan Interfauna Iberica) for 4 weeks previous to the ingestion 
of HFD. After receiving the HFD for 14 weeks, animals 
in groups 2, 3 and 4 were returned to the standard main-
tenance diet until the end of the study (the natural death of 
the animals, which mortality was monitored). This design 
is shown in Fig. 1. During the entire study, mice had free 
access to water and food. The full compositions of all the 
diets used are shown in Table  1. Weight and food intake 
were measured every week throughout the study. The doses 
of supplementation were calculated taking into considera-
tion the daily average food intake of mice and the amount 
of supplemented 2-OHOA (1500  mg/kg) and EPA and 
DHA (3000 mg/kg) in the HFD (Table 2).
Collection of peritoneal leukocytes
The peritoneal suspensions were obtained between 8 a.m. 
and 10 a.m. to minimize circadian variations in the immune 
system, by a procedure previously described, without ani-
mal sacrifice [40, 41], which allowed monitoring the life 
span of the mice. Briefly, 3 ml of Hank’s solution, adjusted 
to pH 7.4, was injected into the peritoneum, the abdomen 
was massaged and the peritoneal exudate cells were col-
lected allowing the recovery of 90–95% of the injected vol-
ume. The peritoneal leukocytes, consisting of lymphocytes 
and macrophages, were counted in Neubauer chambers 
(Blau Brand, Germany). The suspensions were adjusted to 
a final concentration of 5 × 105 macrophages or lympho-
cytes/ml in Hank’s solution or  106 leukocytes/ml in Hank’s 
solution or complete medium (RPMI 1640 enriched with 
L-glutamine (PAA, Pasching, Austria) and supplemented 
with 10% heat-inactivated (56 °C, 30 min) fetal calf serum 
(GIBCO) and gentamicin (100  mg/ml, GIBCO) with or 
without phenol red, depending on the type of assay used). 
Macrophages and lymphocytes were identified by their 
morphology. The cellular viability was measured using the 
trypan-blue (Sigma, St Louis, MO, USA) exclusion test and 
in all cases was higher than 98%.
The immune functions and redox state parameters stud-
ied were performed using unfractionated peritoneal leuko-
cytes, which better preserved the physiological environ-
ment surrounding the immune cells in vivo [42].
Fig. 1  Experimental design diagram. Four groups of mice are shown 
(1) C (control mice, fed with a standard maintenance diet until the 
end of the study with 13% of Kcal from fat); (2) DIO (diet-induced 
obese mice); (3) MUFA-DIO (DIO treated with monounsaturated 
fatty acid, MUFA); (4) PUFA-DIO (DIO treated with polyunsatu-
rated fatty acids). Each square represents a period of 1 week. The first 
square corresponds to the adaptation period of mice in all groups. 
The DIO, MUFA-DIO and PUFA-DIO groups ingested a diet with 
22% of kcal from fat (intermediate-fat diet: IFD) for 4 weeks. After 
this 4 weeks period, these groups received a diet 60% Kcal from fat 
(DIO) for 14 weeks. 6 weeks before the end of this period, mice of 
MUFA-DIO and PUFA-DIO groups ingested this DIO supplemented 
with MUFA and PUFAs. After that, peritoneal leukocyte samples 
were obtained and the animals in groups 2, 3 and 4 returned to the 
standard maintenance diet until the end of the study (the natural death 
of the animals, which mortality was monitored)
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Table 1  Composition of the diets
Components Standard mainte-
nance diet
Intermediate-fat 
diet
High-fat diet High-fat diet + MUFA sup-
plementation
High-fat 
diet + PUFA 
supplementation
Energy (Kcal/g) 2.9 3.3 5.1 5.1 5.1
Protein (%) 14.3 19.0 23.5 23.5 23.5
Carbohydrate (%) 48.0 44.9 27.3 27.3 27.3
Fat (%) 4.0 9.0 34.3 34.4 34.6
 Saturated (%) 0.6 1.2 12.5 12.5 12.5
 Monounsaturated (%) 0.7 1.7 16.1 16.2 16.1
 Polyunsaturated (%) 2.1 4.4 5.4 5.4 5.7
Protein (% of energy) 20.0 23.0 18.4 18.4 18.3
Carbohydrate (% of energy) 67.0 55.0 21.3 21.3 21.2
Fat (% of energy) 13.0 22.0 60.3 60.4 60.5
Fatty acid composition (%)
 C16:0 palmitic 0.5 0.9 8.2 8.2 8.2
 C18:0 stearic 0.1 0.2 3.9 3.9 3.9
 C18:1 oleic 0.7 1.7 14.7 14.8 14.7
 C18:2 linoleic 2.0 3.9 4.7 4.7 4.7
 C18:3 linolenic 0.1 0.4 0.5 0.5 0.8
 n-6: n-3 ratio 20:1 10:1 9:1 9:1 6:1
Table 2  Body weight, food intake and supplementation doses
HFD high-fat diet, DIO diet-induced obese mice, MUFA monounsaturated fatty acids, PUFA polyunsaturated fatty acids, 2OHOA 2-hydroxy-
oleic acid, EPA + DHA eicosapentaenoic acid + docosahexaenoic acid, weeks weeks
Each value represents the mean ± SD of the data obtained weekly during the period indicated corresponding to 8–10 animals
***P < 0.001
**P < 0.01; P < 0.05 with respect to the values of control mice
### P < 0.001 with respect to the values of DIO mice
$$$ P < 0.001 with respect to the values of MUFA-DIO mice
Control mice DIO mice MUFA-DIO mice PUFA-DIO mice
Average weight (g/mouse)
 HFD period (14–22 weeks old) 32 ± 0.7 39 ± 2.3*** 38 ± 2.1*** 40 ± 2.3***
 HFD + supplementation period (22–28 weeks old) 33 ± 0.7 44 ± 1*** 43 ± 1.1*** 43 ± 0.9***
 Standard maintenance diet period (42–72 weeks old) 38 ± 1.7 45 ± 3.1*** 36 ± 2.4### 46 ± 3.6***, $$$
Average food intake
 HFD period (14–22 weeks old) (g/mouse/day) 4.2 ± 0.6 2.8 ± 0.4*** 3.2 ± 0.8*** 2.8 ± 0.4***
 HFD period (14–22 weeks old) (Kcal/mouse/day) 12 ± 1.7 14 ± 1.9* 16 ± 4.0*** 14 ± 2.2*
 HFD + supplementation period (22–28 weeks old) (g/mouse/day) 4 ± 0.6 3.2 ± 0.8* 3 ± 0.5** 3.1 ± 0.6*
 HFD + supplementation period (22–28 weeks old) (Kcal/mouse/day) 11 ± 1.9 17 ± 4.4** 15 ± 2.9* 16 ± 3.2**
 Standard maintenance diet period (42–72 weeks old) (g/mouse/day) 4.3 ± 0.5 4.1 ± 0.6 4.2 ± 0.6 4.2 ± 0.9
 Standard maintenance diet period (42–72 weeks old) (Kcal/mouse/day) 12 ± 1.6 12 ± 2.4 12 ± 1.8 12 ± 2.6
Supplementation doses
 2-OHOA (mg/mouse) 4.5
 EPA + DHA (mg/mouse) 9.3
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Chemotaxis assay
Chemotaxis of peritoneal leukocytes was evaluated accord-
ing to a slight modification of Boyden´s method [40], con-
sisting basically of the use of chambers with two compart-
ments separated by a filter with a pore diameter of 3  µm 
(Millipore, Bedford, MA, USA). Aliquots of 300 μl of the 
peritoneal suspensions, with macrophages or lymphocytes 
adjusted to 5 × 105 cells/ml in Hank’s solution, were depos-
ited in the upper compartment, and aliquots of 400 µl of the 
chemoattractant, formyl–Met–Leu–Phe  (10−8 M) (Sigma, 
St Louis, MO, USA), were put into the lower compart-
ment. The chambers were incubated for 3h and then the fil-
ters were fixed and stained. The chemotaxis index (CI) was 
determined by counting, in an optical microscope (100×), 
the total number of macrophages and lymphocytes on one-
third of the lower face of the filters.
Phagocytosis assay
Phagocytosis assay of inert particles (latex beads) was car-
ried out following a method previously described [40]. 
Aliquots of 200  µl of the peritoneal suspensions adjusted 
to 5 × 105 macrophages/ml in Hank’s medium were incu-
bated in migration inhibitory factor (MIF) plates (Kartell, 
Noviglio, Italy) for 30  min. The adhered monolayer was 
washed with pre-warmed PBS (phosphate buffer saline), 
and then 200 µl of Hank’s medium and 20 µl of latex bead 
suspension (1.09 µm, diluted to 1% PBS) (Sigma, St Louis, 
MO, USA) were added. After 30  min of incubation, the 
plates were washed, fixed and stained. The number of par-
ticles ingested by 100 macrophages was counted using an 
optical microscope (100×) and expressed as phagocytic 
index (PI). The percentage of macrophages, which phago-
cyted at least one latex bead, was also determined and 
expressed as phagocytic efficiency (PE).
Superoxide anion level assay
The superoxide anion level was evaluated assessing its 
capacity to reduce nitroblue tetrazolium (NBT, Sigma), in 
an equimolecular reaction, following the method previously 
described [40]. Briefly, aliquots of 250 µl of peritoneal cell 
suspensions (1 × 106 leukocytes/ml Hank’s medium) were 
mixed with 250  µl of NBT solution (1  mg/ml in Hank’s 
solution) (Sigma, St Louis, MO, USA) and with 50  µl of 
latex bead suspension (1%) in stimulated samples. After 
60 min of incubation at 37 °C, the reaction was stopped, the 
samples were centrifuged, and the supernatants discarded. 
The reduced NBT was extracted with dioxin (Merck, 
Darmstadt, FRG) and the absorbance of the supernatants 
was determined at 525 nm using a spectrophotometer. The 
data obtained were expressed as nmoles of NBT reduced 
per  106 leukocytes by extrapolating in a standard curve of 
NBT reduced with 1,4-dithoerythritol (Sigma, St Louis, 
MO, USA).
Natural killer assay
An enzymatic colorimetric assay was carried out to meas-
ure the cytolysis of tumour cells (Cytotox 96 TM Promega, 
Boehringer, Ingelheim) based on the determination of lac-
tate dehydrogenase enzyme (LDH), as previously described 
[40]. Aliquots of 100 µl of peritoneal leukocytes, used as 
effector cells, were seeded in 96-well U-bottom culture 
plates (Numc, Roskilde, Denmark) adjusted to  106 leuko-
cytes per well in RPMI 1640 medium without phenol red. 
Murine lymphoma YAC-1 cells, used as target cells, were 
added adjusted to  105 cells per well. Thus, the effector/
target ratio was 10:1. The plates were centrifuged at 250 g 
for 4 min to facilitate cell contacts. After 4 h of incubation, 
lactate dehydrogenase enzymatic activity was measured in 
50  µl/well of the supernatants by addition of the enzyme 
substrate and absorbance recording spectrophotometrically 
at 490 nm. Three kinds of control measurements were per-
formed: a target spontaneous release, a target maximum 
release, and an effector spontaneous release. The results 
were expressed as percentage of lysis of target cells. To 
determine this percentage the following equation was used: 
%lysis = [(E−ES−TS)/M−ES−TS)] x 100, where E is the 
mean of absorbance in the presence of effector cells; ES, 
the mean of absorbance of effector cells incubated alone; 
TS, the mean of absorbance in target cells incubated with 
medium alone; and M is the mean of maximum absorbance 
after incubating target cells with lysis solution.
Lymphoproliferation assay
Following the method previously described [41], aliquots 
(200  µl) of peritoneal leukocytes  (106 cells/ml complete 
medium) were seeded in 96 well flat-bottomed microtitre 
plates (Numc, Roskilde, Denmark) and 20 µl of concanav-
aline A (ConA 1  µg/ml; Sigma, St Louis, MO), 20  µl of 
lipopolysaccharide (LPS, E. coli, 055:B5 1 µg/ml; Sigma) 
or 20  µl of complete medium (spontaneous proliferation) 
were added per well. After 48h of incubation at 37 °C in 
an atmosphere of 5% CO2, 0.5  µCi 3H-thymidine (Du 
Pont, Boston, MA, USA) was added to each well. The cells 
were harvested in a semiautomatic microharvester, 24h 
later. Thymidine uptake was measured using a beta coun-
ter (LKB, Uppsala, Sweden). The results were expressed as 
3H-thymidine uptake (cpm).
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Total glutathione levels assay
The total intracellular glutathione levels were measured 
using the Tietze enzymatic assay, with some modifica-
tions [43]. Briefly, aliquots of 1 ml of peritoneal suspension 
(adjusted to  106 leukocytes per ml in Hank’s medium) were 
centrifuged at 1200g for 10  min at 4 °C. The pellet cells 
were re-suspended in a medium containing 5% tricloro-
acetic acid (TCA, Panreac, Barcelona, Spain) in 0.01  N 
HCl (previously degassed with helium for a minimum of 
10  min). This was followed by three cycles of sonication 
for 10  s (with 20  s rest between each cycle), keeping the 
sample cold. Then, the samples were centrifuged at 3200g 
for 5  min at 4 °C. Aliquots of the supernatants of leuko-
cytes samples were measured using the following reac-
tion mixture: 5,5′-dithiobis (2-nitrobenzoic acid) (DTNB, 
6 mM, Sigma), β-nicotinamide adenine dinucleotide phos-
phate, reduced form (β-NADPH, 0.3  mM, Sigma), and 
glutathione reductase (10 U/ml, Sigma). The reaction was 
monitored for 240 s and measured using spectrophotometry 
at a wavelength of 412 nm. The results were expressed in 
nmoles/106 cells.
Catalase activity assay
The activity of catalase (CAT) was determined following 
the method described by Beers and Sizer, with slight modi-
fications [16]. The peritoneal suspension was previously 
adjusted to  106 leukocytes/ml and aliquots of 1  ml were 
used to perform the enzymatic assay. The cells were cen-
trifuged at 1076g for 10 min at 4 °C and the pellets were re-
suspended in 50 mM phosphate buffer, containing 14 mM 
of  H2O2 (Merck, Germany). Then, the samples were soni-
cated and centrifuged at 3200g for 20  min at 4 °C. The 
enzymatic assay was followed using spectrophotometry for 
80 s at 240 nm. The results were expressed as international 
units (U) of enzymatic activity per  106 cells.
Xanthine oxidase activity assay
Xanthine oxidase (XO) activity was measured by fluo-
rescence using a commercial kit “Amplex Red Xanthine/
Xanthine Oxidase Assay Kit” (Molecular Probes, Paisley, 
UK), as previously described [44]. The hydrogen peroxide 
 (H2O2) produced by XO reacts with the horseradish peroxi-
dase present in the reaction mixture and generates a fluo-
rescent oxidation compound resorufin whose fluorescence 
is measured in a plate reader (Fluorestar Optima, BMG 
Labtech Biomedal, Spain). Briefly, 50 µl of peritoneal sus-
pension adjusted to  106 leukocytes/ml in Hank’s medium 
was incubated with 50 µl working solution of Amplex Red 
reagent (100 µM) containing HRP (0.4 U/ml) and xanthine 
(200  µM). After 30  min of incubation at 37 °C, measure-
ments of fluorescence was performed in a microplate 
reader using excitation at 530 nm and emission detection at 
595 nm. Data analysis was performed with xanthine stand-
ard curves at different concentrations, the results being 
expressed in international milliunits (mU) of enzymatic 
activity per  106 cells.
Lipid peroxidation (MDA) assay
The estimation of malondialdehyde (MDA) in cells was 
evaluated using the commercial kit “MDA Assay Kit” (Bio-
vision, Mountain View, CA, USA), which measures the 
reaction of MDA with thiobarbituric acid (TBA) and the 
MDA-TBA adduct formation. Aliquots of 1  ml of leuko-
cytes adjusted to  106 cells/ml of Hank’s were centrifuged at 
1200 g for 10 min at 4 °C and the pellets were re-suspended 
in 300 µl of MDA lysis buffer with 3 µl BHT. Then, the cell 
suspensions were sonicated and centrifuged at 13,000g for 
10 min at 4 °C to remove insoluble material. The superna-
tant (200 µl) from each sample was added to 600 µl of TBA 
reagent. After the incubation at 95 °C for 60 min, samples 
were cooled to room temperature in an ice bath for 10 min 
and then 200 µl of supernatant was dispensed into a 96-well 
microplate. The MDA-TBA adduct was measured using a 
spectrophotometer at 532 nm of absorbance.
Statistical analysis
SPSS 10.0 (SPSS, Inc., Chicago, IL) was used for the sta-
tistical analysis of the results. The data were expressed as 
mean ± standard deviation (SD). Each value is the mean of 
the data from an assay performed in duplicate or triplicate. 
Normality of the samples was checked by the Kolmogo-
rov–Smirnov test and homogeneity of variances with the 
Levene test. The data were statistically evaluated by one-
way ANOVA followed by Tukey’s post hoc test for homog-
enous variances, whereas Games–Howell´s post hoc test 
was used for unequal variances. Finally, a Kaplan–Meier 
survival analysis was conducted to verify the effects of both 
MUFA and n-3 PUFA treatments on the survival of DIO 
mice. P < 0.05 was considered statistically significant and 
0.05 < P < 0.1 as a trend.
Results
Body weight and food intake
As shown in Table  2, all mice fed on a high-fat diet 
increased their body weight significantly in comparison 
with controls (P < 0.001). After nutritional supplementa-
tion, when all mice received the standard maintenance 
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diet, only DIO mice that were supplemented with MUFA 
significantly decreased their body weight when compared 
with DIO mice and with n-3 PUFA-DIO mice (P < 0.001), 
having similar weights to those of controls. In addition, the 
three groups of DIO mice (DIO, MUFA-DIO and PUFA-
DIO) fed a HFD, although ingesting a lower food intake, 
showed significantly higher values of calories consumed 
than animals that fed a standard diet (P < 0.05, P < 0.001 
and P < 0.05, respectively; Table  2). However, when DIO 
mice supplemented with MUFA and n-3 PUFA or not, 
returned to the standard maintenance diet, no significant 
differences in food intake and total calories consumed were 
observed among all groups of mice (Table 2).
Macrophage peritoneal functions
The peritoneal macrophage functions are shown in Fig. 2. 
The chemotaxis index of macrophages in response to a 
chemotactic gradient (formylated peptide), which mim-
ics the migration of immune cells towards the infection 
site, was significantly suppressed in DIO mice compared 
with controls (P < 0.01; Fig. 2a). In addition, the number 
of latex beads ingested by macrophages, which is meas-
ured by the phagocytic index (P < 0.01; Fig. 2b), and the 
phagocytic efficiency (P < 0.01; Fig.  2c) were signifi-
cantly lower in DIO mice with respect to controls. Nev-
ertheless, the supplementations, with MUFA or with n-3 
PUFA, in DIO mice were able to increase the chemotaxis 
index (P < 0.01 and P < 0.01, respectively; Fig.  2a), the 
phagocytic index (P < 0.001 and P < 0.05, respectively; 
Fig.  2b) and the phagocytic efficiency (P < 0.05 and 
P = 0.06, respectively; Fig.  2c) in comparison with non-
supplemented DIO mice.
The levels of intracellular superoxide anion in stimu-
lated leukocytes (in the presence of latex beads), an 
important capacity of immune cells in killing pathogens 
Fig. 2  Macrophage functions. a Macrophage chemotaxis index (CI, 
number of macrophages). b Macrophage phagocytic index (PI, num-
ber latex beads/100 macrophages). c Macrophage phagocytic effi-
cacy (PE, number of phagocyting macrophages/100 macrophages). 
d Stimulated intracellular superoxide anion levels (nmol/106 cells). 
Each column represents the mean ± SD of 8–10 values corresponding 
to that number of animals and each value being the mean of dupli-
cate or triplicate assays. ***P < 0.001; **P < 0.01 with respect to the 
values of non-obese control mice. ###P < 0.001; ##P < 0.01; #P < 0.05 
with respect to the values of DIO mice
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in their phagosomes, showed significantly lower val-
ues in DIO mice (P < 0.01) when compared with con-
trols (Fig.  2d). The supplementation with the two types 
of dietary unsaturated fatty acids, MUFA or n-3 PUFA, 
resulted in higher levels of the superoxide anion than 
those of DIO mice (P < 0.001 and P < 0.01, respectively; 
Fig. 2d).
Lymphocyte peritoneal functions
The lymphocyte functions are displayed in Fig.  3. The 
chemotaxis index induced by a chemotactic peptide 
(Fig.  3a) showed a significant decrease in DIO mice in 
comparison with control mice (P < 0.001). The MUFA-
DIO and PUFA-DIO groups of mice showed a significant 
increase when compared with non-supplemented DIO mice 
(P < 0.01; Fig. 3a).
The NK cell activity against tumour cells (Fig. 3b) was 
significantly suppressed in DIO mice as compared with 
that in non-obese control mice (P < 0.05). However, the 
supplementation with n-3 FUFA tended to enhance this 
activity compared with that in non-supplemented DIO mice 
(P = 0.08).
The lymphoproliferation in response to T-cell mitogen 
(ConA) and to B-cell mitogen (LPS) (Fig. 3c, d) was highly 
suppressed in DIO mice with respect to non-obese control 
mice (P < 0.001). The supplementation with MUFA and 
n-3 PUFA in DIO mice significantly increased the prolif-
eration of lymphocytes in response to ConA (Fig. 3c) and 
LPS (Fig. 3d) when compared with non-supplemented DIO 
mice (P < 0.05 and P < 0.01, respectively, for ConA and 
P < 0.05 and P < 0.001, respectively, for LPS).
Peritoneal leukocyte oxidative stress parameters
Figure  4 shows oxidative stress parameters of perito-
neal leukocytes. The levels of total glutathione (Fig.  4a), 
which have an important antioxidant role, were decreased 
in leukocytes of DIO mice in comparison with those in 
non-obese controls (P < 0.001). Mice that were supple-
mented either with MUFA or with n-3 PUFA displayed 
Fig. 3  Lymphocyte functions. a Lymphocyte CI (number of lym-
phocytes). b Natural killer cell activity (% lysis). c Lymphoprolif-
erative response to concanalvaline A (ConA) (cpm). d Lymphopro-
liferative response to lipopolysaccharide (LPS) (cpm). ***P < 0.001; 
**P < 0.01; *P < 0.05 with respect to the values of non-obese control 
mice. ###P < 0.001; ##P < 0.01; #P < 0.05 with respect to the values of 
DIO mice
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significantly higher values of total glutathione than DIO 
animals (P < 0.001; Fig. 4a).
The catalase activity (Fig.  4b), an antioxidant enzyme, 
was significantly diminished in DIO mice as compared 
with that in non-obese controls (P < 0.01). The DIO mice 
that were supplemented with MUFA or with n-3 PUFA 
showed a significant increase in catalase activity (P < 0.01 
and P < 0.05, respectively; Fig. 4b).
The activity of xanthine oxidase (Fig. 4c), which is asso-
ciated with the production of free radicals, was significantly 
increased in DIO mice as compared with non-obese control 
mice (P < 0.05). DIO mice supplemented with n-3 PUFA 
showed lower levels of xanthine oxidase when compared 
with those in non-supplemented DIO mice (P < 0.001).
The MDA levels (Fig.  4d), which are an indicator of 
lipid oxidation and oxidative damage in cells, were signifi-
cantly increased in DIO mice with respect to those in non-
obese control mice (P < 0.05). In turn, the supplementation 
with MUFA was able to diminish MDA levels in compari-
son with DIO mice (P < 0.05).
Life span
The differences were not statistically significant among the 
groups of mice; however, DIO mice exhibited a lower aver-
age survival (105 ± 13 weeks old) than controls (115 ± 15 
weeks old). In addition, DIO mice supplemented with 
2-OHOA displayed values similar to controls (110 ± 20 
weeks old), whereas DIO mice supplemented with n-3 
PUFA remained similar to DIO mice (105 ± 35 weeks old) 
(Fig. 5).
Discussion
Previous results, in which a similar experimental design 
was used, have demonstrated that the ingestion of a high-
fat diet during early ages produces obesity and dysfunc-
tional immunity in adulthood. Animals fed on a high-fat 
diet during 14 weeks of their adolescence showed elevated 
levels of triglycerides and systolic arterial pressure, which 
are common features of obesity [7, 45]. The parameters of 
Fig. 4  Oxidative stress parameters. a Total glutathione levels 
(nmol/106 cells). b Catalase activity (CAT, U CAT/106 cells). c Xan-
thine oxidase activity (mUXO/106 cells). d Malondialdehyde (MDA) 
levels (nmol/106 cells). ***P < 0.001; *P < 0.05 with respect to the 
values of non-obese control mice. ###P < 0.001; ##P < 0.01; #P < 0.05 
with respect to the values of DIO mice
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function and redox state of peritoneal leukocytes evaluated 
in the current study have been established as markers of 
health and rate of aging [14]. Thus, the adult diet-induced 
obese mice presented some characteristics of premature 
aging, such as premature immunosenescence. Moreover, 
these adult obese animals reached old age in a worsened 
condition, in spite of having returned to a control diet dur-
ing their aging process. Hence, they continued to exhibit 
higher impairments of immune cell functions and conse-
quently a shorter life span than the non-obese animals [7]. 
Because of the deleterious and lasting effects of obesity on 
immune cell functions, we investigated whether the supple-
mentation with dietary unsaturated fatty acids (MUFA and 
n-3 PUFA), which are known for their immune-modulatory 
action, could improve the immune response and redox state 
of peritoneal leukocytes of mice, as well as their life span.
The results of the present study found that the dietary 
supplementations with 2-OHOA or with the combination 
of EPA and DHA were able to restore several immune 
cell functions and redox state of leukocytes, which were 
impaired in DIO mice. In addition, a long-lasting decrease 
in the body weight of 2-OHOA supplemented-DIO mice 
was observed during their aging process. Similarly, another 
study also found that 2-OHOA-treated rats experience a 
decrease in body weight through reduction of adipose fat 
mass [36]. The beneficial effects of 2-OHOA were also 
reflected in the life span of mice, and thus, although with-
out statistical significance, the treated mice displayed an 
average survival (number of weeks) similar to control mice. 
Nevertheless, n-3 PUFA supplemented-DIO mice only 
showed significant improvements in immune and oxida-
tive stress parameters, but no decrease in body weight or 
increase in life span. In that sense, evidence from a recent 
meta-analysis also indicates that supplementation with n-3 
PUFA does not promote anti-obesity effects, such as reduc-
tion of weight, in overweight/obese individuals [46].
The dietary supplementation with 2-OHOA or with 
the combination of EPA and DHA was able to revert the 
impaired macrophage functions of DIO mice, indicating 
a boost of the innate immune response towards pathogen 
destruction. Thus, DIO-treated mice displayed improved 
chemotaxis, phagocytosis and generation of stimulated 
superoxide anion in peritoneal leukocytes. In agreement, 
findings from in  vitro studies showed that neutrophils 
Fig. 5  Mortality records from control (ICR/CD1 female) mice and from DIO (diet-induced obese) mice, as well as from DIO treated with mon-
ounsaturated fatty acid (MUFA-DIO) or with polyunsaturated fatty acid (PUFA-DIO) mice
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incubated with MUFA or with n-3 PUFA presented 
enhanced migration, phagocytic capacity and ROS produc-
tion by immune cells, suggesting immune-enhancing prop-
erties of fatty acids [20–23]. Several studies demonstrated 
that EPA and DHA could modulate immune functions in 
neutrophils of rats and humans, increasing chemotactic 
response, phagocytic activity and ROS production [24, 25]. 
In addition, administration of oleic acid induced neutrophil 
recruitment in a rat air-pouch model [26] and mice that 
were fed a diet enriched with olive oil (MUFA) exhibited 
increased phagocytic activity in peritoneal macrophages 
[27].
The NK cell activity from peritoneal immune cells, 
which has also been shown to be impaired in DIO mice [3, 
7, 15], tended to be higher after supplementation with n-3 
PUFA. Previous work has demonstrated that ingestion of 
n-3 PUFA is able to improve NK cell cytotoxicity in seden-
tary rats [28]. However, supplementation with MUFA did 
not lead to significant differences in the NK cell activity of 
DIO mice. Similarly, another study also did not find differ-
ences in the activity of NK cells in middle-aged men sup-
plemented with MUFA-rich diet [29].
The lymphocyte functions, such as migration and pro-
liferation in response to T cell-specific mitogen (ConA) 
or B cell-specific mitogen (LPS), showed lower values in 
DIO mice than in non-obese mice. However, the dietary 
supplementation used led to higher values for these func-
tions. In this sense, an increased resistance to infection was 
found associated with enhanced proliferation of peritoneal 
cells under LPS stimulation in mice fed fish oil, rich in 
EPA and DHA, during 6 weeks [30]. An improvement in 
the production of circulating IgM in response to an antigen 
was obtained after administration of a n-3 PUFA-rich diet 
in obese mice [31]. Another study, in which mice were fed 
an olive oil-rich diet, exhibited slightly increased splenic 
lymphocyte proliferation [32]. Nevertheless, some animal 
studies have described an inhibition of lymphocyte prolif-
eration with MUFA supplementation [33], whereas human 
studies have shown no changes [29]. It is possible that these 
contradictory results could be influenced by the doses sup-
plemented in the diets. A study in this regard found that 
lower doses of oleic acid enhanced lymphocyte prolifera-
tion, while higher concentrations could result in inhibition 
of proliferation through an increase in apoptosis [47].
Oxidative stress, which is generated by an imbalance 
between antioxidants and oxidants, also seems to play a 
critical role in obesity and obesity-related diseases [48]. 
In fact, in this study, DIO mice showed higher values of 
oxidant production, such as xanthine oxidase activity and 
lipid peroxidation (MDA), as well as lower values of anti-
oxidants (catalase activity and total glutathione levels) than 
non-obese control mice. This indicates that these mice 
seemed to exhibit an augmented oxidative stress state in 
comparison with controls. However, the dietary supple-
mentation with MUFA or n-3 PUFA seems to enhance 
endogenous antioxidant defences in immune cells, as both 
treatments have resulted in increased catalase activity and 
GSH levels. In addition, n-3 PUFA supplementation led to 
a lower activity of xanthine oxidase, whereas dietary sup-
plementation with MUFA, resulted in a diminished produc-
tion of MDA in peritoneal immune cells. Thus, these find-
ings suggest that EPA plus DHA as well as 2-OHOA have 
a role in improving redox state in obese mice. Moreover, 
2-OHOA appears to be less susceptible to lipid peroxida-
tion than n-3 fatty acids, since supplementation with n-3 
did not significantly diminish MDA levels. In agreement, 
previous studies described that the supplementation with 
extra virgin olive oil, which has been attributed an anti-
oxidant role mostly by its high content of oleic acid [19], 
diminished the lipid peroxidation in rats [49, 50]. Supple-
mentation with n-3 PUFA also exhibited antioxidant prop-
erties in rats [51] and in a mouse model [52].
In conclusion, the supplementation with 2-OHOA or 
n-3 PUFA (EPA and DHA) improved several function and 
oxidative stress parameters of impaired leukocytes in obese 
mice, bringing the values to similar levels as those found 
in non-obese controls. The results suggest that these nutri-
tional treatments could be a promising strategy to improve 
functions of the immune system and to decrease the oxi-
dative state in obese individuals. Moreover, given that an 
improved immune system is associated with a diminish-
ment of oxidation and inflammation states [7, 14, 17], it 
could also be related to an amelioration of the pathophysi-
ology of obesity and its related diseases, thus, ensuring bet-
ter health in adulthood and during the aging process.
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3.3.2. Effects of the dietary supplementations with 2-OHOA or with the combination of 
n-3 fatty acids (EPA and DHA) on the redox state of several organs from adult female diet-
induced obese mice 
 
 
Experimental design  
At 9 weeks of age, the animals were separated into four groups (n=8, per group), similar to 
those in the previous design. 1) The control mice group was fed a standard maintenance diet until 
the end of the study. 2) The diet-induced obese mice group (DIO) was fed a high-fat diet (HFD, 
60% of calories from fat, reference TD. 06414, Harlan Interfauna Iberica) for 14 weeks. 3) The 
MUFA-supplemented DIO mice group (MUFA-DIO) was fed a high-fat diet for 14 weeks, but 
during the last 6 weeks of HFD, this diet was supplemented with 2-OHOA (1500 mg of 2-OHOA 
per Kg of HFD, BTSA-Biotecnologías Aplicadas S.L.). 4) The n-3 PUFA-supplemented DIO mice 
group (PUFA-DIO) was fed a HFD for 14 weeks, this being supplemented during the last 6 weeks 
with the combination of EPA and DHA (3000 mg of EPA and DHA per Kg of HFD, BTSA-
Biotecnologías Aplicadas S.L.). In order to progressively increase the amount of fat in the diet of 
groups 2, 3 and 4, they were fed with an intermediate-fat diet (IFD, 22% of calories from fat, 
Teklad Global 2019, Harlan Interfauna Iberica) for 4 weeks previous to the ingestion of HFD. 2-
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OHOA is a synthetic derivative of oleic acid, and it is also known as 2-hydroxy-D9-cis-
octadecenoic acid. The n-3 PUFA were extracted from fish (anchovy). The fatty acid supplements 
(2-OHOA in powdered form and n-3 PUFA in oil form) were mixed with the chow, which was of 
malleable consistency, and then pelleted. Animals were euthanized at 8:00 am by decapitation. The 
brain, liver, lungs and kidneys were frozen in liquid nitrogen and stored at -80° C until performing 
the oxidative stress assays.  
Main results 
Left and right cerebral cortex and hypothalamus  
The glutathione peroxidase (GPx) and reductase (GR) activities, two antioxidant enzymes of 
the glutathione system, were significantly lower in the left and right cerebral cortex, respectively, of 
DIO mice as compared to non-DIO controls. However, DIO mice that were supplemented with 
MUFA or with n-3 PUFA showed significantly higher activity of these enzymes in comparison with 
DIO mice.  
The MDA concentration was significantly higher in the hypothalamus of DIO mice with 
respect to non-DIO mice. In turn, the supplementation with MUFA was able to lower this 
concentration in comparison with non-supplemented DIO mice.  
Liver 
The antioxidant catalase (CAT) and GR activities were significantly lower in the liver of 
DIO mice as compared with that in non-DIO controls. By contrast, the GPx activity was 
significantly higher in DIO mice than in their respective non-DIO controls. The supplementation 
with MUFA or with n-3 PUFA resulted in significantly higher CAT activity in the liver in 
comparison with non-supplemented DIO mice. In addition, the supplementation with n-3 PUFA 
resulted in the lower activity of GPx and higher activity of GR in the liver of DIO mice than in non-
supplemented DIO mice. No statistically significant differences were observed in the activities of 
GPx and GR in the liver of MUFA-supplemented DIO mice and non-supplemented DIO mice. 
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The activity of xanthine oxidase (XO) was significantly higher in DIO mice in comparison 
with that in non-DIO controls. The supplementation with MUFA or with n-3 PUFA resulted in 
significantly lower XO activity in the liver in comparison with non-supplemented DIO mice. In 
addition, the supplementation with n-3 PUFA resulted in lower GSSG/GSH ratios and higher MDA 
concentrations in the liver of DIO mice than in non-supplemented DIO mice.  
Lungs 
The activities of CAT and GR were significantly lower in the lungs of DIO mice than in 
non-DIO controls. However, the GPx activity was significantly higher in DIO mice than in their 
respective non-DIO controls. The supplementation with MUFA or with n-3 PUFA in DIO mice 
resulted in significantly lower activity of GPx and higher activity of GR with respect to non-
supplemented DIO mice. In addition, the supplementation with n-3 PUFA in DIO mice resulted in 
significantly higher CAT activity than in non-supplemented DIO mice.  
The XO activity, GSSG/GSH ratio and MDA concentration were significantly higher in DIO 
mice than in non-DIO controls. The supplementation with MUFA or with n-3 PUFA resulted in 
significantly lower values of these parameters in the lungs of DIO mice in comparison with non-
supplemented DIO mice. 
Kidneys. Renal medulla and cortex 
The activities of CAT and GR were significantly lower in the renal medulla of DIO mice in 
comparison with non-DIO controls. By contrast, the GPx activity was significantly higher in DIO 
mice than in their respective non-DIO controls. The supplementation with MUFA or with n-3 
PUFA resulted in significantly higher activity of CAT in the renal medulla of DIO mice in 
comparison with non-supplemented animals. In addition, the supplementation with MUFA resulted 
in significantly higher activity of GR in the renal medulla of DIO mice in comparison with non-
supplemented DIO mice.  
The XO activity, GSSG/GSH ratio and MDA concentration were significantly higher in DIO 
mice than in non-DIO controls. The supplementation with MUFA or with n-3 PUFA resulted in 
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significantly lower XO activity, GSSG/GSH ratio and MDA concentration in the renal medulla of 
DIO mice than in non-supplemented animals. 
The activities of CAT and GR were significantly lower in the renal cortex of DIO mice than 
in non-DIO controls. However, the GPx activity was significantly higher in DIO mice than in their 
respective non-DIO controls. The supplementation with MUFA or with n-3 PUFA resulted in 
significantly higher activities of catalase and GR in the renal cortex of DIO mice in comparison 
with non-supplemented animals. The activity of GPx was significantly lower after the 
supplementation with MUFA or with n-3 PUFA in the renal cortex of DIO animals in comparison 
with non-supplemented DIO mice. 
The XO activity, GSSG/GSH ratio and MDA concentration were significantly higher in DIO 
mice than in non-DIO controls. The supplementation with MUFA or with n-3 PUFA resulted in 
significantly lower values of these parameters in the renal cortex of DIO mice in comparison with 
non-supplemented DIO animals. 
 
Partial conclusions 
The supplementations with 2-OHOA or with the combination with n-3 PUFA (EPA and 
DHA) improve redox state in the brain, liver, lungs and kidneys, which were impaired in DIO mice, 
bringing them to similar values as those in the non-DIO controls.  
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33 Abstract
34
35 Obesity and its related diseases have been associated with oxidative stress. Thus, the search for nutritional strategies to 
36 ameliorate oxidative stress in obese individuals seems important. We hypothesized that the supplementations with 
37 monounsaturated and n-3 polyunsaturated fatty acids would ameliorate oxidative stress in different organs, including 
38 brain, liver, lungs, and kidneys of adult diet-induced obese (DIO) mice. Adult female ICR-CD1 mice were fed a high-
39 fat diet (HFD) for 14 weeks. During the last 6 weeks on HFD feeding, one group of DIO mice received the same HFD, 
40 supplemented with 1500 mg of 2-hydroxyoleic acid (2-OHOA) and another group with 3000 mg of eicosapentaenoic 
41 acid (EPA) and docosahexaenoic acid (DHA). At the end of the experiment, several parameters of oxidative stress were 
42 assessed. The supplementations with 2-OHOA or with EPA and DHA in DIO mice were able to revert oxidative stress, 
43 enhancing the activities of catalase and glutathione reductase, as well as diminishing the activity of xanthine oxidase, 
44 the concentration of malondialdehyde and the ratio between oxidized glutathione and reduced glutathione in several 
45 organs. These reached similar values to those of control mice, which were fed a standard diet. These data suggest that 
46 the supplementations with monounsaturated and n-3 polyunsaturated fatty acids could be an effective nutritional 
47 intervention to restore an appropriate redox state in DIO mice. 
48
49 Keywords 
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65 1. Introduction
66
67 The consumption of diets high in fat and calories has been associated with the development and maintenance 
68 of obesity in both humans and rodents (Hairi and Thibault 2010; Swinburn et al. 2011). Obesity has become a global 
69 health problem and represents an important contributor to the current burden of chronic diseases (Hruby and Hu 2015).
70 Increasing evidence suggests that oxidative stress plays a critical role in the pathogenesis of obesity and its 
71 related diseases, such as type-2 diabetes, cardiovascular and neurodegenerative diseases (Manna and Jain 2015). It is 
72 known that moderate concentrations of reactive oxygen species (ROS) are essential to regulate biological and 
73 physiological processes, such as several signaling pathways, gene expression and apoptosis (Schieber and Chandel 
74 2014). However, the excessive generation of these compounds (accompanied by decreased antioxidant defenses) leads 
75 to oxidative stress. Oxidative stress when maintained for a long period of time can damage cellular structures and 
76 trigger an inflammatory response, closing a detrimental feedback loop (de Heredia et al 2012; Fernández-Sánchez et al 
77 2011). It is known that high values of xanthine oxidase (XO) activity, glutathione redox ratio (GSSG/GSH) and 
78 malondialdehyde (MDA) concentration (measured as a lipid peroxidation product) are considered markers of oxidative 
79 damage (Fernández-Sánchez et al 2011; Hunsche et al 2018; Martínez de Toda et al 2019). By contrast, inadequate 
80 endogenous antioxidant defenses, such as low values of catalase (CAT), glutathione peroxidase (GPx) and glutathione 
81 reductase (GR) activities, which act as ROS scavengers, can aggravate oxidative damage (Hunsche et al 2018; Martínez 
82 de Toda et al 2019). In addition, there are other factors that also seem to contribute to oxidative stress in obesity, such as 
83 chronic inflammation (Fernández-Sánchez et al 2011), a process very related to oxidative stress (Fernández-Sánchez et 
84 al 2011), hyperglycemia (Fiorentino et al 2013), hyperleptinemia (Heymsfield et al 1999), elevated tissue lipid levels 
85 (Vincent et al 2011), adipocyte dysfunction (Trayhurn 2013), and endothelial ROS production (Egan et al 2011; 
86 Wheatcroft et al 2003). Similar to obesity, the process of aging has also been associated with oxidative stress (De la 
87 Fuente and Miquel 2009). In fact, according to the oxidative-inflammatory theory of aging, the generation of chronic 
88 oxidative stress and inflammatory stress is the basis of the age-related impairment of the functions of the organism (De 
89 la Fuente and Miquel 2009). We have found that obesity results in premature features of aging in adult mice, such as 
90 oxidative stress and immunosenescence (i.e., age-related changes of the immune system), suggesting obesity as a 
91 possible model of premature and accelerated aging (Hunsche et al 2016; 2019). Therefore, the search for strategies to 
92 ameliorate oxidative stress, and consequently to promote healthy aging in obese individuals seems important. 
93 In this context, the consumption of diets rich in monounsaturated fatty acids (MUFAs) from olive oil and n-3 
94 polyunsaturated fatty acids (PUFAs), namely eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), from 
95 marine-based fish oil and fish have been reported to promote beneficial effects for obesity and related diseases 
96 (including cardiovascular disease and lipid profile) (Savini et al 2013). However, the specific role of these unsaturated 
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97 fatty acids on oxidative stress remains unknown. Previous studies from our laboratory, focused on immunity, found that 
98 the supplementation with 2-hydroxyoleic acid (2-OHOA), a synthetic derivative of the MUFA oleic acid, and with EPA 
99 and DHA were able to revert oxidative stress and the altered functions in immune cells of diet-induced obese (DIO) 
100 mice (Gheorghe et al 2017; Hunsche et al 2018). We hypothesized that these supplementations would revert oxidative 
101 stress also in other non-immune organs, such as brain, liver, lungs and kidneys, of DIO mice. The aim of this study was 
102 to evaluate several oxidative stress parameters in the brain, liver, lungs and kidneys of DIO mice supplemented with 2-
103 OHOA or with the combination of n-3 fatty acids (EPA and DHA).
104
105 2. Materials and methods 
106
107 2.1. Animals
108
109 Female ICR/CD1 mice, 8 weeks of age, were purchased from Harlan Interfauna Iberica (Barcelona, Spain). 
110 During the first 5 days of acclimatization to a new environment, all mice were fed a standard maintenance diet (Teklad 
111 Global 14%). The animals were housed in polyurethane cages and maintained at a constant temperature of 22±2ºC, 
112 adequate ventilation and relative humidity of 50-60% on a 12/12h reversed light/dark cycle (lights on at 8:00 pm). The 
113 experiments procedures and handling of animals were performed with approval of the Committee for Animal 
114 Experimentation of the Complutense University of Madrid (ref. CEA-UCM 06/2012) and were conducted in accordance 
115 with the guidelines and protocols of the Royal Decree 53/2013 regarding the care and use of laboratory animals.
116
117
118 2.2. Experimental groups
119
120 The animals, at 9 weeks of age, were separated into four groups (n=8, per group). (1) Control mice group were 
121 fed a standard maintenance diet until the end of the study; (2) Diet-induced obese mice group (DIO) were fed a high-fat 
122 diet (HFD, 60% of calories from fat, reference TD. 06414, Harlan Interfauna Iberica) for 14 weeks; (3) MUFA-
123 supplemented DIO mice group (MUFA-DIO) were fed a high-fat diet for 14 weeks, but received during the last 6 weeks 
124 of HFD, the supplementation with 2-OHOA (1500 mg of 2-OHOA per Kg of HFD, BTSA-Biotecnologías Aplicadas 
125 S.L.); (4) n-3 PUFA-supplemented DIO mice group (PUFA-DIO) were fed a HFD for 14 weeks, this being 
126 supplemented during the last 6 weeks with the combination of EPA and DHA (3000 mg of EPA and DHA per Kg of 
127 HFD, BTSA-Biotecnologías Aplicadas S.L.). In order to progressively increase the amount of fat in the diet of groups 2, 
128 3 and 4, the animals were fed with an intermediate-fat diet (IFD, 22% of calories from fat, Teklad Global 2019, Harlan 
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129 Interfauna Iberica) for 4 weeks previous to the ingestion of HFD. The 2-OHOA is a synthetic derivative of oleic acid, 
130 and it is also known as 2-hydroxy-D9-cis-octadecenoic acid. The n-3 PUFA were extracted from fish (anchovy). The 
131 supplements 2-OHOA n-3 PUFA were provided in powdered form and in oil form, respectively, and were mixed into 
132 the chow, which was of malleable consistency. After the chow was uniformly mixed, it was pellet. The MUFA and n-3 
133 PUFA supplementation doses were chosen according to a previous study, in which the same supplemented doses were 
134 associated with changes in the gut microbiota of DIO mice (Mujico et al 2013). The animals and the experimental 
135 design used in this study were the same as those used in a previously published paper that studied the same 
136 supplementations with monounsaturated and n-3 polyunsaturated fatty acids on the immune functions and oxidative 
137 stress of spleen leukocytes (Gheorghe et al 2017). During the entire study, all mice were given ad libitum access to 
138 water and diet. The full compositions of all the diets used are shown in Table 1. Weight and food intake were measured 
139 every week throughout the study (data previously published) (Gheorghe et al 2017).
140
141 2.3 Collection of organs
142
143 Animals were euthanized at 8:00 am by decapitation, and no anesthetic was used to avoid the effect of 
144 anesthesia on the results. Organs were extracted post-mortem immediately and washed carefully with phosphate buffer, 
145 pH 7.4. The brain, liver, lungs and kidneys were frozen in liquid nitrogen and stored at -80 C until performing the 
146 oxidative stress assays.   
147
148 2.4. Catalase activity assay
149
150 The activity of catalase (CAT) was determined following the method previously described (Alvarado et al 
151 2006). The assays were performed using aliquots of the homogenized tissue samples (50 mg/ml, for kidneys and lungs, 
152 and 25 mg/ml, for liver) in phosphate buffer (66 mM, pH 8.4) and centrifuged at 3200 g for 20 min at 4°C. The 
153 supernatant extract (30 μl) was mixed with 670 μl of hydrogen peroxide (H2O2) (14 mM of H2O2 in phosphate buffer) 
154 (Merck, Germany). The enzymatic assay was followed using spectrophotometry for 80 seconds at 240 nm through the 
155 decomposition of H2O2 into H2O + O2. Protein content of the samples was assessed following the bicinchoninic acid 
156 (BCA) protein assay kit protocol (Sigma-Aldrich, Madrid, Spain). The results were expressed as units (U) of enzymatic 
157 activity per milligram of protein (U CAT/mg protein).
158
159 2.5. Glutathione peroxidase activity assay
160
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161 The glutathione peroxidase (Gpx) activity was determined according to the method previously described 
162 (Alvarado et al 2006). The assays were performed with aliquots of the homogenate tissue samples (50 mg/ml, for brain, 
163 kidneys and lungs, and 25 mg/ml for liver) in phosphate buffer (50 mM, pH 7.4) and centrifuged at 3200 g for 20 min at 
164 4°C. The total activity was determined using cumene hydroperoxide (Sigma-Aldrich), which carried out the oxidation 
165 of β-nicotinamide adenine dinucleotide phosphate, in its reduced form (β-NADPH, Sigma-Aldrich, Spain), in the 
166 presence of glutathione reductase (Sigma-Aldrich). The reaction was measured spectrophotometrically by the decrease 
167 of the absorbance at 340 nm. The protein contents were evaluated following the previously mentioned protocol. The 
168 results were expressed as miliunits of enzymatic activity per milligram of proteins (mU GPx/mg protein).
169
170 2.6. Glutathione reductase activity assay
171
172 The glutathione reductase (GR) activity was measured by the technique previously described (Alvarado et al 
173 2006). The assays were performed with aliquots of the homogenate tissue samples (50 mg/ml, for kidneys and lungs, 
174 and 25 mg/ml for liver) in phosphate buffer 50 mM, pH 7.4 with 6.3 mM ethylenediaminetetraacetic acid (EDTA), and 
175 centrifuged at 3200 g for 20 min at 4°C. The total activity was measured through the oxidation of NADPH 
176 spectrophotometrically at 340 nm. The protein contents of samples were evaluated following the previously described 
177 protocol. The results were expressed as milliunits of enzymatic activity per milligram of proteins (mU GR/mg protein). 
178
179 2.7. Glutathione concentrations assay
180
181 Both reduced (GSH) and oxidized (GSSG) concentrations of glutathione were measured using a fluorometric 
182 method. This method is based on the reaction of a fluorescence probe, o-phthaldialdehyde (OPT; Sigma-Aldrich), with 
183 GSH at pH 8 and with GSSG at pH 12, which generates a fluorescence derivative. The tissue samples were 
184 homogenized (50 mg/ml, for kidneys and lungs, and 25 mg/ml for liver) in sodium phosphate-EDTA buffer (0.1 M, pH 
185 8) and proteins were precipitated by adding 5 μl of 60% perchloric acid (HClO4) (60%, Sigma-Aldrich). The 
186 homogenate tissue samples were centrifuged at 9500 g for 10 min at 4°C and supernatants were maintained in ice for 
187 the measurement of GSH and GSSG concentrations. For GSH content determination, 10 μl of the supernatant, 190 μl of 
188 phosphate-EDTA buffer and 20 μl of OPT solution (1 mg/ml in methanol) were added to a 96-well black plate (Nunc, 
189 Roskilde, Denmark), and incubated at room temperature for 15 minutes. Fluorescence was determined in a plate reader 
190 (Fluostar Optima, BMG Labtech, Spain) using excitation at 350 nm and emission detection at 420 nm. For the 
191 measurement of GSSG contents, 8 μl of N-ethylmaleimide (NEM, 0,04M, Sigma-Aldrich) were added to each well and 
192 incubated at room temperature for 30 minutes. Then, 182 μl of sodium hydroxide (NaOH) (0.1 N, Panreac Quimica SA, 
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193 Barcelona, Spain) with 20 μl of OPT solution were added to a 96-well black plate. After incubation (room temperature, 
194 15 min), fluorescence was measured as previously described for GSH determination. Protein concentration of the 
195 samples was measured following the bicinchroninic acid protein assay kit protocol (Sigma-Aldrich). The results were 
196 analyzed with GSH and GSSG standard curves at different concentrations and expressed as nmol/mg protein. The 
197 GSSG/GSH ratios were then calculated for each sample. 
198
199 2.8. Xanthine oxidase (XO) activity assay
200
201 Xanthine oxidase (XO) activity was measured, by a fluorescence assay, in homogenates of tissues, using a 
202 commercial kit (Amplex Red Xanthine/Xanthine Oxidase Assay Kit, Molecular Probes, Paisley, UK). The hydrogen 
203 peroxide (H2O2) produced by XO reacts with horseradish peroxidase (HRP) present in the reaction mixture and 
204 generates a fluorescent oxidation compound resorufin whose fluorescence is measured in a plate reader (Fluorestar 
205 Optima, BMG Labtech Biomedal, Spain). Tissue samples were homogenized (50 mg/ml, for kidneys and lungs, and 25 
206 mg/ml for liver) in phosphate buffer (50 mM, pH 7.4) containing 1 mM EDTA. The homogenate was centrifuged (5000 
207 g), and the supernatant (50 μl) was collected and incubated with 50 μl working solution of Amplex Red reagent (100 
208 μM) containing HRP (0.4 U/ml) and xanthine (200 μM). After 30 min of incubation at 37°C, measurement of 
209 fluorescence was performed in the microplater reader, using excitation at 530 nm and emission detection at 595 nm. XO 
210 supplied in the kit was used as the standard. Protein content of the samples was assessed using the BCA protein assay 
211 (Sigma-Aldrich). The results were expressed as milliunits of enzymatic activity per milligram of protein (mU XO/mg 
212 protein). 
213
214 2.9. Malondialdehyde  (MDA) assay
215
216 The estimation of malondialdehyde (MDA), a marker of lipid peroxidation, was evaluated using a colorimetric 
217 assay kit (BioVision, Mountain View, CA, USA), which measures the reaction of MDA with thiobarbituric acid (TBA) 
218 and the MDA-TBA adduct formation. The tissue samples were homogenized (50 mg/ml, for brain, kidneys and lungs, 
219 and 25 mg/ml for liver) in 300 μl of MDA lysis buffer with 3 μl butylhydroxytoluene (BHT) (X100) and then 
220 centrifuged (13000 g, 10 min, 4°C) to remove insoluble material. An aliquot (200 μl) of each supernatant was added to 
221 600 μl of thiobarbituric acid (TBA) and incubated at 95°C for 60 min. The samples were then maintained in an ice bath 
222 for 10 min and 200 μl from each 800 μl reaction mixture were placed into a 96-well microplate for spectrophotometric 
223 measurement at 532 nm. Protein concentration was measured following the BCA protein assay kit (Sigma-Aldrich). The 
224 results were obtained using a MDA standard curve at different concentrations and expressed as nmol MDA/mg protein. 
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225
226 2.10. Statistical analysis 
227
228 The statistical analysis of results was performed in SPSS IBM, version 25.0 (SPSS, Inc., Chicago, USA). The 
229 data were expressed as mean ± standard error of the mean (SEM). Each value is the mean of the data from an assay 
230 performed in duplicate or triplicate. The normality of the samples was checked by the Kolmogorov-Smirnov test and 
231 homogeneity of variances with the Levene test. The data were statistically evaluated by one-way ANOVA followed by 
232 Tukey´s post hoc test for homogenous variances. Games-Howell´s post hoc test was used for unequal variances. P<0.05 
233 was considered statistically significant. 
234
235 3. Results
236
237 3.1. Left and right cerebral cortex and hypothalamus 
238
239 The glutathione peroxidase (GPx) and reductase (GR) activities, two antioxidant enzymes of the glutathione 
240 system, were significantly lower in the left (P<0.001; Fig. 1A) and right cerebral cortex (P=0.026; Fig. 1B), 
241 respectively, of DIO mice as compared to non-DIO controls. However, DIO mice that were supplemented with MUFA 
242 or with n-3 PUFA showed significantly higher activity of these enzymes in comparison with DIO mice (P=0.03 and 
243 P<0.001 for GPx activity, respectively; Fig. 1A) and (P=0.04 and P=0.01 for GR activity, respectively; Fig. 1B). 
244 The MDA concentrations, which are an indicator of lipid oxidation and oxidative damage in cells, was 
245 significantly higher in the hypothalamus of DIO mice with respect to non-DIO mice (P=0.04; Fig. 1C). In turn, the 
246 supplementation with MUFA was able to lower the concentrations of MDA in comparison with non-supplemented DIO 
247 mice (P=0.009; Fig. 1C). No significant differences were observed between PUFA-DIO supplemented and non-
248 supplemented mice regarding the concentrations of MDA in the hypothalamus (P=0.4; Fig 1C).
249
250 3.2. Liver
251
252 The antioxidant catalase and glutathione reductase activities were significantly lower in the liver of DIO mice 
253 as compared with that in non-DIO controls (P=0.008 and P=0.012, respectively; Fig. 2A and 2C). By contrast, the GPx 
254 activity was significantly higher in DIO mice than in their respective non-DIO controls (P=0.015; Fig. 2B). The 
255 supplementation with MUFA or with n-3 PUFA resulted in significantly higher CAT activity in the liver (P=0.015 and 
256 P<0.001, respectively; Fig. 2A) in comparison with non-supplemented DIO mice. In addition, the supplementation with 
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257 n-3 PUFA resulted in lower activity of GPx and higher activity of GR in the liver of DIO mice  (P<0.001 and P=0.038, 
258 respectively; Fig. 2B and 2C) than in non-supplemented DIO mice. No statistically significant differences were 
259 observed in the activities of GPx and GR in the liver of MUFA-supplemented DIO mice and non-supplemented DIO 
260 mice (P=0.073 and P=0.108, respectively; Fig. 2B and 2C).
261 The activity of xanthine oxidase (XO), which is associated with the production of free radicals, as well as the 
262 GSSG/GSH ratio, an indicator of oxidative stress, were significantly higher in DIO mice in comparison with those in 
263 non-DIO controls (P=0.001 and P<0.001, respectively; Fig. 2D and 2E). No statistically significant differences were 
264 observed in the concentrations of MDA in the liver of DIO mice and non-DIO mice (P=0.564; Fig. 2F). The 
265 supplementation with MUFA or with n-3 PUFA resulted in significantly lower XO activity in the liver (P=0.028 and 
266 P=0.032, respectively; Fig. 2D) in comparison with non-supplemented DIO mice. In addition, the supplementation with 
267 n-3 PUFA resulted in lower GSSG/GSH ratios and higher MDA concentrations in the liver of DIO mice  (P=0.017 and 
268 P=0.006, respectively; Fig. 2E and 2F) than in non-supplemented DIO mice. No statistically significant differences 
269 were observed in the GSSG/GSH ratios and MDA concentrations in the liver of MUFA-supplemented DIO mice and 
270 non-supplemented DIO mice (P=0.510 and P=0.079, respectively; Fig. 2E and 2F).
271
272 3.3. Lungs
273
274 The activities of CAT and GR were significantly lower in the lungs of DIO mice that in non-DIO controls 
275 (P<0.001and P<0.001, respectively; Fig. 3A, 3C). However, the GPx activity was significantly higher in DIO mice than 
276 in their respective non-DIO controls (P<0.001; Fig. 3B). The supplementation with MUFA or with n-3 PUFA in DIO 
277 mice resulted in significantly lower activity of GPx (P<0.001 and P<0.001, respectively; Fig. 3B) and higher activity of 
278 GR (P=0.001 and P=0.001, respectively; Fig. 3C) with respect to non-supplemented DIO mice. In addition, the 
279 supplementation with n-3 PUFA in DIO mice resulted in significantly higher CAT activity (P<0.001; Fig. 3A) than in 
280 non-supplemented DIO mice. No statistically significant differences were observed in the CAT activity in the lungs of 
281 MUFA-supplemented DIO mice and non-supplemented DIO mice (P=0.062; Fig. 3A).
282 The XO activity, GSSG/GSH ratios and MDA concentrations were significantly higher in DIO mice than in 
283 non-DIO controls (P<0.001, P<0.001 and P<0.001, respectively; Fig. 3D, 3E and 3F). The supplementation with 
284 MUFA or with n-3 PUFA resulted in significantly lower XO activity (P=0.005 and P<0.001, respectively; Fig. 3D), 
285 GSSG/GSH ratios (P=0.002 and P<0.001, respectively; Fig. 3E) and MDA concentrations (P<0.001 and P<0.001, 
286 respectively; Fig. 3F) in the lungs of DIO mice in comparison with non-supplemented DIO mice.
287
288 3.4. Kidneys: Renal medulla and cortex
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289
290 The activities of CAT and GR were significantly lower in the renal medulla of DIO mice in comparison with 
291 non-DIO controls (P=0.001 and P=0.006, respectively; Fig. 4A, 4C). By contrast, the GPx activity was significantly 
292 higher in DIO mice than in their respective non-DIO controls (P=0.025; Fig. 4B). The supplementation with MUFA or 
293 with n-3 PUFA resulted in significantly higher activity of catalase (P=0.001 and P<0.001, respectively; Fig. 4A) and 
294 lower activity of GPx (P=0.024 and P=0.015, respectively; Fig. 4B) in the renal medulla of DIO mice in comparison 
295 with non-supplemented animals. In addition, the supplementation with MUFA resulted in significantly higher GR 
296 activity (P=0.022; Fig. 4C) in the renal medulla of DIO mice in comparison with non-supplemented DIO mice. No 
297 statistically significant differences were observed in the GR activity in the renal medulla of n-3 PUFA-supplemented 
298 DIO mice and non-supplemented DIO mice (P=0.995; Fig. 4C).
299 The XO activity, GSSG/GSH ratios and MDA concentrations were significantly higher in DIO mice than in 
300 non-DIO controls (P=0.032, P<0.001 and P=0.034, respectively; Fig. 4D, 4E and 4F). The supplementation with 
301 MUFA or with n-3 PUFA resulted in significantly lower XO activity (P=0.003 and P=0.003, respectively; Fig. 4D), 
302 GSSG/GSH ratios (P=0.015 and P<0.001, respectively; Fig. 4E) and MDA concentrations (P=0.001 and P<0.001, 
303 respectively; Fig. 4F) in the renal medulla of DIO mice than in non-supplemented animals.
304 The activities of CAT and GR were significantly lower in the renal cortex of DIO mice than in non-DIO 
305 controls (P=0.020 and P<0.001, respectively; Fig. 5A, 5C). However, the GPx activity was significantly higher in DIO 
306 mice than in their respective non-DIO controls (P<0.001; Fig. 5B). The supplementation with MUFA or with n-3 PUFA 
307 resulted in significantly higher activities of catalase (P=0.039 and P=0.011, respectively; Fig. 5A) and GR (P=0.003 
308 and P=0.007, respectively; Fig. 5C) in the renal cortex of DIO mice in comparison with non-supplemented animals. The 
309 activity of GPx was significantly lower after the supplementation with MUFA or with n-3 PUFA (P=0.006 and 
310 P=0.039, respectively; Fig. 5B) in the renal cortex of DIO animals in comparison with non-supplemented DIO mice.
311 The XO activity, GSSG/GSH ratios and MDA concentrations were significantly higher in DIO mice than in 
312 non-DIO controls (P<0.001, P=0.001 and P=0.002, respectively; Fig. 5D, 5E and 5F). The supplementation with 
313 MUFA or with n-3 PUFA resulted in significantly lower XO activity (P<0.001 and P=0.001, respectively; Fig. 5D), 
314 GSSG/GSH ratios (P=0.013 and P=0.001, respectively; Fig. 5E) and MDA concentrations (P<0.001 and P=0.002, 
315 respectively; Fig. 5F) in the renal cortex of DIO mice in comparison with non-supplemented DIO animals.
316
317 4. Discussion 
318
319 Although we previously demonstrated that the supplementations with monounsaturated (2-OHOA) and n-3 
320 polyunsaturated (DHA plus EPA) fatty acids improved the functions and redox state of immune cells (Gheorghe et al 
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321 2017; Hunsche et al 2018), the effect of these supplementations on the oxidative stress of the brain, liver, lungs and 
322 kidneys from diet-induced obese (DIO) mice, have not been studied. 
323 As shown in our previously published paper, which used the same animals, the mice fed a high-fat diet gained 
324 significantly more body weight than controls (fed a standard diet) (Gheorghe et al 2017). In addition, other studies from 
325 our laboratory confirmed that the high-fat diet intake is a good model to induce obesity in ICR-CD1 mice. These 
326 animals also showed common features of obesity, such as elevated levels of triglycerides, total cholesterol and systolic 
327 arterial pressure (Hunsche et al 2016; 2019; 2018). In turn, we observed that the supplementation with 2-OHOA, but not 
328 with n-3 PUFA, resulted in significantly lower body weight of high-fat fed mice than that of non-supplemented high-fat 
329 fed animals (Gheorghe et al 2017). In this sense, 2-OHOA seems to promote body weight loss through the induction of 
330 UCP-1 (uncoupling protein-1) expression in the adipose tissue, a process probably accompanied by enhanced energy 
331 expenditure (Vögler et al 2008). Regarding the non-effects of the supplementation with n-3 PUFA on body weight, a 
332 previous study also found that this supplementation did not reduce body weight of obese individuals (Du et al 2015). 
333 In addition, our current results showed increased oxidative stress in the brain (left and right cerebral cortex and 
334 hypothalamus), liver, lungs and kidneys (renal medulla and cortex) of diet-induced obese (DIO) mice in comparison 
335 with non-DIO controls. Thus, these DIO animals showed lower antioxidant defenses, such as CAT and GR activities, as 
336 well as higher production of oxidants, including XO activity, GSSG/GSH ratio and lipid peroxidation (MDA 
337 concentration) than non-DIO mice. The increased oxidative stress seems to be associated with lipotoxicity in these 
338 organs, which is generated when triglycerides are inappropriately stored in non-adipose tissues. The excessive 
339 accumulation of intracellular triglycerides is known to reduce the efficacy of the electron transport chain, causing the 
340 release of ROS and the generation of oxidative damage (Savini et al 2013). In agreement with our current findings, 
341 previous reports also indicate that obesity increased oxidative stress in a variety of organs, such as cerebral cortex 
342 (Freeman and Keller 2012), liver and kidneys (Noeman et al 2011; Yuzefovych et al 2013). These studies suggest that 
343 oxidative stress is related to adiposity, lipotoxicity, mitochondrial dysfunction and endoplasmic reticulum stress in a 
344 variety of organs from obese rodents (Freeman and Keller 2012; Noeman et al 2011; Yuzefovych et al 2013). 
345 Moreover, another study showed that high-fat diet feeding increased mitochondrial hydrogen peroxide (H2O2) 
346 production, causing abnormal expression of antioxidant enzymes (such as CAT) (Rindler et al 2013). Interestingly, we 
347 found higher values of glutathione peroxidase (GPx) activity (an antioxidant enzyme) in the liver, lungs and kidneys of 
348 DIO mice in comparison with non-DIO mice. However, lower values of GPx activity were observed in the brain (right 
349 cerebral cortex) of DIO mice in comparison with non-DIO mice. The higher activity of this antioxidant enzyme could 
350 possibly be explained as a compensatory mechanism to protect these cells against oxidative damage (Vincent et al 
351 2011). Similarly, another study from our laboratory also found increased values of GPx in peritoneal leukocytes of DIO 
352 mice (Hunsche et al 2019). Thus, the activity of this enzyme has been reported to increase or decrease in response to 
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353 oxidative damage depending on the moment of its evolution and the amount of peroxides generated (Liu et al 2002; Yan 
354 and Harding 1997). 
355 In turn, the dietary supplementations with 2-OHOA or with the combination of EPA and DHA in general were 
356 able to restore oxidative stress in the brain (with higher values of GPx and GR activities and lower values of MDA 
357 concentration) as well as in the liver, lungs and kidneys of DIO mice (with higher values of CAT and GR activities and 
358 lower values of XO activity, GSSG/GSH ratio and MDA concentration) in comparison with non-supplemented DIO 
359 mice. In all cases, the values showed similar levels to those of non-DIO controls. In agreement, our previous studies in 
360 spleen and peritoneal immune cells also showed amelioration of oxidative stress after the supplementations with 2-
361 OHOA or n-3 PUFA (EPA and DHA) (with increased values of catalase activity and total glutathione concentration and 
362 decreased values of XO activity, GSSG/GSH ratio and MDA concentration) (Gheorghe et al 2017; Hunsche et al 2018). 
363 Furthermore, another study demonstrated that oleic acid exhibited an antioxidant activity in Caenorhabditis elegans, 
364 which was regulated by the forkhead transcription factor DAF-16/FOXO (forkhead box protein O) (Wei et al 2016). 
365 Other studies also showed the antioxidant properties of n-3 PUFA against lead acetate-induced toxicity in the liver and 
366 kidneys of rats (Abdou and Hassan 2014), as well as in the brain of rats exposed to ethanol during gestation (Patten et al 
367 2013). One of the possible mechanisms involved in these effects could be the incorporation of unsaturated fatty acids 
368 into the cell membranes, which occurs in all tissues of the body, following their consumption. In addition, these fatty 
369 acids are known to modulate cell functions, by modifying membrane fluidity, lipid peroxide formation, eicosanoid 
370 production and gene regulation (De Pablo and Alvarez de Cienfuegos 2000; Surette 2008). 
371 Interestingly, the supplementation with 2-OHOA was not able to improve the activity of GR and the 
372 GSSG/GSH ratio in the liver of DIO mice. In addition, the supplementation with n-3 PUFA (EPA and DHA) increased 
373 the lipid peroxidation in the liver of DIO mice compared to non-supplemented DIO mice. These findings showed that 
374 both supplementations, especially with n-3 PUFA, were less effective in restoring an appropriate redox state in the liver 
375 of DIO mice in comparison with the other organs of DIO animals. This could possibly be explained by the central role 
376 of the liver in the metabolism of fatty acids and by fact that PUFA supplemented DIO mice received a higher dose 
377 (3000 mg of EPA and DHA per Kg of HFD) than that of MUFA supplemented DIO mice (1500 mg of 2-OHOA per Kg 
378 of HFD). Thus, it is possible that the lipototoxity and oxidative stress generated in the liver as a result of obesity could 
379 not be completely reversed by these supplementations. Similarly, our previous findings also showed higher 
380 susceptibility to lipid peroxidation in the spleen and peritoneal leukocytes of n-3 PUFA supplemented DIO mice than 
381 MUFA supplemented DIO mice (Gheorghe et al 2017; Hunsche et al 2018).
382 In conclusion, diet-induced obesity resulted in increased oxidative stress in the brain, liver, lungs and kidneys 
383 of mice. In turn, both supplementations with 2-OHOA and n-3 PUFA (EPA and DHA) were able to restore the redox 
384 state in these organs, bringing the values to similar levels to those of non-DIO controls. Thus, these supplementations 
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385 with 2-OHOA and n-3 PUFA could be a promising nutritional strategy to reduce the progression of obesity-related 
386 diseases as well as to promote a healthy aging, probably through the reduction of oxidative stress.
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519 FIGURE LEGENDS
520
521 Figure 1. Oxidative stress parameters in the brain. (A) Glutathione peroxidase (GPx) activity in the left cerebral cortex 
522 (mU/mg protein). (B) Glutathione reductase (GR) activity in the right cerebral cortex (mU/mg protein). (C) 
523 Malondialdehyde (MDA) concentrations in the hypothalamus (nmol/mg protein). Each column represents the mean ± 
524 SEM of 8 values corresponding to that number of animals and each value being the mean of duplicate or triplicate 
525 assays. *** P<0.001; * P<0.05 with respect to the values in non-obese control mice. ### P<0.001; ## P<0.01; # P<0.05 
526 with respect to the values in DIO mice. 
527
528 Figure 2. Oxidative stress parameters in the liver. (A) Catalase (CAT) activity (U/mg protein). (B) Glutathione 
529 peroxidase (GPx) activity (mU/mg protein). (C) Glutathione reductase (GR) activity  (mU/mg protein). (D) Xanthine 
530 oxidase (XO) activity (mU/mg protein). (E) oxidized glutathione (GSSG)/ reduced glutathione (GSH) ratio. (F) 
531 Malondialdehyde (MDA) concentrations. Each column represents the mean ± SEM of 8 values corresponding to that 
532 number of animals and each value being the mean of duplicate or triplicate assays. *** P<0.001; ** P<0.01; *P<0.05 
533 with respect to the values in non-obese control mice. ### P<0.001; ## P<0.01; # P<0.05 with respect to the values in 
534 DIO mice. 
535
536 Figure 3. Oxidative stress parameters in the lungs. (A) Catalase (CAT) activity (U/mg protein). (B) Glutathione 
537 peroxidase (GPx) activity (mU/mg protein). (C) Glutathione reductase (GR) activity  (mU/mg protein). (D) Xanthine 
538 oxidase (XO) activity (mU/mg protein). (E) oxidized glutathione (GSSG)/ reduced glutathione (GSH) ratio. (F) 
539 Malondialdehyde (MDA) concentrations. Each column represents the mean ± SEM of 8 values corresponding to that 
540 number of animals and each value being the mean of duplicate or triplicate assays. *** P<0.001 with respect to the 
541 values in non-obese control mice. ### P<0.001; ## P<0.01 with respect to the values in DIO mice.
542
543 Figure 4. Oxidative stress parameters in the renal medulla. (A) Catalase (CAT) activity (U/mg protein). (B) Glutathione 
544 peroxidase (GPx) activity (mU/mg protein). (C) Glutathione reductase (GR) activity  (mU/mg protein). (D) Xanthine 
545 oxidase (XO) activity (mU/mg protein). (E) Oxidized glutathione (GSSG)/ reduced glutathione (GSH) ratio. (F) 
546 Malondialdehyde (MDA) concentrations. Each column represents the mean ± SEM of 8 values corresponding to that 
547 number of animals and each value being the mean of duplicate or triplicate assays. *** P<0.001; ** P<0.01; *P<0.05 
548 with respect to the values in non-obese control mice. ### P<0.001; ## P<0.01; # P<0.05 with respect to the values in 
549 DIO mice. 
550
551 Figure 5. Oxidative stress parameters in the renal cortex. (A) Catalase (CAT) activity (U/mg protein). (B) Glutathione 
552 peroxidase (GPx) activity (mU/mg protein). (C) Glutathione reductase (GR) activity  (mU/mg protein). (D) Xanthine 
553 oxidase (XO) activity (mU/mg protein). (E) Oxidized glutathione (GSSG)/ reduced glutathione (GSH) ratio. (F) 
554 Malondialdehyde (MDA) concentrations. Each column represents the mean ± SEM of 8 values corresponding to that 
555 number of animals and each value being the mean of duplicate or triplicate assays. *** P<0.001; ** P<0.01; *P<0.05 
556 with respect to the values in non-obese control mice. ### P<0.001; ## P<0.01; # P<0.05 with respect to the values in 
557 DIO mice. 
558
559
560
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1 Table 1. Composition of diets
2
Components Standard maintenance diet
Intermediate-fat 
diet High-fat diet
Energy (Kcal/g) 2.9 3.3 5.1
Protein (%) 14.3 19.0 23.5
Carbohydrate (%) 48.0 44.9 27.3
Fat (%) 4.0 9.0 34.3
   Saturated (%) 0.6 1.2 12.5
   Monounsaturated (%) 0.7 1.7 16.1
   Polyunsaturated (%) 2.1 4.4 5.4
Protein (% of energy) 20.0 23.0 18.4
Carbohydrate (% of energy) 67.0 55.0 21.3
Fat (% of energy) 13.0 22.0 60.3
Fatty acid composition (%)
   C16:0 Palmitic 0.5 0.9 8.2
   C18:0 Stearic 0.1 0.2 3.9
   C18:1 Oleic 0.7 1.7 14.7
   C18:2 Linoleic 2.0 3.9 4.7
   C18:3 Linolenic 0.1 0.4 0.5
3
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3.4. EFFECTS OF THE DIETARY SUPPLEMENTATION WITH FERMENTED MILK 
CONTAINING PROBIOTICS DURING DIFFERENT PERIODS OF TIME ON 
BEHAVIOUR, IMMUNE FUNCTION AND REDOX STATE OF OLD MICE, AS WELL AS 
ON THEIR LIFE SPAN. 
 
3.4.1. Effects of the dietary supplementation with fermented milk containing probiotics 
for one and four weeks on behaviour and immune function of old female mice, as well as on 
their life span 
 
 
Experimental design  
Old mice (80 weeks old) were separated into three groups (n=8-10, per group). 1) Old mice 
without dietary supplementation. 2) Old mice supplemented with fermented milk containing 
probiotics (a commercial fermented milk drink for four weeks). 3) Old mice supplemented with 
skimmed milk containing the same amount of vitamins B6 and D as the commercially fermented 
milk for four weeks. An additional group of adult mice (n=8-10) was used as an age control. The 
commercial fermented milk drink studied contains two bacterial strains commonly used in yogurt, 
Lactobacillus delbrueckii subsp. Bulgaricus and Streptococcus thermophiles, and the probiotic 
Lactobacillus casei DN114001 (109 CFU/100g). The vitamins B6 and D were also present (0.21 
mg/100g and 0.75µg/100g, respectively). Weight, food and supplementation intakes were measured 
every day. After one week of dietary supplementation with fermented milk (probiotics) or skimmed 
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milk (vitamins), a variety of tests and assays were performed in order to evaluate the behaviour of 
animals. Peritoneal leukocytes were also obtained for the analysis of several functions. Given that 
mice are capable of remembering recently performed behavioural tests, only the immunological 
functions were studied after four weeks of dietary supplementations. Furthermore, in parallel with 
these groups, another group of old mice (n=5) was used in order to test the in vitro effect of 
probiotic, vitamins and other components, present in the fermented milk, on several functions of 
peritoneal leukocytes.  
 
Main results 
Body weight, food and drink intake measurements 
There were no significant differences in the body weight after four weeks of dietary 
supplementation. Thus, old mice supplemented with fermented milk (probiotics) exhibited an 
average weight of 42 ± 6 g, with skimmed milk (vitamins) of 44 ± 6 g and without supplementation 
of 42 ± 7 g. Also, there were no significant differences in the average daily food intake during the 
supplementation period among the three groups of old mice (5 ± 1 g/day/mouse, in old mice 
supplemented with fermented milk, 5 ± 1.4 g/day/mouse, in old mice supplemented with skimmed 
milk and 5 ± 1g/day/mouse, in old non-supplemented controls). However, with respect to the 
average daily water intake, old non-supplemented controls ingested a significantly higher amount of 
water (10 ± 3 ml/day/mouse) than old mice supplemented with fermented milk (7 ± 2 
ml/day/mouse) and with skimmed milk (6 ± 3 ml/day/mouse). The average daily supplementation 
intake during four weeks was 8 ml/day/mouse, for the group of old mice supplemented with 
fermented milk and 9 ml/day/mouse, for old mice supplemented with skimmed milk.  
Behavioural parameters 
Reflexes 
The hindlimb extensor reflex was significantly lower in old controls than in adult controls. 
Old mice supplemented with fermented milk (probiotics) or skimmed milk (vitamins B6 and D) for 
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one week exhibited a significantly higher performance of the hindlimb extensor reflex than old non-
supplemented controls. No significant differences were found among the groups of mice studied 
regarding the performance of the visual placing reflex. 
Motor coordination and equilibrium 
In the wood rod test, old controls showed significantly impaired motor coordination and 
equilibrium abilities in comparison with adult controls. However, dietary supplementation for one 
week with fermented milk (probiotics) or with skimmed milk (vitamins) resulted in a significantly 
lower percentage of old animals falling off from the rod than old non-supplemented controls. In 
addition, the percentage of old mice supplemented with fermented milk that covered at least 1 
segment and that completed the test, was significantly higher in comparison with old non-
supplemented controls and old mice supplemented with skimmed milk. 
Muscular vigour and traction 
In the tightrope test, old controls showed significantly impaired muscular vigour and traction 
capacities in comparison with adult controls. However, the supplementation with fermented milk 
for one week was able to diminish the percentage of mice that fell off the rope compared with old 
non-supplemented controls and old mice supplemented with skimmed milk. With respect to the 
percentage of mice that covered at least 1 segment and that completed the test, old mice 
supplemented with fermented milk (probiotics) or with skimmed milk (vitamins) displayed 
significantly better results than old non-supplemented controls. In addition, both supplementations 
resulted in maximum traction capacity in old mice in comparison with old non-supplemented 
controls. However, old mice supplemented with fermented milk showed significantly better 
response in all parameters that evaluated muscular vigour and traction than old mice supplemented 
with skimmed milk.  
Vertical exploratory activity 
The vertical exploratory activity of mice was assessed by the frequency of rearing. The 
percentage of old controls that performed rearings in the corner test and in the holeboard test was 
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significantly lower than in adult controls. The one-week supplementation with fermented milk 
resulted in significantly higher percentage and number of rearings in the corner test and in the 
holeboard test in comparison with old non-supplemented controls. In addition, in the holeboard test, 
there was a higher percentage of old mice supplemented with skimmed milk that performed rearings 
in comparison with old non-supplemented controls. Nevertheless, old mice supplemented with 
fermented milk showed a higher percentage of rearings performed in the corner test and in the 
holeboard test than old mice supplemented with skimmed milk.  
Horizontal exploratory activity 
In the corner test, old mice supplemented with fermented milk for one week displayed a 
higher number of corners visited than old non-supplemented controls. With respect to central 
locomotion in the holeboard test, old mice supplemented with fermented milk exhibited a 
significantly higher locomotion than old non-supplemented controls and old mice supplemented 
with skimmed milk. There were no significant differences in the total and in the peripheral 
locomotion among the groups of mice studies in the holeboard test. In addition, no significant 
differences were observed among the groups of animals in the performance of the T-maze test.  
Goal-directed exploratory behaviour  
The goal-directed exploratory behaviour of mice was significantly lower in old controls with 
respect to adults. However, the one-week supplementation with fermented milk or with skimmed 
milk resulted in a higher percentage of old mice performing head-dips than old non-supplemented 
controls. In addition, old mice supplemented with fermented milk performed more head-dips than 
old mice supplemented with skimmed milk.  
Behaviours related to anxiety-like behaviour 
Old controls showed a higher frequency performing self-grooming in the holeboard test and 
in the T-maze test than adult controls. The one-week supplementation with fermented milk or with 
skimmed milk resulted in a lower percentage of old mice performing self-grooming in the T-maze 
test in comparison with old non-supplemented controls. In addition, in the holeboard test, old mice 
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supplemented with fermented milk showed a lower number of self-groomings with respect to old 
non-supplemented controls. The presence of fecal bolei in the T-maze test was significantly higher 
in old controls in comparison with adult controls. The supplementation with fermented milk or with 
skimmed milk for one week resulted in a significantly lower presence of fecal bolei than old non-
supplemented controls. 
Peritoneal leukocyte function parameters 
The chemotaxis index of macrophages (mobility in response to a chemotactic gradient such 
as formylated peptide) was significantly suppressed in old mice compared with adult mice. Old 
mice supplemented with fermented milk (probiotics) for one and four weeks displayed significantly 
higher values of this chemotaxis index in comparison with old non-supplemented controls and old 
mice supplemented with skimmed milk. No significant differences were observed between old mice 
supplemented with skimmed milk (one and four weeks) and old non-supplemented controls. 
The phagocytic index was significantly lower in old mice with respect to adult mice. The 
supplementation with fermented milk (probiotics) in old mice, at different times (one and four 
weeks), resulted in a higher phagocytic index than in old non-supplemented controls. The 
supplementation with skimmed milk (vitamins) was not able to improve this function in comparison 
with old non-supplemented controls. However, a significantly higher phagocytic index in the group 
of old mice supplemented with skimmed milk (vitamins) for four weeks was observed with respect 
to the same group supplemented for one week. The number of macrophages with phagocytic ability 
(phagocytic efficiency) was significantly lower in old controls than in adult controls. Old mice 
supplemented with fermented milk (probiotics) for one and four weeks or with skimmed milk 
(vitamins) for four weeks showed significantly higher phagocytic efficiency than old non-
supplemented animals. In addition, old mice supplemented with fermented milk (probiotics) for 
four weeks exhibited higher phagocytic efficiency in comparison with old mice supplemented with 
skimmed milk (vitamins). There were no statistically significant differences between old mice 
supplemented with skimmed milk (vitamins) for one week and old non-supplemented controls. 
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However, old mice supplemented with skimmed milk for four weeks displayed significantly higher 
values of phagocytic efficiency than the same group of old mice supplemented for one week.  
The chemotaxis index of peritoneal lymphocytes induced by a chemotactic peptide showed 
significantly lower values in old mice than in adult mice. The one and four weeks supplementation 
with fermented milk (probiotics) in old mice resulted in significantly higher chemotaxis index than 
in non-supplemented old mice and old mice supplemented with skimmed milk (vitamins). 
Furthermore, old mice supplemented with skimmed milk for four weeks showed a higher 
chemotaxis index of lymphocytes when compared with old non-supplemented controls. No 
significant differences were found between old mice supplemented with skimmed milk for one 
week and old non-supplemented controls.  
The anti-tumour NK activity was significantly suppressed in old mice in comparison with 
adult mice. Old mice supplemented with fermented milk (probiotics) at different times (one and 
four weeks) showed significantly higher NK activity than old non-supplemented controls. In 
addition, old mice supplemented with skimmed milk (vitamins) for four weeks resulted in higher 
NK activity than old non-supplemented controls. However, old mice supplemented with skimmed 
milk (vitamins) for one week did not show significant differences in comparison with old non-
supplemented controls.  
The lymphoproliferation in response to T-cell mitogen (ConA) and to B-cell mitogen (LPS) 
was lower in old mice than in adults. Old mice supplemented with fermented milk (probiotics) for 
four weeks displayed significantly higher proliferation of lymphocytes in response to ConA and 
LPS than old non-supplemented controls. In addition, in the group of old mice supplemented with 
skimmed milk for four weeks a higher proliferation of lymphocytes in response to LPS in 
comparison with old non-supplemented controls was observed. Nevertheless, old mice 
supplemented with skimmed milk for four weeks did not show significant differences in the 
proliferation of lymphocytes in response to ConA in comparison with old non-supplemented 
controls. Furthermore, old mice supplemented with fermented milk or with skimmed milk for one 
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week showed no significant differences in the proliferation of lymphocytes in response to ConA or 
LPS.  
In vitro immunoassays 
The chemotaxis index of lymphocytes with the presence of fermented milk supernatant, 
which contains probiotic bacteria, showed significantly higher values than in controls. In addition, 
the chemoattractant capacity of fermented milk supernatant tended to be higher than the 
chemoattractant capacity of the formyl peptide. With respect to antitumour NK activity, the 
fermented milk supernatant added to the effector cells (leukocytes) showed significantly higher 
values than in controls.  
Life span 
The differences were not statistically significant among the groups of mice. The average of 
life span of old mice supplemented with fermented milk containing probiotics was 108 ± 10 weeks, 
with skimmed milk (vitamins B6 and D) it was 100 ± 15 weeks, and in old non-supplemented 
controls it was 111 ± 15 weeks. 
 
Partial conclusions 
The results of this experiment indicate that a short-term (one week) supplementation with a 
commercial drink containing probiotics is able to improve behaviour and immune function of old 
mice, these reaching similar values to those found in adult controls. Furthermore, a longer-term 
supplementation (four weeks) maintains these improvements in the same immune function 
parameters. 
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Abstract
Aging is associated with an impairment of the regulatory systems, including the nervous and immune systems as
well as the communication between them. The consumption of fermented milk containing live probiotic bacteria
seems to have neurological and immunological benefits. The aim of the present study was to evaluate the effects of
the supplementation with a fermented milk containing yogurt cultures and the probiotic Lactobacillus casei
DN-114001 on behaviour and immune functions of old mice as well as on their life span. Also, the in vitro properties
of these probiotics on functions of peritoneal leukocytes were analysed. Old female ICR-CD1 mice were
supplemented with fermented milk containing probiotics. After 1 and 4 weeks of supplementation, behavioural tests
were performed and immunological functions in peritoneal leukocytes studied. The results showed that a short-term
(one week) supplementation with fermented milk containing probiotics was able to improve behavioural aspects
(such as motor coordination, equilibrium, muscular vigour, exploratory activity and anxiety-related behaviour) as well
as immune functions in old mice that had been impaired by age, reaching similar levels to those found in adult
controls. Furthermore, a longer-term supplementation (four weeks) was able to maintain these improvements in the
immunological parameters. Probiotics seem to have a direct effect on several immune functions. In conclusion, the
supplementation with fermented milk containing probiotics could be a good nutritional strategy to improve behaviour
and immune system functions in old individuals and, consequently, to promote healthier aging.
Keywords: Aging; Fermented milk with probiotics; Behaviour;
Immune system functions
Introduction
The impairment in aging of the immune and nervous systems has
been associated with increased susceptibility to infectious diseases,
cancer, and neurodegenerative diseases [1]. It is well known that the
nervous and immune systems are intricately connected and share a
bidirectional communication. Thus, any alteration exerted on the
immune system will promote an effect on the nervous system and vice
versa [1,2]. With respect to the central nervous system, there is an age-
related progressive deterioration of a variety of brain and behavioural
functions, including memory, cognitive, and motor activity [3,4].
Moreover, old individuals become more susceptible to suffer mental
disorders, such as anxiety [5]. Also, the immune system undergoes a
variety of changes, denominated immunosenescence, which include
altered innate and adaptive immune functions, such as a marked
decreased activity of phagocytic cells, anti-tumour natural killer (NK)
cytotoxicity and proliferation of lymphocytes [6]. Increasing evidence
suggests that the age-related deterioration of the nervous and immune
systems are mainly based on oxidative and inflammatory stresses (an
imbalance between oxidant and pro-inflammatory compounds versus
antioxidant and anti-inflammatory compounds in favour of the
former). Although the production of low levels of oxidants and
inflammatory compounds is essential for effective immune response,
an overproduction of these compounds by immune cells may lead to
cellular and tissue damages [7]. In fact, an oxidative-inflammatory
theory has been proposed to explain the cause of aging. Moreover, in
this theory, the immune system has been described as a critical player
in these stresses and consequently in the rate of aging [8].
The composition and functionality of gut microbiota are also
affected by aging, the gut microbiota diversity of aged individuals being
lower compared with younger people [9,10]. There is also a decrease in
beneficial species, such as Bifidobacteria [11]. In this sense, the
consumption of fermented milk containing probiotics has gained
much attention from scientific and commercial communities [12].
Probiotics are live microorganisms that are claimed to confer health
benefits when administered in adequate amounts [13]. Many reports
have indicated that certain strains of probiotics are capable of
stimulating and modulating the immune response of the host. Thus,
there is an increased application of probiotics to treat immune
impairments, such as allergic, inflammatory and autoimmune
disorders [14-18]. Several studies also indicated anti-aging
(ameliorating immunosenescence) [19] and anti-tumour proprieties of
probiotics [20]. In addition, growing evidence suggest that probiotics
could also affect brain and behavioural functions [21-25]. It seems that
probiotics through the modulation of gut microbiota, or directly, could
beneficially affect the bidirectional communication between gut and
brain, from which has emerged the concept of microbiota-gut-brain
axis [21].
Many studies have been conducted in order to analyse the immune
modulating properties of probiotics in adults, and several on their
behavioural effects. However, little research has been developed to
study particularly the repercussion of probiotics on these aspects in
older individuals, as well as on life spans, for which is necessary to use
experimental animals with very shorter longevity than humans. Thus,
the aim of the present work was to evaluate the effects of the
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supplementation with a fermented milk containing yogurt cultures and
the probiotic Lactobacillus casei DN-114001 on behaviour and
immune functions of old mice as well as on their life span. The in vitro
properties of these probiotics on some functions of peritoneal
leukocytes were also analysed to detect possible direct effects.
Materials and Methods
Animals
Old (80 ± 4 weeks of age) and adult (32 ± 4 weeks of age) female
ICR/CD1 mice (Mus musculus) (Janvier SAS, Chassal, Francia) were
used. The animals were housed in polyurethane cages (5 animals per
cage) and maintained under standard laboratory conditions (12:12 h
reversed light/dark cycle; lights on at 8:00 pm, relative humidity of
50-60%, temperature of 22 ± 2°C and adequate ventilation). All mice
were fed a standard maintenance diet (Teklad Global 14% Protein
Rodent Maintenance Diet, Harlan Interfauna Iberica, Barcelona,
Spain) and water at libitum. The experiments were conducted in
accordance with the guidelines and protocols of the Royal Decree
53/2013 regarding the care and use of laboratory animals for
experimental procedures, and were approved by the Committee for
Animal Experimentation of the Complutense University of Madrid.
Experimental groups
Old mice were separated into three groups (n=8-10, per group),
namely (1) old mice which were not dietary supplemented; (2) old
mice supplemented with fermented milk containing probiotics (a
commercial fermented milk drink during four weeks); (3) old mice
supplemented with skimmed milk containing the same amount of
vitamins B6 and D as the commercially fermented milk for four weeks.
An additional group of adult mice (n=8-10) was used as age controls.
The commercial fermented milk drink studied contains two bacterial
strains commonly used in yogurt, Lactobacillus delbrueckii subsp.
Bulgaricus and Streptococcus thermophilus, and the probiotic
Lactobacillus casei DN114001 (109 CFU/100 g). The vitamins B6 and
D were also present (0.21 mg/100 g and 0.75 μg/100 g, respectively).
Weight, food and supplementation intakes were measured every day.
After one week of dietary supplementation with ferment milk
(probiotics) or skimmed milk (vitamins), a variety of tests and assays
were performed in order to evaluate the behaviour of animals and
peritoneal leukocytes were obtained for the analysis of several
functions. Given that mice are capable of remembering recently
performed behavioural tests, only the immunological functions were
studied after four weeks of dietary supplementations. Furthermore, in
parallel with these groups, another group of old mice (n=5) was used
in order to test the in vitro effect of probiotic, vitamins and other
components, present in the fermented milk, on several functions of
peritoneal leukocytes.
Fermented milk supernatant for the in vitro immunoassays
A sample of the fermented milk drink was centrifuged at 3600 g for
10 minutes at 4°C and two successive centrifugations under the same
conditions were performed from the resulting supernatant. The
supernatant, composed of microbial probiotic strains (Lactobacillus
delbrueckii subsp. Bulgaricus, Streptococcus thermophilus,
Lactobacillus casei DN114001), vitamins and other components of the
fermented milk drink, was used to evaluate the chemotaxis capacity of
lymphocytes and the natural killer cytotoxicity, as well as assessing its
chemoattractant activity.
Behavioural tests
Behavioural tests were carried out between 8 am and 10 am during
two consecutive days, followed a procedure previously described [2].
On the first day, a battery of tests (reflexes, T-maze, wood rod, corner
and tightrope tests) was performed. On the second day, mice were
subjected to the holeboard test. The experimental apparatus was
cleaned before the performance of each mouse in order to avoid
olfactory trails.
Reflexes: Visual and hindlimb extensor reflex: When the mouse was
suspended by the tail and lowered toward a solid black surface, the
visual placing reflex was evaluated by observing the complete
extension of the forelimbs, and the hindlimb reflex was measured by
the complete extension of these limbs. The mean response was rated in
three trials.
Motor coordination and equilibrium abilities: In order to assess
motor coordination and equilibrium, animals were placed in the centre
of a wood elevated rod (rod dimensions: 22 cm height, 80 cm length,
2.9 cm width, divided in segments of 10 cm) for one trial of 60 s. Motor
coordination and equilibrium were measured by the percentage of
mice falling off the rod. In addition, the percentages of mice that cover
at least 1 segment and that complete the test were also considered as
motor coordination and equilibrium abilities.
Muscular vigour and traction: As an index of muscular vigour, mice
were hanged by its forelimbs in the middle of an elevated horizontal
tightrope (40 cm height, 60 cm length and divided into 6 segments of
10 cm) [2]. This method is used to evaluate the muscular vigour and
traction in one training trial of 5 seconds and a test trial of 60 seconds.
Muscular vigour was assessed as the percentage of mice falling off the
rope and as the percentages of mice that cover at least 1 segment and
that complete the test. Traction was evaluated by analysing the
different parts of the body that mice used to remain hanged (forelimbs,
hindlimbs and tail) and, subsequently, the percentages of mice
displaying the maximum traction capacity (using forelimbs, hindlimbs
and tail).
Non-goal-directed: Behaviour vertical exploratory activity: The
vertical exploratory activity (studied as the performance of “rearing”,
that is, when the mouse stands up on his hindlimbs so that his body
becomes more perpendicular to the ground) was evaluated in the
corner test and in the holeboard test. The corner test consists in placing
the mouse in a new cage (22.0 × 22.0 × 14.5 cm) with bedding during
30 s. In contrast, the holeboard test consists in placing the animal in a
box made of wood (60 × 60 × 45 cm) with matte-painted metallic
walls, divided into 36 squares (10 × 10 cm), bearing four equally
spaced holes (3.8 cm of diameter). All but 20 peripheral squares were
considered central. The test was performed during 5 minutes [2].
Horizontal exploratory activity: Horizontal exploratory activity was
assessed as the number of corners of the cage visited (in the corner
test) and as the peripheral locomotion (number of line crossings in the
peripheral area, by the walls) and central locomotion (number of line
crossings in the central area) in the holeboard test. In addition,
horizontal exploratory behaviour was also recorded using the T-maze
test, which is a wooden apparatus with three enclosed arms (short arm:
27 × 10 cm; long arm: 64 × 10 cm; walls: 19 cm high) [2]. The mouse
was placed inside the “short” arm of the maze with its head facing the
wall. The time elapsed (in seconds) until the animal crosses with both
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hindlimbs the intersection of the T-maze and the time (in seconds) to
explore the entire maze (exploration of all three maze arms) were
assessed.
Goal-directed exploratory behaviour: The goal-directed exploratory
behaviour of mice was assessed in the holeboard test. An object formed
by a white plastic was placed into each of the four holes of the
holeboard to attract mice attention. The frequency (percentage and
number) of mice that perform head-dips (when the animal places its
head into the hole) was considered as a goal-directed exploratory
behaviour.
Behaviours related to anxiety-like behaviour: Behaviour related to
anxiety-like behaviour was measured in holeboard and T-maze tests.
The total number and percentage of mice that perform self-grooming
(when mouse cleans, licks or scratches its body) in both tests and the
presence of defecation in the T-maze test were recorded. This last
parameter was also considered as an index of anxiety-like behaviour.
Collection of peritoneal leukocytes
The peritoneal suspensions were obtained between 8 am and 10 am
to minimize circadian variations in the immune system, by a
procedure previously described, without animal sacrifice [26,27],
which allowed monitoring the life span of the mice. Briefly, 3 ml of
Hank´s solution, adjusted to pH 7.4, were injected into the
peritoneum, the abdomen was massaged and the peritoneal exudate
cells were collected allowing the recovery of 90-95% of the injected
volume. The peritoneal leukocytes, consisting of lymphocytes and
macrophages, were counted in Neubauer chambers (Blau Brand,
Germany). The suspensions were adjusted to a final concentration of 5
× 105 macrophages or lymphocytes/ml in Hank´s solution or 106
leukocytes/ml in Hank’s solution or complete medium (RPMI 1640
enriched with L-glutamine (PAA, Pasching, Austria) and
supplemented with 10% heat-inactivated (56°C, 30 min) fetal calf
serum (PAA) and gentamicin (100 mg/ml, PAA) with or without
phenol red, depending on the type of assay used. Macrophages and
lymphocytes were identified by their morphology. The cellular viability
was measured using the trypan-blue (Sigma-Aldrich, Madrid, Spain)
exclusion test and in all cases was higher than 98%.
The immune functions parameters studied were performed using
unfractionated peritoneal leukocytes, which better preserved the
physiological environment surrounding the immune cells in vivo [28].
Chemotaxis assay: Chemotaxis of peritoneal leukocytes was
evaluated according to a slight modification of Boyden’s method [26],
consisting basically of the use of chambers with two compartments
separated by a filter with a pore diameter of 3 µm (Millipore, Bedford,
MA, USA). Aliquots of 300 μl of the peritoneal suspensions, with
macrophages or lymphocytes adjusted to 5 × 105 cells/ml in Hank’s
solution, were deposited in the upper compartment, and aliquots of
400 µl of the chemoattractant, formyl-Met-Leu-Phe (10-8 M) (Sigma-
Aldrich), were put into the lower compartment. The chambers were
incubated for 3 h and then the filters were fixed and stained. The
chemotaxis index (CI) was determined by counting, in an optical
microscope (100X), the total number of macrophages and lymphocytes
on one third of the lower face of the filters.
Phagocytosis assay: Phagocytosis assay of inert particles (latex
beads) was carried out following a method previously described [26].
Aliquots of 200 µl of the peritoneal suspensions adjusted to 5 × 105
macrophages/ml in Hank’s medium were incubated in migration
inhibitory factor (MIF) plates (Kartell, Noviglio, Italy) for 30 min. The
adhered monolayer was washed with pre-warmed PBS (phosphate
buffer saline), and then 200 µl of Hank’s medium and 20 µl of latex
bead suspension (1.09 µm, diluted to 1% PBS) (Sigma-Aldrich) were
added. After 30 min of incubation, the plates were washed, fixed and
stained. The number of particles ingested by 100 macrophages was
counted using an optical microscope (100X) and expressed as
phagocytic index (PI). The percentage of macrophages, which
phagocyted at least one latex bead, was also determined and expressed
as phagocytic efficiency (PE).
Natural killer assay: An enzymatic colorimetric assay was carried
out to measure the cytolysis of tumour cells (Cytotox 96 TM Promega,
Boehringer Ingelheim, Germany) based on the determination of
lactate dehydrogenase enzyme (LDH), as previously described [26].
Aliquots of 100 µl of peritoneal leukocytes, used as effector cells, were
seeded in 96-well U-bottom culture plates (Numc, Roskilde, Denmark)
adjusted to 106 leukocytes per ml in RPMI 1640 medium without
phenol red. Murine lymphoma YAC-1 cells, used as target cells, were
added adjusted to 105 cells per ml. Thus, the effector/target ratio was
10:1. The plates were centrifuged at 250 g for 4 min to facilitate cell
contacts. After 4 hours of incubation, lactate dehydrogenase enzymatic
activity was measured in 50 µl/well of the supernatants by addition of
the enzyme substrate and absorbance recording
spectrophotometrically at 490 nm. Three kinds of control
measurements were performed: a target spontaneous release, a target
maximum release, and an effector spontaneous release. The results
were expressed as percentage of lysis of target cells. To determine this
percentage the following equation was used: %lysis=((E-ES-TS)/M-ES-
TS)) × 100, where E is the mean of absorbance in the presence of
effector cells; ES, the mean of absorbance of effector cells incubated
alone; TS, the mean of absorbance in target cells incubated with
medium alone; and M is the mean of maximum absorbance after
incubating target cells with lysis solution.
Lymphoproliferation assay: Following the method previously
described [27], aliquots (200 µl) of peritoneal leukocytes (106
lymphocytes/ml complete medium) were seeded in 96 well flat-
bottomed microtitre plates (Numc, Roskilde, Denmark) and 20 µl of
concanavaline A (ConA 1 µg/ml; Sigma-Aldrich), 20 µl of
lipopolysaccharide (LPS, E. coli, 055:B5 1 µg/ml; Sigma-Aldrich) or 20
µl of complete medium (spontaneous proliferation) were added per
well. After 48 h of incubation at 37°C in an atmosphere of 5% CO2, 0.5
µCi 3H-thymidine (Du Pont, Boston, MA, USA) were added to each
well. The cells were harvested in a semiautomatic microharvester 24 h
later. Thymidine uptake was measured using a beta counter (LKB,
Uppsala, Sweden). The results were expressed as 3H-thymidine uptake
(cpm).
In vitro immunoassays for testing microbial probiotic strains
and other components of fermented milk
Chemotaxis assay: The chemotaxis index of lymphocytes was
assessed as previously described above. However, aliquots of 300 μl of
the peritoneal suspensions adjusted to 5 × 105 lymphocytes/ml in
Hank’s solution were added to 30 μl of Hank’s solution (control) or to
30 μl of fermented milk supernatant and then deposited in the upper
compartment of the chamber. Also, for evaluation of the
chemoattractant capacity of lymphocytes, 400 µl of the fermented milk
supernatant or aliquots of the chemoattractant, formyl-Met-Leu-Phe
(10-8 M) (Sigma-Aldrich) were put into the lower compartment of the
chamber. The chemotaxis index (CI) was determined by counting, in
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an optical microscope (100X), the total number of lymphocytes on one
third of the lower face of the filters.
Natural killer assay: An enzymatic colorimetric assay was carried
out to measure the cytolysis of tumour cells (Cytotox 96 TM Promega,
Boehringer Ingelheim, Germany) as previously described above.
Nevertheless, it was used as effector cells aliquots of 100 µl of
peritoneal leukocytes (adjusted to 106 leukocytes/ml) with 10 μl of
fermented milk supernatant. Murine lymphoma YAC-1 cells (target
cells) were added adjusted to 105 cells/ml. The results were expressed as
percentage of lysis of target cells.
Statistical analysis: SPSS 21.0 (SPSS, Inc., Chicago, USA) was used
for the statistical analysis of the results. The data were expressed as
mean ± standard deviation (SD). Each value is the mean of the data
from an assay performed in duplicate or triplicate. Normality of the
samples was checked by the Kolmogorov-Smirnov test and
homogeneity of variances with the Levene test. The data were
statistically evaluated by the Student’s t-test for independent and paired
samples. P<0.05 was considered statistically significant and 0.05<P<0.1
was considered as a trend.
Results
Body weight, food and drink intakes
There were no significant differences in the body weight after four
weeks of dietary supplementation. Thus, old mice supplemented with
fermented milk (probiotics) exhibited an average weight of 42 ± 6 g,
with skimmed milk (vitamins) of 44 ± 6 g and without
supplementation of 42 ± 7 g. Also, there were no significant differences
in the average daily food intake during supplementation period among
the three groups of old mice (5 ± 1 g/day/mouse, in old mice
supplemented with fermented milk, 5 ± 1.4 g/day/mouse, in old mice
supplemented with skimmed milk and 5 ± 1 g/day/mouse, in old non-
supplemented controls). However, with respect to the average daily
water intake, old non-supplemented controls ingested a significant
higher amount of water (10 ± 3 ml/day/mouse) than old mice
supplemented with fermented milk (7 ± 2 ml/day/mouse) and with
skimmed milk (6 ± 3 ml/day/mouse) (P<0.001). The average daily
supplementation intake during four weeks was 8 ml/day/mouse, for
the group of old mice supplemented with fermented milk and 9
ml/day/mouse, for old mice supplemented with skimmed milk.
Behavioural tests
Table 1 shows the results obtained in the behavioural assessments of
old non-supplemented mice and old mice supplemented with
fermented milk (probiotics) or skimmed milk (vitamins).
Behaviour Old mice
1 week supplementation
Adult crtl Old crtl Fermented milk
with probiotics
Skimmed milk
with vitamins
Reflexes
% of mice that show visual placing reflex 100 100 100 100
% of mice that show hindlimb extensor reflex 100*** 86 100*** 100***
Motor coordination and equilibrium (Wood rod test)
% of mice falling off 0*** 29 14*** 12***
% of mice that cover at least 1 segment 100*** 71 100***### 75
% of mice that complete the test 100*** 57 86***### 62
Muscular vigour (Tightrope test)
% of mice falling off 14*** 87 71**## 87
% of mice that cover at least 1 segment 100*** 0 57***## 37***
% of mice that complete test 87*** 0 29***## 12**
Traction (Tightrope test)
% of mice that show maximum traction capacity 87*** 14 57***## 37***
Non-goal-directed exploratory behaviour
Vertical exploratory activity
% of mice that perform rearing (Corner test) 100*** 86 100***### 87
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Total number of rearings (Corner test) 5 ± 1.5 3.5 ± 2.5 6 ± 1.5* 4.5 ± 2.5
% of mice that perform rearing (Holeboard test) 86* 71 100***## 88**
Horizontal exploratory activity
Number of corners visited (Corner test) 7 ± 1.5 8.5 ± 2 11 ± 1.5* 9.5 ± 4
Total number of line crossings (Holeboard test) 217 ± 30 222 ± 50 267 ± 74 229 ± 96
Number of line crossings in the peripheral area (Holeboard test) 118 ± 26 137 ± 40 149 ± 54 148 ± 74
Number of line crossings in the central area (Holeboard test) 99 ± 13 85 ± 31 118 ± 33*# 81 ± 28
Time for crossing the intersection of the maze (s) (T-maze test) 10 ± 2 10 ± 6 7 ± 4 14 ± 8
Time to complete the test (s) (T-maze test) 36 ± 9 27 ± 11 25 ± 13 48 ± 30
Goal-directed exploratory behaviour
% of mice that perform head-dips (Holeboard test) 100* 93 100* 100*
Number of head-dips (Holeboard test) 10 ± 3 7 ± 4 10 ± 3## 5 ± 2
Behaviours related to anxiety-like behaviour
Total number of self-grooming (Holeboard test) 1 ± 1* 4 ± 3 2 ± 0.5* 2 ± 1
% of mice that perform self-grooming (T-maze test) 0*** 14 0*** 0***
% fecal bolei presence (T-maze test) 0*** 29 14* 12**
Table 1: Behavioural tests in old mice supplemented with fermented milk (probiotics) and with skimmed milk (vitamins) during one week.
Results are expressed as percentage (%) or mean ± SD in adult control (n=8-10), old control (n=8-10), old mice supplemented with fermented
milk (n=8-10) and old mice supplemented with skimmed milk (n=8-10). *P<0.05; **P<0.01; ***P<0.001 with respect to the values of old control
mice. #P<0.05; ##P<0.01; ###P<0.001 with respect to the values of old mice supplemented with skimmed milk.
Reflexes: The hindlimb extensor reflex, which is shown in Table 1,
was significantly lower in old controls than in adult controls (P<0.001).
Old mice supplemented with fermented milk (probiotics) or skimmed
milk (vitamins B6 and D) during one week exhibited a significantly
higher performance of the hindlimb extensor reflex than old non-
supplemented controls (P<0.001). No significant differences were
found among the studied groups of mice regarding the performance of
the visual placing reflex (Table 1).
Motor coordination and equilibrium: In the wood rod test, old
controls showed significantly impaired motor coordination and
equilibrium abilities in comparison with adult controls (P<0.001, Table
1). However, dietary supplementation during one week with fermented
milk (probiotics) or with skimmed milk (vitamins) resulted in
significantly lower percentage of old animals falling off from the rod
than old non-supplemented controls (P<0.001, Table 1). In addition,
the percentage of old mice supplemented with fermented milk that
covered at least 1 segment and that completed the test was significantly
higher in comparison with old non-supplemented controls and old
mice supplemented with skimmed milk (P<0.001, Table 1).
Muscular vigour and traction: In the tightrope test, old controls
showed significantly impaired muscular vigour and traction capacities
in comparison with adult controls (P<0.001, Table 1). However, the
supplementation with fermented milk during one week was able to
diminish the percentage of mice that fell off from the rope compared
with old non-supplemented controls and old mice supplemented with
skimmed milk (P<0.01, Table 1). With respect to the percentage of
mice that covered at least 1 segment and that completed the test (Table
1), old mice supplemented with fermented milk (probiotics) (P<0.001)
or with skimmed milk (vitamins) (P<0.001 and P<0.01, respectively)
displayed significantly better results than old non-supplemented
controls. In addition, both supplementations resulted in maximum
traction capacity in old mice in comparison with old non-
supplemented controls (P<0.001, Table 1). However, old mice
supplemented with fermented milk showed significantly better
response in all parameters that evaluated muscular vigour and traction
than old mice supplemented with skimmed milk (P<0.01, Table 1).
Non-goal-directed behaviour: Vertical exploratory activity: The
vertical exploratory activity of mice, which was assessed by the
frequency of rearing, is shown in Table 1. The percentage of old
controls that performed rearings in the corner test and in the
holeboard test was significantly lower than in adult controls (P<0.001
and P<0.05, respectively, Table 1). The one-week supplementation with
fermented milk resulted in significantly higher frequency (percentage
and number) of rearings in the corner test (P<0.001 and P<0.05,
respectively) and in the holeboard test (P<0.001) in comparison with
old non-supplemented controls (Table 1). In addition, in the holeboard
test, there was a higher percentage of old mice supplemented with
skimmed milk that performed rearings in comparison with old non-
supplemented controls (P<0.01, Table 1). Nevertheless, old mice
supplemented with fermented milk showed a higher percentage of
rearing performance in the corner test and in the holeboard test than
old mice supplemented with skimmed milk (P<0.001 and P<0.01,
respectively, Table 1).
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Horizontal exploratory activity: The results of horizontal
exploratory activity are shown in Table 1. In the corner test, old mice
supplemented with fermented milk during one week displayed a higher
number of corners visited than old non-supplemented controls
(P<0.05, Table 1). With respect to the central locomotion in the
holeboard test, old mice supplemented with fermented milk exhibited
a significantly higher locomotion than old non-supplemented controls
and old mice supplemented with skimmed milk (P<0.05, Table 1).
There were no significant differences in the total and in the peripheral
locomotion among the studied groups of mice in the holeboard test
(Table 1). In addition, no significant differences were observed among
the groups of animals in the performance of the T-maze test (Table 1).
Goal-directed exploratory behaviour: The goal-directed exploratory
behaviour of mice, which is shown in Table 1, was significantly lower
in old controls with respect to adult controls (P<0.05). However, the
one-week supplementation with fermented milk or with skimmed milk
resulted in a higher percentage of old mice performing head-dips than
old non-supplemented controls (P<0.05, Table 1). In addition, old mice
supplemented with fermented milk performed more head-dips than
old mice supplemented with skimmed milk (P<0.01, Table 1).
Behaviours related to anxiety-like behaviour: The results of the
different tests that assessed behaviours related to anxiety-like
behaviour of old mice are shown in the Table 1. Old controls showed a
higher frequency performing self-grooming in the holeboard test and
in the T-maze test than adult controls (P<0.05 and P<0.001,
respectively, Table 1). The one-week supplementation with fermented
milk or with skimmed milk resulted in a lower percentage of old mice
performing self-grooming in the T-maze test in comparison with old
non-supplemented controls (P<0.001, Table 1). In addition, in the
holeboard test, old mice supplemented with fermented milk showed a
lower number of self-grooming with respect to old non-supplemented
controls (P<0.05, Table 1). The presence of fecal bolei in the T-maze
test was significantly higher in old controls in comparison with adult
controls (P<0.001, Table 1). The supplementation with fermented milk
or with skimmed milk during one week resulted in significantly lower
presence of fecal bolei than old non-supplemented controls (P<0.05
and P<0.01, respectively, Table 1).
Immune function parameters
Macrophage peritoneal functions: The peritoneal macrophage
functions are shown in Figure 1. The chemotaxis index of macrophages
in response to a chemotactic gradient (formylated peptide), which
mimics the migration of immune cells towards the infection site, was
significantly suppressed in old mice compared with adult mice
(P<0.01, Figure 1A). Old mice supplemented with fermented milk
during one and four weeks displayed significantly higher values of the
chemotaxis index of peritoneal macrophages (Figure 1A) in
comparison with old non-supplemented controls (P<0.05 and P<0.001,
respectively) and old mice supplemented with skimmed milk (P<0.05).
No significant differences were observed between old mice
supplemented with skimmed milk (one and four weeks) and old non-
supplemented controls (Figure 1A).
Figure 1: Macrophage functions. (A) Macrophage chemotaxis index
(CI, number of macrophages). (B) Macrophage phagocytic index
(PI, number latex beads/100 macrophages). (C) Macrophage
phagocytic efficacy (PE, number of phagocyting macrophages/100
macrophages). Each column represents the mean ± SD of 8-10
values corresponding to that number of animals and each value
being the mean of duplicate or triplicate assays. *** P<0.001; **
P<0.01 with respect to the values of old control mice. ### P<0.001; #
P<0.05 with respect to the values of old mice supplemented with
skimmed milk (vitamins) during one week. &&& P<0.001 with
respect to the values of old mice supplemented with skimmed milk
(vitamins) during four weeks.
The number of latex beads ingested by macrophages, which is
measured by the phagocytic index (Figure 1B), was significantly lower
in old mice with respect to adult mice (P<0.001). The supplementation
with fermented milk (probiotics) in old mice, at different times (one
and four weeks), resulted in a higher phagocytic index than old non-
supplemented controls (P<0.001, Figure 1B). The supplementation
with skimmed milk (vitamins) was not able to improve this function in
comparison with old non-supplemented controls (Figure 1B).
However, it was observed a significantly higher phagocytic index in the
group of old mice supplemented with skimmed milk (vitamins) during
four weeks with respect to the same group supplemented during one
week (P<0.05, Figure 1B). The number of macrophages with
phagocytic ability (Figure 1C) was significantly lower in old controls
than in adult controls (P<0.001, Figure 1C). Old mice supplemented
with fermented milk (probiotics) during one and four weeks or with
skimmed milk (vitamins) during four weeks showed significantly
higher phagocytic efficiency than old non-supplemented controls
(P<0.001, Figure 1C). In addition, old mice supplemented with
fermented milk (probiotics) during four weeks exhibited higher
phagocytic efficiency in comparison with old mice supplemented with
skimmed milk (vitamins) (P<0.001, Figure 1C). There were no
statistically significant differences between old mice supplemented
with skimmed milk (vitamins) during one week and old non-
supplemented controls (Figure 1C). However, old mice supplemented
with skimmed milk during four weeks displayed significantly higher
values of phagocytic efficiency than the same group of old mice
supplemented during one week (P<0.001, Figure 1C).
Lymphocyte peritoneal functions: The lymphocyte functions are
displayed in Figure 2. The chemotaxis index of peritoneal lymphocytes
induced by a chemotactic peptide (Figure 2A) showed significantly
lower values in old mice than in adult mice (P<0.05). The one and four
weeks supplementation with fermented milk (probiotics) in old mice
resulted in significantly higher chemotaxis index (Figure 2A) than in
old mice non-supplemented (P<0.05 and P<0.001, respectively) and
old mice supplemented with skimmed milk (vitamins) (P<0.05).
Furthermore, old mice supplemented with skimmed milk during four
weeks showed higher chemotaxis index of lymphocytes when
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compared with old non-supplemented controls (P<0.01, Figure 2A).
No significant differences were found between old mice supplemented
with skimmed milk during one week and old non-supplemented
controls (Figure 2A).
Figure 2: Lymphocyte functions. (A) Lymphocyte CI (number of
lymphocytes). (B) Natural killer cell activity (% lysis). (C)
Lymphoproliferative response to concanalvaline A (ConA) (cpm).
(D) Lymphoproliferative response to lipopolysaccharide (LPS)
(cpm). Each column represents the mean ± SD of 8-10 values
corresponding to that number of animals and each value being the
mean of duplicate or triplicate assays. *** P<0.001; ** P<0.01;
*P<0.05 with respect to the values of old control mice. ## P<0.01; #
P<0.05 with respect to the values of old mice supplemented with
skimmed milk (vitamins) during one week. & P<0.05 with respect
to the values of old mice supplemented with skimmed milk
(vitamins) during four weeks. $ P<0.05 with respect to the values of
old mice supplemented with fermented milk (vitamins) during one
week.
The antitumour NK activity (Figure 2B) was significantly suppressed
in old mice in comparison with adult mice (P<0.01). Old mice
supplemented with fermented milk (probiotics) at different times (one
and four weeks) showed significantly higher NK activity than old non-
supplemented controls (P<0.001, Figure 2B). In addition, old mice
supplemented with skimmed milk (vitamins) during four weeks
resulted in higher NK activity than old non-supplemented controls
(P<0.001, Figure 2B). However, old mice supplemented with skimmed
milk (vitamins) during one week did not show significant differences
in comparison with old non-supplemented controls (Figure 2B).
The lymphoproliferation in response to T-cell mitogen (ConA) and
to B-cell mitogen (LPS) (Figure 2C and 2D) was suppressed in old
mice with respect to adult mice (P<0.05 and P<0.01, respectively). Old
mice supplemented with fermented milk (probiotics) during four
weeks displayed significantly higher proliferation of lymphocytes in
response to ConA (P<0.01, Figure 2C) and LPS (P<0.01, Figure 2D)
than old non-supplemented controls. In addition, it was observed in
the group of old mice supplemented with skimmed milk during four
weeks higher proliferation of lymphocytes in response to LPS in
comparison with old non-supplemented controls (P<0.05, Figure 2D).
Nevertheless, old mice supplemented with skimmed milk during four
weeks did not show significant differences in the proliferation of
lymphocytes in response to ConA in comparison with old non-
supplemented controls (Figure 2C). Furthermore, old mice
supplemented with fermented milk or with skimmed milk during one
week showed no significant differences in the proliferation of
lymphocytes in response to ConA or LPS (Figures 2C and 2D).
In vitro immunoassays: Figure 3 shows the results from the in vitro
immunoassays for testing microbial probiotic strains and other
components of fermented milk drink. The chemotaxis index of
lymphocytes with the presence of fermented milk supernatant, which
contains probiotic bacteria, showed significantly higher values than
control (P<0.05, Figure 3A). In addition, the chemoattractant capacity
of fermented milk supernatant tended to be higher than the
chemoattractant capacity of the formyl peptide (P=0.07, Figure 3B).
With respect to antitumour NK activity, the fermented milk
supernatant added to the effector cells (lymphocytes) showed
significantly higher values than control (P<0.05, Figure 3C).
Citation: Hunsche C, Cruces J, Garrido A, Hernandez O, Fuente MDL (2018) Dietary Supplementation with Fermented Milk Containing
Probiotics Improves Behaviour and Immune Response of Aged Mice. J Prob Health 6: 201. doi:10.4172/2329-8901.1000201
Page 7 of 10
J Prob Health, an open access journal
ISSN: 2329-8901
Volume 6 • Issue 1 • 1000201
287
Figure 3: In vitro immunoassays for testing fermented milk supernatant. (A) Lymphocyte chemotaxis index (CI, number of lymphocytes). (B)
Chemoattractant capacity (CI, number of lymphocytes). (C) Natural killer cell activity (% lysis). Each column represents the mean ± SD of 5
values corresponding to that number of animals and each value being the mean of duplicate or triplicate assays. *P<0.05; t 0.05<P<0.1 with
respect to the values of controls.
Life span
The differences were not statistically significant among the groups of
mice. The average of life span of old mice supplemented with
fermented milk containing probiotics was 108 ± 10 weeks old, with
skimmed milk (vitamins B6 and D) was 100 ± 15 weeks and old non-
supplemented controls was 111 ± 15 weeks old.
Discussion
The consumption of fermented milk containing yogurt cultures plus
Lactobacillus casei DN-114001 has demonstrated several
immunological and gastrointestinal benefits in the elderly population.
Thus, there is evidence that this dietary supplementation is capable of
reducing the duration of infections [29,30] and preventing antibiotic-
associated diarrhoea in old individuals [31]. However, to our
knowledge, nothing has been studied so far to show whether this
specific fermented milk drink could improve behavioural and immune
cell function parameters, which are impaired in older individuals.
Therefore, we investigated the effects of the consumption of fermented
milk with probiotics on the behaviour and peritoneal leukocyte
functions of old mice, as well as their life span. The immune cell
function parameters studied here have been used as predictors of
health status and consequently of life span. Moreover, the age-related
alterations in these parameters are similar to those observed in mice
(peritoneal leukocytes) and in humans (blood leukocytes) [6].
The present study found that a short-term (one week)
supplementation with fermented milk containing probiotics was able
to improve behaviour parameters and immune cell functions of old
mice, these reaching similar values to those found in adult controls.
Furthermore, a longer-term supplementation (four weeks) was able to
maintain these improvements in the same immunological parameters.
Nevertheless, the consumption of fermented milk with probiotics did
not produce significant differences in the life span of mice. In this
sense, it is possible that this consumption at old age is not sufficient to
extend the life span, although the benefits found on behaviour and
immune response could indicate that this supplementation leads to
healthier aging. Similar results were obtained with other lifestyle
strategies such as environmental enrichment, which when started in
old and adult age improved these parameters of health, but was only
able to increase longevity in the latter [32].
The values of the parameters measured in the battery of behavioural
tests, which evaluated the abilities of motor coordination, equilibrium,
muscular vigour, exploratory activity and anxiety-like behaviour, were
significantly impaired in old mice in comparison to adults. However,
the one-week supplementation of fermented milk with probiotics was
able to improve the performance of these behavioural parameters with
respect to old non-supplemented controls. Thus, supplemented
animals displayed improvements in motor coordination and
equilibrium (assessed by the wood rod test) and in muscular vigour
(assessed by the tightrope test). There was also significantly higher
exploratory activity, given that old mice supplemented with fermented
milk displayed higher percentages of rearings and total number of
head-dips in the holeboard test. Moreover, they showed higher
locomotion in the central area of the holeboard, which indicates higher
exploratory activity and lower anxiety-like behaviour. Previous reports
showed that mice tend to stay in the peripheral area (close to the walls)
and avoid the central area of the holeboard, which is considered more
threatening by these animals [33,34]. In addition, the self-grooming
behaviour and the presence of defecation, which is usually considered
an index of anxiety in mice [35,36], were significantly lower in old
mice supplemented with fermented milk. Currently, there is little
investigation about the effect of probiotics on the behaviour of old
individuals, given that most of the studies were performed using
adults. In these studies, an association was found between the
supplementation of probiotics and brain function and behaviour. Thus,
Lactobacilli (latic acid bacteria) treatment for two months affected
motor behaviour and decreased astrocyte reactivity of growing rats
[22]. Also, the probiotic ingestion of Lactobacillus and Bifidobacterium
strains has been associated with lower anxiety in adult mice [23,24].
There is also some evidence in humans that probiotics could affect
mood and cognition [25]. The mechanisms by which probiotics affect
brain function and behaviour remain unclear, but some evidence
suggests their association with microbial composition changes,
immune activation and production of neurometabolites [21].
The fermented milk with probiotic supplementation used in the
present study, was also able to improve macrophage functions of old
mice, which suffer an age-related impairment [6], indicating immune-
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enhancing proprieties of these probiotics. Thus, old mice with the
present supplementation displayed enhanced directed migration
(chemotaxis) and phagocytic capacity of peritoneal macrophages in
comparison to non-supplemented old mice. In agreement, another
study demonstrated that the supplementation with fermented milk
containing the same probiotics, i.e. yogurt cultures and the probiotic
bacteria L. casei DN-114001, for 14 days resulted in increased
phagocytic activity in peritoneal macrophages of young mice [14]. In
addition, a human-based study showed that the supplementation with
the probiotic Bifidobacterium lactis Bi-07 was capable of enhancing
phagocytosis of monocytes and granulocytes in healthy elderly
individuals [15].
The NK cells, known by their ability to recognize and kill tumour
cells, showed a lower activity in old animals [6]. This immune function
in old mice improved after supplementation in our study. Previous
research on old individuals has also shown the positive effect on NK
activity of several probiotics. Thus, the ingestion of a fermented drink
containing Lactobacillus casei Shirota for four weeks improved the NK
cytotoxicity of healthy aged people [16]. Moreover, another report
indicated anti-tumour effects of fermented milk with probiotic
consumption [20]. This anti-tumour activity of probiotics seems to be
the result of a better immune response in the host (especially due to
the improvement of NK cell activity). In addition, the consumption of
probiotics appears to favor the decrease of the formation of
carcinogenic and mutagenic compounds [20].
The lymphocyte functions, such as migration and proliferation in
response to the T cell-specific mitogen (ConA) or the B cell-specific
mitogen (LPS), showed lower values in old mice than in adult mice, in
agreement with previous results [6]. However, supplementation (one
and four weeks) of fermented milk with probiotics led to
improvements in the migration of lymphocytes. With respect to
proliferation of lymphocytes in response to mitogens ConA and LPS,
only a long-term supplementation (4 weeks) with probiotics increased
this function in old mice. The effects of probiotics on lymphocyte
functions have been more studied using adult subjects. Thus, for
example, they increased the response of specific antibodies against
infection [17,18]. Nevertheless, there are also several articles showing
the positive effects of probiotics on old experimental animals [19,
37,38].
The improvement of the immune function studied seems to be due
to the direct action of probiotics since in the experiment carried out in
vitro, the fermented milk supernatant containing probiotics enhanced
chemotaxis and NK activities. It even showed a chemoattractant
capacity.
Interestingly, although with fewer improvements than that with
supplementation with probiotics, the control group of old mice, which
were supplemented with skimmed milk enriched with vitamins B6 and
D, also exhibited some benefits in behaviour and immune cell function
parameters (specially after four weeks of supplementation). These
results could be expected considering that these vitamins are known by
their action on the nervous and immune functions [39-42].
Conclusion
In conclusion, the present study supports the effects of fermented
milk containing probiotic supplementation on the function of two
major regulatory systems (the nervous and the immune systems).
Thus, the consumption of fermented milk with probiotics seems to be a
good nutritional strategy to improve several behavioural and immune
cell function parameters, which were shown to be impaired in old
individuals. For this reason, this strategy could be proposed to
promote healthier aging.
Conflict of Interest
The authors declare no conflict of interest.
Acknowledgements
This work was supported by grants from Ministry of Science and
Innovation (BFU2011-30336), the Research Group of Madrid
Complutense University (910379ENEROINN), and FIS (PI15/01787)
from the Institute de Salud Carlos III-Fondo Europeo de Desarrollo
Regional (ISCIII-FEDER) of the European Union.
C.H. is the recipient of a PhD fellowship from CNP-q-Brazil.
References
1. De la Fuente M (2008) Role of neuroimmunomodulation in aging.
Neuroimmunomodulation 15: 213-223.
2. Baeza I, De Castro NM, Giménez Llort L, De la Fuente M (2010)
Ovariectomy, a model of menopause in rodents, causes a premature aging
of the nervous and immune systems. J Neuroimmunol 219: 90-99.
3. Rosenzweig ES, Barnes CA (2003) Impact of aging on hippocampal
function: plasticity, network dynamics, and cognition. Prog Neurobiol 69:
143-179.
4. Vandervoort AA (2002) Aging of the human neuromuscular system.
Muscle Nerve 25: 17-25.
5. Flint AJ (1994) Epidemiology and comorbidity of anxiety disorders in the
elderly. Am J Psychiatry 151: 640-649.
6. Martínez de Toda I, Maté I, Vida C, Cruces J, De la Fuente M (2016)
Immune function parameters as markers of biological age and predictors
of longevity. Aging (Albany NY) 8: 3110-3119.
7. Vida C, González EM, De la Fuente M (2014) Increase of oxidation and
inflammation in nervous and immune systems with aging and anxiety.
Curr Pharm Des 20: 4656-4678.
8. De la Fuente M, Miquel J (2009) An update of oxidation-inflammatory
theory of aging: The involvement of the immune system in oxi-inflamm-
aging. Curr Pharm Des 15: 3003-3026.
9. Tiihonen K, Ouwehand AC, Rautonen N (2010) Human intestinal
microbiota and healthy ageing. Ageing Res Rev 9: 107-116.
10. Maffei VJ, Kim S, Blanchard E, Luo M, Jazwinski SM, et al. (2017)
Biological aging and the human gut microbiota. J Gerontol A Biol Sci
Med Sci 72: 1474-1482.
11. Kumar M, Babaei P, Boyand J, Nielsen J (2016) Human gut microbiota
and healthy aging: Recent developments and future prospective. Nutr
Healthy Aging 4: 3-16.
12. Raghuwanshi S, Misra S, Sharma R, Bisen PS (2018) Probiotics:
Nutritional Therapeutic Tool. J Prob Health 6: 194.
13. World Health Organization (2006) Probiotics in Food: Health and
nutritional properties and guidelines for evaluation. Food and nutritional
paper.
14. De Moreno de LeBlanc A, Chaves S, Carmuega E, Weill R, Antóine J, et
al. (2008) Effect of long-term continuous consumption of fermented milk
containing probiotic bacteria on mucosal immunity and the activity of
peritoneal macrophages. Immunobiology 213: 97-108.
15. Maneerat S, Lehtinen MJ, Childs CE, Forssten SD, Alhoniemi E, et al.
(2013) Consumption of Bifidobacterium lactis Bi-07 by healthy elderly
adults enhances phagocytic activity of monocytes and granulocytes. J
Nutr Sci 2: e44.
16. Dong H, Rowland I, Thomas LV, Yaqoob P (2012) Immunomodulatory
effects of a probiotic drink containing Lactobacillus casei Shirota in
healthy older volunteers. Eur J Nutr 52: 1853-1863.
Citation: Hunsche C, Cruces J, Garrido A, Hernandez O, Fuente MDL (2018) Dietary Supplementation with Fermented Milk Containing
Probiotics Improves Behaviour and Immune Response of Aged Mice. J Prob Health 6: 201. doi:10.4172/2329-8901.1000201
Page 9 of 10
J Prob Health, an open access journal
ISSN: 2329-8901
Volume 6 • Issue 1 • 1000201
289
17. Shu Q, Gill HS (2001) A dietary probiotic (Bifidobacterium lactis HN019)
reduces the severity of Escherichia coli O157:H7 infection in mice. Med
Microbiol Immunol 189: 147-152.
18. Yasui H, Kiyoshima J, Hori T, Shida K (1999) Protection against influenza
virus infection of mice fed Bifidobacterium breve YIT4064. Clin Diagn
Lab Immunol 6: 186-192.
19. Sharma R, Kapila R, Kapasiya M, Saliganti V, Dass G, et al. (2014) Dietary
supplementation of milk fermented with probiotic Lactobacillus
fermentum enhances systemic immune response and antioxidant capacity
in aging mice. Nutr Res 34: 968-981.
20. Ohashi Y, Nakai S, Tsukamoto T, Masumori N, Akaza H, et al. (2002)
Habitual intake of lactic acid bacteria and risk reduction of bladder
cancer. Urol Int 68: 273-280.
21. Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of
the gut microbiota on brain and behaviour. Nat Rev Neurosci 13:
701-712.
22. Ushakova G, Fed´kiv O, Prykhod`ko, Pierznowski S, Kruszewska D
(2009) The effect of long-term lactobacilli (lactic acid bacteria) enteral
treatment on the central nervous system of growing rats. J Nutr Biochem
20: 677-684.
23. Savignac HM, Kiely B, Dinan TG, Cryan JF (2014) Bifidobacteria exert
strain-specific effects on stress-related behaviour and physiology in
BALB/c mice. Neurogastroenterol Motil 26: 1615-1627.
24. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, et al. (2011)
Ingestion of Lactobacillus strain regulates emotional behaviour and
central GABA receptor expression in a mouse via the vagus nerve. Proc
Natl Acad Sci USA 108: 16050-16055.
25. Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, et al. (2011)
Assessment of psychotropic-like properties of a probiotic formulation
(Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in
rats and human subjects. Br J Nutr 105: 755-764.
26. Guayerbas N, Catalán M, Víctor VM, Miquel J, De la Fuente M (2002)
Relation of behaviour and macrophage function to life span in a murine
model of premature immunosenescence. Behav Brain Res 134: 41-48.
27. Guayerbas N, Puerto M, Victor VM, Miquel J, De la Fuente M (2002)
Leukocyte function and life span in a murine model of premature
immunosenescence. Exp Gerontol 37: 249-256.
28. Alonso Fernández P, De la Fuente M (2011) Role of the immune system
in aging and longevity. Curr Aging Sci 4: 78-100.
29. Turchet P, Laurenzano M, Auboiron S, Antoine JM (2003) Effect of
fermented milk containing the probiotic casei DN-114001 on winter
infections in free-living elderly subjects: a randomised, controlled pilot
study. J Nutr Health Aging 7: 75-77.
30. Guillemard E, Tondu F, Lacoin F, Schrezenmeir J (2010) Consumption of
a fermented dairy product containing the probiotic Lactobacillus casei
DN-114001 reduces the duration of respiratory infections in elderly in a
randomised controlled trial. Br J Nutr 103: 58-68.
31. Dietrich CG, Kottmann T, Alavi M (2014) Commercially available
probiotic drinks containing Lactobacillus casei DN-114001 reduce
antibiotic-associated diarrhea. World J Gastroenterol 20: 15837-15844.
32. Arranz L, De Castro NM, Baeza I, Maté I, Viveros MP, et al. (2010)
Environmental enrichment improves age-related immune system
impairment: Long-term exposure since adulthood increases life span in
mice. Rejuvenation Res 13: 415-428.
33. Lipkind D, Sakov A, Kafkafi N, Elmer GI, Benjamini Y, et al. (1985) New
replicable anxiety-related measures of wall vs center behaviour of mice in
the open field. J Appl Physiol 97: 347-359.
34. Simon P, Dupuis R, Costentin J (1994) Thigmotaxis as an index of anxiety
in mice. Influence of dopaminergic transmissions. Behav Brain Res 61:
59-64.
35. Kalueff AV, Stewart AM, Song C, Berridge BC, Graybiel AM, et al. (2016)
Neurobiology of rodent self-grooming and its value for translational
neuroscience. Nat Rev Neurosci 17: 45-59.
36. Archer J (1973) Tests for emotionality in rats and mice: A review. Anim
Behav 21: 205-235.
37. Vidal K, Benyacoub J, Moser M, Sanchez Garcia J, Serrant P, et al. (2008)
Effect of Lactobacillus paracasei NCC2461 on antigen-specific T-cell
mediated immune responses in aged mice. Rejuvenation Res 11: 957-964.
38. Kaushai D, Kansal VK (2011) Age-related in macrophage and lymphocyte
functions in mice and its alleviation by treatment with probiotic dahi
containing Lactobacillus acidophilus and Bifidobacterium bifidum. J
Dairy Res 78: 404-411.
39. Wrzosed M, Lukaszkiewicz J, Wrzosed M, Jakubczyk A, Matsumoto H, et
al. (2013) Vitamin D and the central nervous systems. Pharmacol Rep 65:
271-278.
40. Prietl B, Treiber G, Pieber TR, Amrein K (2013) Vitamin D and immune
function. Nutrients 5: 2502-2521.
41. Dakshinamurti S, Dakschinamurti K (2015) Antihypertensive and
neuroprotective action of pyridoxine and its derivatives. Can J Physiol
Pharmacol 93: 1083-1090.
42. Rail LC, Meydani SN (1993) Vitamin B6 and immune competence. Nut
Rev 51: 217-225.
 
Citation: Hunsche C, Cruces J, Garrido A, Hernandez O, Fuente MDL (2018) Dietary Supplementation with Fermented Milk Containing
Probiotics Improves Behaviour and Immune Response of Aged Mice. J Prob Health 6: 201. doi:10.4172/2329-8901.1000201
Page 10 of 10
J Prob Health, an open access journal
ISSN: 2329-8901
Volume 6 • Issue 1 • 1000201
290
3.4.2. Effects of the dietary supplementation with fermented milk containing probiotics 
for two weeks on behaviour, immune function and redox state of old mice, as well as on their 
life span.  
 
 
 
Experimental design 
Old mice (72 weeks old) were separated according to their body weight into two groups 
(n=8-10, per group). 1) Old control mice without dietary supplementation. 2) Old mice 
supplemented with fermented milk containing probiotics for two weeks. The commercial fermented 
milk drink studied contains two bacterial strains commonly used in yogurt, Lactobacillus 
delbrueckii subsp. bulgaricus and Streptococcus thermophiles, and the probiotic bacteria 
Lactobacillus casei DN114001 (109 CFU/100g). Weight, food and supplementation intakes were 
measured every day in the study. After the period of two weeks of dietary supplementation with 
fermented milk, a variety of tests and assays were performed on old mice in order to evaluate the 
behaviour of the animals, and peritoneal leukocytes were obtained for the analysis of several 
functions and their redox state. 
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Main results 
Body weight, food and supplementation intake measurements 
At the end of the two weeks supplementation period, old mice supplemented with fermented 
milk (probiotics) weighed significantly more than non-supplemented mice. However, no significant 
differences were observed in the average daily food intake (5 ± 0.2 g/day/mouse, in old mice 
supplemented with fermented milk and 5 ± 0.2 g/day/mouse, in old non-supplemented mice) and in 
the average daily water intake (4 ± 0.2 ml/day/mouse, in old mice supplemented with fermented 
milk and 5 ± 0.3 ml/day/mouse, in old non-supplemented mice). The average daily supplementation 
of fermented milk during the experiment period was 4 ± 1.5 ml/day/mouse.  
Behavioural parameters 
Motor coordination and equilibrium 
In the wood rod test, no significant differences were observed in the parameters that 
evaluated motor coordination and equilibrium abilities between old mice supplemented with 
fermented milk and non-supplemented mice.  
Muscular vigour and traction 
In the tightrope test, old mice supplemented with fermented milk (probiotics) showed a 
significantly lower percentage of mice that fell off the rope than non-supplemented mice. However, 
the supplementation with fermented milk did not result in significant differences regarding the 
percentage of old mice that completed the test in comparison with old controls.  
Vertical exploratory activity 
The vertical exploratory activity of mice was assessed by the frequency of rearings. The 
percentage of old mice supplemented with fermented milk that performed rearings in the holeboard 
test was significantly higher than in old non-supplemented controls. In addition, in the holeboard 
test, the total number of rearings was significantly higher in old mice supplemented with fermented 
milk than in old controls.  
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Horizontal exploratory activity 
In the corner test, no significant differences were observed in the number of corners visited 
between old mice supplemented with fermented milk and non-supplemented controls. The 
percentage of peripheral ambulation in the holeboard test was significantly lower in old mice 
supplemented with fermented milk in comparison with non-supplemented controls. In contrast, the 
percentage of central ambulation in the holeboard was significantly higher in old mice 
supplemented with fermented milk than in non-supplemented controls. With regards to the T-maze 
test, old mice supplemented with fermented milk exhibited lower times (in seconds) to explore the 
three arms of T-maze than old non-supplemented mice.  
Goal-directed exploratory activity  
No significant differences were observed in the goal-directed exploratory activity between 
old mice supplemented with fermented milk and old non-supplemented mice.  
Anxiety-like behaviour 
The supplementation with fermented milk resulted in a higher percentage of old mice 
performing self-grooming and in a lower percentage of old mice performing repeated digging in the 
corner test in comparison with non-supplemented mice. In addition, the presence of defecation in 
the T-maze and holeboard tests was significantly lower in old mice supplemented with fermented 
milk than in old non-supplemented controls.  
Peritoneal leukocyte function parameters 
The chemotaxis index of macrophages was significantly higher in old mice supplemented 
with fermented milk (probiotics) in comparison with old non-supplemented mice. In addition, the 
phagocytic index and the phagocytic efficiency were significantly higher in old mice supplemented 
with fermented milk than old non-supplemented controls.  
The chemotaxis index of peritoneal lymphocytes, the NK cell activity against tumour cells 
and the lymphoproliferatiion in response to T-cell mitogen (ConA) and B-cell mitogen (LPS) were 
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significantly higher in old mice supplemented with fermented milk than in old non-supplemented 
animals. 
Peritoneal leukocyte oxidative stress parameters 
The activities of catalase (CAT) and glutathione reductase (GR) activities were significantly 
higher in old mice supplemented with fermented milk (probiotics) than in old non-supplemented 
controls. However, no significant differences were observed in the values of reduced glutathione 
(GSH) between old mice supplemented with fermented milk and non-supplemented controls. 
Old mice supplemented with fermented milk (probiotics) exhibited lower GSSG 
concentrations than old non-supplemented mice. However, no significant differences were found in 
the GSSG/GSH ratios between old mice supplemented with fermented milk and non-supplemented 
animals. 
Life span 
The differences were not statistically significant in the life span of mice after the 2 weeks of 
supplementation with fermented milk. The average life span of mice supplemented with fermented 
milk containing probiotics was 122 ± 5 weeks, whereas in non-supplemented mice the average of 
life span was 118 ± 6 weeks old. 
 
Partial conclusions 
The results of this experiment indicate that the supplementation with a commercial drink 
containing probiotics for two weeks improves muscular vigour and exploratory activity, as well as 
the anxiety-like behaviour of old female mice. In addition, this supplementation results in improved 
function and redox state of peritoneal leukocytes in old female mice.  
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supplementation with fermented milk containing probiotics for a short period of time
could be a good nutritional strategy to promote healthy aging.
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 4 
Abstract 5 
The homeostatic systems, such as the nervous and immune systems, show deterioration in aging as 6 
consequence of the age-related oxidative-inflammatory stress establishment. The supplementation with fermented milk 7 
containing probiotic bacteria could be a good nutritional strategy to improve homeostatic system functions in aged 8 
individuals through the modulation of their redox state. The aim of the present study was to evaluate the effect of two 9 
weeks supplementation with a commercial fermented milk containing yogurt probiotics (Lactobacillus delbrueckii 10 
subsp. bulgaricus and Streptococcus thermophiles), and the probiotic Lactobacillus casei DN-114001 on behavior, 11 
redox state and immune cell functions of old mice as well as on their life span. Old female ICR-CD1 mice were 12 
supplemented with fermented milk containing these probiotics for two weeks. After this period, a variety of behavioral 13 
tests were performed and several parameters of redox state and function of peritoneal leukocytes were analyzed. The 14 
results showed that the two weeks supplementation of fermented milk containing probiotics improved behavior (such as 15 
muscular vigor, exploratory activity and anxiety-like behavior) as well as the redox state and functions of peritoneal 16 
immune cells in old mice. In conclusion, the present study shows that the supplementation with fermented milk 17 
containing probiotics for a short period of time could be a good nutritional strategy to promote healthy aging. 18 
 19 
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1. Introduction 33 
The age-related impairment of the homeostatic systems such as the nervous and immune systems, which 34 
resulting in an increase of morbidity and mortality, can be caused principally by the oxidative stress (unbalance between 35 
oxidants and antioxidants with increase of the first) that appears with aging [9,10]. In fact, according to the oxidative-36 
inflammatory theory of aging, the chronic oxidative stress and the inflammatory stress situations are the basis of the 37 
age-related impairment of functions of the organism, the homeostatic system being the most affected. In addition, this 38 
theory also suggests that the immune system, due to its property of producing oxidants, which in low levels are essential 39 
to carry out an effective immune response, if not well regulated, could be involved in the rate of aging of each 40 
individual through the generation of oxidative stress [5,9,10]. Moreover, one of the causes of the age-related changes in 41 
the immune system, which is denominated immunosenescence, could be the altered redox state of the immune cells 42 
[9,10]. Importantly, the oxidative stress observed in peripheral immune cells with aging seems to reflect the redox state 43 
of the rest of the organism [10]. 44 
Immunosenescence is characterized by a marked impairment of innate and adaptive immune responses, which 45 
includes lower migration to the infectious focus or chemotaxis, phagocytosis and proliferation of immune cells in 46 
response to mitogens, as well as lower anti-tumor activity of natural killer (NK) cells [35]. With respect to the nervous 47 
system, there is an age-related progressive deterioration of a variety of brain and behavioral functions, including 48 
memory, cognitive, and motor activity [6,41,51]. Given that the nervous system and the immune system share a 49 
bidirectional communication [9], it is expected that immunosenescence would have an impact on brain function and 50 
behavior. In fact, increasing evidence suggests that aged individuals show an increased infiltration of immune cells and 51 
oxidative and inflammatory compounds into the brain. This condition is associated with dysfunctions in the brain and 52 
increased susceptibility to neurological disorders [13,17].  53 
The adequate function of the homeostatic systems, and consequently the maintenance of health, depends 54 
mostly on lifestyle factors, while genetic background seems to influence less [10,26,40]. Thus, several lifestyle 55 
strategies have been used to slow down the rate of aging [11]. In this context, nutrition has been proposed as a positive 56 
intervention capable of modifying the age-related impairments and concretely the consumption of diet with adequate 57 
amounts of antioxidant compounds showed to ameliorate the age-related alterations of the immune system in rodent 58 
models of chronological and premature aging, improving redox state and functions of immune cells [11,24]. In addition, 59 
increasing evidence suggests that the consumption of food containing probiotic bacteria (such as lactobacilli and 60 
bifidobacteria) is a good nutritional strategy to improve health status during the aging process [31]. In this sense, a great 61 
body of evidence indicates that the consumption of certain strains of probiotics can improve the immune response of the 62 
host [12,15,34,46,48,52,55], as well as brain functions and behavior [7,8,53]. This capacity of probiotics to improve 63 
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homeostatic system functions could be carried out, at least in part, through protecting the host against oxidative stress 64 
[25,26]. In fact, some studies have shown that certain strains of probiotics exhibit antioxidant properties [22,39].  65 
In particular, the consumption of fermented milk containing yogurt cultures and Lactobacillus casei DN-66 
114001 has shown immunological and gastrointestinal benefits in the elderly population. Thus, there is evidence that 67 
this dietary supplementation is capable of reducing the duration of infection diseases [21,52] and preventing antibiotic-68 
associated diarrhea in old individuals [14]. In addition, we previously demonstrated that a short-term (one week) 69 
supplementation with this same fermented milk drink was able to improve behavior parameters and functions of 70 
peritoneal leukocytes in old mice. Furthermore, a longer-term supplementation (four weeks) maintained or loss these 71 
improvements in the same immune functions [23]. However, it remains unknown whether the supplementation with this 72 
fermented milk drink could affect the redox state of the immune cells. Therefore, we hypothesized that this 73 
supplementation for the period of two weeks would ameliorate age-related alterations in the functions of the nervous 74 
system (behavior) and immune system (redox state and functions of peritoneal leukocytes). To examine this hypothesis, 75 
we investigated the effects of the dietary supplementation with fermented milk containing yogurt cultures and the 76 
probiotic Lactobacillus casei DN-114001, for two weeks, on several parameters of redox state and functions of 77 
peritoneal leukocytes as well as on behavior responses, in old mice. In addition, we analyzed if this supplementation 78 
could improve the life span of these animals.  79 
2. Materials and methods  80 
2.1 Animals 81 
Old (72±4 weeks of age) female ICR/CD1 mice (Mus musculus) (Janvier SAS, Chassal, France) were used. 82 
The animals were housed in polyurethane cages and maintained under standard laboratory conditions (12:12 h reversed 83 
light/dark cycle; lights on at 8:00 pm, relative humidity of 50-60%, temperature of 22±2ºC and adequate ventilation). 84 
All mice were fed a standard maintenance diet (Teklad Global 14% Protein Rodent Maintenance Diet, Harlan 85 
Interfauna Iberica, Barcelona, Spain) and water at libitum.  86 
2.2 Experimental groups 87 
 Old mice were separated according to their body weight into two groups (n=8-10, per group), namely (1) old 88 
control mice which were not dietary supplemented and (2) old mice supplemented with fermented milk containing 89 
probiotics for two weeks. The commercial fermented milk drink studied contains two bacterial strains commonly used 90 
in yogurt, Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus thermophilus, and the probiotic bacteria 91 
Lactobacillus casei DN114001 (109 CFU/100g). Weight, food and supplementation intakes were measured every day in 92 
the study. After the period of two weeks of dietary supplementation with ferment milk, a variety of tests and assays 93 
were performed in old mice in order to evaluate behavior as well as the redox state and functions of peritoneal 94 
leukocytes.  95 
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2.3 Behavioral tests 96 
 Behavioral tests were conducted between 8 am and 10 am during two consecutive days, under illumination of 97 
fluorescent lamps (20 W), which followed a procedure previously described [4]. On the first day, a battery of tests (T-98 
maze, wood rod, corner and tightrope tests) was performed in mice. On the second day, mice were subjected to the 99 
holeboard test. The experimental apparatus was cleaned before the performance of each mouse in order to avoid 100 
olfactory trails. 101 
2.3.1 Motor coordination and equilibrium abilities 102 
 In order to assess motor coordination and equilibrium, animals were placed in the center of a wood elevated 103 
rod (rod dimensions: 22 cm height, 80 cm length, 2.9 cm width divided in segments of 10 cm) for one trial of 60 s, 104 
following a procedure previously described [4]. 105 
2.3.2 Muscular vigor and traction 106 
 As an index of muscular vigor, mice were hanged by its forelimbs in the middle of an elevated horizontal 107 
tightrope (40 cm height, 60 cm length and divided into 6 segments of 10 cm), following a procedure previously 108 
described [4].  109 
2.3.3 Vertical exploratory activity 110 
 The vertical exploratory activity (studied as the performance of “rearing”, that is, when the mouse stands up on 111 
his hindlimbs so that his body becomes more perpendicular to the ground) was evaluated in the holeboard test. The 112 
holeboard test consists in placing the animal in a box made of wood (60 X 60 X 45 cm) with matte-painted metallic 113 
walls, divided into 36 squares (10 X 10 cm), bearing four equally spaced holes (3.8 cm of diameter). All but 20 114 
peripheral squares were considered central. The test was performed during 5 minutes [4].  115 
2.3.4 Horizontal exploratory activity 116 
 Horizontal exploratory activity was assessed in the corner test, as the number of corners of the cage visited, 117 
and as the percentages of mice that performed peripheral ambulation (number of line crossings in the peripheral area, by 118 
the walls) and central ambulation (number of line crossings in the central area) in the holeboard test. Peripheral 119 
ambulation was considered lower exploratory activity than central ambulation due to the tendency of mice to remain 120 
close to walls (thigmotaxis) [49]. The corner test consists in placing the mouse in a new cage (22.0 X 22.0 X 14.5 cm) 121 
with bedding during 30 s.  In addition, horizontal exploratory behavior was recorded using the T-maze test, which is a 122 
wooden apparatus with three enclosed arms (short arm: 27 X 10 cm; long arm: 64 X 10 cm; walls: 19 cm high) [35]. 123 
The mouse was placed inside the “short” arm of the maze with its head facing the wall. The time (in seconds) to 124 
complete the test (exploration of all three maze arms) was assessed. 125 
2.3.5 Goal-directed exploratory behavior 126 
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The goal-directed exploratory behavior of mice was assessed in the holeboard test. An object formed by a 127 
plastic was placed into each of the four holes of the holeboard to attract mice attention. The frequency (percentage and 128 
number) of mice that performed head-dips (when the animal places its head into the hole) was considered as a goal-129 
directed exploratory behavior.  130 
2.3.6 Anxiety-like behavior  131 
 Repeated self-grooming and digging, and defecation presence were considered as anxiety-like behaviors 132 
[3,42]. Thus, the anxiety-like behavior was measured as the percentages of mice that performed repeated self-grooming 133 
and digging in the corner test. In addition, the presence of defecation in the T-maze and holeboard tests was also 134 
evaluated. 135 
2.4 Collection of peritoneal leukocytes 136 
The peritoneal suspensions were obtained between 8 am and 10 am to minimize circadian variations in the 137 
immune system, by a procedure previously described, without animal sacrifice [19,20], which allowed monitoring the 138 
life span of the mice. Briefly, 3 ml of Hank´s solution, adjusted to pH 7.4, were injected into the peritoneum, the 139 
abdomen was massaged and the peritoneal exudate cells were collected allowing the recovery of 90-95% of the injected 140 
volume. The peritoneal leukocytes, consisting of lymphocytes and macrophages, were counted in Neubauer chambers 141 
(Blau Brand, Germany). The suspensions were adjusted to a final concentration of 5X105 macrophages or 142 
lymphocytes/ml in Hank´s solution or 106 leukocytes/ml in Hank´s solution or complete medium (Roswell Park 143 
Memorial Institute (RPMI) 1640 enriched with L-glutamine (PAA, Pasching, Austria) and supplemented with 10% 144 
heat-inactivated (56ºC, 30 min) fetal calf serum (PAA) and gentamicin (100 mg/ml, PAA) with or without phenol red, 145 
depending on the type of assay used. Macrophages and lymphocytes were identified by their morphology. The cellular 146 
viability was measured using the trypan-blue (Sigma-Aldrich, Madrid, Spain) exclusion test and in all cases was higher 147 
than 98%.  148 
2.5 Immune functions 149 
2.5.1 Chemotaxis assay 150 
Chemotaxis of peritoneal leukocytes was evaluated according to a slight modification of Boyden´s method 151 
[19], consisting basically of the use of chambers with two compartments separated by a filter with a pore diameter of 3 152 
µm (Millipore, Bedford, MA, USA). The chemotaxis index (CI) was determined by counting, in an optical microscope 153 
(100X), the total number of macrophages and lymphocytes on one third of the lower face of the filters. 154 
2.5.2 Phagocytosis assay 155 
Phagocytosis assay of inert particles (latex beads) was carried out following a method previously described 156 
[19]. The number of particles ingested by 100 macrophages was counted using an optical microscope (100X) and 157 
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expressed as phagocytic index (PI). The percentage of macrophages, which phagocyted at least one latex bead, was also 158 
determined and expressed as phagocytic efficiency (PE). 159 
2.5.3 Natural Killer assay 160 
An enzymatic colorimetric assay was carried out to measure the cytolysis of tumor cells (Cytotox 96 TM 161 
Promega, Boehringer Ingelheim, Germany) based on the determination of lactate dehydrogenase enzyme (LDH), as 162 
previously described [19]. The results were expressed as percentage of lysis of target cells.  163 
2.5.4 Lymphoproliferation assay 164 
Following the method previously described [20], aliquots (200 µl) of peritoneal leukocytes (106 165 
lymphocytes/ml complete medium) were seeded in 96 well flat-bottomed microtitre plates (Numc, Roskilde, Denmark) 166 
and 20 µl of concanavaline A (ConA 1µg/ml; Sigma-Aldrich), 20 µl of lipopolysaccharide (LPS, E. coli, 055:B5 167 
1µg/ml; Sigma-Aldrich) or 20 µl of complete medium (spontaneous proliferation) were added per well. The cells were 168 
harvested in a semiautomatic microharvester 24h later. Thymidine uptake was measured using a beta counter (LKB, 169 
Uppsala, Sweden). The results were expressed as 3H-thymidine uptake (cpm). 170 
2.6 Oxidative stress parameters 171 
2.6.1 Catalase activity assay 172 
The activity of catalase (CAT) was determined following a previously described method [1]. The enzymatic 173 
assay was followed using spectrophotometry for 80 seconds at 240 nm. The results were expressed as international units 174 
(U) of enzymatic activity per 106 cells. 175 
2.6.2 Glutathione reductase activity 176 
 The glutathione reductase (GR) activity was measured by a method previously described [1]. The total activity 177 
was measured through the oxidation of nicotinamide adenine dinucleotide phosphate (NADPH) spectrophotometrically 178 
at 340 nm. The results were expressed as international milliunits (mU) of enzymatic activity per 106 cells. 179 
2.6.3 Glutathione concentrations  180 
 Both reduced (GSH) and oxidized (GSSG) concentrations of glutathione were measured using a fluorometric 181 
method, with some modifications [18] Fluorescence was determined in a plate reader (Fluostar Optima, BMG Labtech, 182 
Spain) using excitation at 350 nm and emission detection at 420 nm. The results were expressed as nmol/106 cells. The 183 
GSSG/GSH ratios were then calculated for each sample.  184 
2.7 Statistical analysis  185 
SPSS 21.0 (SPSS, Inc., Chicago, USA) was used for the statistical analysis of the results. The data were 186 
expressed as mean ± standard error of the mean (SEM). Each value is the mean of the data from an assay performed in 187 
duplicate or triplicate. Normality of the samples was checked by the Kolmogorov-Smirnov test and homogeneity of 188 
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variances with the Levene test. The data were statistically evaluated by the Student´s t-test for independent and paired 189 
samples. P<0.05 was considered statistically significant.  190 
3. Results 191 
3.1 Body weight, food and supplementation intakes 192 
At the end of the two weeks supplementation period, there were significant differences in the body weight 193 
between old mice supplemented with fermented milk (probiotics) and non-supplemented mice (P<0.001. Figure 1). 194 
However, no significant differences were observed in the average daily food intake (5 ± 0.2 g/day/mouse, in old mice 195 
supplemented with fermented milk and 5 ± 0.2 g/day/mouse, in old non-supplemented mice) and in the average daily 196 
water intake (4 ± 0.2 ml/day/mouse, in old mice supplemented with fermented milk and 5 ± 0.3 ml/day/mouse, in old 197 
non-supplemented mice). The average daily supplementation of fermented milk intake during the experiment period 198 
was 4 ± 1.5 ml/day/mouse.  199 
3.2 Behavioral tests 200 
 Table 1 shows the results obtained in the behavioral assessments of old non-supplemented mice and old mice 201 
supplemented with fermented milk (probiotics). 202 
In the wood rod test, no significant differences were observed in the parameters that evaluated motor 203 
coordination and equilibrium abilities between old mice supplemented with fermented milk and non-supplemented mice 204 
(Table 1). 205 
 In the tightrope test, old mice supplemented with fermented milk (probiotics) showed significantly lower 206 
percentage of mice that fell off from the rope than non-supplemented mice (P<0.001. Table 1). However, the 207 
supplementation with fermented milk did not result in significant differences regarding the percentage of old mice that 208 
completed the test in comparison with old controls (Table 1).  209 
 The vertical exploratory activity of mice, which was assessed by the frequency of rearings, is shown in Table 210 
1. The percentage of old mice supplemented with fermented milk that performed rearings in the holeboard test was 211 
significantly higher in comparison with non-supplemented controls (P<0.001. Table 1). In addition, in the holeboard 212 
test, the total number of rearings was significantly higher in old mice supplemented with fermented milk than in old 213 
controls (P<0.01. Table 1).  214 
 The results of horizontal exploratory activity are shown in Table 1. In the corner test, no significant differences 215 
were observed in the number of corners visited between old mice supplemented with fermented milk and non-216 
supplemented controls (Table 1). The percentage of peripheral ambulation in the holeboard test was significantly lower 217 
in old mice supplemented with fermented milk in comparison with non-supplemented controls (P<0.05. Table 1). In 218 
contrast, the percentage of central ambulation in the holeboard was significantly higher in old mice supplemented with 219 
fermented milk than in non-supplemented controls (P<0.05. Table 1). With regards to the T-maze test, old mice 220 
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supplemented with fermented milk exhibited lower time (in seconds) to explore the three arms of T-maze than non-221 
supplemented mice (P<0.05. Table 1). 222 
No significant differences were observed in the goal-directed exploratory activity between old mice 223 
supplemented with fermented milk and non-supplemented mice (Table 1).  224 
 The results of the anxiety-like behavior of mice are shown in the table 1. The supplementation with fermented 225 
milk resulted in a higher percentage of old mice performing self-grooming and in a lower percentage of old mice 226 
performing repeated digging in the corner test in comparison with non-supplemented mice (P<0.01 and P<0.001, 227 
respectively. Table 1). In addition, the presence of defecation in the T-maze and holeboard tests was significantly lower 228 
in old mice supplemented with fermented milk than in old non-supplemented controls (P<0.05 and P<0.01, 229 
respectively. Table 1).  230 
3.3 Immune function parameters 231 
The peritoneal macrophage functions are shown in Figure 2. The chemotaxis index of macrophages in response 232 
to a chemotactic gradient (formylated peptide), which mimics the migration of immune cells towards the infection site, 233 
was significantly higher in old mice supplemented with fermented milk (probiotics) in comparison with old non-234 
supplemented mice (P<0.05. Figure 2A). In addition, the number of latex beads ingested by macrophages, which is 235 
measured by the phagocytic index (Figure 2B), was significantly higher in old mice supplemented with fermented milk 236 
than old non-supplemented controls (P<0.01). Also, the number of macrophages with phagocytic ability, which is 237 
measured by the phagocytic efficiency, was significantly higher in old mice supplemented with fermented milk than in 238 
old non-supplemented mice (P<0.001. Figure 2C).  239 
The lymphocyte functions are displayed in Figure 3. The chemotaxis index of peritoneal lymphocytes induced 240 
by a chemotactic peptide (Figure 3A) was significantly higher in old mice supplemented with fermented milk than in 241 
old non-supplemented mice (P<0.05).  242 
The NK cell activity against tumor cells (Figure 3B) was significantly higher in old mice supplemented with 243 
fermented milk in comparison with old non-supplemented mice (P<0.05).  244 
The lymphoproliferation in response to T-cell mitogen (ConA) and to B-cell mitogen (LPS) (Figure 3C and 245 
3D) was significantly higher in old mice supplemented with fermented milk with respect to old non-supplemented mice 246 
(P<0.05).  247 
3.4 Peritoneal leukocyte oxidative stress parameters 248 
The results of enzymatic and non-enzymatic antioxidants, such as catalase and glutathione reductase activities, 249 
as well as reduced glutathione (GSH), respectively, are shown in Figure 4. The activity of the antioxidant enzymes 250 
catalase and glutathione reductase was significantly higher in old mice supplemented with fermented milk (probiotics) 251 
than in non-supplemented controls (P<0.05. Figures 4A and 4B). However, no significant differences were observed in 252 
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the concentration of GSH between old mice supplemented with fermented milk and non-supplemented controls (Figure 253 
4C).  254 
The results of the values of non-enzymatic oxidants, which includes the concentration of oxidized glutathione 255 
(GSSG) and the GSSG/GSH ratios are shown in Figure 5. Old mice supplemented with fermented milk (probiotics) 256 
exhibited lower GSSG concentrations than old non-supplemented mice (P<0.05. Figure 5A). However, no significant 257 
differences were found in the GSSG/GSH ratios between old mice supplemented with fermented milk and non-258 
supplemented mice (Figure 5B). 259 
3.5 Life span 260 
The differences were not statistically significant in the life span of mice after the 2 weeks of supplementation 261 
with fermented milk. The average of life span of mice supplemented with fermented milk containing probiotics was 122 262 
± 5 weeks, whereas in non-supplemented mice the average of life span was 118 ± 6 weeks old. 263 
4. Discussion  264 
Although we previously demonstrated that the short-term (one week) supplementation with fermented milk 265 
containing yogurt cultures plus Lactobacillus casei DN-114001 was able to improve behavior parameters and functions 266 
of immune cells in old mice [23], the effect of this supplementation on redox state parameters has not been studied. In 267 
the present work, the changes in several parameters of oxidative stress have been studied in peritoneal leukocytes, 268 
together with functions of these cells and behavior response in old mice after the supplementation with this same 269 
fermented milk drink during a different period of time (two weeks). In addition, we analyzed the body weight of theses 270 
animals.   271 
The results of the present study found that the supplementation with fermented milk containing probiotics 272 
during two weeks was able to improve behavior as well as the redox state and functions of peritoneal leukocytes in old 273 
mice. Moreover, during the supplementation period, there were significant differences in the body weight between old 274 
mice supplemented with fermented milk (probiotics) and non-supplemented mice. Thus, old supplemented mice 275 
maintained a similar body weight during this period of two weeks, whereas old non-supplemented mice had a 276 
significant loss of body weight. In this sense, it is known that the maintenance of a constant body weight during 277 
advanced aging is considered a positive health outcome, since the age-related body weight loss is often associated with 278 
malnutrition and sarcopenia, as well as is one of the parameter characteristic of frailty [25,29,35]. In fact, malnutrition, 279 
sarcopenia and frailty have been associated with increased risk of morbidity and mortality in older age [25,29,35]. 280 
Nevertheless, the consumption of fermented milk with probiotics did not result in significant differences in the life span 281 
of mice, similarly to that observed when mice were supplemented with this fermented milk drink for the period of four 282 
weeks [23]. Thus, it is possible that the supplementation with fermented milk at old age is not sufficient to extend the 283 
life span of mice, although the benefits found on behavior, redox state and immune functions could indicate a healthier 284 
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aging. In fact, the immune cell function parameters studied here have been shown to predict health status [35]. Another 285 
strategy of lifestyle, such as the environment enrichment, has also shown an improvement of the redox state and 286 
immune functions in old mice without a significant effect on longevity. However, when this strategy was applied from 287 
adult age, there was a significant increase of the life span [2]. 288 
With aging, there is a progressive deterioration of brain and behavioral functions, such as muscular vigor, 289 
motor coordination, and equilibrium [44,45]. In addition, old individuals are more likely to suffer from mental 290 
disorders, such as anxiety [16]. In the present study, the supplementation with fermented milk during two weeks was 291 
able to restore this impaired behavioral response of old mice. Thus, several behavioral parameters, such as muscular 292 
vigor (assessed by the tightrope test), vertical exploratory activity (assessed by the performance of rearings) and 293 
horizontal exploratory activity (assessed by the ambulation of mice in the holeboard test) were improved in old mice 294 
supplemented with fermented milk. In addition, these supplemented animals showed a higher central exploratory 295 
activity in the holeboard. In this sense, previous studies indicate that the central ambulation is associated with lower 296 
anxiety-like behavior, given that mice prefer to stay in the peripheral area (close to the walls), avoiding the central area 297 
(which is considered more threatening for mice) [49,50]. Moreover, the behavior of repeated digging and the presence 298 
of defecation, which may be considered anxiety-related measures [3,42], were significantly lower in old mice 299 
supplemented with fermented milk than in non-supplemented mice. Nevertheless, the performance of self-grooming, 300 
which is usually considered an anxiety-like behavior [27], was higher in old supplemented animals than in non-301 
supplemented controls. In this regard, previous studies suggest that the self-grooming behavior could be elicited by both 302 
opposite conditions, such as comfort and stress [28]. Thus, it is possible that the higher performance of self-grooming in 303 
old supplemented mice could indicate comfortable, rather than stressful situations. These results are in agreement with 304 
those previously found in old mice supplemented with the same fermented milk during one week [23]. Thus, a longer 305 
time of supplementation (two weeks) maintained these improvements. In addition, other studies performed in different 306 
probiotic strains (Lactobacillus plantarum, L. fermentum, L. rhamnosus, L. helveticus R0052, Bifidobacterium longum 307 
1714, B. breve 1205 and B. longum R0175) have also shown their positive effects on behavior, including improved 308 
motor coordination and reduced anxiety-like behavior, in young and adult rodents [7,53,37,43]. The mechanism by 309 
which probiotics affect brain function and behavior remain unclear, but some evidence suggests the association of 310 
ingestion of probiotics with microbial composition changes, immune activation and production of neurometabolites [8]. 311 
Antioxidant defenses are an important mechanism developed by organisms against reactive oxygen species 312 
(ROS)-induced oxidative stress. In this study, old mice supplemented with fermented milk displayed higher activity of 313 
the antioxidant enzyme catalase. Catalase acts eliminating the excess of hydrogen peroxide (H2O2). In addition, the non-314 
enzymatic antioxidant tripeptide glutathione (GSH), which is described as the major thiol intracellular redox buffer in 315 
cells, is known to exist in its reduced (GSH) or oxidized (glutathione disulphide or GGSG) forms. GSSG is reduced 316 
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back to GSH by the action of glutathione reductase (GR) [36]. In the present study, we found a higher activity of GR as 317 
well as a lower concentration of oxidized glutathione (GSSG). These results are indicative of lower oxidative stress in 318 
peritoneal leukocytes of old mice supplemented with fermented milk. In this sense, increasing evidence suggests that 319 
certain strains of lactobacilli and bifidobacteria have antioxidant properties both in vivo and in vitro, and therefore could 320 
decrease oxidative stress  [30,32,38,47,50,56]. In particular, a previous study showed that the supplementation of 321 
fermented milk with Lactobacillus fermentum for two months enhanced the activity of several antioxidant enzymes 322 
(superoxide dismutase, catalase and glutathione peroxidase) in old mice [46]. The mechanisms of the antioxidant action 323 
of probiotics are largely unknown, however, some evidence suggests that probiotics may modulate the redox status of 324 
the host via their metal ion chelating ability, ROS scavenging, enzyme inhibition, and regulating signaling pathways 325 
[54].  326 
With respect to the functions of immune cells, the present supplementation was also able to improve age-327 
related impairments of macrophage functions [10,35]. Thus, these supplemented animals displayed enhanced migration 328 
(chemotaxis) and phagocytic capacity of peritoneal macrophages in comparison with non-supplemented mice. In 329 
agreement, our previous results also showed immune-enhancing proprieties after the consumption of the same 330 
fermented milk drink during one week [23]. Another study, which also used the same fermented milk drink, 331 
demonstrated that this supplementation, in young mice, resulted in increased phagocytic activity of peritoneal 332 
macrophages [12]. In addition, the supplementation with the probiotic Bifidobacterium lactis Bi-07 or Lactobacillus 333 
fermentum, in aged humans and mice, respectively, was able to enhance the phagocytosis of monocytes and neutrophils 334 
[34,46].  335 
With aging, NK cells show lower anti-tumor activity [35]. However, the supplementation with fermented milk 336 
during two weeks was able to increase this immune function in old supplemented mice in comparison with non-337 
supplemented mice. In agreement, our previous results showed increased anti-tumor activity of NK cells after one and 338 
four weeks of supplementation [23]. Similarly, the ingestion of a commercial fermented drink containing Lactobacillus 339 
casei Shirota for four weeks increased the NK activity of healthy aged people [15]. 340 
The functions carried out by lymphocytes, such as migration and proliferation in response to T cell-specific 341 
mitogen (ConA) or B cell-specific mitogen (LPS), suffer age-related impairments [35]. The supplementation with 342 
fermented milk, however, was able to improve these functions in old mice. Although these results are in agreement with 343 
those found in the long-term supplementation (four weeks) as we observed in our previous work, the short-term 344 
supplementation (one week) was not able to improve the mitogen-stimulated lymphocyte proliferation [23]. Thus, it 345 
seems that this immune response of lymphocytes, which is considered a typical function of the adaptive immunity, are 346 
only improved after a period of supplementation of at least two weeks.  347 
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In conclusion, the present study shows that the supplementation of a commercial drink containing probiotics 348 
during two weeks improved behavior (such as muscular vigor, exploratory activity and anxiety-like behavior), as well 349 
as the redox state and functions of peritoneal leukocytes in old mice. Given that oxidative stress is the main contributor 350 
of age-related impairments in the homeostatic systems (including the nervous and immune systems), the 351 
supplementation of fermented milk with probiotics could be a good nutritional strategy to ameliorate these impairments 352 
in old individuals through the modulation of their redox state. Moreover, since the parameters of immune function 353 
analyzed are markers of health [35], and it has been recently demonstrated that the age-related alterations in these 354 
functions are similar in mice (peritoneal leukocytes) and in humans (blood leukocytes) [10,35], we could suggest the 355 
use of this strategy to improve health in the elderly. 356 
 357 
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Table 1. Behavioral tests in old mice supplemented with fermented milk (probiotics) and old non-supplemented mice. 563 
 
OLD MICE 
 
CRTL 
 FERMENTED MILK 
WITH PROBIOTICS 
Motor coordination and equilibrium (Wood rod test) 
  % of mice falling off 19 9 
Total number of crossings segments 4±0.5 5±1 
% of mice that complete the test 60 73 
Muscular vigor (Tightrope test) 
  % of mice falling off 90 55*** 
% of mice that complete test 10 18 
Traction (Tightrope test) 
  % of mice that show maximum traction capacity 50 45 
Non-goal-directed exploratory behavior 
  Vertical exploratory activity 
  % of mice that perform rearing (Holeboard test) 50 91*** 
Total number of rearings (Holeborad test) 25±3 38±4** 
Horizontal exploratory activity 
  Number of corners visited (Corner test) 4±2 4±3 
Total number of line crossings (Holeboard test) 316±22 304±15 
% of mice that perform central ambulation 35±2 47±2* 
% of mice that perform peripheral ambulation 65±2 53±2* 
Time to complete the test (s) (T-maze test) 25±4 16±1* 
Goal-directed exploratory activity  
  % of mice that perform head-dips (Holeboard test) 100 100 
Number of head-dips (Holeboard test) 8±1 8±1 
Anxiety-like behavior 
  % of mice that perform self-grooming (Corner test) 0 9** 
% of mice that show repeated digging (Corner test) 50 9*** 
% faeces presence (T-maze test) 20 9* 
% faeces presence (Holeboard test) 100 91** 
Results are expressed as percentage (%) or mean ± SEM in old control mice (n=8-10) and old mice supplemented with 564 
fermented milk (n=8-10) *P<0.05; **P<0.01; ***P<0.001 with respect to the values of old control mice.  565 
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FIGURE LEGENDS 578 
 579 
Figure 1. Body weight control in old control mice and old mice supplemented with fermented milk (probiotics) during 580 
two weeks. Each group represents the mean ± SEM of 8-10 values corresponding to that number of animals *** 581 
P<0.001; ** P<0.01; * P<0.05 with respect to the values of old control mice.  582 
 583 
Figure 2. Macrophage functions. (A) Macrophage chemotaxis index (CI, number of macrophages). (B) Macrophage 584 
phagocytic index (PI, number latex beads/100 macrophages). (C) Macrophage phagocytic efficacy (PE, number of 585 
phagocyting macrophages/100 macrophages). Each column represents the mean ± SEM of 8-10 values corresponding to 586 
that number of animals and each value being the mean of duplicate or triplicate assays. *** P<0.001; ** P<0.01; * 587 
P<0.05 with respect to the values of old control mice.  588 
 589 
Figure 3. Lymphocyte functions. (A) Lymphocyte CI (number of lymphocytes). (B) Natural killer cell activity (% 590 
lysis). (C) Lymphoproliferative response to concanalvaline A (ConA) (cpm). (D) Lymphoproliferative response to 591 
lipopolysaccharide (LPS) (cpm). Each column represents the mean ± SEM of 8-10 values corresponding to that number 592 
of animals and each value being the mean of duplicate or triplicate assays. *** P<0.001; ** P<0.01; *P<0.05 with 593 
respect to the values of old control mice.  594 
 595 
Figure 4. Antioxidant parameters. (A) Catalase activity (U/106 cells). (B) Glutathione reductase  (mU/106 cells). (C) 596 
Reduced glutathione concentration (nmol/106 cells). Each column represents the mean ± SEM of 8-10 values 597 
corresponding to that number of animals and each value being the mean of duplicate or triplicate assays. *P<0.05 with 598 
respect to the values of old control mice. 599 
 600 
Figure 5. Oxidative parameters. (A) Oxidized glutathione concentration (nmol/106 cells). (B) Ratio Oxidized 601 
glutathione (GSSG)/reduced glutathione (GSH). Each column represents the mean ± SEM of 8-10 values corresponding 602 
to that number of animals and each value being the mean of duplicate or triplicate assays. *P<0.05 with respect to the 603 
values of old control mice. 604 
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4. DISCUSSION 
	   	  
	   
4.1. DISCUSSION OF RESULTS 
 
4.1.1. Effects of diet-induced obesity onset on behaviour, immune function and 
redox/inflammatory state at different ages, as well as on the life span of mice  
 
In this thesis we wanted to study as the first sub-objective the effects of the early 
adulthood diet-induced obesity onset on immune function and redox/inflammatory state of 
adult female mice, as well as on their life span. The results obtained showed that a high fat intake 
during adolescence produced obesity in adult age associated with premature immunosenescence, 
and this condition was aggravated throughout aging.  
Adolescent female mice progressively and significantly increased their body weights by the 
administration of a high-fat diet for 14 weeks. These animals also presented significantly elevated 
concentrations of triglycerides and higher systolic arterial pressures when compared to the control 
group. Moreover, these mice showed conditions associated with obesity similar to those obtained in 
mice of a previous study in which an identical experimental design was followed to generate adult 
obesity (Baccan et al., 2013). Thus, the administration of a high-fat diet during adolescence seems 
to be a good model to induce obesity in adult mice. Additionally, this type of diet and the higher 
adiposity have also been reported to increase the levels of oxidation and inflammation and to 
promote a dysfunctional immune response (Bailey-Downs et al., 2013; Lamas et al., 2004; Swindell 
et al., 2010). Since obesity has been proposed as a possible model of premature immunosenescence 
(De la Fuente and De Castro, 2012), it seemed relevant to evaluate whether obesity generated at 
adolescence, a critical development period, could produce some features of immunosenescence at 
adult age. Moreover, it is also important to know if individuals that started their aging process at 
adult age with premature immunosenescence reached old age with a higher deterioration of immune 
response than those adults that start their aging showing an appropriate immune response. In this 
first sub-objective, we found, on one hand, that the development of obesity during adolescence 
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promoted a premature immunosenescence and oxidative state of peritoneal leukocytes in early 
adulthood. Thus, adult diet-induced obese (DIO) mice, when compared to controls of the same age, 
presented several deteriorated immune parameters, such as chemotaxis of both macrophages and 
lymphocytes, phagocytosis of macrophages, anti-tumour NK activity, mitogen-stimulated 
lymphoproliferation and mitogen-stimulated release of several cytokines (IL-1β, TNF-α, IL-6, IL-2 
and IL-10) derived from leukocyte culture supernatants. These parameters showed values similar to 
those of chronologically old animals. On the other hand, these adult DIO mice with a premature 
immunosenescence reached old age in worsened conditions, although they were fed a standard diet 
during aging.  
With respect to the functions studied in the peritoneal macrophages, which represent the first 
line of immune response, adult DIO mice showed diminished chemotaxis, phagocytosis as well as 
stimulated intracellular concentrations of superoxide in comparison with adult non-DIO control 
mice. These parameters showed similar values to those of old mice. Previous studies confirmed an 
impaired migration of macrophages to the site of inflammation, a diminished phagocytosis capacity 
as well as decreased levels of intracellular superoxide needed to kill intracellular pathogens in aged 
individuals (Arranz et al., 2010a; De la Fuente et al., 2004a; Linehan et al., 2014). Also, studies in 
obese individuals (both rodents and humans) corroborated these findings, indicating a decreased 
phagocytic capacity and an impaired oxidative burst of macrophages (Lee et al., 1999; Mancuso et 
al., 2002; Morrow et al., 1985; Palmblad et al., 1980). Nevertheless, another study performed in 
obese humans showed a significantly increased phagocytosis and oxidative burst activity by 
monocytes and neutrophils (Nieman et al., 1999), which could indicate a compensatory mechanism 
to possible impaired immune cell functions, as has been previously suggested in another study on 
obesity (McInnis et al., 2014). Moreover, a different assay technique was used in this study, which 
could also explain the different results obtained.  
With respect to the anti-tumour NK activity, also a critical player in innate immunity, the 
data obtained in the present thesis showed a decreased cytotoxic capacity in old and in adult DIO 
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mice compared to adult controls. Previous research demonstrated that aged individuals, despite their 
increased number of NK cells, presented depressed NK cytotoxicity (Arranz et al., 2010a; 
Hazeldine and Lord, 2013). Obesity also seems to produce an impaired NK cell activity. In 
agreement with our results, earlier findings indicate that DIO rats and mice, fed a cafeteria diet and 
a high-fat diet, respectively, as well as obese human subjects, suffered from a diminished NK cell 
cytotoxicity (De la Fuente and Castro, 2012; Lamas et al., 2004; Morrow et al., 1985; O´Shea et al., 
2010). Moreover, another study found that DIO mice fed a high-fat diet exhibited a poor 
cytotoxicity against influenza infection and increased mortality (Smith et al., 2010).  
In addition, immune functions driven by T and B lymphocytes, such as migration and 
proliferation, were affected by the early onset of obesity. In fact, the present findings showed that 
both adult DIO and old mice presented similar deteriorated values in relation to peritoneal 
lymphocyte functions, including chemotaxis and proliferation in response to T and B cell mitogens 
such as ConA and LPS, respectively, in comparison with adult controls. In agreement, there is 
previous evidence showing that aged individuals exhibited both impaired chemotaxis and 
proliferative response to mitogens of lymphocytes (Arranz et al., 2010a; Maijó et al., 2014). In 
relation to obese individuals, we did not find studies that evaluated chemotaxis of lymphocytes. 
Therefore, our results regarding chemotaxis of lymphocytes seem to be the first to describe a 
decrease in this activity of DIO mice. In relation to the proliferative response of lymphocytes to 
mitogen stimulation, several studies indicate a reduced capacity of this parameter in obese 
individuals. In obese mice, Sato Mito et al. (2009) found a decreased splenocyte proliferative 
response with T and B cell mitogens. Moreover, obese humans also exhibited suppressed stimulated 
proliferation of T and B lymphocytes (Nieman et al., 1999; Tanaka et al., 1993).  
Increasing evidence suggests that the conditions of aging and obesity are accompanied by 
overactivation of some innate immune functions with increased production of pro-inflammatory 
cytokines, such as TNF-α, IL-6 and IL-1β, especially in basal conditions (Alvarez-Rodríguez et al., 
2012; Arranz et al., 2010c; Martin-Cordero et al., 2009; Shaw et al., 2013; Tilg and Moschen, 
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2006). However, a previous study showed decreased levels of IL-1β, TNF-α, IL-6, IL-2 and IL-10 
in peritoneal leukocytes from aged mice under mitogen-stimulated states (Arranz et al., 2010c). The 
present data agree with these results. Thus, following stimulation with mitogens ConA and LPS, the 
secretion of these cytokines presented a decrease (tendency or statistically significant differences) in 
old and in adult DIO mice in comparison with adult controls. These findings are in agreement with 
those obtained in DIO mice, in which peritoneal macrophages, in response to a bacterial infection, 
exhibited low levels of the pro-inflammatory cytokines TNF-α, IL-β and IL-6 (Amar et al., 2007; 
Lawrence et al., 2012; Martin-Cordero et al., 2009). A decrease in IL-6 of spleen cells under LPS-
stimulated conditions (Baumgarner et al., 2014) and of IL-2 following mitogen stimulation (Mito et 
al., 2000) from obese with respect to lean human individuals have also been shown. Nevertheless, 
in young-adult overweight human subjects, the generation of IL-2 by mononuclear or lymphocyte 
cells in response to LPS increased, while the levels of IL-10 were similar between obese and lean 
individuals (Han et al., 2011). One possible explanation for these differences could be that 
individuals were considered mildly obese and thus might not produce significantly impaired 
immunity. The present results also demonstrated that the release of mitogen-stimulated IL-2 was 
further impaired in adult DIO mice with respect to old controls. Among several factors that 
modulate the release of cytokines, prostaglandin E2 (PGE2) has been described to inhibit the 
release of IL-2 (Santoli et al., 1990). Even though this inflammatory mediator is increased in both 
processes of aging and obesity (Osborn et al., 2008; Wu et al., 1998), a study found that adipocytes 
from young obese mice displayed higher levels of PGE2 with respect to old mice (Wu et al., 2013). 
Therefore, it is possible that the release of IL-2 was more suppressed in adult DIO mice by higher 
levels of PGE2 than in old controls.  
Oxidative stress, which is generated by an increase of oxidants and a decrease of 
antioxidants, has been linked to aging and obesity (De la Fuente and Miquel, 2009; Kregel et al., 
2007; Vincent et al., 2007). In fact, oxidative stress seems to contribute to the pathogeneses of 
several diseases that are common to both aging and obesity, including diabetes mellitus, 
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cardiovascular diseases, and cancer (Fernández-Sánchez et al., 2011). In the present results, old and 
adult DIO mice exhibited elevated xanthine oxidase activity (an enzyme that produces oxidants) 
and diminished catalase activity and glutathione concentrations (two relevant antioxidant defences). 
Previous studies confirmed that peritoneal leukocytes from old mice or from prematurely aging 
mice showed enhanced activity of xanthine oxidase (Vida et al., 2011; 2014) and a decrease of 
enzymatic and non-enzymatic antioxidants, such as catalase activity and glutathione concentration 
(Arranz et al., 2000a; Alvarado et al., 2006; De la Fuente and Miquel, 2009). In obese individuals 
an increased production of oxidants and a decreased capacity of antioxidants have also been 
observed. Thus, Saiki et al. (2001) found increased levels in the blood of serum hypoxanthine and 
uric acid in obese compared to non-obese individuals, while Chiney et al. (2011) found that 
xanthine oxidase activity was significantly elevated in obese when compared to non-obese children. 
Regarding antioxidant defences, a decrease of glutathione concentrations in erythrocytes of obese 
individuals during their childhood and adulthood was reported (Charles et al., 2008; Codoñer-
Franch et al., 2010; Pastore et al., 2012). In addition, catalase activity was significantly lower in 
erythrocytes of obese women than non-obese women (Amirkhizi et al., 2014). Therefore, these data 
indicate that the early adulthood diet-induced obesity onset might produce a similar oxidative stress 
to those reported in the elderly and this condition could contribute to the premature aging of obese 
individuals. 
Surprisingly, when DIO animals grew older, although they were fed a standard diet during 
their aging process, they continued to exhibit a significant higher body weight than old controls. 
Biochemical parameters, such as glucose and triglycerides, as well as systolic blood pressure levels, 
were also significantly increased in old DIO mice. In addition, these animals, which maintained 
obesity during their aging process, showed an increased deterioration of the immune and oxidative 
parameters, with respect to old non-DIO mice. This aggravated immunosenescence was reflected in 
the life span of mice, although not statistically significant, DIO mice tended to exhibit a shorter life 
span than non-DIO mice. In addition, the consumption of a standard diet across aging was not able 
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to restore functions and the redox state of the immune cells to the normal levels of the 
corresponding chronological age.  
 
In a second sub-objective we wanted to study the effects of the late adulthood diet-
induced obesity onset on behaviour, immune function and redox state parameters of middle-
aged male and female mice, as well as on their life span. The results obtained showed that the 
late adulthood diet-induced obesity onset led to significant impairments in behaviour as well as in 
functions and redox state of peritoneal leukocytes of middle-aged male and female mice, with males 
being significantly more affected than females. Thus, middle-aged male diet-induced obese (DIO) 
mice exhibited greater impairments in a variety of behavioural, immune function and redox state 
parameters, and consequently showed a shorter life span than their female counterparts. In the 
middle-aged female DIO mice some parameters presented values similar to those of old female 
animals. These data confirm the state of accelerated aging as a consequence of the onset of diet-
induced obesity in late adulthood. In addition to obesity-related impairments of the immune system, 
other factors, such as insulin resistance (Frasca et al., 2017), dysbiosis and increased intestinal 
permeability (Boulangé et al., 2016), could also contribute to oxidative and inflammatory systemic 
stresses, and consequently to the process of accelerated aging in obese individuals.  
Previous studies have shown that the high-fat diet intake is a good model to develop obesity 
in mice (Baccan et al., 2013; Kanasaki and Koya, 2011; Lutz and Woods, 2012). In addition, this 
experimental animal model of obesity mimics human obesity, regarding its etiologic aspects 
(Kanasaki and Koya, 2011). Thus, this is applied to both sexes, since in the present study, middle-
aged male and female mice fed on a high-fat diet for 14 weeks of their late-adulthood displayed 
significantly higher body weight and fat mass than their respective non-DIO counterparts. 
Moreover, middle-aged male and female DIO mice showed high concentrations of triglycerides and 
total cholesterol, which are well-known common features of obesity (Klop et al., 2013). Also, the 
late adulthood diet-induced obesity onset affected in a different manner the total body fat of middle-
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aged male and female mice. Thus, female DIO mice showed significantly higher body fat mass in 
comparison with their male counterparts. In agreement, previous studies found that females have a 
higher propensity to gain body weight and consequently to store more fat in the adipose tissue than 
males (Mauvais-Jarvis, 2015). In general, females, prior to menopause, tend to accumulate more fat 
in the subcutaneous adipose tissue, while males in the visceral adipose tissue. This visceral 
accumulation of fat has been associated with worsened metabolic outcomes in this sex (Palmer and 
Clegg, 2015). In fact, in the present study, middle-aged male DIO mice showed higher plasma 
concentrations of glucose and total cholesterol than their female counterparts.  
With respect to the results of behavioural tests, we observed lower motor coordination, 
equilibrium, muscular vigour, horizontal and vertical exploratory activities as well as higher anxiety 
in middle-aged male and female DIO mice than their respective non-DIO controls. Middle-aged 
male and female DIO mice displayed a significantly decreased central ambulation in the holeboard 
test, which indicates low exploratory activity and high anxiety behaviour, since mice with anxiety 
tend to ambulate more in the peripheral area (close the walls) (Simon et al., 1994). Moreover, 
middle-aged male and female DIO mice exhibited a longer time to complete the exploration of the 
three arms of the T-maze test than their respective non-DIO counterparts, which also indicates a 
lower exploratory activity. Regarding the elevated plus maze test, middle-aged male and female 
DIO mice displayed a decreased percentage of time in the open arms. It is known that a decreased 
activity in the open arms of the elevated plus maze apparatus indicates higher anxiety behaviour 
(Walf and Frye, 2007). Moreover, the behaviour of self-grooming and the presence of defecation, 
which could be considered as anxiety-related measures (Archer, 1973; Sake and Graybiel, 2003), 
were also significantly higher in middle-aged male and female DIO mice in comparison with their 
respective non-DIO controls. Previous studies indicate decreased cognitive and exploratory activity 
as well as increased anxiety in DIO mice. However, in these studies, the high-fat diet was 
administered soon after weaning (André et al., 2014; Arnold et al., 2014; da Costa et al., 2015; 
Sharma and Fulton, 2013; Vallodolid-Acebes et al., 2011; Yamada et al., 2011). Studies in humans, 
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including data from young to old individuals, also observed an association between increased body 
weight and worse performance on motor skills, equilibrium and muscular vigour (Deforche et al., 
2009; Gentier et al., 2013; Kumar et al., 2008; Maffiuletti et al., 2007). Accordingly, it can be 
suggested that obese individuals perform worse motor tasks because a greater proportion of excess 
mass has to be supported or moved against gravity during these tasks. However, the poor 
performance of fine motor tasks cannot be solely explained by the excess of fat, given that fine 
motor skills are not directly influenced by mass (Gentier et al., 2013). In this sense, obese 
individuals have shown lower neural efficiency and slower integration and processing of 
information than non-obese individuals (Gunning-Dixon and Raz, 2000; Mehta and Shortz, 2014). 
In addition, an association has been found between increased muscular fat infiltration in obese and 
aged individuals and decreased muscle quality and strength (Marcus et al., 2010; Moore et al., 
2014). The present results also showed differences between males and females in the evaluation of 
behavioural tests, with males being more affected than females. Thus, middle-aged male DIO mice 
showed a worse performance than their female counterparts in the tests that evaluated motor 
coordination, equilibrium, muscular vigour, vertical and horizontal exploratory activities and 
anxiety-like behaviour. However, most of the previous studies on obesity performed in rodents have 
used a single sex (André et al., 2014; da Costa et al., 2015; Sharma and Fulton, 2013; Vallodolid-
Acebes et al., 2011; Yamada et al., 2011), thus there is little information comparing the behavioural 
effects of obesity in both sexes. Nevertheless, in agreement with our data, a previous study 
considering sex differences in the performance of behavioural tests, showed that males were more 
vulnerable than females to high-fat diet (HFD)-induced impairments, such as learning functions and 
synaptic plasticity (Hwang et al., 2010). The mechanism underlying the higher impact of HFD and 
obesity in males than in females remains unknown, but some evidence indicates that oestrogen 
could have a positive effect in protecting female mice. In this study, male mice treated with 
estradiol showed less adiposity than controls (Salinero et al., 2018). 
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With respect to the functions studied in the peritoneal macrophages, middle-aged male and 
female DIO mice showed diminished chemotactic and phagocytic capacities of these cells in 
comparison with their respective non-DIO counterparts. These results are in agreement with those 
obtained in our previous sub-objective in which obesity in early adulthood was induced during the 
adolescent period. Thus, both the different ages of obesity onset (early and late adulthood), resulted 
in an impaired innate immune response. In addition, in this sub-objective we also evaluated the 
immune effects of obesity in males. The results showed that middle-aged male DIO mice had lower 
chemotactic and phagocytic indexes than their respective female counterparts. Moreover, 
differences were also observed in non-DIO controls, with males showing lower values than females 
in some functions. Previous evidence confirmed that males display a lower innate immune response 
against infection in comparison with females (Jaillon et al., 2017). Thus, it is possible that obesity 
could further exacerbate these aspects of the innate immunity of males.  
Regarding the NK anti-tumour activity of peritoneal leukocytes, middle-aged male and 
female DIO mice showed a lower response than their non-DIO counterparts, although no 
differences were observed between males and females in this function. The migration capacity of 
lymphocytes to a chemoattractant was significantly lower in middle-aged male and female DIO 
mice in comparison with their respective non-DIO controls. Similarly, the proliferation of 
lymphocytes in ConA and LPS-stimulated conditions, two mitogens for T and B lymphocytes, 
respectively, was also lower in middle-aged male and female DIO mice than in their non-DIO 
counterparts. These results are in agreement with those obtained in adult DIO female mice that 
ingested the fat rich diet during adolescence. Thus, both early and late adulthood obesity onsets 
resulted in impaired functions of lymphocytes. Although in controls middle-aged males showed 
lower values than females in chemotaxis of lymphocytes, male DIO mice presented higher 
chemotactic index and LPS-stimulated proliferation of lymphocytes than their female counterparts. 
The higher response of these immune functions in males could possibly be interpreted as a 
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compensatory mechanism to counteract the decreased response found in innate immune cell 
functions (Franceschi et al., 1995), especially in the context of obesity. 
Oxidative stress, which is generated by an imbalance between oxidants and antioxidants in 
favour of oxidants, has been associated with the development of obesity, aging and age-related 
health complications (Bauer and De la Fuente, 2016; Marseglia et al., 2015). In the current results, 
middle-aged male and female DIO mice showed high values of oxidants, such as xanthine oxidase 
activity, oxidized glutathione (GSSG) and lipid peroxidation (MDA) concentrations, and 
GSSH/GSH ratios as well as low values of antioxidant defences (such as catalase activity and GSH 
concentrations). These results are partly in concordance with our previous sub-objective in which it 
was found an increased oxidative stress in adult DIO female mice was found. However, on the 
contrary, the activity of glutathione peroxidase (an antioxidant enzyme) was significantly higher in 
middle-aged DIO animals in comparison with their respective non-DIO counterparts. In this sense, 
it is possible that the high activity of this antioxidant enzyme could be explained by a compensatory 
mechanism in an attempt to restore the appropriate redox state of DIO animals. In fact, the activity 
of this enzyme can increase or decrease in oxidative stress situations depending on the moment of 
their evolution and the amount of peroxides generated (Liu et al., 2004; Yan and Harding, 1997). 
Differences were also observed between the sexes in the redox parameters studied of middle-aged 
DIO animals, with males being more affected than females. Thus, in response to the late age of 
obesity onset, middle-aged male DIO mice showed higher values of xanthine oxidase and lipid 
peroxidation (MDA) and lower values of catalase activity in comparison with their female 
counterparts. Previous studies indicate that males are more susceptible to present higher oxidative 
stress than females (Baeza et al., 2011); however this situation is still controversial, and 
contradictory data have been reported (Kander et al., 2017). Moreover, there is a lack of evidence 
about the redox state of obese individuals comparing males and females.  
At old age, female DIO mice continue to exhibit worse immune functions and redox state 
parameters than old female non-DIO controls. However, in contrast to our previous sub-objective 
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(in the early adulthood obesity onset), the late adulthood diet-induced obesity onset resulted in no 
significant differences in some immune functions (such as anti-tumour NK cell activity and basal 
proliferation of lymphocytes), redox state (xanthine oxidase activity, GSSG/GSH ratio, catalase and 
glutathione peroxidase activities) as well as in the life span between female DIO and non-DIO mice. 
Thus, the early adulthood obesity onset, in which adolescent mice were exposed to a high-fat diet, 
had more long-lasting deleterious effects on the immune system, and consequently on the life span 
than a later obesity onset. Importantly, increasing evidence suggests adolescence as a critical period 
in which the nervous and immune systems are still experiencing developmental changes and thus 
are more susceptible to stresses, such as an increased consumption of a high-fat diet (Boitard et al., 
2012; Holder and Blaustein, 2014; Simon et al., 2015; Spear, 2000).  
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4.1.2. Effects of the blockage of the neonatal leptin surge (PND5-9) on the immune 
function and redox/inflammatory state in male and female rats at different ages  
 
In the two first sub-objectives we studied the effects of the blockage of the neonatal leptin 
surge (PND5-9) on the redox/inflammatory state and immune function in 
peripubertal/adolescent male and female rats, and in the third sub-objective we analysed the 
effects in adult rats.  
Similar to that described in mice (Ahima et al., 1998), rats also experience a plasma surge of 
leptin during the neonatal period (Delahaye et al., 2008). In these animals, the production of leptin 
increases between PND4 and 7, is elevated between PND7 and 10 and declines by PND14. 
Therefore, the present leptin antagonist treatment was administered precisely during the time of the 
leptin surge. Leptin appears to play a key role in immune and inflammatory responses (Conde et al., 
2014; Valleau and Sullivan, 2014). However, the implication of the neonatal leptin surge in the 
development and establishment of these responses later in life has not been previously analysed.  
The spleen is the largest secondary immune organ in the body and is responsible for 
initiating immune reactions to blood-borne antigens and for filtering the blood of foreign material 
and old or damaged red blood cells. In rats, this organ reaches peak development at puberty, 
followed by gradual involution. It appears to be a key player in cytokine production when there is 
an infection or after trauma resulting in systemic inflammation regulated by the autonomic nervous 
system (Gigliotti and Okusa, 2014). We found changes in the spleen weights of peripubertal 
animals treated neonatally with the leptin antagonist. The spleen of treated males weighed less and 
those of treated females weighed more than their controls. Since leptin acts as an immunomodulator 
(Conde et al., 2014; Valleau and Sullivan, 2014), it seemed plausible that the treatment affected the 
correct development of the spleen in both sexes. Neonatal leptin antagonist treatment clearly 
impaired the maturation of peripheral tissue such as pancreas, kidney, thymus and ovary in rats 
(Attig et al., 2011), so it is not surprising to find changes in spleen weight. Nevertheless, we were 
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not able to explain the mechanisms that resulted in these higher and lower spleen weights of males 
and females, respectively. However, these abnormal weights could indicate impaired development 
and function in the spleen of both sexes. Regarding body weight, we found no effect of the leptin 
antagonist treatment of either sex during neonatal and pre-pubertal life, as has been reported (Attig 
et al., 2008; Granado et al., 2011; Mela et al., 2012a; 2012b). As previously suggested (Mela et al., 
2015), one possible explanation for no change in body weight, but a decrease in adipose tissue in 
males could be that there is an increase in lean body mass.  
SOD acts as an enzymatic antioxidant defence that transforms the superoxide anion to H2O2 
and works in parallel with CAT, which is responsible for the elimination of the excess of H2O2 
(Vida et al., 2014). We found lower activities of both enzymes in the animals treated in the neonatal 
period with the leptin antagonist. These results are indicative of decreased antioxidant defences in 
the spleen. The glutathione system includes GPx and GR, two enzymes that play an important role 
in maintaining the correct balance between GSH and GSSG ratio. In normal conditions, glutathione 
is usually found in its reduced form since GR is constitutively active (Vida et al., 2014). In the 
present study, the treated animals showed higher GR activity and lower GPx activity than the 
corresponding controls. It is plausible that an increase in GR activity acts as a compensatory 
mechanism to mitigate the oxidative stress. In fact, when the ratio GSSG/GSH was analysed as a 
marker of oxidative stress, no significant effect of the neonatal treatment was found. 
Appropriate concentrations of leptin are needed for a correct immune response (Stofkova, 
2009). Leptin appears to stimulate both innate immunity, through the up-regulation of TLR 
expression in monocytes, and adaptive immune response carried out by lymphocytes. This 
stimulation is related with the protection against infections and associated with the production of 
pro-inflammatory cytokines and autoimmune diseases (Conde et al., 2014; Zabeau et al., 2014; 
Zarkesh-Esfahani et al., 2001). Indeed, both obese ob/ob (leptin deficient) and db/db (deficient in 
leptin receptors) mice had deteriorated immune responses and increased infection susceptibility 
(Milner and Beck, 2012) and leptin administration counteracts this impaired immune response in 
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animal models of leptin deficiency (Busso et al., 2002; Lord et al., 1998). In addition, leptin 
deficiency is associated with the decreased production of several cytokines. However, leptin 
regulation of cytokines is very different depending on several factors, notably the type of stimulus 
involved (Faggioni et al., 2000a; 2000b). Therefore, in order to measure the effects of the leptin 
antagonist on pro-inflammatory and anti-inflammatory cytokine secretion by spleen leukocytes, 
these cells were stimulated with either LPS or ConA. With both types of stimulation, we found 
lower IL-10 concentrations in spleen leukocytes from males and females that have been treated with 
the antagonist. Since IL-10 is clearly an anti-inflammatory cytokine, this observation suggests 
decreased protection against a potential inflammatory state. Moreover, lower concentrations of anti-
inflammatory cytokines such as IL-10 have been detected in ob/ob mice after LPS treatment 
(Faggioni et al., 2000b). The concentrations of IL-13, a typical Th2 cytokine with anti-
inflammatory and immunoregulatory actions (Huang et al., 2015; Wynn, 2015), were lower in LPS-
stimulated leukocytes from males and in ConA-stimulated leukocytes from females. The pro-
inflammatory cytokine TNF-α was lower in the LPS-stimulated leukocytes from males treated with 
the leptin antagonist, whereas the opposite was found in LPS-stimulated leukocytes from treated 
females, i.e. TNFα concentrations increased. In regards to this latter result, leptin has been shown to 
inhibit TNF-α induction by LPS in female mice. However, the methodology was different from our 
study, given that, in this study, female mice were 5 to 6 weeks old, and the LPS was administered 
intravenously (Faggioni et al., 2000a; 2000b). Some results suggest that a defect in leptin 
production is associated with a shift of the immune response toward a pro-inflammatory phenotype 
as a consequence of the up-regulation of pro-inflammatory and down-regulation of anti-
inflammatory cytokines. However, no conclusive data are available on TNF concentrations with 
LPS, with unchanged, decreased or increased production of this cytokine having been reported 
(Faggioni et al., 2001). As a whole, the present data support the view that the pattern of cytokines 
regulated by leptin is very different depending on the type of stimulus used to induce their release 
(Faggioni et al., 2000a; 2000b). Moreover, we showed clear differences between males and 
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females. It is worth re-emphasizing that the males and females used in this study were of different 
chronological ages and, therefore, the differences observed between males and females may not be 
exclusively attributed to their sex. This does not negate the fact that blockage of neonatal leptin 
signalling affects the future oxidative status of the animals and their ability to respond to 
inflammatory insults during the critical period close to pubertal onset in both males and females.  
When we analysed if there were changes in the mRNA of these antioxidants and cytokines 
in other tissues, we found significant effects in WAT. Males appear to be more affected by the 
treatment with leptin antagonist than females, as they present an increase in IL-1β and IL-6 and a 
decrease in CAT and GR mRNA concentrations. However, we found a decrease in TNF-α mRNA 
concentrations in females treated with the antagonist, corroborating the idea that the effect of this 
leptin antagonist is sex dependent. How these effects compromise the health status of individuals in 
the presence of an injury or immune challenge is unknown. Further investigation is needed to 
clarify the inflammatory state of these animals throughout their life. We previously found that 
maternal deprivation (MD) for 24 hours on postnatal day 9 (i.e., during the neonatal leptin surge 
period) produces a marked decrease in leptin concentrations (Viveros et al., 2010), as well as short- 
and long-term detrimental effects on the immune system (De la Fuente et al., 2009; Viveros et al., 
2009). Thus, it is likely that both a social intervention such as MD and the present pharmacological 
treatment affect the development of the organism’s defence system by interfering with the neonatal 
leptin surge. Therefore, in the second sub-objective we studied the effects of the blockage of the 
neonatal leptin surge (PND5-9) on the function and inflammatory state in spleen leukocytes of 
peripubertal/adolescent male and female rats. The results, as previously mentioned, also showed 
severe impairments in these parameters.  
This study was only carried out in spleen since this secondary lymphoid organ, which is the 
largest in both humans and rodents, is responsible for mounting effective innate and adaptive 
immune responses and for regulating cytokine production (Cesta et al., 2006; Nolte et al., 2002). 
The animals treated with a specific leptin antagonist during the leptin surge (PND5-10) displayed 
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significantly impaired chemotactic capacity, anti-tumour NK activity and proliferation of 
lymphocytes in response to mitogens (LPS and ConA). Moreover, in cultures of those leukocytes 
under ConA and LPS-stimulated conditions, an impairment of the release of several cytokines was 
generaly shown in those rats treated with the leptin antagonist.  
 The immune system in early life goes through rapid and critical changes. Thus, 
perturbations in this period could result in long-lasting detrimental effects in later life (Goenka and 
Kollmann, 2015). In this sense, the neonatal programming of adult immune function has been 
previously reported. Thus, the neonatal exposure to an immune challenge, such as bacterial 
endotoxin LPS, has shown to alter neuroendocrine and immune responses in adult animals (Shanks 
et al., 1995; 2000; Spencer et al., 2001). Several mechanisms underlying these effects seem to be 
related to hypothalamic-pituitary-adrenal axis modifications (Spencer et al., 2001). In fact, a 
previous study in which rats were neonatally treated with the same leptin antagonist found long-
term alterations on hypothalamic expression of reproductive and metabolic neuropeptides (Mela et 
al., 2016). Given the bidirectional communication between the nervous and immune systems, this 
alteration exerted on the hypothalamus could also have an impact on the immune system (Gomez-
Nicola et al., 2013; Vida et al., 2014). In addition, although there is increasing evidence showing 
the effects of leptin on several immune system functions, no information is available specifically 
correlating the neonatal leptin surge with these functions at peripubertal age. For this, in the present 
sub-objective, the pegylated super leptin antagonist was administrated in male and female rats from 
PND5 to 9. This period of time is coincident, according with previous reports, to the plasma surge 
of leptin in neonatal mice and rats (Ahima et al., 1998; Delahaye et al., 2008).  
With respect to the innate immunity, the functions studied were significantly impaired in 
spleen leukocytes of peripubertal male and female rats neonatally treated with leptin antagonist. 
Thus, the NK cells showed a lower lytic activity against tumour cells in treated animals than in 
controls. Therefore, it seems that the leptin surge has an important role in establishing and 
maintaining the proper function of NK cells. In fact, as  previously reported leptin is involved in the 
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processes of NK cell development, differentiation, activation, and cytoxicity (Tian et al., 2002; 
Zhao et al., 2003). It was found that leptin enhances these processes in NK cells via the activator of 
transcription 3 (STAT-3) and by the up-regulation of the expression of IL-2 and perforin genes 
(Zhao et al., 2003). In relation to the activity of chemotaxis, this function was suppressed in cells 
from male and female treated animals. The role of leptin in the migration of immune cells has been 
observed given that it shows a chemoattractant capacity at low concentrations. This effect seems to 
be mediated via full-length leptin receptors and canonical migratory signalling pathways (Gruen et 
al., 2007). Moreover, leptin has been shown to stimulate the expression of chemokines in murine 
macrophages through the activation of the Janus kinase 2/signal transducers and the activators of 
transcription 3 (JAK2/STAT3) pathway (Kiguchi et al., 2009).  
The neonatal administration of the leptin antagonist also resulted in impaired adaptive 
immunity in peripubertal rats. Thus, the proliferation of spleen lymphocytes in response to T- and 
B-cell mitogens, such as ConA and LPS, respectively, was lower in peripubertal female treated rats 
than in controls. An increased proliferation of lymphocytes has been observed in the presence of 
leptin (Lord et al., 1998). Enhanced proliferation and activation of human T lymphocytes with 
leptin were also observed when cells are co-stimulated with phytohaemagglutinin (PHA) or 
concanavalin A (ConA) (Martín-Romero et al., 2000). Moreover, leptin also plays an important role 
in the development of lymphocytes. In this sense, leptin receptor-deficient db/db mice showed 
impaired lymphopoiesis and reduced numbers of lymphocytes in peripheral blood (Bennett et al., 
1996).  
Increasing evidence suggests that leptin has a regulatory role within the cytokine network 
(Gainsford et al., 1996; Lam and Lu, 2007; Lord et al., 2006; Martín-Romero et al., 2000; Santos-
Alvarez et al., 1999). Thus, in this study, in agreement with the impairments found in innate and 
adaptive immune functions, the neonatal leptin antagonist treatment also resulted, in general, in a 
lower release of several cytokines in ConA and LPS-stimulated spleen leukocytes of peripubertal 
rats. The IL-2, which is an essential regulatory cytokine that acts mainly on lymphoid populations, 
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including T, B, and NK cells (Liao et al., 2011), was found to be diminished in female neonatally 
treated animals. In this sense, leptin has been shown to influence the proliferation and secretion of 
IL-2 by immune cells, through the activation of the mitogen-activated protein kinase (MAPK) and 
phosphatidylinositol-3-kinase (PI3-K) pathways (Liao et al., 2011; Lord et al., 1998). Since IL-2 is 
related to the proliferation of lymphocytes, the lower levels of this cytokine in treated females could 
explain the reduced lymphoproliferative response in the cells of this sex. 
In addition, several studies showed that leptin signalling increased inflammatory mediators 
through direct activation of immune cells (Matarese et al., 2005; Procaccini et al., 2012; Tian et al., 
2002). Thus, IL-1α and IL-1β, which are classic pro-inflammatory cytokines and are also involved 
in the proliferative response of lymphocytes (Zarkesk-Esfahani et al., 2001), exhibited lower 
concentrations in peribupertal male and female rats neonatally treated with leptin antagonist under 
LPS or ConA-stimulated conditions. Lower concentrations of IL-6 were also found in treated 
peripubertal male and female animals under mitogen (LPS or ConA) stimulation. Together with IL-
2, IL-1α and IL-1β, IL-6 is crucial in the orchestration of the differentiation and function of innate 
and adaptive immune cells (Dinarello, 2009). These cytokines regulate T lymphocyte activation and 
differentiation (Garlanda et al., 2013; Sims and Smith, 2010). In addition, IL-1β and IL-6 promote 
B cell functions and antibody production (Dinarello, 2009; Fisher et al., 2014). Previous studies 
clearly demonstrated an association between the regulation of these cytokines and leptin. Thus, 
leptin has been shown to directly induce the release of IL-1β and IL-6 in microglia cells (Ataie-
Kachoie et al., 2014; Tang et al., 2007) and to mediate the LPS-induced symptoms of sickness 
behaviour through a process that involves IL-1β induction in the brain (Lafrance et al., 2010; 
Sachot et al., 2004). 
The levels of IL-12p70, a pro-inflammatory cytokine known to promote Th1 immune 
differentiation against intracellular pathogens, including bacteria and some viruses (Raphael et al., 
2015), were lower in ConA or LPS-stimulated leukocytes from male and female treated rats. In 
addition, GM-CSF concentrations were diminished in LPS-stimulated leukocytes from treated 
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males and it should be borne in mind that this cytokine, which has been typically recognized as a 
haematopoietic growth factor, plays an important role in Th1 and Th17 responses (Shiomi and Usui, 
2015). However, the concentrations of IFN-γ, also known as a Th1 cytokine with pro-inflammatory 
properties, were increased in ConA-stimulated leukocytes from treated males, whereas no 
differences were found in female treated rats. The previous sub-objective, in which the same 
experimental design was used, also found increased concentrations of TNF-α (which is also a Th1 
cytokine with pro-inflammatory properties) in ConA-stimulated leukocytes from treated males. In 
addition, previous data indicate that, in several cases, a defect in leptin production could lead to an 
increase in the secretion of several pro-inflammatory cytokines, favouring the up-regulation of pro-
inflammatory mediators (Faggioni et al., 2001). However, other studies using rodents with genetic 
abnormalities in leptin or leptin receptors showed suppressed expression of pro-inflammatory 
cytokines, such as IL-12 and IL-6, in response to LPS stimulation (Loffreda et al., 1998). 
The release of T-helper type 2 (Th-2) cytokines, including the anti-inflammatory cytokines 
IL-4 and IL-5, which are commonly involved in the clearance of parasites and allergic reactions (Li 
et al., 2011), were reduced in LPS-stimulated leukocytes from male treated rats. However, no 
significant differences were found in female animals.  
Our results suggest that the blockage of the neonatal leptin surge led to impairments both in 
Th1 and Th2 responses, although with a greater impact on Th1, since statistically significant 
differences were greater in Th1 cytokines, such as IL-2, IL-12p70 and IFN-γ, than in Th2 cytokines 
(IL-4 and IL-5). In this sense, previous data have shown that the reduction of leptin levels 
(commonly seen in conditions of malnutrition, anorexia nervosa or genetic leptin deficiency) 
resulted in impaired Th1 response and reduced immunocompetence as well as increased 
susceptibility to infection (Procaccini et al., 2012). 
Given that previous studies showed the activation of JAK/STAT, MAPK and PI3K 
signalling pathways by leptin (Sánchez-Margalet et al., 2003), we could suggest a possible 
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involvement of these intracellular pathways in the alterations of immune and inflammatory 
responses of peripubertal rats neonatally treated with a leptin antagonist. 
We have demonstrated in these previous studies that the neonatal disruption of the leptin 
surge resulted in impairments of immune functions, as well as of redox and inflammatory stress 
state during the peripubertal/adolescence period of rats. However, it seemed relevant to investigate 
whether the blockage of the neonatal leptin surge (PND5-9) could produce these effects on 
immune function and redox state in adult male and female rats (i.e., when the immune system 
has reached its complete development) (Simon et al., 2015). The results of the present sub-objective 
found that the exposure to the leptin antagonist from PND 5 to 9 resulted in a long-term impaired 
immune function and oxidative stress state in spleen leukocytes of adult male and female rats. The 
immune functions and oxidative state were also evaluated in the spleen, as in the previous studies.   
With respect to the functions of the innate immunity analysed, both the chemotaxis and anti-
tumour NK activities, were significantly impaired in spleen leukocytes of adult male and female 
rats treated with a leptin antagonist. However, the neonatal leptin antagonist treatment resulted in 
chemotactic response differences between peripubertal/adolescent and adult rats. Thus, adult treated 
rats showed a higher chemotactic response after peptide stimulation, whereas, in 
peripubertal/adolescent treated rats, this response was lower in comparison with their respective 
controls. The higher chemotactic response in adult treated rats could be interpreted as a possible 
compensatory mechanism, given that there is a lower response in other immune cell functions, such 
as the anti-tumour NK activity (Franceschi et al., 1995). In fact, the blockage of leptin in the 
neonatal period affected the NK activity so highly that not only did this function appear diminished 
at peripubertal age, but also at adult age. Previous studies demonstrated that leptin was able to 
modulate immune innate response, such as chemotaxis and NK cell activities. Therefore, as 
previously mentioned, leptin at low concentrations exhibited a chemoattractant capacity (Gruen et 
al., 2007) as well as to stimulating the expression of chemokines in immune cells (Kiguchi et al., 
2009). In addition, leptin seems to modulate the NK cell activity via the activator of transcription 3 
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(STAT-3) and by the up-regulation of IL-2 and perforin genes (Zhao et al., 2003). The lack of leptin 
receptor expression in mice also results in impaired NK cell activity, which highlights the important 
role of leptin in regulating immune responses (Tian et al., 2002; Zhao et al., 2003). 
The neonatal administration of the leptin antagonist also resulted in long-term impaired 
adaptive immune response in adult rats. In agreement with our previous data found in peripubertal 
rats, the proliferation of spleen lymphocytes in response to T- and B-cell mitogens, such as ConA 
and LPS, respectively, continued to be lower in adult male and female treated rats. Increasing 
evidence indicates that leptin is able to modulate immune functions of lymphocytes. For instance, 
leptin receptor deficient mice displayed impaired lymphopoiesis and a low number of lymphocytes 
in peripheral blood, which indicates that leptin is important for the development of lymphocytes 
(Bennett et al., 1996). In addition, an in vitro study demonstrated that leptin increased the 
proliferation of lymphocytes in the presence of mitogens (Martín-Romero et al., 2000). 
In the present sub-objective, we found a long-term increased oxidative stress state in spleen 
leukocytes of adult treated rats. Thus, adult male and female rats neonatally treated with a leptin 
antagonist exhibited higher values of oxidant production, such as xanthine oxidase (XO) activity 
and GSSG contents, as well as lower concentrations of the antioxidant GSH and activities of its 
related antioxidant enzymes (GPx and GR) than those in the corresponding controls. Moreover, the 
GSSG/GSH ratios were higher, which showed increased oxidative stress (Asensi et al., 1999) and 
consequently the amount of MDA, a lipid peroxidation marker (Ayala et al., 2014), was also higher 
than in controls. These findings are partially in concordance with those found in the previous sub-
objective of this thesis, which also evaluated a variety of oxidative stress parameters in the spleen 
leukocytes of peripubertal rats. Thus, in contrast to the results in adult rats, in which a lower activity 
of GR (an antioxidant enzyme) was observed, this activity was higher in treated peripubertal rats. 
The higher values of GR activity in treated peripubertal rats could be potentially explained as a 
compensatory mechanism in an attempt to the restore redox homeostasis in animals treated with 
leptin antagonist. Similarly, the aging process, which has been linked to increased oxidative stress 
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state, also described higher production of antioxidant enzymes as a compensatory mechanism 
(Rizvi and Maurya, 2007). Some studies have pointed to the possible involvement of leptin in 
modulating the oxidative stress response. Thus, in malnourished children with low amounts of 
leptin, enhanced lipid peroxidation as well as decreased antioxidant defence such as SOD and CAT 
activities as well as GSH concentrations were observed (Boşnak et al., 2010). Moreover, another 
study found that enhanced concentrations of leptin (in obesity and cardiovascular diseases) were 
also associated with an increased production of ROS. In this study, leptin seemed to increase ROS 
generation mainly by the activation of NADPH oxidase (Dong et al., 2006; Morawietz and 
Bornstein, 2006). Therefore, it appears that abnormal circulating concentrations of leptin, either 
diminished or enhanced, could contribute to the imbalance of redox homeostasis. It is curious that 
the decrease of leptin concentrations in the neonatal period allowed the maintenance of an oxidative 
stress in spleen at adult age. This is another aspect that should be studied in depth in the future.  
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4.1.3. Effects of the dietary supplementations with 2-OHOA or with the combination of 
n-3 fatty acids (EPA AND DHA) on immune function and redox state of adult female diet-
induced obese mice, as well as on their life span  
 
As we observed in the results of the first objective, DIO mice show an impaired function and 
a redox state in their immune cells. In the present objective we have shown that the dietary 
supplementations with 2-OHOA or with the combination of n-3 fatty acid (EPA and DHA) 
improve immune function and redox state parameters in peritoneal leukocytes of adult female 
DIO mice, as well as their life span. With respect to body weight, a long-lasting decrease in the 
body weight of 2-OHOA supplemented-DIO mice was observed during their aging process. 
Similarly, another study also found that 2-OHOA-treated rats experience a decrease in body weight 
through the induction of UCP-1 (uncoupling protein-1) expression in the adipose tissue, a process 
probably accompanied by enhanced energy expenditure (Vögler et al., 2008). The beneficial effects 
of 2-OHOA were also reflected in the life span of mice, and thus, although without statistical 
significance, the treated mice displayed an average survival (number of weeks) similar to control 
mice. Nevertheless, n-3 PUFA supplemented-DIO mice only showed significant improvements in 
immune and oxidative stress parameters, but no decrease in body weight or increase in life span. In 
that sense, evidence from a recent meta-analysis also indicated that supplementation with n-3 PUFA 
did not promote anti-obesity effects, such as reduction of weight, in overweight/obese individuals 
(Du et al., 2015).  
The dietary supplementations with 2-OHOA or with the combination of EPA and DHA were 
able to revert the impaired macrophage functions of DIO mice, indicating a boost of the innate 
immune response towards pathogen destruction. Thus, DIO treated mice displayed improved 
chemotaxis, phagocytosis and generation of stimulated superoxide anion in peritoneal leukocytes. 
In agreement, findings from in vitro studies showed that neutrophils incubated with MUFA or with 
n-3 PUFA presented enhanced migration, phagocytic capacity and ROS production by immune 
346
	   	  
	   
cells, suggesting immune-enhancing properties of fatty acids (Kumaratilake et al., 1997; Li et al., 
1996; Padovese and Curi, 2009; Pisani et al., 2009). Several studies demonstrated that EPA and 
DHA could modulate immune functions in neutrophils of rats and humans, increasing chemotactic 
response, phagocytic activity and ROS production (Gorjão et al., 2007; Paschoal et al., 2013). In 
addition, administration of oleic acid induced neutrophil recruitment in a rat air-pouch model 
(Rodrigues et al., 2010) and mice fed a diet enriched with olive oil (MUFA) exhibited increased 
phagocytic activity in peritoneal macrophages (De Pablo et al., 1998b). 
The anti-tumour NK activity of peritoneal leukocytes, which was shown to be impaired in 
DIO mice in the previous sub-objectives of this thesis and in other studies (De la Fuente and De 
Castro, 2012; Lamas et al., 2004) tended to be higher after supplementation with n-3 PUFA. 
Previous work demonstrated that ingestion of n-3 PUFA was able to improve NK cell cytotoxicity 
in sedentary rats (Robinson and Field, 1998). However, supplementation with MUFA did not lead 
to significant differences in the NK cell activity of DIO mice. Similarly, another study also did not 
find differences in the activity of NK cells in middle-aged men supplemented with a MUFA-rich 
diet (Yaqoob et al., 1998).  
The lymphocyte functions, such as migration and proliferation in response to T cell-specific 
mitogen (ConA) or B cell-specific mitogen (LPS), showed lower values in DIO mice than in non-
obese mice. However, the dietary supplementations used led to higher values for these functions. In 
this sense, an increased resistance to infection was found associated with enhanced proliferation of 
peritoneal cells under LPS stimulation in mice fed fish oil, rich in EPA and DHA, for 6 weeks (Blok 
et al., 1992). An improvement in the production of circulating IgM in response to an antigen was 
obtained after administration of a n-3 PUFA-rich diet in obese mice (Teague et al., 2013). Another 
study, in which mice were fed an olive oil-rich diet, exhibited slightly increased splenic lymphocyte 
proliferation (De Pablo et al., 1998a). Nevertheless, some animal studies have described an 
inhibition of lymphocyte proliferation with MUFA supplementation (Yaqoob et al., 1994a), 
whereas human studies have shown no changes (Yaqoob et al., 1998). It is possible that these 
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contradictory results could be influenced by the doses supplemented in the diets. A study in this 
regard found that lower doses of oleic acid enhanced lymphocyte proliferation, while higher 
concentrations could result in inhibition of proliferation through an increase in apoptosis (Gorjão et 
al., 2007). 
Oxidative stress, which is generated by an imbalance between antioxidants and oxidants, 
also seems to play a critical role in obesity and obesity-related diseases (Grattagliano et al., 2008). 
In fact, in the present study, DIO mice showed higher values of oxidant production, such as 
xanthine oxidase activity and lipid peroxidation (MDA), as well as lower values of antioxidants 
(catalase activity and total glutathione concentrations) than non-obese control mice. This indicates 
that these DIO mice seem to exhibit an augmented oxidative stress state in comparison with 
controls. However, the dietary supplementations with MUFA or n-3 PUFA appear to enhance 
endogenous antioxidant defences in immune cells, as both treatments resulted in increased catalase 
activity and GSH concentrations. In addition, n-3 PUFA supplementation led to a lower activity of 
xanthine oxidase, whereas dietary supplementation with MUFA, resulted in a diminished 
production of MDA in peritoneal immune cells. Thus, these findings suggest that EPA plus DHA as 
well as 2-OHOA have a role in improving redox state in obese mice. Moreover, 2-OHOA appears 
to be less susceptible to lipid peroxidation than n-3 fatty acids, since supplementation with n-3 did 
not significantly diminish MDA concentrations. In agreement, previous studies described that the 
supplementation with extra virgin olive oil, which has been attributed an antioxidant role mostly by 
its high content of oleic acid (Pérez-Martínez et al., 2011), diminished the lipid peroxidation in rats 
(El-Kholy et al., 2014; Musumeci et al., 2014). Supplementation with n-3 PUFA also exhibited 
antioxidant properties in rats (Abdou and Hassan, 2014) and in a mouse model (Patten et al., 2013).  
 
Although we demonstrated in the previous sub-objective that the supplementations with 
monounsaturated (2-OHOA) and n-3 polyunsaturated (DHA plus EPA) fatty acids improved the 
functions and redox state of immune cells, the study of the effect of these supplementations on 
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the oxidative stress in the brain, liver, lungs and kidneys of diet-induced obese (DIO) mice 
seemed relevant.  
Our current findings showed increased oxidative stress in the brain (left and right cerebral 
cortex and hypothalamus), liver, lungs and kidneys (renal medulla and cortex) of diet-induced obese 
(DIO) mice in comparison with non-DIO controls. Thus, these DIO animals showed lower 
antioxidant defences, such as CAT and GR activities, as well as higher production of oxidants, 
including XO activity, GSSG/GSH ratios and lipid peroxidation (MDA concentrations) than non-
DIO mice. The increased oxidative stress seems to be associated with lipotoxicity in these organs, 
which is generated when triglycerides are inappropriately stored in non-adipose tissues. The 
excessive accumulation of intracellular triglycerides is known to reduce the efficacy of the electron 
transport chain, causing the release of ROS and the generation of oxidative damage (Savini et al., 
2013). In agreement with our current results, previous reports also indicate that obesity increased 
oxidative stress in a variety of organs, such as the cerebral cortex (Freeman and Keller, 2012), liver 
and kidneys (Noeman et al., 2011; Yuzefovych et al., 2013). These studies suggest that oxidative 
stress was related to adiposity, lipotoxicity, mitochondrial dysfunction and endoplasmic reticulum 
stress in a variety of organs from obese rodents (Freeman and Keller, 2012; Noeman et al., 2011; 
Yuzefovych et al., 2013). Moreover, another study showed that high-fat diet feeding increased 
mitochondrial hydrogen peroxide (H2O2) production, causing abnormal expression of antioxidant 
enzymes (such as CAT) (Rindler et al., 2013). Interestingly, we found higher values of glutathione 
peroxidase (GPx) activity (an antioxidant enzyme) in the liver, lungs and kidneys of DIO mice than 
in that of non-DIO mice. However, lower values of GPx activity were observed in the brain (right 
cerebral cortex) of DIO mice in comparison with non-DIO mice. The higher activity of this 
antioxidant enzyme could possibly be explained as a compensatory mechanism to protect these cells 
against oxidative damage (Vincent et al., 2001). The activity of this enzyme has been reported to 
increase or decrease in response to oxidative damage depending on the moment of its evolution and 
the amount of peroxides generated (Liu et al., 2004; Yan and Harding, 1997).  
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In turn, the dietary supplementations with 2-OHOA or with the combination of EPA and 
DHA in general were able to avoid the oxidative stress in the brain (with higher values of GPx and 
GR activities and lower values of MDA concentration) as well as in the liver, lungs and kidneys of 
DIO mice (with higher values of CAT and GR activities and lower values of XO activity, 
GSSG/GSH ratio and MDA concentration) in comparison with non-supplemented DIO mice. In all 
cases, the values showed similar values to those of the non-DIO controls. In agreement, our 
previous sub-objective also showed amelioration of oxidative stress after supplementation with 2-
OHOA or n-3 PUFA (EPA and DHA) (with increased values of CAT and total glutathione 
concentration and decreased values of XO activity, GSSG/GSH ratio and MDA concentration) in 
peritoneal leukocytes of adult female DIO mice. Furthermore, another study demonstrated that oleic 
acid exhibited an antioxidant activity in Caenorhabditis elegans, which was regulated by the 
forkhead transcription factor DAF-16/FOXO (forkhead box protein O) (Wei et al., 2016). Other 
studies also showed the antioxidant properties of n-3 PUFA against lead acetate-induced toxicity in 
the liver and kidneys of rats (Abdou and Hassan, 2014) as well as in the brain of rats exposed to 
ethanol during gestation (Patten et al., 2013). One of the possible mechanisms involved in these 
effects could be the incorporation of unsaturated fatty acids into the cell membranes, which occurs 
in all tissues of the body, following their consumption. In addition, these fatty acids are known to 
modulate cell functions, by modifying membrane fluidity, lipid peroxide formation, eicosanoid 
production and gene regulation (De Pablo and Alvarez de Cienfuegos, 2000; Surette, 2008). 
Interestingly, the supplementation with 2-OHOA did not improve the activity of GR and the 
ratio of GSSG/GSH in the liver of DIO mice. In addition, the supplementation with n-3 PUFA 
(EPA and DHA) increased the lipid peroxidation in the liver of DIO mice compared to non-
supplemented DIO mice. These findings suggest that both supplementations, in particular with n-3 
PUFA, were less effective in ameliorating the redox state in the liver in comparison with the other 
organs of DIO animals. This could possibly be explained by the central role of liver in the 
metabolism of fatty acids and by fact that PUFA supplemented DIO mice received a higher dose 
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(3000 mg of EPA and DHA/Kg HFD) than that of MUFA supplemented DIO mice (1500 mg of 2-
OHOA/Kg HFD). Thus, it is possible that the lipototoxity and oxidative stress generated in the liver 
as a result of obesity could not be completely reversed by these supplementations. Similarly, our 
findings in the previous sub-objective also showed higher susceptibility to lipid peroxidation in 
peritoneal leukocytes of n-3 PUFA supplemented DIO mice than of MUFA supplemented DIO 
mice.  
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4.1.4. Effects of the dietary supplementation with fermented milk containing probiotics 
for different periods of time on behaviour, immune function and redox state in old mice, as 
well as on their life span 
 
When the effects of the dietary supplementation with fermented milk containing 
probiotics for one and four weeks on behaviour and immune function, as well as on the life 
span old mice, were analysed, the results showed that a short-term (one week) supplementation 
was able to improve behaviour and immune cell functions of old mice, reaching similar values to 
those found in the adult controls. Furthermore, a longer-term supplementation (four weeks) 
maintained these improvements in the same parameters of immune functions. Nevertheless, the 
consumption of fermented milk with probiotics did not produce significant differences in the life 
span of mice. In this sense, it is possible that this consumption at old age was not sufficient to 
extend the life span, although the benefits found on behaviour and immune response indicate that 
this fermented milk with probiotics could allow a healthy aging. Similar results were obtained with 
other lifestyle strategies, such as the environmental enrichment, which started in old and adult age 
improved these parameters of health, but only was able to increase longevity in the latter (Arranz et 
al., 2010b) 
The battery of behavioural tests, which evaluated the abilities of motor coordination, 
equilibrium, muscular vigour, exploratory activity and anxiety-like behaviour, was significantly 
impaired in old mice in comparison with adult mice. However, the one-week supplementation of 
fermented milk with probiotics was able to improve the performance of these behavioural 
parameters with respect to old non-supplemented controls. Thus, those animals displayed 
improvements in motor coordination and equilibrium (assessed by the wood rod test) and in 
muscular vigour (assessed by the tightrope test). There was also significantly increased exploratory 
activity, given that old mice supplemented with fermented milk displayed higher percentage of 
rearings and total number of head-dips in the holeboard test in comparison with old non-
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supplemented mice. Moreover, they performed higher locomotion in the central area of the 
holeboard, which indicate higher exploratory activity and lower anxiety-like behaviour. Previous 
reports showed that mice tend to stay in the peripheral area (close the walls) and avoid the central 
area of the holeboard, which is considered more threatening for these animals (Lipkind et al., 1985; 
Simon et al., 1994). In addition, the self-grooming behaviour and the presence of defecation, which 
is usually considered an index of anxiety in mice (Archer, 1973; Kalueff et al., 2016), were 
significantly lower in old mice supplemented with fermented milk in comparison with old non-
supplemented mice. Currently, there is little investigation about the effect of probiotics on 
behaviour of old individuals, given that most of the studies were performed in adults. In these 
studies, an association was found between the supplementation of probiotics and brain function and 
behaviour. Thus, Lactobacilli (latic acid bacteria) treatment for two months affected motor 
behaviour and decreased astrocyte reactivity of normal growing rats (Ushakova et al., 2009). Also, 
the ingestion of probiotics Lactobacillus and Bifidobacterium strains was associated with decreased 
anxiety in adult mice (Bravo et al., 2011; Savignac et al., 2014). There is also some evidence in 
humans that probiotics could affect mood and cognition (Messaoudi et al., 2011). The mechanisms 
by which probiotics affect brain function and behaviour remain unclear, but some evidence suggests 
their association with microbial composition changes, immune activation and production of 
neurometabolites (Cryan and Dinan, 2012).  
The fermented milk with probiotics supplementation for one and four weeks was also able to 
improve macrophage functions of old mice, indicating immune-enhancing proprieties of probiotics. 
Thus, old mice supplemented with fermented milk displayed enhanced directed migration 
(chemotaxis) and phagocytic capacity of peritoneal macrophages in comparison with non-
supplemented old mice. In agreement, another study demonstrated that the supplementation with 
fermented milk containing yogurt cultures and the probiotic bacteria L. casei DN-114001 for 14 
days led to increased phagocytic activity in peritoneal macrophages of young mice (de Moreno de 
LeBlanc et al., 2008). In addition, a human-based study showed that the supplementation with the 
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probiotic Bifidobacterium lactis Bi-07 was capable of enhancing phagocytosis of monocytes and 
granulocytes in healthy elderly individuals (Maneerat et al., 2013).  
The NK cells, known by their ability to recognize and kill tumour cells, showed decreased 
activity in old animals. However, the supplementation with fermented milk was able to improve this 
immune function in old mice after one and four weeks of supplementation. Previous studies in old 
individuals confirmed these results. Thus, a study showed that the ingestion of a fermented drink 
containing Lactobacillus casei Shirota for four weeks improved the NK cytotoxicity of healthy aged 
people (Dong et al., 2013). Moreover, another report indicated anti-tumour effects of fermented 
milk with probiotics consumption (Ohashi et al., 2002). This anti-tumour activity of probiotics 
seems to be the result of an improved immune response in the host (specially due to improvement 
of NK cell activity). Moreover, the consumption of probiotics appears to favour the reduction of the 
formation of carcinogenic and mutagenic compounds (Ohashi et al., 2002). 
The lymphocyte functions, such as migration and proliferation in response to T cell-specific 
mitogen (ConA) or B cell-specific mitogen (LPS), showed decreased values in old mice than in 
adult mice. However, supplementation (one and four weeks) of fermented milk with probiotics led 
to improvements in the migration of lymphocytes. With respect to proliferation of lymphocytes in 
response to mitogens ConA and LPS, only a long-term supplementation (4 weeks) with probiotics 
increased this function in old mice. Others reports also indicated that probiotics ingestion could 
increase the response of specific antibodies against infection (Shu and Gill, 2001; Yasui et al., 
1999). 
The positive effects of the ingestion of fermented milk with probiotics in these immune 
functions studied, seems to be due to the direct action of probiotics. Thus, in the experiment carried 
out in vitro, the fermented milk supernatant (containing probiotics) enhanced chemotaxis activity 
and even showed a higher chemoattractant capacity. Moreover, this milk supernatant also 
stimulated the activity of NK cells.  
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Interestingly, although with fewer improvements than that with supplementation with 
probiotics, the control group of old mice which were supplemented with skimmed milk enriched 
with vitamins B6 and D also exhibited some benefits in behaviour and immune cell function 
parameters (specially after four weeks of supplementation). These results could be expected 
considering that these vitamins are known by their action in the nervous and immune functions 
(Dakshinamurti and Dakshinamurti, 2015; Prietl et al., 2013; Rail and Meydani, 1993; Wrzosed et 
al., 2013). 
Since in the previous sub-objective the effects of the supplementation of fermented milk 
with probiotics on redox parameters had not been studied, and neither the effects of two weeks of 
this supplementation on behaviour and immune functions of peritoneal leukocytes, in this second 
sub-objective we investigated the changes in several parameters of oxidative stress in peritoneal 
leukocytes, together with functions of these cells and behaviour response in old mice after the 
supplementation with a fermented milk drink for the period of two weeks. In addition, we 
analysed the body weight of these animals. The results showed that the supplementation with 
fermented milk containing probiotics for two weeks was able to improve behaviour as well as the 
redox state and functions of peritoneal leukocytes in old mice. Moreover, during the 
supplementation period, there were significant differences in the body weight between old mice 
supplemented with fermented milk (probiotics) and non-supplemented mice. Thus, old 
supplemented mice maintained a similar body weight during this period of two weeks, whereas old 
non-supplemented mice had a significant loss of body weight. In this sense, it is known that the 
maintenance of a constant body weight during advanced aging is considered a positive health 
outcome, since the age-related body weight loss is often associated with malnutrition and 
sarcopenia, as well as is one of the parameter characteristic of frailty (Janssen et al., 2002; Keller 
and Engelhardt, 2014; Martínez de Toda et al., 2018). In fact, malnutrition, sarcopenia and frailty 
have been associated with increased risk of morbidity and mortality in old age (Janssen et al., 2002; 
Keller and Engelhardt, 2014; Martínez de Toda et al., 2018). Nevertheless, the consumption of 
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fermented milk with probiotics did not result in significant differences in the life span of mice, 
similarly to that observed when mice were supplemented with this fermented milk drink for the 
period of four weeks. Thus, it is possible that the supplementation with fermented milk at old age 
was not sufficient to extend the life span of mice, although the benefits found on behaviour, redox 
state and immune functions could indicate a healthy aging. Another strategy of lifestyle, such as the 
environment enrichment, has also shown an improvement of the redox state and immune functions 
in old mice without a significant effect on longevity, as previously mentioned. However, when this 
strategy was applied from adult age, there was a significant increase of the life span (Arranz et al., 
2010b). 
With aging, there is a progressive deterioration of brain and behavioural functions, such as 
muscular vigour, motor coordination, and equilibrium (Schulz et al., 2002; Seidler et al., 2010). In 
addition, old individuals are more likely to suffer from mental disorders, such as anxiety (Flint, 
1994). In the present study, the supplementation with fermented milk for two weeks was able to 
restore this impaired behavioural response of old mice. Thus, several behavioural parameters, such 
as muscular vigour (assessed by the tightrope test), vertical exploratory activity (assessed by the 
performance of rearings) and horizontal exploratory activity (assessed by the ambulation of mice in 
the holeboard test) were improved in old mice supplemented with fermented milk. In addition, these 
supplemented animals showed a higher central exploratory activity in the holeboard. In this sense, 
previous studies indicated that the central ambulation was associated with lower anxiety-like 
behaviour, given that mice prefer to stay in the peripheral area (close to the walls), avoiding the 
central area (which is considered more threatening for mice) (Lipkind et al., 2004; Simon et al., 
1994). Moreover, the behaviour of repeated digging and the presence of defecation, which may be 
considered anxiety-related measures (Archer, 1973; Saka and Graybiel, 2003), were significantly 
lower in old mice supplemented with fermented milk than in non-supplemented mice. Nevertheless, 
the performance of self-grooming, which is usually considered an anxiety-like behaviour (Kalueff 
et al., 2016), was higher in old supplemented animals than in non-supplemented controls. In this 
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regard, previous studies suggest that the self-grooming behaviour could be elicited by both opposite 
conditions, such as comfort and stress (Kalueff and Tuohimaa, 2004). Thus, it is possible that the 
higher performance of self-grooming in old supplemented mice could indicate comfortable, rather 
than stressful situations. These results are in agreement with those previously found in old mice 
supplemented with the same fermented milk for one week. Thus, a longer time of supplementation 
(two weeks) maintained these improvements. In addition, other studies performed with different 
probiotic strains (Lactobacillus plantarum, L. fermentum, L. rhamnosus, L. helveticus R0052, 
Bifidobacterium longum 1714, B. breve 1205 and B. longum R0175) have also shown their positive 
effects on behaviour, including improved motor coordination and reduced anxiety-like behaviour, in 
young and adult rodents (Bravo et al., 2011; Messaoudi et al., 2011; Savignac et al., 2014; 
Ushakova et al., 2009). In this sense, current evidence indicates that the gut microbiota and the 
administration of probiotics could regulate behaviour and functions of the central nervous system 
through neuroimmune and neuroendocrine mechanisms, which mostly involving the vagus nerve 
(Bravo et al., 2011). This communication seems to be mediated by microbially derived molecules, 
including short-chain fatty acids, secondary bile acids, and tryptophan metabolites (Yano et al., 
2015; Samuel et al., 2008). These molecules appear to interact primarily with enteroendocrine cells, 
enterochromaffin cells and the mucosal immune system, but also could cross the intestinal barrier, 
enter systemic circulation, and reach brain sites (Martin et al., 2018).   
In the present sub-objective, we found higher activities of CAT and GR as well as a lower 
concentration of oxidized glutathione (GSSG) in peritoneal leukocytes of old mice supplemented 
with fermented milk in comparison with non-supplemented old mice. These results are indicative of 
lower oxidative stress in the supplemented old animals than in the non-supplemented old animals. 
In this sense, increasing evidence suggests that certain strains of lactobacilli and bifidobacteria have 
antioxidant properties both in vivo and in vitro, and therefore could decrease oxidative stress 
(Kullisaar et al., 2002; Lin and Yen, 1999; Mikelsaar and Zilmer, 2009; Shen et al., 2011; 
Spyropoulos et al., 2011; Zanoni et al., 2008). In particular, a previous study showed that the 
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supplementation of fermented milk with Lactobacillus fermentum for two months enhanced the 
activity of several antioxidant enzymes (superoxide dismutase, catalase and glutathione peroxidase) 
in old mice (Sharma et al., 2014b). The mechanisms of the antioxidant action of probiotics are 
largely unknown, however, some evidence suggests that probiotics may modulate the redox status 
of the host via their metal ion chelating ability, ROS scavenging, enzyme inhibition, and regulation 
of signalling pathways (Wang et al., 2017).  
With respect to the functions of immune cells, the present supplementation was also able to 
improve age-related impairments of macrophage functions in old mice (Martínez de Toda et al., 
2016). Thus, these supplemented animals displayed enhanced migration (chemotaxis) and 
phagocytic capacity of peritoneal macrophages in comparison with non-supplemented mice. In 
agreement, our previous findings also showed immune-enhancing proprieties after the consumption 
of the same fermented milk drink for one week. Another study, which also used the same fermented 
milk drink, demonstrated that this supplementation, in young mice, resulted in increased phagocytic 
activity of peritoneal macrophages (de Moreno de Le Blanc et al., 2008). In addition, the 
supplementation with the probiotic Bifidobacterium lactis Bi-07 or Lactobacillus fermentum, in 
aged humans and mice, respectively, was able to enhance the phagocytosis of monocytes and 
neutrophils (Maneerat et al., 2013; Sharma et al., 2014b). 
With aging, the anti-tumour activity of NK cells was impaired (Martínez de Toda et al., 
2016). However, the supplementation with fermented milk for two weeks was able to enhance the 
values of this immune function in old supplemented mice in comparison with non-supplemented 
mice. In agreement, our previous results showed higher anti-tumour NK activity after one and four 
weeks of supplementation than in the controls. Similarly, the ingestion of a commercial fermented 
drink containing Lactobacillus casei Shirota for four weeks increased the NK activity of healthy 
aged people (Dong et al., 2013). 
The functions carried out by lymphocytes, such as migration and proliferation in response to 
T cell-specific mitogen (ConA) or B cell-specific mitogen (LPS), are known to suffer age-related 
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impairments (Martínez de Toda et al., 2016). The supplementation with fermented milk, however, 
was able to improve these functions in old mice. Although these results are in agreement with those 
found in the long-term supplementation (four weeks) as we observed in our previous work, the 
short-term supplementation (one week) was not able to improve the mitogen-stimulated lymphocyte 
proliferation. Thus, it seems that this immune response of lymphocytes, which is considered a 
typical function of the adaptive immunity, were only improved after a period of supplementation of 
at least two weeks.  
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4.2. GENERAL DISCUSSION 
 
4.2.1. Diet-induced obesity as a model of premature and accelerated aging  
 
According to the oxidative and inflammatory theory of aging, the generation of chronic 
oxidative stress and inflammatory stress is the main cause of aging, affecting especially the 
regulatory systems. This theory also proposes the immune system as a critical player in these 
stresses, and consequently in the rate of aging (De la Fuente and Miquel, 2009). Thus, as previously 
mentioned in this thesis, several immune function and redox parameters have been suggested as 
markers of health, rate of aging and predictors of longevity (De la Fuente and Miquel, 2009; 
Martínez de Toda et al., 2016; 2019).  
Animal models have been used to study the process of aging, which although shorter, 
essentially mimics that of humans (Mitchell et al., 2015). There are several animal models of 
premature aging that have been suggested by our research group, such as ovariectomised rats and 
mice, tyrosine hydroxylase haploinsufficient mice, obese animals, and anxious mice. These animal 
models showed premature/accelerated immunosenescence, chronic oxidative and inflammatory 
stresses, and consequently a shorter life span (Baeza et al., 2011; De Castro, 2016; De la Fuente, 
2010; 2018a; De la Fuente and De Castro, 2012; Garrido et al., 2018).  
The results obtained in the present thesis indicate diet-induced obesity as a model of 
premature and accelerated aging. On one hand, the early adulthood diet-induced obesity onset, in 
which adolescent female mice were exposed to a high-fat diet, resulted in impaired immune 
functions, such as chemotaxis of both macrophages and lymphocytes, phagocytosis of 
macrophages, anti-tumour NK activity, mitogen-stimulated lymphoproliferation, and mitogen-
stimulated release of several cytokines (IL-1β, TNF-α, IL-6, IL-2, and IL-10), as well as increased 
oxidative stress. These functions and redox state in peritoneal leukocytes of adult female diet-
induced obese (DIO) mice showed similar values to those of chronologically old female animals. 
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Thus, these results confirm the state of premature immunosenecence and oxidative stress as a 
consequence of the early adulthood obesity onset. In addition, these DIO animals could be 
considered as prematurely aging, since they reached adulthood (which is when aging begins) with 
those characteristics of chronologically old mice. On the other hand, the late adulthood diet-induced 
obesity onset, in which late-adult male and female mice were exposed to a high-fat diet, resulted in 
impaired behaviour (such as low exploratory activity and high anxiety-like behaviour), deteriorated 
immune functions, including chemotaxis of both macrophages and lymphocytes, phagocytosis of 
macrophages, anti-tumour NK activity, basal and mitogen-stimulated lymphoproliferation, as well 
as increased oxidative stress. Some of these functions and redox state in peritoneal leukocytes of 
middle-aged female DIO mice showed values similar to those of chronologically old female 
animals. Thus, these results confirm the state of accelerated immunosenescence as a consequence of 
the late adulthood diet-induced obesity onset. These DIO animals could be considered as an 
accelerated aging model.  
In addition, adult female DIO mice with premature immunosenescence (as a consequence of 
the early obesity onset) reached old age with aggravated immunosenescence, and consequently 
lived shorter than female non-DIO mice. However, differently from the early obesity onset, the late 
obesity onset resulted in no significant differences in some immune function parameters (such as 
the anti-tumour NK activity and LPS-stimulated proliferation of lymphocytes), redox state 
(xanthine oxidase activity, GSSG/GSH ratios, catalase and glutathione peroxidase activities) and in 
the life span between female DIO mice and female non-DIO mice. Therefore, there were 
differences in the age of obesity onset, with the early adulthood obesity onset resulting in more 
long-lasting deleterious effects in the immune system, and consequently in the life span than a late 
obesity onset. In this regard, increasing evidence suggest adolescence as a critical period in which 
the nervous and immune system are still experiencing developmental changes, and thus are more 
susceptible to stresses, such as an increased consumption of high-fat diet (Boitard et al. 2012; 
Holder and Blaustein, 2014; Simon et al., 2015; Spear, 2000).  
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4.2.2. Differences between males and females in the nervous and immune systems 
resulting from the late adulthood diet-induced obesity  
 
There is increasing recognition that males and females show differences in the function of 
regulatory systems, and consequently in disease susceptibility and life span (Klein and Flanagan, 
2016; Zagni et al., 2016). In the present thesis, we have demonstrated differences between males 
and femlaes in the body fat mass, biochemical parameters, behaviour, immune function and redox 
parameters, as a consequence of the late adulthood diet-induced obesity. In particular, middle-aged 
male DIO mice exhibited greater impairments in these parameters and functions, and consequently 
showed a shorter life span than their female counterparts.  
It is largely accepted that there are differences in the body fat distribution between males 
and females, which have as major determinant the sexual steroids (Zore et al., 2018). Thus, males 
and oestrogen-deficient post-menopausal females tend to accumulate more abdominal and visceral 
fat and premenopausal females more lower body (gluteo-femoral) fat (Lovejoy et al., 2009). The 
visceral fat has been associated with increased occurrence of cardiovascular diseases, 
hyperlipidaemia, insulin resistance, and hypertension (Karastergiou et al., 2012). A recent study 
found that these differences in the effect of diet-induced obesity of mice depended on the age of 
onset. Thus, in juvenile mice (aged 18 weeks), the percentage of body weight gain was higher and 
the glucose tolerance was greater impaired in males than in females. However, in middle-aged mice 
(aged 44 weeks), the difference between males and females was reversed, and females gained 
substantially more weight and had greater impairment in glucose tolerance than males. This study 
also suggests that these differences in obesity could be influenced by sexual steroids, particularly 
oestrogen (Salinero et al., 2018). In a similar way, we also found that middle-aged female DIO 
mice, as a result of the late adulthood diet-induced obesity, displayed a higher total body fat mass 
than middle-aged male DIO mice. However, in contrast to this study, we found that middle-aged 
male DIO mice exhibited higher plasma levels of glucose and total cholesterol, indicating a worse 
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metabolic profile, than their female counterparts. In this regard, it is possible that the difference 
between the ages of diet-induced obesity onset (44 weeks vs 42 weeks) could have resulted in the 
changes of metabolic parameters. Moreover, this study used C57BL/6J mice, while we used 
ICR/CD1 mice. 
Regarding behaviour, immune function and redox state parameters, males showed greater 
impairments than females, as a result of the late onset of obesity. In agreement, previous studies 
showed males more vulnerable than females to high-fat diet (HFD)-induced impairments, such as 
learning functions and synaptic plasticity (Hwang et al., 2010). In addition, males exhibited a lower 
innate immune response against infection in comparison with females, which could be further 
exacerbated by obesity (Jaillon et al., 2017). In obesity, there was an increased adipose tissue 
infiltration of M1 macrophages in males, but of M2 macrophages in females, and higher levels of 
inflammatory mediators in males compared to females (Singer et al., 2015). Thus, these findings 
suggest an increased pro-inflammatory milieu in males that could contribute to the higher 
impairments found in the immune and nervous system functions of this sex in comparison with 
females. 
In the context of diet-induced obesity, the present thesis highlights the importance of 
studying age and sex as biological variables. In addition, the present data provide important 
evidence of diet-induced obesity as a model of premature and accelerated aging.  
 
As limitations of the present study we could point out the not inclusion of males in the 
experiments performed at old age. Also, other relevant aspects of immunosenescence, such as 
senescence-associated phenotype (SASP), immunophenotyping aging subsets, and intracellular 
signalling pathways, could be considered in future studies to confirm the premature and accelerated 
immunosenescence of obese individuals.  
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4.2.3. Programming effect of the neonatal leptin surge in the redox/inflammatory state 
and immune function of peripubertal and adult ages of rats.  
 
We found that the neonatal leptin surge disruption resulted in impaired functions and 
redox/inflammatory state in the spleen of peripubertal and adult male and female rats. Thus, these 
animals exposed to a leptin antagonist from PND5 to 9, which is coincident with the neonatal leptin 
surge, displayed significantly impaired chemotactic capacity, anti-tumour NK activity, LPS and 
ConA-stimulated lymphoproliferation, as well as an altered redox/inflammatory state of spleen 
leukocytes. Additionally and confirming the bidirectional communication between the regulatory 
systems, namely the nervous, endocrine and immune systems, the hypothalamus and white adipose 
tissue also showed an altered redox/inflammatory state in peripubertal treated animals. Thus, these 
results point to a possible programming effect of the neonatal leptin surge on the establishment 
and maintenance of immune function and redox/inflammatory state. In addition, it is 
reasonable to assume that any disruption/blockage of the neonatal leptin surge could represent a risk 
factor for the proper maintenance of the immune system function as well as overall health in later 
life.  
 
As limitations of the present study we could point out that males and females at 
peripubertal/adolescent age were euthanized at slightly different ages. These animals were the same 
as those used in a previous study that focused on the effects of the same leptin antagonist treatment 
on hypothalamic systems related to reproduction. In addition, there was a lack of exploration of 
possible mechanisms between the neonatal leptin disruption and the impairments found in the 
redox/inflammatory state and immune function. Although beyond the scope of the current objective, 
this subject should be considered in future studies.  
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4.2.4. Nutritional interventions in models of premature and chronological aging 
 
Many lifestyle interventions, such as physical exercise, physical and mental activity through 
environmental enrichment, hormesis and nutrition, have been proposed to improve functions of 
immune cells, decreasing their oxidative and inflammatory stresses, in animal models of premature 
and chronological aging. These interventions have demonstrated to ameliorate immunosenescence 
and oxidative stress, and consequently to promote healthy aging (De la Fuente et al., 2011). In 
particular, nutrition, such as the consumption of antioxidant compounds showed to ameliorate the 
age-related changes of the immune system in premature and chronological aging, through the 
modulation of function and redox state of immune cells (Alvarado et al., 2006; De la Fuente et al., 
2011). In addition, this nutritional intervention demonstrated positive effects on the nervous system 
(with treated animals showing a better response in behavioural tests than non-treated animals) (De 
la Fuente, 2010; De la Fuente et al., 1998).    
The present thesis focuses on two different nutritional interventions (unsaturated fatty acids 
and probiotics) in animal models of premature and chronological aging, respectively. Diet-induced 
obesity was considered a model of premature aging, since adult diet-induced obese (DIO) mice, as a 
consequence of being fed with a high-fat diet during their adolescence, presented values of immune 
function and redox state similar to those of chronologically old female mice.  
We found that the nutritional interventions with 2-hydroxyoleic acid (2-OHOA), a synthetic 
monounsaturated fatty acid (MUFA), or with the combination of n-3 fatty acids (polyunsaturated 
fatty acids of the n-3 series), namely eicosapentaenoic acid (EPA) and docosahexaenoic acid 
(DHA), were able to revert impaired function and oxidative stress of peritoneal leukocytes in adult 
female diet-induced obese (DIO) mice. Furthermore, the nutritional intervention with 2-OHOA also 
resulted in a tendency to increase the longevity of mice. Additionally, these nutritional interventions 
showed to revert oxidative stress in the brain, liver, lungs and kidneys of adult female DIO mice. 
Thus, these results confirm that the nutritional interventions with 2-OHOA or with the 
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combination of EPA and DHA could contribute to the promotion of a healthy aging through 
amelioration of immune dysfunction and oxidative stress in adult female DIO mice.  
In addition, we found that the nutritional intervention with fermented milk containing yogurt 
cultures plus Lactobacillus casei DN-114001 at different periods of time (one, two and four weeks) 
was able to improve behaviour, immune function and redox state in chronologically old female 
mice. Nevertheless, this nutritional intervention was not able to extend the life span of mice. Thus, 
it is possible that the supplementation with fermented milk at old age was not sufficient to extend 
the life span of mice, although the benefits found on behaviour, immune function and redox state 
could indicate a healthy aging. Therefore, these results confirm that the nutritional intervention 
with fermented milk containing probiotics for different periods of time resulted in the 
amelioration of behavioural and immune dysfunctions as well as oxidative stress in old female 
mice, thus contributing to a healthy aging.    
 
As limitations of the present study we could point out the lack of exploration of putative 
mechanisms through which the dietary supplementations improved behaviour, immune function and 
redox state of premature and chronological aging mice. Although beyond the scope of the proposed 
research, this subject should be considered in future studies.  
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5. CONCLUSIONS 
	   	  
	   
The following conclusions can be drawn from the results obtained in the present thesis. 
 
Regarding the first objective “To study the effects of diet-induced obesity onset on 
behaviour, immune function and redox/inflammatory state at different ages, as well as on the life 
span of mice”, the following conclusions can be drawn. 
 
1. The early adulthood diet-induced obesity onset produces premature 
immunosenescence and oxidative-inflammatory stresses in adult female mice. 
2. The early adulthood diet-induced obesity onset aggravates immunosenescence in old 
female mice. 
3. The late adulthood diet-induced obesity onset produces accelerated 
immunosenescence, oxidative stress and impaired behaviour in middle-aged male and female mice. 
4. The late adulthood diet-induced obesity onset affects more middle-aged males than 
middle-aged females in several parameters of behaviour, immune function and redox state. 
5. The late adulthood diet-induced obesity partially aggravates immunosenescence in 
old female mice. 
 
Regarding the second objective “To study the effects of the blockage of the neonatal leptin 
surge (PND5-9) on the immune function and redox/inflammatory state of male and female rats at 
different ages”, the following conclusions can be drawn.  
 
6. The blockage of the neonatal leptin surge produces an impaired redox/inflammatory 
state in the spleen, hypothalamus and white adipose tissue of peripubertal/adolescent male and 
female rats.  
7. The blockage of the neonatal leptin surge produces impairments in the functions and 
the inflammatory state of spleen leukocytes of peripubertal/adolescent male and female rats. 
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8. The blockage of the neonatal leptin surge produces impairments in the functions and 
redox state of spleen leukocytes of adult male and female rats. 
9. The neonatal leptin surge seems to have an important physiological role in the 
establishment and maintenance of an appropriate immune system functioning. 
 
With regards to the third objective “To study the effects of dietary supplementation with 2-
OHOA or with the combination of n-3 fatty acids (EPA and DHA) on immune function and redox 
state of adult female diet-induced obese mice, as well as on their life span”, the following 
conclusions can be drawn.  
 
10. The dietary supplementation with 2-OHOA or n-3 PUFA (EPA and DHA) improves 
functions and redox state of peritoneal leukocytes in diet-induced obese (DIO) female mice, 
bringing the values similar to those found in non-DIO mice.  
11. The dietary supplementation with 2-OHOA or n-3 PUFA (EPA and DHA) improves 
redox state in the brain, liver, lungs and kidneys of DIO mice, bringing the values similar to those 
found in non-DIO mice.  
12. The dietary supplementation with 2-OHOA or n-3 PUFA (EPA and DHA) could be 
an effective nutritional intervention to restore the immune response and redox state of DIO mice.  
 
With regards to the fourth objective “To study the effects of the dietary supplementation 
with fermented milk containing probiotics for different periods of time on behaviour, immune 
function and redox state of old mice, as well as on their life span”, the following conclusions can be 
drawn. 
 
13. The dietary supplementation with fermented milk containing probiotics for one and 
four weeks improves behaviour and immune function of old female mice, bringing the values 
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similar to those found in adult female mice. The improvement of the immune functions seems to be 
due to the direct action of probiotics. 
14. The dietary supplementation with fermented milk containing probiotics for two 
weeks improves behaviour, immune function and redox state of old female mice. 
15. The dietary supplementation with fermented milk containing probiotics, even in a 
short period of time, seems to be a good nutritional intervention to improve behaviour as well as 
functions and redox state of peritoneal leukocytes in old female mice.  
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7. ABBREVIATIONS 
	   	  
	   
2-OHOA  2-hydroxyoleic acid 
4-HNE   4-hydroxynonenal 
AA    Arachidonic acid 
AgRP   Agouti-related peptide 
AMPK  5´ adenosine monophosphate-activated protein kinase 
ASP   Acylation stimulating protein 
ATM   Adipose tissue macrophages 
BAT   Brown adipose tissue 
BCR   B-cell receptor 
BDNF   Brain-derived neurotrophic factor 
BMI   Body mass index  
CART   Cocaine- and amphetamine-regulated transcript 
CAT   Catalase 
CCL   Chemokine C-C motif ligand  
CD   Cluster of differentiation  
CH2   Methylene group 
CI   Chemotactic index 
CLP   Common lymphoid progenitor 
CLS   Crown-like structures 
CMP   Common myeloid progenitor 
CNS   Central nervous system 
ConA   Concanavalin A 
COX   Cyclooxygenase 
Cu   Copper 
CVD    Cardiovascular diseases 
CXCL   C-X-X motif chemokine ligand  
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DAMP  Damage-associated molecular pattern 
DC   Dendritic cell 
DHA   Docosahexaenoic acid 
DIO   Diet-induced obese mice 
DNA   Deoxyribonucleic acid 
DPA   Docosapentaenoic acid 
ENS   Enteric nervous system 
EPA   Eicosapentaenoic acid 
ER   Endoplasmic reticulum      
Fe   Iron 
FFA   Free fatty acid 
fMLP   Formylated peptide 
GABA   gamma-aminobutyric acid 
GLUT   Glucose transporter 
GPx   Glutathione peroxidase 
GM-CSF  Granulocyte-macrophage colony-stimulating factor 
GR   Glutathione reductase 
GSH   Tripeptide gamma-glutamylcysteine or reduced glutathione 
GSSG   Glutathione disulphide or oxidized glutathione 
HDL   High-density lipoprotein 
HFD   High fat diet 
HNO2         Nitrous acid 
H2O2         Hydrogen peroxide 
HPA      Hypothalamic pituitary adrenal 
HSC           Haematopoietic stem cell 
ICAM-1      Intercellular adhesion molecule 1 
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IFD   Intermediate-fat diet 
IFN              Interferon 
IκBβ        Inhibitor of kappa B kinase beta 
IL                Interleukin 
iNKT             Invariant Natural killer T 
iNOS           Inducible nitric oxide synthase 
JAK2    Janus kinase 2 
JNK       c-Jun N-terminal kinase 
LAB      Lactic acid bacteria 
LDL      Low-density lipoprotein 
LOO         Lipid peroxyl  
LOX     Lipoxygenase 
LPS             Lipopolysaccharide 
M                Macrophage 
MALT          Mucosal-associated lymphoid tissue 
MAPK      Mitogen-activated protein kinase 
MCP-1     Macrophage and monocyte chemoattractant protein-1 
MDA           Malondialdehyde 
MHC           Histocompatibility complex 
Mn            Manganese 
MNC    Mononuclear cell 
MPO          Myeloperoxidase 
mRNA        Messenger ribonucleic acid 
MSH       Melanocyte-stimulating hormone receptor 
mtDNA       Mitochondrial deoxyribonucleic acid 
mTOR       Mammalian target of rapamycin 
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mtROS        Mitochondrial respiratory chain 
MUFA     Monounsaturated fatty acid 
NADPH     Nicotinamide adenine dinucleotide phosphate oxidase, reduced form  
NFκB    Nuclear factor kappa B 
NK                Natural killer 
NKT            Natural killer T 
NLR           Nucleotide-binding oligomerization-domain protein-like receptor 
NLRP3        Nucleotide-binding oligomerization-domain protein-like receptor 
family pyrin domain containing 3 
NMN      Nicotinamide mononucleotide 
NOD           Nucleotide-binding oligomerization-domain protein 
NOS            Nitric oxide synthase 
NO           Nitric oxide 
NO3              Nitrogen  dioxide   
NPY      Neuropeptide Y 
nucDNA     Nuclear mitochondrial deoxyribonucleic acid 
O2             Molecular oxygen 
O2-          Superoxide anion 
Ob-R       Leptin receptor 
OH          Hydroxyl anion 
ONOO     Peroxynitrite 
OPN       Osteopontin 
PAM   Prematurely aging mice 
PAI-1      Plasminogen activator inhibitor 
PE     Phagocytic efficacy 
PECAM-1     Platelet endothelial cell adhesion-1 
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PGE2           Prostaglandin E2 
PHA            Phytohaemagglutinin 
PI      Phagocytic index 
PI3K      Phosphatidylinositol 3-kinase 
PMN           Polymorphonuclear leukocyte 
PND    Postnatal day 
POMC       Pro-opiomelanocortin 
PRPP     Phosphoribosyl pyrophosphate 
PUFA     Polyunsaturated fatty acid 
PWS   Prader-Willi syndrome 
R              Free radical species 
RBP4      Retinol-binding protein 4 
ROS         Reactive oxygen species 
RNS         Reactive nitrogen species 
RNA           Ribonucleic acid 
SFA      Saturated fatty acid 
SOD          Superoxide dismutase 
STAT-3    Activator of transcription 3 
SVF        Stroma-vascular fraction 
TCR           T-cell receptor 
Th              T helper   
TLR           Toll-like receptor 
TNF            Tumour necrosis factor 
UCP        Uncoupling protein 
VEGF     Vascular endothelial growth factor 
VLA-2    Very late antigen 2 
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WAT     White adipose tissue 
XO      Xanthine oxidase 
Zn             Zinc 
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